valid as of 12 april 2016 - НП "Здоровое...

Valid as of 12 April 2016

Coronary Interventions Interventions for Valvular Disease and Heart Failure Peripheral Interventions Interventions for Hypertension and Stroke

Coronary Interventions Interventions for Valvular Disease and Heart Failure Peripheral InterventionsInterventions for Hypertension and Stroke2

Tuesday 17 May 2016 - Afternoon - Programme valid as of 12-04-2016

- 12:00 -12:00 - 13:30

THEATRE BLEUFFR / iFR-guided PCI in patientswith multivessel diseaseChairpersons: P. L'Allier, K.G. OldroydPanellists: M. Balghith, G. Cassel, B. DeBruyne, H.C. Gwon, J. Tan (awaitingconfirmation), G. Tarantini

Attend this session if you want:To discuss similarities, differences andcontroversies of pertinent stablecoronary artery disease /revascularisation guidelinesTo identify key elements indecision-makingTo discuss management optimisationof stable multivessel disease patients

12:00 Session objectivesP. L'Allier

12:03 How physiology can impact clinicalmanagement and procedural strategyV. Farooq

12:10 Time to React@PCR12:17 Review of the tools to be used during the

LIVE demonstrationG. Tarantini (awaiting confirmation)

12:23 LIVE demonstration from InstitutCardiovasculaire Paris Sud - Massy,France

13:03 Time to React@PCR13:13 Which patient characteristics impact

management decisions?A. Banning

13:20 Time to React@PCR13:27 Session evaluation and key learnings

K.G. Oldroyd

12:00 - 13:30THEATRE

BORDEAUX

FocusInnovation

Hot Line

Update on BRSChairpersons: A. Al Nooryani, M. JonerPanellists: P. Capranzano, T. Gori, S.M.Hiremath, G. Musumeci, A. Serra(awaiting confirmation), A. Waqar

12:00 Two-year clinical, angiographic and serialOCT follow-up after implantation ofeverolimus-eluting BRS andeverolimus-eluting metallic stent: insightsfrom the randomised ABSORB Japan trialY. Onuma (awaiting confirmation)

12:08 Discussion and audience interaction12:13 Six-year follow-up of the first-in-man use of

a polylactide everolimus-eluting BRS forthe treatment of coronary stenosis: anassessment of FFR by multislice CTP.W. Serruys

12:21 Discussion and audience interaction12:26 Effect of DAPT termination at 12 months

on very late scaffold thrombosis in regularclinical practice: data of a regionalcollaboration including 868 patientsR.J. Van Geuns

12:34 Discussion and audience interaction12:39 Thirty-day results of the Italian diffuse /

multivessel disease ABSORB prospectiveregistry (IT-DISAPPEARS)A.S. Petronio

12:47 Discussion and audience interaction12:52 Clinical outcomes following coronary

revascularisation with theeverolimus-eluting BRS in patients withdiabetes: the ABSORB trial diabetic studyG.W. Stone

13:00 Discussion and audience interaction13:05 Thirty-day outcome of the Italian ABSORB

registry (RAI), a prospective registry ofconsecutive patients treated withbiovascular scaffoldB. Cortese

13:13 Discussion and audience interaction13:18 France ABSORB registry: in-hospital and

one-month results in 2,000 patientsR. Koning

13:26 Discussion and audience interaction




12:00 - 13:30THEATREHAVANE

TAVI in low-risk patientsChairpersons: P. MacCarthy, T. Walther(awaiting confirmation)Panellists: A.M. Al Abdullah, P.Boekstegers (awaiting confirmation), S.Saito, S. Von Bardeleben

Attend this session if you want:To understand the remaining shortfallsof TAVITo learn more about the maintechnological innovations developedto improve TAVI resultsTo understand who are the low-riskpatients with aortic stenosis

12:00 Session objectives P. MacCarthy

12:03 Which factors have made TAVI a valuableoption for low-risk patients? H. Treede


LIVE demonstration and patient selectionprocessS. Von Bardeleben

12:23 LIVE demonstration from HerzzentrumRostock - Rostock, Germany

13:03 Time to React@PCR13:13 What is required for TAVI to become the

new gold standardO. Wendler


T. Walther (awaiting confirmation)

12:00 - 13:30ROOM MAILLOT

FocusInnovation

Hot Line

Renal and peripheralinterventionsChairpersons: T.F. Lüscher, F. MahfoudPanellists: S. Ewen, F. Fanelli, B. Reimers(awaiting confirmation), C. Setacci

12:00 Dramatic change in quality of life forpatients undergoing percutaneousvascular interventions: a study from theBlue Cross Blue Shield of MichiganCardiovascular Consortium

12:08 Discussion and audience interaction12:13 New concepts of carotid artery stenting

with dual-layer micromesh stent system:30-day primary endpoint results in theCLEAR-ROAD trialM. Bosiers

12:21 Discussion and audience interaction12:26 Prospective evaluation of All-comer

peRcutaneous cArotiD revascularisation Insymptomatic and increased-riskasymptomatic carotid artery stenosis usingthe Micronet-covered embolic preventionstent system in 101 consecutive patients:PARADIGM-101P. Musialek (awaiting confirmation)

12:34 Discussion and audience interaction12:39 A randomised comparison between DEB

and conventional balloon angioplasty forlesions in the penile artery in patients witherectile dysfunction: the PERFECT-4 studyT.D. Wang

12:47 Discussion and audience interaction12:52 A novel endovascular debranching

technique using a thoracic bifurcation andvisceral manifold for repair ofthoracoabdominal aneurysmsP. Kelly

13:00 Discussion and audience interaction13:05 Simplicity denervation system for

pulmonary artery denervation in patientswith residual pulmonary hypertensionafter pulmonary thromboembolism andsurgical thrombendarterectomy(first-in-man study)B. Rudenko

13:13 Discussion and audience interaction13:18 Alcohol-mediated endovascular renal

denervation: the PEREGRINE studyW. Wojakowski





12:00 - 13:30ROOM

LEARNING

Learning bifurcation: T andprotrusion (TAP) techniqueFacilitators: B. Farah, D. Hildick-Smith, G.StankovicMedia Driver: E. Karacop (awaitingconfirmation)

Attend this session if you want:To understand what is the rightstrategy for each individual patient,taking into consideration specificanatomiesTo learn how to perform the T andprotrusion (TAP) technique step bystep:

- Planning: preprocedural aspects- Treating: procedural tools andtechniques- Preventing and managing: potentialprocedure-related complications

12:00 - 13:30ROOM TERNES 1

Cases

Left main PCI techniquesSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: P. StellaPanellists: S. Alkandari, G. Kumar, J.Legutko

12:00 A novel technique for PCI of isolated ostialcoronary stenosisA. Mechery

12:08 Discussion and audience interaction12:13 Kissing-balloon technique of left main

coronary artery using 5Fr catheter with0.014 inch wireY. Hada

12:21 Discussion and audience interaction12:26 KISS - keep it simple

E. Asher12:34 Discussion and audience interaction12:39 PCI of left main, circumflex and

intermediate artery: balloon anchoringwith T-stenting and small protrusionZ. Dimitriadis

12:47 Discussion and audience interaction12:52 Simplified two-stent crush technique in

left main bifurcationC.W. Khoo

13:00 Discussion and audience interaction13:05 Emergency angioplasty in multivessel

patient with chronic occlusion of the leftanterior descending artery and complexinjury of distal left main with thedouble-kissing crush techniqueL. Dallan

13:13 Discussion and audience interaction13:18 Left main bifurcation by culotte technique

in a haemodynamically unstable patientS. Gupta (awaiting confirmation)


12:00 - 13:30ROOM TERNES 2

Cases

Carotid stenting and acuteischaemic stroke interventionsSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: O. GoktekinPanellists: C. Bahuleyan, S. Kedev(awaiting confirmation), O. Ozdemir

12:00 Treating stroke patient with severebilateral carotid diseaseC. Christou (awaiting confirmation)

12:08 Discussion and audience interaction12:13 Large carotid artery dissection successfully

treated by a double-mesh new technologystent: an OCT-guided procedureR. Nerla

12:21 Discussion and audience interaction12:26 Carotid intramural haematoma as a cause

of stroke in a young womanC. Cigalini (awaiting confirmation)

12:34 Discussion and audience interaction12:39 Acute posterior stroke intervention

K. Chawla12:47 Discussion and audience interaction12:52 Endovascular repair of spontaneous

dissection of petrous part of internalcarotid artery in two casesM. Ostovan

13:00 Discussion and audience interaction13:05 Endovascular management of a patient

with ischaemic stroke in after cardiacsurgeryZ. Stankov

13:13 Discussion and audience interaction13:18 Hyperacute in-stent carotid thrombosis

after systemic recombinant tissueplasminogen activator (rtPA)administration in acute ischaemic strokesuccesfully treated with mechanicalrecanalisationP. Kurray





12:00 - 13:30ROOM 241

Abstracts

PCR's Got Talent - round 1:Cathlab tools, techniques andpharmacologySession comprising selected EuroPCR 2016abstract submissionsChairpersons: J.P. Collet, L. RäberJury Members: T. Adriaenssens, M. AlZaibag, A. Bartorelli, J. Belardi, M. Radu

12:00 Introduction12:02 Euro16A-OP0038 - OCT: influence of

contrast concentration on diagnosticcertaintyF. Blachutzik

12:06 Euro16A-OP0104 - Comparison ofadenosine vs. regadenoson for themeasurement of FFR: a meta-analysisI. Tanboga

12:10 Euro16A-OP0110 - Effect of preloadingwith high-dose of rosuvastatin in geneexpression and serum levels ofinflammatory markers after PCI withmetallic stentsJ. Slhessarenko

12:14 Euro16A-OP0156 - Antiscatter grid removalduring coronary angiography and PCI inlow body mass index patients: a simpleand safe technique for radiation dosereductionJ. Roy

12:18 Euro16A-OP0233 - Randomised studycomparing strategies to treat radial arteryspasm: the combat spasm trialC. Collet

12:22 Euro16A-OP0245 - Major infection aftercoronary bypass surgery and stenting inthe randomised SYNTAX trial: incidence,predictors and impact on five-yearmortalityR. Cavalcante

12:26 Euro16A-OP0392 - Systematic review ofnon-invasive CT-derived FFR studies: canwe use it to numerically predict invasiveFFR and plan our intervention virtually?C. Cook

12:30 Euro16A-OP0530 - Baseline coronary flowvaries with normal cardiac catheterlaboratory stimuliB.N. Modi

12:34 Euro16A-OP0621 - PCI at patients coronaryheart diseases with low ejection fraction ofleft ventricleH. Fozilov (awaiting confirmation)

12:38 Euro16A-OP0718 - Imaging andphysiology-guided PCI without contrastadministration in advanced renal failure: afeasibility, safety and outcome studyA. Ziad

12:42 Euro16A-OP0819 - Physiological severity ofcoronary artery stenosis depends on theamount of myocardial mass subtended bythe coronary arteryJ.H. Choi

12:46 Euro16A-OP0843 - Geographical missphenomenon: device motion indicator, anew insight into an angiographic curiosityR. Abu Fanne

12:50 Euro16A-OP0870 - Long-term follow-up ofpatients evaluated with FFR: the LA SPEZIAregistryM. Arena

12:54 Euro16A-OP1071 - OCT evaluation of thevascular responses of thepolylactide-based, novolimus-eluting BRSfrom implantation to three years: insightsfrom the DESolve NX trialD. Chamié (awaiting confirmation)

12:58 Euro16A-OP0805 - Mental stress inducedmyocardial ischaemiaS. Arri

13:02 Euro16A-OP0821 - Comparison ofmyocardial mass subtended by mainvessel and side: allometric scaling analysisof fractional myocardial mass subtendedby 5,860 coronary arteriesJ.H. Choi

13:06 Euro16A-OP0292 - Impact of proton pumpinhibitors on clinical outcomes in patientstreated with a six-month or 24-monthDAPT duration: insights from the PRODIGYtrialF. Costa

13:10 Euro16A-OP0224 - Crossover rates intransradial catheterisation: are they reallyhigh?C. Christou (awaiting confirmation)

13:13 Deliberation13:18 Announcement of presentations selected

for round 2

12:00 - 13:30ROOM 242AB

Focus TheEssentials for

YoungPractitioners

The Essentialsfor Young

Practitioners

A STEMI patient approachingand I am on call: a practice guideto primary PCI in 2016Senior Advisor: S.B. King IIIFacilitators: N. Amabile, S. Brugaletta, O.Sukhorukov

Attend this session if you want:To re-appraise your strategy andtechnique in view of new evidences inthe fieldTo agree and... disagree oncontroversial topics (e.g. thrombusaspiration, immediate completerevascularisation in multivesseldisease)To take home an update on modernantithrombotic strategies in differentclinical scenarios




12:00 - 13:30ROOM 243

Plenary

What's new in hypertension? Anupdate for interventionistsWith the collaboration of the Practical Course onHypertension (PCH)Facilitators: A. Pathak, K. TsioufisPanellists: R. Schmieder, C. Ukena(awaiting confirmation), S. Worthley, T.Zeller

Attend this session if you want:To be updated on new studies andrecently published data which willchange your clinical practiceTo discuss current interventional andnon-interventional treatmentstrategies for hypertensive patients atriskTo actively share your experience andget answers to your burning questions

12:00 Session objectives and audience pollK. Tsioufis

12:05 Changing landscape: impact of newstudies in hypertension (e.g. SPRINT,PATHWAY) on my clinical practiceR. Schmieder

12:15 Discussion and audience interaction12:25 Renal denervation for hypertension

treatment: what has happened in 2015 andwhere to go next?K. Tsioufis

12:35 Discussion and audience interaction12:45 Innovations in catheter design

H. Sievert12:55 Discussion and audience interaction13:05 Extrarenal intervention for hypertension

treatment (carotid bulb restoration,arteriovenous fistula...)C. Ukena (awaiting confirmation)

13:15 Discussion and audience interaction13:25 Key learnings and session evaluation

A. Pathak

12:00 - 13:30ROOM 243

Cases

Endovascular management forcalcified lesionSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: M. BrodmannPanellists: H. Khamis, M. Manzi (awaitingconfirmation), E. Vuruskan

12:00 Heavily calcified occlusion of posteriortibial artery in patient affected by criticallimb ischaemia: a stepwise approachP. Sbarzaglia

12:08 Discussion and audience interaction12:13 Angioplasty of anterior dominant peroneal

artery through transcollateral approach insecond metatarsus ostheomyelitisP. Sbarzaglia

12:21 Discussion and audience interaction12:26 The efficiency of debulking calcified lesion

with refractory of balloon expansion byusing debulking device under angioscopein critical limb ischaemia patient withhaemodialysisH. Uehara

12:34 Discussion and audience interaction12:39 Endovascular treatment for

femoropopliteal arterial lesions with ano-stent zoneY. Yanagita

12:47 Discussion and audience interaction12:52 The role of hybrid surgery in the treatment

of critical limb ischaemiaM.P. Borrelli (awaiting confirmation)

13:00 Discussion and audience interaction13:05 Unusual cause of critical limb ischaemia

S.T. Rab13:13 Discussion and audience interaction13:18 Successful angioplasty to chronic total

occluded popliteal artery in a patient withthromboangitis obliteransF. Kacmaz





12:00 - 13:30ROOM 251

Cases

Complex lesions in ACS settingSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: K. NiemelaPanellists: M.A.K. Akanda, P. Barlis, H.C.Lee

12:00 Single stage complete coronaryrevascularisation in a post-CABG patientpresenting with ACSH.K. Bali (awaiting confirmation)

12:08 Discussion and audience interaction12:13 Use of drug-eluting ballon in de novo

lesionsS. Athukorala (awaiting confirmation)

12:21 Discussion and audience interaction12:26 Complex bifurcation PCI post-TAVI: specific

issues to deal withL. Janssens

12:34 Discussion and audience interaction12:39 V-stenting in critical bifurcation lesion

S. Banerjee12:47 Discussion and audience interaction12:52 Single inflation dilation in main and side

branchS. Banerjee

13:00 Discussion and audience interaction13:05 Make the angioplasty complex for more

safety...A. Abdelmalek

13:13 Discussion and audience interaction13:18 Two bifurcation techniques, same patient,

same settingA. El Amrawy


12:00 - 13:30ROOM 252AB

Plenary

CVIT@EuroPCR - learning frombailout cases in complex PCIWith the collaboration of the Japanese Associationof Cardiovascular Intervention and Therapeutics(CVIT)Chairpersons: G. Guagliumi, M.NakamuraPanellists: E. Eeckhout, H. Eteiba, K.Kadota, T. Ueno (awaiting confirmation)

Attend this session if you want:To discuss unexpected complicationsduring PCITo review useful bailout techniqueswhen facing complex complicationsTo share tips and tricks in order toprevent or correct complications

12:00 EuroPCR welcomes CVITG. Guagliumi

12:02 Session objectivesM. Nakamura

12:05 Complications and bailout techniques incomplex PCIT.K. Kawasaki

12:13 Discussion and audience interaction12:25 Role of physiology to understand the

pathophysiology in complex PCIN.H. Pijls

12:33 Discussion and audience interaction12:45 Tips and tricks for bailout from complex

complicationS. Sumitsuji

12:53 Discussion and audience interaction13:05 Importance of imaging to demonstrate the

pathophysiology in complex PCIP. Motreff (awaiting confirmation)

13:13 Discussion and audience interaction13:25 Session evaluation and key learnings

G. Guagliumi




12:00 - 13:30ROOM 253

All you need to know about BRSChairpersons: M. Haude, N.E.J. West

Attend this session if you want:To review a comprehensive andclinically relevant update on this fieldTo identify the current evidence baseand existing guidelinesTo recognise the open questions thatneed addressing in the near future

12:00 Session objectivesM. Haude

12:05 Background: current technologyH. Nef

12:18 Discussion and audience interaction12:25 Clinical results

J. Byrne12:38 Discussion and audience interaction12:45 Recommendations: implantation

techniqueJ. Wykrzykowska

12:58 Discussion and audience interaction13:05 Unresolved issues and outlook: the next

generationA. Abizaid


N.E.J. West

12:00 - 13:30ROOM 341

Cases

Balloon aortic valvuloplasty as aforgotten therapySession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: A. CribierPanellists: R. Bhindi, S. Selvamani, R.Trillo Nouche

12:00 Balloon aortic valvuloplasty as a forgottentherapyF. Safi

12:09 Discussion and audience interaction12:15 Concurrent antegrade transseptal mitral

and aortic Inoue balloon valvuloplasty inan octogenarian with rheumatic heartdisease and pulmonary oedemaY. Chang

12:24 Discussion and audience interaction12:30 Usefulness of intracardiac

echocardiography during balloon aorticvalvuloplastyK. Meguro

12:39 Discussion and audience interaction12:45 Combined aortic valvuloplasty and alcohol

septal ablation in high-risk patient asbridge to transcatheter aortic valvereplacementF. Leite Vincenti (awaiting confirmation)

12:54 Discussion and audience interaction13:00 Balloon dilatation of the aortic valve in a

pregnant patient with severe rheumaticaortic valve stenosisF. Maatouk

13:09 Discussion and audience interaction13:15 Bailout TAVI: a successful case of

emergency TAVI in massive aorticregurgitation after balloon aorticvalvuloplastyP. Gatto (awaiting confirmation)





12:00 - 13:30ROOM 342A

Plenary

Difficult decisions in STEMIpatients with cardiogenic shockChairpersons: M. Noc, H. ThielePanellists: D. Dudek, P.J.L. Ong

Attend this session if you want:To learn optimal primary PCI strategyin STEMI with cardiogenic shockTo assess options for haemodynamicsupport beyond intra-aortic balloonpumpingTo discuss how to deal withmechanical complications in STEMI

12:00 Session objectivesM. Noc

12:05 Case 1: STEMI, cardiogenic shock andmultivessel disease - going beyond PCI ofculprit lesion?M. Behan

12:13 Discussion and audience interaction12:25 Case 2: extracorporeal membrane

oxygenation or / and percutaneousmechanical circulatory support as firstchoice or only after failed intra-aorticballoon pumping?C. Spaulding

12:33 Discussion and audience interaction12:45 Case 3: post-infarction ventricular septal

ruptureG. Pedrazzini

12:53 Discussion and audience interaction13:05 Case 4: acute mitral insufficiency

M. Bilge (awaiting confirmation)13:13 Discussion and audience interaction13:25 Session evaluation and key learnings

H. Thiele

12:00 - 13:30ROOM 342B

Cases

Coronary perforations: bailoutstrategies - part 2Session comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: V. SchächingerPanellists: M. Ashraf Al Anie (awaitingconfirmation), M. Loutfi, I. Ungi (awaitingconfirmation)

12:00 Patients should keep their fatL. Nait Saidi

12:08 Discussion and audience interaction12:13 Type III coronary perforation - a hole in

your planI. Dregoesc

12:21 Discussion and audience interaction12:26 Elective PCI complicated by coronary

rupture and pericardial tamponadeC. Galvão Braga

12:34 Discussion and audience interaction12:39 The enemy of perfection might be a

perforationH. Abu-Hantash

12:47 Discussion and audience interaction12:52 Massive coronary artery perforation: a

second rescue catheter can save lifeK. Bejar

13:00 Discussion and audience interaction13:05 OCT follow-up of a patient with coronary

artery perforation during elective PCI andfive layers of stent in the left anteriordescending arteryC. McQuillan

13:13 Discussion and audience interaction13:18 A clinical case of complication performing

hybrid culotteJ. Chavarria





12:00 - 13:30ROOM 343

Abstracts

Importance of coronary anatomyin risk stratificationSession comprising selected EuroPCR 2016abstract submissionsChairperson: D. WagnerPanellists: V. Kumar (awaitingconfirmation), S. Munwar, H. Warda

12:00 Euro16A-OP0825 - Prevalence, pattern andmanagement of myocardial brides among4,288 patients undergoing coronaryangiography at a tertiary care centre:ACE-BRIDGE studyD.S. Bisht

12:08 Discussion and audience interaction12:15 Euro16A-OP1040 - Coronary anatomy and

complications during PCI: predict toprevent!J. Ribeiro

12:23 Discussion and audience interaction12:30 Euro16A-OP0539 - Does coronary artery

dominance predict the outcome incoronary artery disease?S. Devadathan

12:38 Discussion and audience interaction12:43 Euro16A-OP0331 - Coronary artery

dominance in Bangladeshi populationM. Kalimuddin

12:51 Discussion and audience interaction12:58 Euro16A-OP0676 - Usefulness of a novel

technique to quantify the extension ofcoronary artery disease and percentage ofmyocardium at risk of ischaemia:HemotoolM. Garcia-Guimaraes

13:06 Discussion and audience interaction13:13 Euro16A-OP0277 - Severe calcifications in

target lesions of patients with acutemyocardial infarction undergoing PCIpredict adverse cardiac events inlong-term follow-upW. Zimoch


12:00 - 13:30ROOM 351

Abstracts

Transcatheter mitralinterventions: from sizing toclinical outcomeSession comprising selected EuroPCR 2016abstract submissionsChairperson: F. MaisanoPanellists: N. Dumonteil, G. Manoharan,H. Moellmann

12:00 Euro16A-OP0910 - Annular sizing fortranscatheter mitral valve replacementM. Abdelghani

12:08 Discussion and audience interaction12:13 Euro16A-OP0138 - One-year follow-up

results of mitral valve reconstructionsystem multicentre trialG. Nickenig

12:21 Discussion and audience interaction12:26 Euro16A-OP0705 - Transcatheter mitral

valve replacement for severe mitralregurgitation: the TENDYNE earlyfeasibility trialD. Muller

12:34 Discussion and audience interaction12:39 Euro16A-OP0570 - Combined results on

safety and efficacy of two prospective,multicentre trials for the treatment offunctional mitral regurgitation bypercutaneous annuloplastyS. Goldberg

12:47 Discussion and audience interaction12:52 Euro16A-OP1083 - Direct access

transcatheter mitral repair with asutureless neochordal device: preclinicalexperienceA. Weber

13:00 Discussion and audience interaction13:05 Euro16A-OP0260 - The EVEREST II REALISM

continued access study: one-yearoutcomes in patients with degenerativemitral regurgitation reported by baselineNew York Heart Association functionalclassS. Kar (awaiting confirmation)

13:13 Discussion and audience interaction13:18 Euro16A-OP0950 - Results of the

multicentre (Phase II) mitral valve repairclinical trial (MAVERIC trial) for thetreatment secondary mitral regurgitationin chronic heart failureA. Erglis





12:00 - 13:30ROOM 352A

How Should ITreat?

Finland and Norway share theirmost educational cases:anticoagulated patientsundergoing PCIWith the collaboration of the Working Group onInterventional Cardiology of the Finnish Society ofCardiology and the Working Group ofInterventional Cardiology of the NorwegianSociety of CardiologyChairpersons: C. Eek, E. Ilveskoski

Attend this session if you want:To understand both periproceduraland long-term problems associatedwith PCI in anticoagulated patientTo discuss different stent options inanticoagulated patients

12:00 Session objectivesE. Ilveskoski

12:05 Case 1: atrial fibrillation patient on directoral anticoagulant and gastrointestinalbleeding undergoing primary PCI forSTEMIT. Kiviniemi

12:10 How would I treat the case?T. Trovik

12:15 How would I treat the case?T. Rissanen

12:20 How did I treat the case?T. Kiviniemi

12:30 Discussion and audience interaction12:40 Consensus

C. Eek12:45 Case 2: acute stent-thrombosis and

simultaneous bleedingB. Bendz (awaiting confirmation)

12:50 How would I treat the case?T. Rissanen

12:55 How would I treat the case?T. Trovik

13:00 How did I treat the case?B. Bendz (awaiting confirmation)


E. Ilveskoski13:25 Session evaluation and key learnings

C. Eek

12:00 - 13:30ROOM 352B

Complications

Argentina and France share theirmost educational cases: TAVIprocedure complicationsWith the collaboration of the Argentinian Collegeof Interventional Cardioangiologists (CACI) andthe Atheroma Coronary and InterventionalCardiology Group of the French Society ofCardiology (GACI)Chairpersons: A. Cherro, J. Monsegu

Attend this session if you want:To understand and identify acutecomplication during TAVI procedureTo learn how to prevent TAVIcomplicationsTo share experiences on TAVIprocedures management

12:00 Session objectivesJ. Monsegu

12:03 Case 1: valve-in-valve in a patient withhigh-risk of left main occlusion during theprocedure: safety measuresJ. Leguizmaon (awaiting confirmation)

12:09 Discussion and audience interaction12:17 Case 2: SAPIEN XT balloon rupture during

inflationB. Faurie

12:23 Discussion and audience interaction12:31 Case 3: valve embolisation during TAVI

J. Vicario12:37 Discussion and audience interaction12:45 Case 4: bailout of an EDWARDS SAPIEN 3

prosthesis through an expandable sheathH. Benamer

12:51 Discussion and audience interaction12:59 Case 5: paravalvular leak after

transcatheter aortic bicuspid and heavycalcified valve replacementA. Alvarez Iorio

13:05 Discussion and audience interaction13:13 Case 6: left main occlusion during

transfemoral TAVI using an EDWARDSSAPIEN 3 prosthesisC. Tron


A. Cherro




12:00 - 13:30ROOM 353

Abstracts

Bifurcation PCI: fate of the sidebranchSession comprising selected EuroPCR 2016abstract submissionsChairperson: J. OrmistonPanellists: W.H. Ahmed, A. Chopra(awaiting confirmation), S. Garg

12:00 Euro16A-OP0472 - An angiographic toolbased on visual estimation for riskprediction of side-branch occlusion incoronary bifurcation intervention: theV-RESOLVE score systemK. Dou

12:08 Discussion and audience interaction12:13 Euro16A-OP0619 - Provisional stent

technique in coronary bifurcation lesions:predictors and outcomes of side-branchocclusionA. Jurado-Roman

12:21 Discussion and audience interaction12:26 Euro16A-OP0505 - How carina angle

impact the fate of side branch after mainvessel stenting in coronary bifurcationintervention: analysis from a consecutivecohort of 1,200 bifurcation lesionsD. Zhang

12:34 Discussion and audience interaction12:39 Euro16A-OP0667 - CR12 registry:

side-branch strut opening after mainvessel stenting in provisional stenttechniqueA. Jurado-Roman

12:47 Discussion and audience interaction12:52 Euro16A-OP0794 - Single-string technique

for stenting of complex coronarybifurcation stenosesG. Toth

13:00 Discussion and audience interaction13:05 Euro16A-OP0693 - Modified jailed balloon

technique: a novel technique to avoidside-branch occlusion regarding with PCIfor bifurcation lesionsK. Shishido

13:13 Discussion and audience interaction13:18 Euro16A-OP0810 - Feasibility and efficacy

of side-branch dilation using the dedicatedballoon combined with proximaloptimisation after cross-over stenting inthe coronary bifurcation lesionY. Murasato


12:00 - 13:30ROOM

ARLEQUIN

Cases

Anomalous coronary arteriesand ACSSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: P. KalaPanellists: M. Babu (awaitingconfirmation), F. Begum, K. Toutouzas

12:00 An anomalous STEMIG. Sacchetta

12:08 Discussion and audience interaction12:13 Primary PCI in a patient with

a single coronary artery arising fromthe right sinus of valsalvaM. Boukhris

12:21 Discussion and audience interaction12:26 A challenging PCI in an anomalous right

coronary artery from left coronary sinus: ahardware fiesta!L.H. Shetty (awaiting confirmation)

12:34 Discussion and audience interaction12:39 Single right coronary artery occlusion,

thrombus aspirationI. Tsiafoutis

12:47 Discussion and audience interaction12:52 Paroxysmal supraventricular tachycardia

and recurrent ACS in a young lady: anunusual causeW. Alshamkhani

13:00 Discussion and audience interaction13:05 Bifurcation stenting of left anterior

descending, right coronary artery - story ofanomalous right coronaryH.K. Bali (awaiting confirmation)

13:13 Discussion and audience interaction13:18 Multivessel PCI transradial approach in

dextrocardiaD. Kaewkes





- 13:00 -13:45 - 15:15

THEATRE BLEUPCI of complex bifurcationlesion: when and why two stentsare neededChairpersons: T.H. Koh, G. StankovicPanellists: A. Bartorelli, M. Costa(awaiting confirmation), J.M. De La TorreHernandez, R. De Palma, D. Tresukosol, C.Zambakides

Attend this session if you want:To understand current indications andchoices for two-stent techniquesTo learn about procedural steps in thetreatment of complex bifurcationTo review the potential role ofadjunctive tools

13:45 Session objectivesG. Stankovic

13:48 Which bifurcation lesions require anupfront two-stent technique?A. Chieffo

13:55 Time to React@PCR14:02 Review of the technique to be used during

the LIVE demonstrationR. De Palma


14:48 Time to React@PCR14:58 Which technique: main vessel first or side

branch first?G. Stankovic


T.H. Koh

13:45 - 15:15THEATRE

BORDEAUX

FocusInnovation

Hot Line

Advances in treatment of ACSChairpersons: S. James, M. RoffiPanellists: P. Genereux, S. Jolly (awaitingconfirmation), L. Räber, M. Radu, L.Tokgozoglu (awaiting confirmation), C.Von Birgelen

13:45 Contemporary trends and outcomesassociated with the preprocedural use oforal P2Y12 inhibitors in patientsundergoing PCID. Sukul

13:55 Discussion and audience interaction14:00 Safety of a regional standardised protocol

to optimise the use of most effectiveplatelet inhibition in ACS treated with PCI:final results from the Dutch, multicentreand Observational Rijnmond CollectiveCardiology Research (CCR) studyR.J. Van Geuns

14:10 Discussion and audience interaction14:15 Assessment of the plaque characteristics

by OCT in patients presenting with ACS:insights from the OCT-FORMIDABLEregistryC. Moretti (awaiting confirmation)

14:25 Discussion and audience interaction14:30 18-month clinical follow-up of the BRS

STEMI FIRST studyR. Diletti

14:40 Discussion and audience interaction14:45 Long-term follow-up after BRS

implantation in STEMI patients -PRAGUE-19 study updateV. Kocka

14:55 Discussion and audience interaction15:00 Safety and efficacy of biodegradable

polymer DES in management of patientswith acute STEMI: MASTER study - one-yearclinical outcomesM. Valdés Chávarri






Transcatheter aorticvalve-in-valve implantationChairpersons: T. Modine, G. NickenigPanellists: J. Byrne, P.H.L. Kao, C. Ruiz(awaiting confirmation), P. Wenaweser

Attend this session if you want:To receive an update on the clinicalevidence for aortic valve-in-valveproceduresTo understand the important steps inpreprocedural planning of an aorticvalve-in-valve procedureTo observe a step-by-step approach toaortic valve-in-valve implantation

13:45 Session objectivesG. Nickenig

13:48 Bioprothetic valve failure: mechanisms andtreatment optionsV. Bapat


LIVE demonstrationP. Wenaweser

14:08 LIVE demonstration from Rabin MedicalCentre - Petah Tikva, Israel

14:48 Time to React@PCR14:58 Valve-in-valve TAVI is not always the right

option: a note of cautionT. Modine


T. Modine


FocusInnovation

Hot Line

First-in-man and DES trialsChairpersons: E. Edelman, M. JonerPanellists: H.M. Garcia-Garcia, T. Kimura,P. L'Allier, F.J. Neumann

13:45 Fantom sirolimus-eluting BRSJ. Anderson (awaiting confirmation)

13:54 Discussion and audience interaction13:58 Safety and clinical performance of the

drug-eluting absorbable metal scaffold inthe treatment of subjects with de novolesions in native coronary arteries at12-month follow-up BIOSOLVE-IIM. Haude

14:07 Discussion and audience interaction14:11 One-year results of first-in-man trial

randomising the sirolimus-elutingpolylactide scaffold and theeverolimus-eluting polylactide scaffoldY. Onuma (awaiting confirmation)

14:20 Discussion and audience interaction14:24 Primary endpoint results from the NIREUS

trial. A prospective randomised trialcomparing the novel ridaforolimus-elutingBioNIR stent to the zotarolimus-elutingResolute stentP. Smits

14:33 Discussion and audience interaction14:37 In-vivo healing response to bioresorbable,

abluminal polymer everolimus-elutingstents vs. durable, conformal polymerzotarolimus-eluting stents.TRANSFORM-OCT trialG. Guagliumi

14:46 Discussion and audience interaction14:50 Angiographic outcomes of orsiro

biodegradable polymer sirolimus-elutingstents and resolute integrity durablepolymer zotarolimus-eluting stents: resultsof ORIENT trialS.H. Kang

14:59 Discussion and audience interaction15:03 Nine-month clinical and angiographic

outcomes after coronary stenting of smallvessels in Japanese population using2.25mm diameter sirolimus-eluting stentwith bioresorbable polymer: CENTURY JSVstudy - primary endpointS. Saito


13:45 - 15:15ROOM

LEARNING

Learning radial access forcomplex interventionsFacilitators: H. Amin, S. Kedev, J.Monsegu

Attend this session if you want:To better assess radial access forcomplex interventions, including:bypass, complex bifurcation, left main,CTO, acute myocardial infarction




13:45 - 15:15ROOM TERNES 1

Cases

Left main PCI: is it still a place forIVUS?Session comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: K. Al-Shaibi (awaitingconfirmation)Panellists: A. Erglis, O. Sakhov, P. Singh(awaiting confirmation)

13:45 Selection of left main stem stent size andlength based on IVUS angiographyco-registrationN. Ryan

13:53 Discussion and audience interaction13:58 Two catheters and two wires

C.W. Khoo14:06 Discussion and audience interaction14:11 Old technique - new DES: IVUS-guided

culotte stenting with new generation DESfor a complex bifurcational lesionA. Menozzi

14:19 Discussion and audience interaction14:24 IVUS-supported left main bifurcation

stenting by mini-crush techniqueR. Vijayvergiya

14:32 Discussion and audience interaction14:37 Identification and management of

longitudinal stent distortion in the leftmain stemN. Ryan

14:45 Discussion and audience interaction14:50 Left main coronary artery stent retrieval

T. Snow14:58 Discussion and audience interaction15:03 Young female with Takayasu arteritis and

atypical chest painR. Garcia-Borbolla Fernández (awaitingconfirmation)


13:45 - 15:15ROOM TERNES 2

Cases

Complex aortoiliac angioplastySession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: Z. KrajcerPanellists: O. Al Shammeri, M.S. Mourali,H. Reinecke

13:45 Endovascular therapy of chroniccomplicated abdominal aorta dissection ina patient with aortoiliac carrefour occlusivediseaseR. Padalino (awaiting confirmation)

13:53 Discussion and audience interaction13:58 Thrombosuction and balloon angioplasty

of acute abdominal aorta occlusionS. Gupta (awaiting confirmation)

14:06 Discussion and audience interaction14:11 A pitfall of endovascular treatment for

Leriche syndromeY. Kaetsu

14:19 Discussion and audience interaction14:24 Aortic CTO

Q. Labarre14:32 Discussion and audience interaction14:37 Is it safe to puncture abdominal aorta with

a re-entry catheter?E. Vuruskan

14:45 Discussion and audience interaction14:50 Should we consider endovascular therapy

for internal iliac lesion as well as commonand external iliac lesion?T. Suzuki (awaiting confirmation)

14:58 Discussion and audience interaction15:03 Bifemoral approach with use of snare

catheter in iliac CTOB. Teymen





13:45 - 15:15ROOM 241

Abstracts

PCR's Got Talent - round 1: TAVI -part 1Session comprising selected EuroPCR 2016abstract submissionsChairpersons: A. Cribier (awaitingconfirmation), N. PiazzaJury Members: J. Bartunek, H.Baumgartner (awaiting confirmation), N.Dumonteil, A.P. Kappetein, F. Maisano,M. Monaghan

13:45 Introduction13:47 Euro16A-OP0041 - Impact of new cerebral

ischaemic lesions on the occurrence ofdelirium after TAVIM. Abawi

13:51 Euro16A-OP0064 - Reduced need forpermanent pacemaker rates followingLOTUS device implantation fortranscatheter aortic valve replacement dueto modified implantation protocolB. Kherad (awaiting confirmation)

13:55 Euro16A-OP0166 - Sheathless use of a newtranscatheter aortic valve system incomplex vascular access sitesF. Scalise

13:59 Euro16A-OP0844 - Impact of permanentpacemaker on mortality after TAVI: thePRAGMATIC (Pooled Rotterdam - Milan -Toulouse in Collaboration) pacemakersubstudyR. Van Der Boon

14:03 Euro16A-OP0197 - The effect of TAVI oncognition: a prospective pilot studyR. de Vries

14:07 Euro16A-OP0167 - A new percutaneoustechnique for effective vascular access siteclosure in patients receiving transfemoralTAVI and thoraco abdominal aorticaneurysm repairF. Scalise

14:11 Euro16A-OP0227 - Electrocardiogrampredictors of permanentpacemaker-dependency following TAVI ina real-world cohortT. Tichelbäcker

14:15 Euro16A-OP0249 - Angiographicclassification of access-site andaccess-related vascular injury (ASARVI) -stratifying TAVI-associated complicationsbeyond VARC-IIA. Sedaghat

14:19 Euro16A-OP0470 - Occurrence ofnew-onset intraventricular conductiondelays after TAVI with new-generationvalvesC. Panico

14:23 Euro16A-OP0535 - Single-centreevaluation of a next generation fullyrepositionable and retrievabletranscatheter aortic valveM. Götberg

14:27 Euro16A-OP0552 - A single-centreexperience of using internal endoconduitfor unfavorable iliac artery anatomy inpatients undergoing TAVI fromtransfemoral approachW.H. Yin

14:31 Euro16A-OP0657 - Transcatheter aorticvalve-in-valve implantation using Lotusvalve system for failed surgicalbioprostheses: the early Italian experienceR. Nerla

14:35 Euro16A-OP0793 - Transfemoral TAVIinduces common femoral artery shrinkageO. Shoeib (awaiting confirmation)

14:39 Euro16A-OP0873 - Transcathetervalve-in-valve implantation using thePortico system: a multicentre registryL. Testa

14:43 Euro16A-OP0983 - Incidence, predictorsand clinical outcomes: who is going toneed a permanent pacemaker followingTAVI? The multicentre TAVI Brazilianregistry revisited Di Leoni Ferrari

14:47 Euro16A-OP1068 - Treatment of severeaortic stenosis with a new generationrecapturable and repositionableself-expanding transcatheter aortic valvesystem: a single-centre experience ofconsecutive patientsN. Perrin

14:51 Euro16A-OP1072 - Second-generationpercutaneous TAVI: single-centreexperience comparing outcomes of aself-expanding valve system with apreloaded stent-mounted valveS. Khogali (awaiting confirmation)

14:55 Euro16A-OP0190 - Outcomes of re-dotranscatheter aortic valve replacement forthe treatment of post-procedural and latetranscatheter valve failureM. Barbanti


for round 2

13:45 - 15:15ROOM 242AB


YoungPractitioners


Practitioners

From smoke to explosion: acoronary perforation clinicSenior Advisor: S. El TobgiFacilitators: J. Adjedj, R. Didier, N. VanMieghem

Attend this session if you want:To learn how to prevent coronaryperforationTo discuss how to manage coronaryperforationsTo share what you have learnt fromyour most frightening nightmareexperiences with your peers




13:45 - 15:15ROOM 243

Cases

Peripheral complicationmanagementSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: M. BosiersPanellists: I. Alhaddad, F. Fanelli, H.Khamis

13:45 Percutaneous closure of a giant ascendingaortic pseudoaneurysm leakM. Vanegas

13:53 Discussion and audience interaction13:58 Too much pressure?

A. Bucsa14:06 Discussion and audience interaction14:11 A nightmare after subclavian artery

interventionW.C. Huang

14:19 Discussion and audience interaction14:24 Successful catheter intervention for

retroperitoneal bleeding due to renalartery aneurysm ruptureK. Komiyama

14:32 Discussion and audience interaction14:37 Strategic management of perforation and

rupture of external iliac artery induced byinfrarenal aortic aneurysm endovascularrepairR.K. Premchand

14:45 Discussion and audience interaction14:50 Multilayer flow modulator device for

thoracoabdominal aneurysm complicatedby iliac artery avulsionR.K. Premchand

14:58 Discussion and audience interaction15:03 Endograft limb occlusion after

endovascular aortic repairR. Vijayvergiya


13:45 - 15:15ROOM 251

Focus Nursesand Allied

Professionals

Plenary

Challenges in complex PCI - therole of nurses and alliedprofessionals Facilitators: S. Carson, R. Esteves, H.FaltotMedia Driver: D. Zughaft

Attend this session if you want:To understand patient selection andpreparationTo gain confidence to assist duringcomplex PCITo improve patient outcome duringand after complex PCI

13:45 Introduction of the Nurses and AlliedProfessionals Programme at EuroPCRW. Wijns

13:50 Session objectivesR. Esteves

13:52 Case 1 - CTOR. Esteves

14:17 Discussion and audience interaction14:32 Case 2 - rotablator

S. Carson14:57 Discussion and audience interaction15:12 Session evaluation and key learnings

H. Faltot




13:45 - 15:15ROOM 252AB

Plenary

AICT and APSIC@EuroPCR - themost educational cases fromAsia-Pacific With the collaboration of the Asian InterventionalCardiovascular Therapeutics (AICT) and the AsianPacific Society of Interventional Cardiology (APSIC)Chairpersons: C.K. Naber, H.C. TanPanellists: R. Gao, U. Kaul, I. Meredith, S.J.Park

Attend this session if you want:To discuss some of the mostchallenging and educational casesperformed in the Asia-Pacific region To discover some interventionaltechniques from the Asia-Pacific regionTo understand the East-Westcommonalities and divides inintervention

13:45 EuroPCR welcomes AICT and APSICC.K. Naber

13:47 Session objectivesH.C. Tan

13:50 A memorable TAVI caseI. Meredith

13:58 Discussion and audience interaction14:10 A memorable left main PCI case

W. Udayachalerm14:18 Discussion and audience interaction14:30 A memorable CTO PCI case

S. Sumitsuji14:38 Discussion and audience interaction14:50 A memorable bifurcation PCI case

S.L. Chen (awaiting confirmation)14:58 Discussion and audience interaction15:10 Session evaluation and key learnings

H.C. Tan

13:45 - 15:15ROOM 253

All you need to know aboutSTEMI and multivessel diseaseChairpersons: M. Behan, D. Dudek


13:45 Session objectivesD. Dudek

13:50 Background: clinical scenarios andproblems in clinical practiceM. Behan

14:03 Discussion and audience interaction14:10 Clinical trials on STEMI with bystander

diseaseK.G. Oldroyd

14:23 Discussion and audience interaction14:30 Guidelines and recommendations - up to

date?G. Ducrocq

14:43 Discussion and audience interaction14:50 Unresolved issues and outlook - when and

how to stage?G. Mikhail (awaiting confirmation)


M. Behan




13:45 - 15:15ROOM 341

Cases

TAVI, tips and tricksSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: U. GerckensPanellists: J. Elias, G. Sorropago(awaiting confirmation)

13:45 Bicuspid aortic valve stenosis andhorizontal aorta-challenging anatomytreated with second-generation TAVIdeviceS. Khogali (awaiting confirmation)

13:53 Discussion and audience interaction13:58 Low-flow low-gradient aortic stenosis:

selecting the right strategy to keep theTAVI procedure safeV. Esteves

14:06 Discussion and audience interaction14:11 Gradient optimisation by intraprocedural

dilatation of a non-metallic repositionableTAVI deviceF. De Marco

14:19 Discussion and audience interaction14:24 A case of TAVI in a patient with a previous

mitral bioprosthesis protruding in theoutflow tractJ. Kefer

14:32 Discussion and audience interaction14:37 TAVI in challenging anatomy with

new-generation valveN.H.V. Luk

14:45 Discussion and audience interaction14:50 Challenging TAVI with a mechanically

expanding heart valve in a patient withprimary aortic regurgitation andcongenital scoliosisL. van Gils

14:58 Discussion and audience interaction15:03 Contralateral sliding balloon technique to

facilitate sheath advancement across acalcified aortic plaque during transfemoralTAVIA. Allali


13:45 - 15:15ROOM 342B

Plenary

Key practical issues forantithrombotics in coronaryinterventionsChairpersons: T. Cuisset, M. ValgimigliPanellists: A. Bellemain-Appaix (awaitingconfirmation), P. Urban

Attend this session if you want:To review recent evidence onantithrombotics in coronaryinterventionsTo discuss how to integrate scientificdata into clinical decisionsTo reflect on how to individualisetreatment for each patient

13:45 Session objectivesM. Valgimigli

13:50 Timing for initiation of P2Y12 blockers incoronary interventionsR. Byrne

14:03 Discussion and audience interaction14:10 Management of patients with oral

anticoagulation undergoing PCIJ. Mehilli

14:23 Discussion and audience interaction14:30 Duration of DAPT duration after coronary

interventionsG. Cayla

14:43 Discussion and audience interaction14:50 What to expect from the new drugs

entering the field of coronaryinterventions? (vorapaxar, cangrelor)D. Angiolillo


T. Cuisset




13:45 - 15:15ROOM 343

Abstracts

Optimisation of BRSimplantation to improveoutcomesSession comprising selected EuroPCR 2016abstract submissionsChairperson: H. NefPanellists: F. Addad (awaitingconfirmation), S. Brugaletta, H. Mehta

13:45 Euro16A-OP0399 - A newnovolimus-eluting BRS for large coronaryarteries: an OCT study of acute mechanicalperformanceN. Boeder (awaiting confirmation)

13:53 Discussion and audience interaction13:58 Euro16A-OP0209 - A hybrid strategy with

BRS and DES for complex coronary arterylesions unsuitable for a pure scaffoldingapproachA. Ielasi

14:06 Discussion and audience interaction14:11 Euro16A-OP0564 - Discrepancies in

measurements between OCT andquantitative coronary angiography afterimplantation of polymeric scaffolds andmetallic stentsY. Sotomi

14:19 Discussion and audience interaction14:24 Euro16A-OP0754 - Characterisation of

coronary restenotic lesions followingeverolimus-eluting vascular scaffoldingJ. Chavarria

14:32 Discussion and audience interaction14:37 Euro16A-OP0369 - Use of hybrid approach

(BRS and DES) in left anterior descendingreconstruction: the BRIVIDO registryG. Boccuzzi

14:45 Discussion and audience interaction14:50 Euro16A-OP0985 - Predictors of 30-days

ischaemic events after Absorb BRSimplantation: 1,933 patient-pooledanalysis from six multicentre registriesA. Caixeta

14:58 Discussion and audience interaction15:03 Euro16A-OP0079 - Clinical outcomes of a

real-world cohort following BRSimplantation utilising an optimisationstrategyA. Tanaka


13:45 - 15:15ROOM 351

Abstracts

Imaging for TAVI: impact onprocedural outcomeSession comprising selected EuroPCR 2016abstract submissionsChairperson: H. DanenbergPanellists: D. Lahidheb (awaitingconfirmation), F. Praz

13:45 Euro16A-OP0195 - Non-contrast 3D MRI forpreprocedural assessment of aorticannulus dimensions in patientsundergoing TAVIA. La Manna

13:53 Discussion and audience interaction13:58 Euro16A-OP0580 - Quantification of aortic

valve calcification for TAVI screeningB. McHenry

14:06 Discussion and audience interaction14:11 Euro16A-OP1042 - Benefit and utility of

baseline CT evaluation to improveoutcomes in transcatheter aortic valvereplacement for failed surgicalbioprostheses: insights from the PARTNERII valve-in-valve registryD. Dvir

14:19 Discussion and audience interaction14:24 Euro16A-OP0423 - IVUS: a way to prevent

acute kidney injury in patients undergoingTAVI?F. Giardinelli

14:32 Discussion and audience interaction14:37 Euro16A-OP0126 - Is there any incremental

value of 2D transesophagealechocardiography for annular sizing priorto TAVI?W.K. Kim

14:45 Discussion and audience interaction14:50 Euro16A-OP0521 - 4D multidetector CT

assessment of leaflet thickening andmotion in patients treated with amechanically expanded TAVI prosthesisR. Gooley

14:58 Discussion and audience interaction15:03 Euro16A-OP0346 - Device landing zone

calcification: impact on paravalvularleakage after TAVI with two generations ofballon-expandable devicesL. Conradi (awaiting confirmation)





13:45 - 15:15ROOM 352A

Complications

Bosnia and Herzegovina, andLuxembourg share their mosteducational cases: stent loss andthrombosis during PCIWith the collaboration of the Working Group ofInterventional Cardiology of the Association ofCardiologists of Bosnia and Herzegovina and theLuxembourg Society of Cardiology Chairpersons: J. Beissel, I. Terzic

Attend this session if you want:To care for stent dislodgmentTo learn how to manage stentthrombosis during PCITo know about OCT complications

13:45 Session objectivesI. Terzic

13:48 Case 1: coronary disaster in a patient withNSTEMI and poor medical pretreatmentD. Wagner

13:54 Discussion with the audience14:02 Case 2: coronary dissection; easy to cause,

but not always easy to treatS. Diedovic

14:08 Discussion with the audience14:16 Case 3: a stent is never lost

B. Pereira14:22 Discussion with the audience14:30 Case 4: PCI on diagonal branch

complicated with left anterior descendingsubocclusion and finished as bifurcationcase by kissing-balloon techniqueI. Terzic

14:36 Discussion with the audience14:44 Case 5: be careful with intracoronary

thrombusJ. Beissel

14:50 Discussion with the audience14:58 Case 6: stent dislodgement during PCI

M. Kulic (awaiting confirmation)15:04 Discussion with the audience15:12 Session evaluation and key learnings

J. Beissel

13:45 - 15:15ROOM 352B

Complications

Egypt and Turkey share theirmost educational cases: fromdissection to perforation, worstscenario, best save With the collaboration of the Egyptian WorkingGroup of Interventional Cardiology (EgIC) and theAssociation of Percutaneous CardiovascularInterventions of the Turkish Society of Cardiology(TAPCI/TSC-Interventions)Chairpersons: A. Magdy, O. Yavuzgil

Attend this session if you want:To understand the potential factorsthat may cause left main complicationsduring interventionsTo understand the seriousness of leftmain complications and how toprevent themTo learn how to deal with left maincomplications

13:45 Session objectivesA. Magdy

13:48 Case 1: flush thrombusE. Akkaya

13:54 Discussion with the audience14:02 Case 2: left main thrombosis: when it

became darkA. Sabri

14:08 Discussion with the audience14:16 Case 3: not always complicated

E. Yeter14:22 Discussion with the audience14:30 Case 4: missing left main lesion is a mess!

Y. Sadek14:36 Discussion with the audience14:44 Case 5: cutting wire

K. Tigen14:50 Discussion with the audience14:58 Case 6: left main dissection: a real

nightmare!A. Alsayed Youssef (awaiting confirmation)

15:04 Discussion with the audience15:12 Session evaluation and key learnings

O. Yavuzgil




13:45 - 15:15ROOM 353

Abstracts

Novel non-invasive approachesto diagnose coronary aterydiseaseSession comprising selected EuroPCR 2016abstract submissionsChairperson: O. GaemperliPanellists: F. Civaia (awaitingconfirmation), R. Singh, R. Thachathodiyl(awaiting confirmation)

13:45 Euro16A-OP0549 - Seattle anginaquestionnaire is able to predict the severityof coronary artery disease as assessed byfour angiographic scoresW.V.N. Guimaraes

13:53 Discussion and audience interaction13:58 Euro16A-OP0345 - Development of a

model for predicting radiological risks ininterventional cardiologyJ.B. Maurice (awaiting confirmation)

14:06 Discussion and audience interaction14:11 Euro16A-OP0775 - CT-derived

atherosclerotic plaque burden andmorphology are associated withhaemodynamic significant coronary arterystenoses using FFR independent of luminalobstructionR. Driessen (awaiting confirmation)

14:19 Discussion and audience interaction14:24 Euro16A-OP0348 - Hybrid iFR - contrast

medium induced Pd / Pa ratiodecision-making strategyK. Senda

14:32 Discussion and audience interaction14:37 Euro16A-OP0237 - Integration of stress

myocardial blood flow, coronary flowreserve, and relative flow reserve improvesdiagnostic performance of myocardialperfusion imaging for identification offunctionally significant coronary arterystenosisJ.M. Lee

14:45 Discussion and audience interaction14:50 Euro16A-OP0193 - Angina status and

presence of ischaemia in echo-stress attwo years after implantation ofdrug-eluting BRS or metallic DESD.H. Lee (awaiting confirmation)

14:58 Discussion and audience interaction15:03 Euro16A-OP0024 - Coronary MRI after

implantation of BRS allows non-invasiveevaluation of vascular patency andhaemodynamicsC. Von Zur Mühlen


13:45 - 15:15ROOM

ARLEQUIN

Abstracts

Mid- and long-term outcomeafter renal denervationSession comprising selected EuroPCR 2016abstract submissionsChairperson: F. SharifPanellists: M. Al Ghamdi (awaitingconfirmation), J. Daemen, S. Ewen

13:45 Euro16A-OP0762 - Resistant arterialhypertension: is there still a role for renalsympathetic denervation?M. Nobre Menezes

13:53 Discussion and audience interaction13:58 Euro16A-OP0418 - Renal denervation

using the EnligHTN renal denervationsystem in alternative hypertensivepopulations: 24-month results from theEnligHTN II studyA. Bennig Dickson

14:06 Discussion and audience interaction14:11 Euro16A-OP0467 - Who are the

non-responders to renal denervation? Aninsight from real-world patientsB. Brochado

14:19 Discussion and audience interaction14:24 Euro16A-OP0230 - Six-month invasive

safety assessment in humans of renalartery denervation using Simplicity Spyralapplied in the main trunk and branchesJ. Davies

14:32 Discussion and audience interaction14:37 Euro16A-OP0437 - Safety and performance

of the EnligHTN renal denervation systemin patients with drug-resistanthypertension: pooled analyses from theEnligHTN 1, 2 and 3 trialsA. Bennig Dickson

14:45 Discussion and audience interaction14:50 Euro16A-OP1033 - Six-month results from

the PEREGRINE study of alcohol-mediatedrenal denervation in refractoryhypertensionW. Wojakowski

14:58 Discussion and audience interaction15:03 Euro16A-OP0304 - Long-term (three-year)

safety and effectiveness from the GlobalSYMPLICITY Registry of renal denervationin a real world patient population withuncontrolled hypertensionF. Mahfoud





- 15:00 -15:30 - 17:00

THEATRE BLEULeft main bifurcation stenting:what is different from otherbifurcations lesions?Chairpersons: H. Amin, A. BanningPanellists: M. Alasnag, G. Amoroso, S.L.Chen (awaiting confirmation), G.Davidavicius, M. Lesiak, J. Mehilli

Attend this session if you want:To define the strategy for optimal leftmain stentingTo learn provisional side-branchtechnique from A to ZTo understand when two stents areneeded and which technique to use

15:30 Session objectivesH. Amin

15:33 What is different about left mainbifurcation?K.G. Oldroyd

15:40 Time to React@PCR15:47 Review of the technique to be used during

the LIVE demonstrationF. Hellig

15:53 LIVE demonstration from St Thomas'Hospital - London, United Kingdom

16:33 Time to React@PCR16:43 One stent vs. two for the left main

bifurcation: when and howK. Al-Shaibi


A. Banning

15:30 - 17:00THEATRE

BORDEAUX

FocusInnovation

Hot Line

Late-breaking trials and trialupdates in coronaryinterventionsChairpersons: T. Cuisset, J.F. TanguayPanellists: S. Cook, M. Sabaté, M.Valgimigli, R. Vijayvergiya, P. Vranckx, A.Yildirim (awaiting confirmation)

15:30 The balance of thrombosis and bleeding inpatients at high bleeding risk fromLEADERS FREE trial P. Urban

15:39 Discussion and audience interaction15:43 Six-month versus 12-month DAPT

following long-length everolimus-elutingstent implantationM.K. Hong

15:52 Discussion and audience interaction15:56 Randomised, double-blinded,

placebo-controlled trial of intramyocardialautologous bone marrow CD133+ cells onleft ventricle perfusion and function inpatients with inducible ischaemia andrefractory angina (REGENT-VSEL)W. Wojakowski

16:05 Discussion and audience interaction16:09 The final five-year results from the

COMPARE II trial: the first real long-termresults between biodegradable polymerbiolimus-eluting stent and durablepolymer everolimus-eluting stentP. Smits

16:18 Discussion and audience interaction16:22 Five-year non-enrolled TWENTE: clinical

outcome of participants in the randomisedTWENTE trial vs. non-enrolled eligiblepatients, treated with the samesecond-generation DESC. Von Birgelen

16:31 Discussion and audience interaction16:35 Three-year clinical follow-up of the RIBS V

randomised clinical trialF. Alfonso Manterola

16:44 Discussion and audience interaction16:48 A randomised control trial comparing two

DES on the degree of early stent healingand late neointima progression usinglongitudinal sequential OCT follow-up: theOCT-ORION studyS. Lee






Percutaneous edge-to-edgerepair of mitral regurgitation:current statusChairpersons: S. Baldus, A. VahanianPanellists: T. Feldman, C. Grasso(awaiting confirmation), J.F. Obadia, S.Von Bardeleben

Attend this session if you want:To be updated on the results ofedge-to edge repair for primary mitralregurgitationTo understand the technical difficultiesencountered during these proceduresand how to overcome themTo gain insights into optimal caseselection

15:30 Session objectivesS. Baldus

15:34 Review of the Mitraclip deviceS. Von Bardeleben

15:44 LIVE demonstration from HerzzentrumRostock - Rostock, Germany

16:29 Time to React@PCR16:39 Anatomical suitability: what are the limits?

C. Grasso16:49 Time to React@PCR16:56 Session evaluation and key learnings

A. Vahanian


FocusInnovation

Hot Line

TAVI registriesChairpersons: A. Cribier, A.S. PetronioPanellists: M. Chen, U. Gerckens, K.Hayashida, A. Linke (awaitingconfirmation)

15:30 Late outcomes of TAVI in high-riskpatients: FRANCE 2 registryM. Gilard

15:39 Discussion and audience interaction15:43 SOURCE 3 post-approval registry - early

outcomes in 1,946 TAVI patients with athird-generation balloon expandabletranscatheter heart valveO. Wendler

15:52 Discussion and audience interaction15:56 The RESPOND study: safety and efficacy of

a fully repositionable and retrievable aorticvalve used in routine clinical practiceV. Falk

16:05 Discussion and audience interaction16:09 30-day registry results using a

second-generation transfemoral aorticvalve implantation system for thetreatment of patients with severe aorticstenosisH. Moellmann

16:18 Discussion and audience interaction16:22 Implantation of novel balloon-expandable

transcatheter heart valves intodegenerated surgical aortic bioprostheses:matched comparison and insights fromthe Valve-In-Valve International Data(VIVID) registryM. Seiffert

16:31 Discussion and audience interaction16:35 Acute and 30-day outcomes of women

after TAVI: results from the first Women INTranscatheter Aortic Valve Implantation(WIN-TAVI) real-world registryA. Chieffo

16:44 Discussion and audience interaction16:48 TAVI in hospitals with and without on-site

cardiac surgery department: insights fromthe prospective German Aortic valvereplacement QUality Assurance registry(AQUA) in 17,919 patientsH. Eggebrecht





15:30 - 17:00ROOM

LEARNING

Learning vascular access forperipheral interventions: fromstick to closureFacilitators: F. Mahfoud, A. Micari, T.ZellerExpert panellists: R. Ferraresi, L.M. Palena

Attend this session if you want:To understand how to better assesswhich access to chooseTo learn how to perform the differentaccesses step by step:

- Femoral antegrade and retrograde - Popliteal - Transpedal - Radial - Brachial

15:30 - 17:00ROOM TERNES 1

Cases

Complex management ofcoronary aneurysmSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: A. WitkowskiPanellists: J. Al Dhaheri (awaitingconfirmation), M. Degertekin, H.C. Tan

15:30 Tertiary syphilisJ. Vasquez Gongora (awaiting confirmation)

15:38 Discussion and audience interaction15:43 Ice burg! How to manage huge burden of

thrombus?A.R. Abdi Ardekani

15:51 Discussion and audience interaction15:56 Coronary aneurism following

bioresorbable vascular scaffoldsimplantation: keep it in mind!L. Barbieri

16:04 Discussion and audience interaction16:09 Complex angioplasty to coronary

aneurysmA. Hailan

16:17 Discussion and audience interaction16:22 How to treat a calcified aneurysmal left

anterior descending arteryS.T. Rab

16:30 Discussion and audience interaction16:38 Multivessel disease treated with DES and

two self-apposing stents: in the rightcoronary artery and a highly complex longsegment left anterior descending stenosiswith coronary aneurysmD. Rulands (awaiting confirmation)

16:43 Discussion and audience interaction16:48 Complex management of coronary

aneurysm feeding a CTOR.A. Latini


15:30 - 17:00ROOM TERNES 2

Cases

Supra-aortic aneurysm repairand carotid angioplastySession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: F. CastriotaPanellists: S. Kedev, M.S. Lin, E. Vuruskan

15:30 Snare-assisted treatment of giantaneurysms of the left subclavian artery anddescending aortaD. Zverev

15:38 Discussion and audience interaction15:43 Internal carotid artery sacrifice for

treatment of a giant aneurysmF. Safi

15:51 Discussion and audience interaction15:56 A challenging bilateral common carotid

artery stenting with one-year follow-up inTakayasu arteritis with almost total lesionsK. Amber

16:04 Discussion and audience interaction16:09 Innominate artery stenting under cerebral

protection through brachial approachM.P. Borrelli (awaiting confirmation)

16:17 Discussion and audience interaction16:22 A case of bailout for iatrogenic occlusion of

subclavian arteryM. Kishi

16:30 Discussion and audience interaction16:35 Modified DEB angioplasty for treatment of

high-risk carotid in-stent restenosisC.W. Wang

16:43 Discussion and audience interaction16:48 Percutaneous treatment of restenosis of

the right internal carotid artery withmultiple stenting in patient submitted toprevious thromboendoarterectomyC. Moncalvo





15:30 - 17:00ROOM 241

Abstracts

PCR's Got Talent - round 1:Clinical and angiographicsubsets in PCISession comprising selected EuroPCR 2016abstract submissionsChairpersons: A. Bartorelli, R. KoningJury Members: H. Call, M. De Belder(awaiting confirmation), D.S. Gambhir, D.Mylotte, S. Verheye

15:30 Introduction15:32 Euro16A-OP0074 - Utility of slow-speed

rotational atherectomy in patients withsevere left ventricular dysfunctionundergoing PCIJ. Palazuelos

15:36 Euro16A-OP0244 - Non-invasive coronaryCT angiography based heart teamassessment using the SYNTAX score II forthe selection of the revascularisationstrategy in patients with multivesselcoronary disease: a subanalysis of theSYNTAX II trialR. Cavalcante

15:40 Euro16A-OP1043 - IVUS-guided wiring ofostial coronary CTO: a single-centreexperienceN. Ryan

15:44 Euro16A-OP0681 - Bifurcationpaclitaxel-eluting bifurcation dedicatedstent for unprotected left main coronaryartery disease: a single-centre experienceI. Petrov

15:48 Euro16A-OP0247 - Long-term impact ofproximal left anterior descending arterylesions in patients with three-vessel and /or left main coronary artery disease: apatient-level pooled analysis of 3,280patients from the SYNTAX, PRECOMBATand BEST trialsR. Cavalcante

15:52 Euro16A-OP0076 - Complications inunstable patients referred to complex PCIwhen rotational atherectomy andbivaluridin are usedJ. Palazuelos

15:56 Euro16A-OP0857 - Determinants of PCIsuccess in repeat procedures following afailed initial attempt in CTON. Ryan

16:00 Euro16A-OP0027 - Percutaneous coronaryrevascularisation for CTO: a novelpredictive score of technical failureM. Boukhris

16:04 Euro16A-OP0063 - Prevalence of ischaemiain patients with a CTO and preserved leftventricular ejection fractionW. Stuijfzand

16:08 Euro16A-OP0075 - Long-term outcomes ofan octogenarian cohort whom underwentrotational atherectomy during complexPCIJ. Palazuelos

16:12 Euro16A-OP0147 - Factors influencingoperator's decision for same-day dischargeafter coronary percutaneous interventionM. Agelaki

16:16 Euro16A-OP0185 - Outcomes of re-attemptPCI for CTO: two-year data fromRETROGRADE SUMMIT RegistryS. Ishihara

16:20 Euro16A-OP0248 - Long-term outcomes ofPCI and CABG in patients with unprotectedleft main coronary artery disease: a pooledanalysis of individual patient level datafrom the SYNTAX and PRECOMBATrandomised trialsR. Cavalcante

16:24 Euro16A-OP0566 - Intervention rates andoutcomes of CTO in comparison to othertypes of coronary artery diseaseO. Odunukan (awaiting confirmation)

16:28 Euro16A-OP0755 - Outcomes of orbitalatherectomy in patients with severe leftventricular systolic dysfunctionE. Shlofmitz

16:32 Euro16A-OP0771 - FFR on compared withangiographic estimation of coronay arterydisease: impact of diabetesJ. Adjedj

16:36 Euro16A-OP0816 - Clinical andangiographic profile, and managementtrends in patients presenting withcoronary CTOs in a tertiary care centre inSouth IndiaT. Hussain (awaiting confirmation)

16:40 Euro16A-OP1017 - Change ofanticoagulant therapy in rotationalatherectomy in population at highcardiovascular riskP. Clares Montón (awaiting confirmation)

16:44 Euro16A-OP1070 - Clinical andangiographic one-year outcome of minicrush stenting for the treatment of truecoronary bifurcations in an all-comerpopulationA. Nicolino


for round 2

15:30 - 17:00ROOM 242AB


YoungPractitioners


Practitioners

My patient has a short CTO.When should I attempt anantegrade PCI? And if yes... how?Senior Advisor: J. EscanedFacilitators: H. Nef, A. Ong

Attend this session if you want:To identify ideal candidates forantegrade PCI of a CTOTo learn about materials to be used inthis setting and a stepwise algorithmto stay out of troubleTo understand when to stop




15:30 - 17:00ROOM 243

Plenary

Personalised management ofhypertension in everydaypractice: learning through casesWith the collaboration of the Practical Course onHypertension (PCH)Chairpersons: F. Sharif, K. TsioufisPanellists: R.J. Gil, R. Schmieder

Attend this session if you want:To learn how to manage ahypertensive patient in your dailypractice through a step-by-steppersonalised approach based onclinical casesTo review current strategies on how todiagnose secondary hypertensionTo understand how to treat and followup your patient with hypertension

15:30 Session objectives and collection ofaudience expectationsF. Sharif

15:35 Case presentation: different bloodpressure measurement modalitiesS. Ewen

15:40 How to confirm hypertension?F. Sharif

15:50 Discussion and audience interaction16:00 Case presentation: exclusion of secondary

causesC. Ukena

16:05 How to exclude a secondary cause?R. Schmieder

16:15 Discussion and audience interaction16:25 Case presentation: management and

follow-upS. Ewen

16:30 How to manage and follow-up yourpatient with hypertension?K. Tsioufis


through a checklist process made By andFor the audienceK. Tsioufis

15:30 - 17:00ROOM 243

Cases

CTO interventions: difficultanatomy / epicardial approachSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: M. YamanePanellists: H.J. Büttner, V. Reddy, G.Sianos

15:30 Successful retrograde CTO PCI to proximalright coronary artery with anomalousoriginM. Tanabe

15:38 Discussion and audience interaction15:43 Twin challenges: CTO intervention in left

anterior descending artery from ananomalously originating left maincoronary artery from right sinusK. Balakrishnan

15:51 Discussion and audience interaction15:56 Double critics

F. Malik16:04 Discussion and audience interaction16:09 Revascularisation of a long left anterior

descending artery CTO usingcontemporary IVUS guidance techniqueM. Kodaira

16:17 Discussion and audience interaction16:22 Successfull retrograde CTO

revascularisation via an epicardialcollateral using a single 6 Fr guidingcatheterT. Schäufele

16:30 Discussion and audience interaction16:35 Retrograde CTO PCI via ipsilateral

collateralsV. Kodoth

16:43 Discussion and audience interaction16:48 Ipsilateral retrograde kissing-wire

technique using an epicardial channelH. Sakai





15:30 - 17:00ROOM 251

Cases

Urgent treatment of a CTO yousaid?Session comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: T. SchmitzPanellists: S. Adiarto (awaitingconfirmation), A. Khan, H. Mehta

15:30 An active treatment approach reducesmorbidity and mortality in a patient withacute myocardial infarction, multivesseldisease and a CTOI. Van Dongen (awaiting confirmation)

15:38 Discussion and audience interaction15:43 Primary retrograde PCI of right coronary

artery CTO to treat inferior STEMIcomplicated by cardiac arrest due to veingraft occlusionN. Kumar (awaiting confirmation)

15:51 Discussion and audience interaction15:56 A challenging CTO case of a patient

presenting after an out-of-hospital cardiacarrestH. Lu

16:04 Discussion and audience interaction16:09 Single-catheter retrograde recanalisation

of ostial left anterior descending CTO inunstable patientR. Parisi (awaiting confirmation)

16:17 Discussion and audience interaction16:22 Refractory angina pectoris referred to

heart transplant due to unattainablerevascularisationP. Pinto-Teixeira

16:30 Discussion and audience interaction16:35 Acute life-threatening presentation of a

previously untreated left anteriordescending coronary artery CTOA. Silvestro

16:43 Discussion and audience interaction16:48 A case of total occlusion of three vessels

with severe left ventricular dysfunctionrelieved by step-by-step revascularisationY. Murasato


15:30 - 17:00ROOM 252AB

Plenary

SOLACI@EuroPCR - STEMI inLatin America and Europe. Thecurrent management in ourcountriesWith the collaboration of the SociedadLatinoamericana de Cardiologia Intervencionista(SOLACI)Chairpersons: R. Lluberas, F. MauriPanellists: D. Echeverri (awaitingconfirmation), J.L. Leiva Pons, O. Mendiz,E.E. Ribeiro

Attend this session if you want:To understand the reality ofreperfusion in STEMI in Latin Americaand EuropeTo learn about the arterial approachcurrently used in STEMI in ourcountriesTo review existing or developing STEMIprogrammes in both continents

15:30 EuroPCR welcomes SOLACIF. Mauri

15:32 Session objectivesR. Lluberas

15:35 The Mexican experience in reperfusion inSTEMIM.A. Alcocer

15:43 Discussion and audience interaction15:55 Stent for Life in Latin America

J. Belardi16:03 Discussion and audience interaction16:15 The radial approach for primary

percutaneous transluminal coronaryintervention: the Uruguayan experienceJ. Mayol

16:23 Discussion and audience interaction16:35 Pharmaco-invasive strategy in STEMI: how

is it applied in our countries?A. Protopopov


R. Lluberas




15:30 - 17:00ROOM 253

Abstracts

Out-of-hospital cardiac arrestand cardiogenic shockSession comprising selected EuroPCR 2016abstract submissionsChairperson: H. ThielePanellists: V. Bogana Shanmugham, G.Olivecrona, N.H. Pijls

15:30 Euro16A-OP0353 - Distance to invasiveheart centre, performance of acutecoronary angiography and angioplastyand associated outcome in out-of-hospitalcardiac arrest: a nationwide studyT. Tranberg

15:38 Discussion and audience interaction15:43 Euro16A-OP0924 - Post-resuscitation

electrocardiogram for selection of patientsfor early invasive coronary treatmentstrategies in comatose survivors ofout-of-hospital cardiac arrestS.R. Kandan

15:51 Discussion and audience interaction15:56 Euro16A-OP0017 - Reduction in ventricular

tachyarrhythmia with prior statin therapyin patients with acute myocardialinfarctionJ.S. Park

16:04 Discussion and audience interaction16:09 Euro16A-OP0338 - Prediction of 30-day

outcome for Out of Hospital Cardiac ArrestSurvivors (OHCAS)C. Tatar

16:17 Discussion and audience interaction16:22 Euro16A-OP0114 - Evaluation of the use of

intra-aortic balloon pump in a tertiarycentreU. Rao

16:30 Discussion and audience interaction16:35 Euro16A-OP0296 - 30-day survival in

patients with cardiogenic shock: Impella2.5 vs. Impella 4.0A. Algin

16:43 Discussion and audience interaction16:48 Euro16A-OP0788 - Early predictors of

weaning failure from veno-arterialextracorporeal membrane oxygenation inpatients with acute myocardialinfarction-induced cardiac arrestA. Sugiura


15:30 - 17:00ROOM 341

Cases

Aortic and coronarycomplications - TAVISession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: C. TamburinoPanellists: A.M. Al Abdullah, H.Eltchaninoff, S. Gunasekaran

15:30 The higher the betterE. Pllaha

15:38 Discussion and audience interaction15:43 Bilateral, reversible coronary obstruction

during aortic valve-in-valve implantationof a repositionable valve systemF. Praz

15:51 Discussion and audience interaction15:56 Successful use of automated resuscitation

following haemodynamic collapse duringTAVIA. Mechery

16:04 Discussion and audience interaction16:09 Annular aortic rupture during

transcatheter aortic valve replacementtreated with unusual conservative strategyM. Crisci

16:17 Discussion and audience interaction16:22 TAVI under local anaesthesia: fast and

effective treatment of a seriouscomplicationE. Roberts

16:30 Discussion and audience interaction16:35 A possible rare complication: vascular

damage caused by the ballonn rupture inTAVI patientC. Topaloglu (awaiting confirmation)

16:43 Discussion and audience interaction16:48 A disturbing surprise during TAVI

A. Albarran16:56 Discussion and audience interaction




15:30 - 17:00ROOM 342B

Plenary

The Heart Team at work: difficultdecisions in patients withcomplex coronary artery andvalvular diseaseFacilitators: E. Barbato, P. Kolh, T.Modine, C.K. Naber

Attend this session if you want:To exchange about indications forsurgery and PCI in complex patientsTo discuss the relevance on the clinicaloutcome for the individual patientTo experience that a true Heart Teamapproach provides real benefit for thepatient

15:30 Session objectivesC.K. Naber

15:36 Case 1 - a patient with left main andmultivessel coronary artery diseaseT. Modine

15:41 How would I treat?E. Barbato

15:46 Discussion and audience interaction15:57 Conclusion of the case and take-home

message from the Heart TeamP. Kolh

16:02 Case 2 - a patient with coronary arterydisease and mitral valve regurgitationC.K. Naber

16:07 How would I treat?T. Modine


message from the Heart TeamE. Barbato

16:28 Case 3 - a patient with coronary arterydisease and aortic stenosisP. Kolh

16:33 How would I treat?C.K. Naber


message from the Heart TeamT. Modine

16:54 Session evaluation and key learningsE. Barbato

15:30 - 17:00ROOM 343

Abstracts

Thromboaspiration: theoculothrombotic reflexSession comprising selected EuroPCR 2016abstract submissionsChairperson: S. Jolly (awaitingconfirmation)Panellists: F. Addad (awaitingconfirmation), U. Zeymer

15:30 Euro16A-OP0949 - Thrombus aspirationalone during primary percutaneouscoronary angioplasty in selected patientswith STEMIL.L. Gheorghe

15:38 Discussion and audience interaction15:43 Euro16A-OP0013 - Forward and back

aspiration during STEMI: a feasibility studyV. Farooq

15:51 Discussion and audience interaction15:56 Euro16A-OP1054 - The use of glycoprotein

IIb / IIIa inhibitors in patients with STEMItreated without thrombectomy deviceM. El Garhy (awaiting confirmation)

16:04 Discussion and audience interaction16:09 Euro16A-OP0212 - Calculate or re-calculate

TIMI thrombus burden: relation ofthrombus burden with clinical outcomes inpatients with STEMII. Tanboga

16:17 Discussion and audience interaction16:22 Euro16A-OP1066 - Circadian impact of

manual thrombus aspiration onmyocardial infarction size in patients withSTEMI undergoing primary PCI: apropensity-matched score analysis of theAcute Myocardial Infarction in Switzerland(AMIS) registryS. Fournier

16:30 Discussion and audience interaction16:35 Euro16A-OP0211 - Routine manual

thrombus aspiration in STEMI: end of theTASTE after TOTALity of dataI. Tanboga

16:43 Discussion and audience interaction16:48 Euro16A-OP0861 - Manual thrombectomy

and simultaneously intracoronaryglycoprotein IIb / IIIa inhibitor infusionduring primary PCI can preserve the indexof microcirculatory resistance in patientswith anterior STEMIS.L. Woo (awaiting confirmation)





15:30 - 17:00ROOM 351

Abstracts

New-generation TAVI devices:outcome from registriesSession comprising selected EuroPCR 2016abstract submissionsChairperson: P. MacCarthyPanellists: F. Bedogni, T. Pilgrim(awaiting confirmation), S.N. Rizvi(awaiting confirmation)

15:30 Euro16A-OP0494 - The DISCOVER trial:three-year outcomes of a fullyrepositionable and retrievablenon-metallic transcatheter aortic valveJ.M. Neyens (awaiting confirmation)

15:38 Discussion and audience interaction15:43 Euro16A-OP0797 - First-in-man experience

with TAVI in severe aortic stenosis usingthe hydra self-expanding aorticbioprosthetic valveS. Srimahachota

15:51 Discussion and audience interaction15:56 Euro16A-OP0991 - Safety and performance

of the Portico valve in patients with severeaortic stenosis and excessive surgical risk: afirst report of 30-day results from thePORTICO I studyL. Sondergaard

16:04 Discussion and audience interaction16:09 Euro16A-OP0792 - Transcatheter aortic

valve replacement with J-Valve for thetreatment for pure aortic regurgitation andaortic stenosis: first-in-human Chinaclinical trialJ. Ye (awaiting confirmation)

16:17 Discussion and audience interaction16:22 Euro16A-OP0173 - Initial experience of a

second-generation self-expandingtranscatheter aortic valve: the UK andIreland IMPLANTERS registryS. Kalra

16:30 Discussion and audience interaction16:35 Euro16A-OP0739 - Procedural and 30-day

clinical outcomes following TAVI withLotus valve: results of the RELEVANT studyR.A. Montone

17:17 Discussion and audience interaction16:48 Euro16A-OP0626 - Third-generation

balloon expandable transcatheter heartvalve: European one-year clinical follow-upof transfemoral intermediate and highsurgical risk patientsJ. Webb


15:30 - 17:00ROOM 352A

Complications

Belarus and Siberia share theirmost educational cases:challenging complicated PCIWith the collaboration of the Belarusian Society ofInterventional Cardiology and EndovascularSurgery and the Siberian Association ofInterventional CardioangiologistsChairpersons: V. Ganyukov, O.Polonetsky

Attend this session if you want:To understand the causes ofcomplications during PCI To share technical and tacticalapproach to solve the problem ofcomplicated PCITo learn how to prevent thecomplications of PCI

15:30 Session objectivesV. Ganyukov

15:33 Case 1: severe dissection of left main, leftcircumflex and first obtuse marginalduring attempt of left anterior descendingartery chronic occlusion recanalisationD. Yurlevich (awaiting confirmation)

15:39 Discussion and audience interaction15:47 Case 2: thrombosis of three vascular

regions in the hospital period in patientwith stable coronary artery disease withhybrid strategy of revascularisationR. Tarasov

15:53 Discussion and audience interaction16:01 Case 3: unsuccessful CTO recanalisation

with arteriovenous fistula formation (leftcircumflex artery to coronary sinus)V. Stelmashok (awaiting confirmation)

16:07 Discussion and audience interaction16:15 Case 4: rupture of left main in ACS patient

treated with grafting procedureS. Evtyagin

16:21 Discussion and audience interaction16:29 Case 5: complicated PCI in case of

myocardial infarction due to fibromusculararterial dysplasia and intramural thrombusformation leading to arterial occlusionP. Chernoglaz (awaiting confirmation)

16:35 Discussion and audience interaction16:43 Case 6: MGuard stent dislocation in

primary PCIA. Shilov


O. Polonetsky




15:30 - 17:00ROOM 352B

Complications

Belgium and Scotland sharetheir most educational cases:coronary complicationsWith the collaboration of the Belgian WorkingGroup of Interventional Cardiology (BWGIC) andthe Interventional Working Group of the ScottishCardiac SocietyChairpersons: W. Desmet, H. Eteiba

Attend this session if you want:To understand spontaneous coronarydissection and appreciate thecomplexity of managing STEMI earlypost-CABG and aortic valvereplacementTo learn about possible technicaldefects of stent delivery systems andshare the experince of treating leftmain occlusion and haemodynamiccollapse following non-coronaryinterventionTo learn about problems with coronarystents protruding in the aorta andreflect on the significance of unusualangiographic appearance andsubsequent recurrent STEMI

15:30 Session objectivesW. Desmet

15:33 Case 1: burning down the house -managing left main occlusion andhaemodynamic collapsepost-radiofrequency ablationR. Good

15:39 Discussion with the audience15:47 Case 2: spontaneous coronary dissection:

from bad to worseN. Hiltrop

15:53 Discussion with the audience16:01 Case 3: sound of silence - managing

inferior STEMI with early prosthetic aorticvalve replacement thrombosisM. Lindsay

16:07 Discussion with the audience16:15 Case 4: fracture of a stent delivery system

P.J. Palmers16:21 Discussion with the audience16:29 Case 5: caught in a trap - unexpected

finding leading to recurrent STEMIA. Stewart

16:35 Discussion with the audience16:43 Case 6: a previously stented coronary

ostium: an open door? Or not?B. Drieghe


H. Eteiba

15:30 - 17:00ROOM 353

Abstracts

Understanding plateletreactivity, personalising DAPTSession comprising selected EuroPCR 2016abstract submissionsChairperson: S. GargPanellists: G. Cayla, K. El Merri, D. Ghosh(awaiting confirmation)

15:30 Euro16A-OP0317 - Impact of greater than12-month DAPT duration on mortality:drug-specific or a class-effect? - ameta-analysisF. Costa

15:38 Discussion and audience interaction15:43 Euro16A-OP0516 - Six vs. 12 months of

clopidogrel therapy after DES in patientswith ACS: a subgroup analysis of theISAR-SAFE studyJ. Michel (awaiting confirmation)

15:51 Discussion and audience interaction15:56 Euro16A-OP0523 - Impact of chronic

kidney disease on two-year clinicaloutcomes in patients treated with asix-month or 24-month DAPT duration:insights from the PRODIGY trialA. Santucci

16:04 Discussion and audience interaction16:09 Euro16A-OP0433 - Prevalence and relation

of CYP2C19 polymorphism withcardiovascular outcome in Iraqi Kurdishpatients undergoing PCIA. Barwari

16:17 Discussion and audience interaction16:22 Euro16A-OP0783 - Impact of test

conditions on the results of plateletfunction testingA.D. Dézsi

16:30 Discussion and audience interaction16:35 Euro16A-OP0299 - Gender differences in

platelet reactivity in patients receivingDAPTM. Verdoia

16:43 Discussion and audience interaction16:48 Euro16A-OP0544 - Predicting value of

platelet reactivity on ischaemic events andbleeding in Eastern Asian PCI patientsW. Wang





15:30 - 17:00ROOM

ARLEQUIN

Images

An image is worth 1,000 wordsSession comprising selected EuroPCR 2016 imagesubmissionsFacilitators: N. Amabile, S. Brugaletta, M.Monaghan

Image 115:30 Image 1: facilitated audience image

interpretation N. Amabile

15:34 Image 1: unveiled and key findingsY. Murasato

15:39 Image 1: discussion and audienceinteraction N. Amabile


interpretation S. Brugaletta

15:47 Image 2: unveiled and key findings J. Wiebe

15:52 Image 2: discussion and audienceinteractionS. Brugaletta


interpretation M. Monaghan

16:00 Image 3: unveiled and key findingsG. Ison

16:05 Image 3: discussion and audienceinterpretationM. Monaghan


interpretationN. Amabile

16:13 Image 4: unveiled and key findings A. Azzano

16:18 Image 4: discussion and audienceinterpretationN. Amabile


interpretationS. Brugaletta

16:26 Image 5: unveiled and key findingsP. Costanzo (awaiting confirmation)

16:31 Image 5: discussion and audienceinterpretationS. Brugaletta


interpretationM. Monaghan

16:39 Image 6: unveiled and key findingsA. Davies

16:44 Image 6: discussion and audienceinteractionM. Monaghan


interpretationN. Amabile

16:52 Image 7: unveiled and key findingsV. Ng

16:56 Image 7: discussion and audienceinteractionN. Amabile

- 17:00 -17:15 - 18:45

THEATRE BLEU

Tools andTechniques

(TNT)

Evolving BRS techniques to theacute myocardial infarctionpatient: Elixir DESolve to AMITYSponsored by ELIXIR MEDICALChairperson: M.B. LeonCo-Chairperson: I. MeredithPanellists: A. Abizaid, H. Nef, S. Verheye

Attend this session if you want:To learn the procedural techniques forAMITY the first scaffold designed foracute myocardial infarctionTo understand Elixir Medical's DESolvebioresorbable scaffold next generationplatforms and future clinical studies

17:15 Session objectivesM.B. Leon

17:20 Review of the tools to be used during theLIVE demonstrationS. Verheye

17:25 Recorded case from Antwerp, Belgium(DESolve AMITY)

S. Verheye18:03 Time to React@PCR18:15 DESolve real-world experience and

learningH. Nef

18:22 DESolve engineering science18:27 DESolve NX data update

A. Abizaid18:34 Ongoing and future DESolve clinical

programmesI. Meredith

18:40 Session evaluation and key learningsM.B. Leon




17:15 - 18:45THEATRE

BORDEAUX

Tools andTechniques

(TNT)

ACURATE TAVI: simple andeffective treatment for severeaortic stenosis patientsSponsored by SYMETIS SAChairperson: T. WaltherCo-Chairperson: C. Tamburino

Attend this session if you want:To learn about the multiaccessACURATE neo TAVI systemTo observe the easy ACURATE neotwo-step implantation procedureTo review results from the globalACURATE neo/transfemoral registry

17:15 Session objectivesT. Walther

17:17 ACURATE TAVI technologyS. Toggweiler

17:24 Review of the tools to be used during theLIVE demonstrationT. Walther


18:09 Time to React@PCR18:19 Results from the global registry SAVI TF

H. Moellmann18:31 Challenging cases using ACURATE neo:

ensuring minimal paravalvular leak and alow new pacemaker implantation rateA. Rück

18:43 Session evaluation and key learningsC. Tamburino


Symposium

From evidence to caseexperience - assessing anexpanding number of lesionoptions with bioresorbablevascular scaffoldsSponsored by ABBOTT VASCULARChairperson: J. FajadetCo-Chairperson: A. SerraPanellists: V.O. Kwok, E. Schampaert

Attend this session if you want:To learn more about optimal patientindications for bioresorbable vascularscaffoldsTo learn about the feasibility to treatpatients with bioresorbable vascularscaffolds through case presentationsTo share evidence-based guidance onthe ideal patient for bioresorbablevascular scaffolds

17:15 Session objectivesJ. Fajadet

Bioresorbable vascular scaffolds forreconstructing tortuous long lesions

17:21 What did I learn from my case?A. Latib

17:29 What does evidence tell us ?M. De Carlo

17:35 Discussion and audience interactionThe optimal patient for bioresorbablevascular scaffolds: young patient withmultivessel disease

17:47 What did I learn from my case?F. Cuculi

17:55 What does evidence tell us ?L. Testa

18:01 Discussion and audience interactionPrimary PCI patient: are these patients asuitable candidate for bioresorbablevascular scaffolds ?

18:13 What did I learn from my case?V. Kocka

18:21 What does evidence tell us ?M. Sabaté


A. Serra





Case in Point

The Synergy stent: expandingtreatment options in complexPCISponsored by BOSTON SCIENTIFICChairperson: K.G. OldroydCo-Chairperson: F.J. Neumann

Attend this session if you want:To recognise how biodegradablepolymer DES design may impact DAPTduration and clinical outcomesTo learn how the Synergy stent isbeing used in complex patient subsetsTo understand the current clinicalevidence, latest available clinical dataand interventional cardiology pipeline

17:15 Session objectivesK.G. Oldroyd

17:20 Case 1- Biodegradable polymer DES inbifurcation lesionR. Byrne

17:28 Discussion and audience interaction17:38 Case 2 - FFR assessment in multivessel PCI

J. Escaned17:46 Discussion and audience interaction17:56 Case 3 - Biodegradable polymer DES in left

main PCIS. Kedev

18:04 Discussion and audience interaction18:14 Case 4 - The European experience with

hybrid approach in CTO PCI: theRECHARGE registryJ. Dens

18:22 Discussion and audience interaction18:32 Building the next chapter in complex PCI :

Biodegradable polymer DES, FRS andbeyond K. Dawkins

18:40 Session evaluation and key learningsF.J. Neumann

17:15 - 18:45ROOM

LEARNING

Learning aortoiliac andfemoropopliteal angioplastyFacilitators: E. Blessing, E. VuruskanMedia Driver: A. Bacaksiz (awaitingconfirmation)

Attend this session if you want:To learn how to perform the procedurestep by step:

- Planning: preprocedural aspects - Treating: procedural tools andtechniques - Preventing and managing: potentialprocedure-related complications

17:15 - 18:45ROOM TERNES 1

Cases

Late and very late stentthrombosisSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: A. WitkowskiPanellists: O. El Khateeb, A. Finkelstein, A.Junker

17:15 STEMI in pregnant patientW. Trenkner

17:23 Discussion and audience interaction17:28 A combination of reasons would lead to a

lethal eventG. Tsigkas

17:36 Discussion and audience interaction17:41 Recurrent stent thrombosis after STEMI

W. Trenkner17:49 Discussion and audience interaction17:54 Stent thrombosis associated with stent

fracture and antiplatelet treatmentdiscontinuationA. Jurado-Roman

18:02 Discussion and audience interaction18:07 Simultaneous two-vessel stent thrombosis

P.P. Sadarmin18:15 Discussion and audience interaction18:20 Double trouble: STEMI due to very late

simultaneous stent thrombosis in twocoronary arteriesA. Sourgounis

18:28 Discussion and audience interaction18:33 "All just a little bit of history repeating": a

case of recurrent very late stentthrombosisD. Collison





17:15 - 18:45ROOM TERNES 2

Cases

Treatment of coronary arteryfistulaSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: F. EberliPanellists: D. Hildick-Smith, B. Karadag(awaiting confirmation), F. Ribichini

17:15 Percutaneous closure of congenitalcoronary artery fistula with one-yearfollow-up in two challenging casesK. Amber

17:24 Discussion and audience interaction17:30 Giant left coronary artery to coronary sinus

fistula closureM. Orzalkiewicz

17:39 Discussion and audience interaction17:45 Giant coronary fistula presenting with

cardiac arrest secondary to ACS: a rare casereportB. Popovic

18:00 Discussion and audience interaction18:09 Transcatheter closure of a tortuous

coronary fistula using an Amplatzervascular plugJ.S. Byon

18:15 Discussion and audience interaction18:24 PCI in active coronary giant cell arteritis

K. Sarathy18:30 Discussion and audience interaction18:39 Just an unstable ACS?

J. Palazuelos18:41 Discussion and audience interaction

17:15 - 18:15ROOM 241

Symposium

Next generation FFR and IVUStechnology: catheter based FFRand high-definition IVUSSponsored by ACIST MEDICALChairperson: N. Van MieghemCo-Chairperson: M.C. Morice (awaitingconfirmation)

Attend this session if you want:To understand the value(s) of guidedPCITo discuss about the clinical relevanceand benefits of microcatheter-basedFFR technologyTo learn how microcatheter-based FFRdevice RXi and high definition IVUSHDi can optimise the quality of pre-and post stent assessments

17:15 Session objectivesN. Van Mieghem

17:20 The CONTRACT study: insights form asingle centre clinical and economicalevaluation with the RXi Rapid-ExchangeFFR deviceJ. Daemen

17:32 Discussion and audience interaction17:37 The value of catheter-based FFR and

high-definition IVUS in the setting ofcomplex PCIA. Chieffo

17:49 Discussion and audience interaction17:54 Assessment of catheter-based

interrogation and standard techniques forFFR measurement - The ACIST FFR trialM. Price


M.C. Morice (awaiting confirmation)

17:15 - 18:45ROOM 242AB


YoungPractitioners


Practitioners

This coronary bifurcation needstwo stents: a stepwise approachto bailout or systematic doublestentingSenior Advisor: M. LesiakFacilitators: A. Elghamaz, D. Milasinovic

Attend this session if you want:To understand which bifurcationlesions require two stents from thebeginningTo be able to identify the besttechnique for each anatomyTo review the technical steps of currenttwo-stent procedures




17:15 - 18:45ROOM 251

Symposium

Interventional Cardiologists atthe edge of a new era:miniaturised transcatheterpacing systems and insertablecardiac monitorsSponsored by MEDTRONICChairperson: W. WijnsCo-Chairperson: W. Jung

Attend this session if you want:To get familiarised, as an InterventionalCardiologist, with monitoringtechnologies (Reveal LINQ) andtranscatheter cardiac pacing (Micra)To discuss specific unmet needs thatminiaturised cardiac pacing andmonitoring technologies may addressin patient population addressed byInterventional CardiologistsTo discuss the way forward forInterventional Cardiologists implantingtranscatheter cardiac pacing andmonitoring technologies

17:15 Session objectivesW. Jung

17:20 New miniaturised insertable cardiacmonitors for patients with suspectedarrhythmias: indications and case reportsR. Hatala

17:35 The role of miniaturised implantablecardiac monitors in post myocardialinfarction patientsA. Bauer

17:50 Discussion and audience interaction18:00 Implantation of a novel transcatheter

pacing systemX. Vinolas

18:15 Micra transcatheter pacing system:indications, experience and case reportsP. Ritter


W. Wijns

17:15 - 18:45ROOM 252AB

EBACaccreditation

has beenapplied for this

programme

FFR-guided PCI: are we ready tomove to acute coronarysyndrome?EBAC Accreditation has been applied for -Programme supported by an unrestrictededucational grant from ST. JUDE MEDICALChairperson: E. BarbatoCo-Chairperson: T. Cuisset

Attend this session if you want:To be updated on the latest news onFFR technology and physiology indices

To learn about the evidence showingthe benefits of full revascularisation inACSTo learn more about absolute flow asmore reliable index to assess themicrocirculation

17:15 Session objectivesE. Barbato

17:17 The diagnostic dilemmas andmanagement strategies in daily practiceP. MacCarthy

17:29 Discussion and audience interaction17:36 Optimal use of the PressureWire in the

contemporary ACS patientE. Barbato

17:54 Discussion and audience interaction18:04 FFR-guided full revascularisation versus

culprit only in ACS patients: is the evidencestrong enough to move it in daily PCI?E. Van Belle

18:16 Discussion and audience interaction18:23 Routine assessment of the microcirculation

and absolute flow: a glimpse to the futureN.H. Pijls


T. Cuisset




17:15 - 18:45ROOM 253

Cases

Venous interventionSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: H. Baumgartner (awaitingconfirmation)Panellists: Y. Goueffic (awaitingconfirmation), M.S. Mourali (awaitingconfirmation), J. Tan (awaitingconfirmation)

17:15 Arteriovenous malformation embolisationC.W. Khoo

17:23 Discussion and audience interaction17:28 Massive bleeding right hand arteriovenous

fistulaeJ. Molina-Martin de Nicolas

17:36 Discussion and audience interaction17:41 Innominate vein CTO angioplasty

P.S. Kanattu17:49 Discussion and audience interaction17:54 Catheter-directed intervention in

submassive pulmonary embolismH. Gurjar

18:02 Discussion and audience interaction18:07 Balloon angioplasty of CTO of long

segment of inferior vena cava and bilateraliliac veinsR. Bhardwaj

18:15 Discussion and audience interaction18:20 Percutaneous transluminal angioplasty

with venous stenting of CTO of subclavianand bilatral brachiocephalic veinsS. Kasturi

18:28 Discussion and audience interaction18:33 Superior vena cava stenting

M. Orzalkiewicz18:41 Discussion and audience interaction

17:15 - 18:45ROOM 341

Cases

CTO interventions: when to useOCT?Session comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: J. Spratt (awaitingconfirmation)Panellists: M. Ochiai, S.A. Pyxaras, K.K.Yeo

17:15 CT-scan and OCT-guided CTOrecanalisation by retrograde approachL. Teruel

17:23 Discussion and audience interaction17:28 Dissections, aneurysms, and eccentric

remodelling after CTO percutaneoustransluminal coronary angioplastyJ. Marques (awaiting confirmation)

17:36 Discussion and audience interaction17:41 Wire across, microcatheter would not pass,

what next? Use of excimer laser to facilitateballoon passage and intracoronary insightswith optical frequency domain imagingA. Khurana

17:49 Discussion and audience interaction17:54 Intravascular insights with OCT in a case of

CTO of the right coronary arteryA. Khurana

18:02 Discussion and audience interaction18:07 A case of OCT-guided PCI for CTO in the

anomalous origin of right coronary arteryfrom the left coronary sinusY. Otaki

18:15 Discussion and audience interaction18:20 Two-way strategies of excimer laser

coronary angioplasty for STEMI includingbifurcation lesion by OCT guidanceT. Ashikaga

18:28 Discussion and audience interaction18:33 A difficult case of coronary CTO and left

main angioplastyE. Tieranu





17:15 - 18:45ROOM 342A

Symposium

Cardioband for mitral repair: anew clinical realitySponsored by VALTECHChairperson: A. VahanianCo-Chairperson: S. Baldus (awaitingconfirmation)

Attend this session if you want:To understand how to perform mitralrepair in patients with functional mitralregurgitationTo learn more about case examples ofthe Cardioband procedures

17:15 Session objectivesA. Vahanian

17:20 A Cardioband case. Step by stepS. Baldus (awaiting confirmation)

17:45 Comments on the Cardioband caseF. Maisano

18:00 Discussion and audience interaction18:05 Echo guidance: navigation throughout the

procedureS. Von Bardeleben

18:20 Discussion and audience interaction18:25 The ideal Cardioband patient based on a

successful case presentation G. Nickenig (awaiting confirmation)

18:35 Session evaluation and key learningsA. Vahanian

17:15 - 18:45ROOM 342B

Cases

Bifurcation PCI: is there a placefor OCT?Session comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: M. PanPanellists: F. Burzotta, B.K. Kim, I. Kranjec

17:15 Optimising left main bifurcationangioplasty with optical frequency domainimaging: how to obtain the best result?M. Araya

17:23 Discussion and audience interaction17:28 Parallel coronary bifurcation treated with

Axxess DES: offline 3D OCT reconstructiondemonstrating stent implantation andavoidance of carina shiftZ. Yao

17:36 Discussion and audience interaction17:41 Left main coronary bifurcation treated with

T-stenting and protrusion: 3D OCTdemonstrating severe left main stentmalapposition flow cross-over left mainleft anterior descending stentingZ. Yao

17:49 Discussion and audience interaction17:54 OCT-guided PCI using V / simultaneous

kissing stenting technique for left anteriordescending diagonal bifurcation diseaseN.B. Senguttuvan

18:02 Discussion and audience interaction18:07 Hybrid culotte technique, complex

strategy at the beginning that becomessimple in the futureJ. Chavarria

18:15 Discussion and audience interaction18:20 More proximally, clearly, regionally;

guideliner-assisted OCT-guided PCIfacilitates complex lesion and complexpatient backgroundH. Iwama

18:28 Discussion and audience interaction18:33 OCT and left main disease

A. Kristensen18:41 Discussion and audience interaction




17:15 - 18:45ROOM 343

Cases

Challenges and complicationsduring transradial PCISession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: O. Bertrand (awaitingconfirmation)Panellists: S. Adiarto (awaitingconfirmation), S. Dutta, I.C. Hsieh

17:15 Radial artery perforation treated withguide catheterK. Hassan

17:23 Discussion and audience interaction17:28 Should free radial artery perforation abort

PCI?S. Mansour

17:36 Discussion and audience interaction17:41 Radial / brachial artery loops are not that

bad after all!H. Abu-Hantash

17:49 Discussion and audience interaction17:54 Securing the way in ACS: radial artery

angioplasty and right coronary artery PCIA. Lux

18:02 Discussion and audience interaction18:07 Radial access trouble shooting

A. Javed18:15 Discussion and audience interaction18:20 Oversheath retrieval of kinked guide

catheter through radial loopK. Longman

18:28 Discussion and audience interaction18:33 Removal of severely kinked diagnostic

catheter in radial artery using modifiednovel homemade snareP. Surunchupakorn


17:15 - 18:45ROOM 351

Cases

Stent thrombosis after PCISession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: T. AdriaenssensPanellists: M. Al Zaibag, A. Cequier, M.Loutfi

17:15 CTO and stent thrombosis treated withbioabsorbable stentA. Jurado-Roman

17:23 Discussion and audience interaction17:28 Stent failure presenting as left main

occlusion and cardiogenic shockH.D. Mejia-Renteria

17:36 Discussion and audience interaction17:41 How to overcome donor artery thrombosis

during retrograde CTO interventionM.W. Kim (awaiting confirmation)

17:49 Discussion and audience interaction17:54 Longitudinal stent deformation during

bifurcation stentingR. Vijayvergiya

18:02 Discussion and audience interaction18:07 Coronary intramural haematoma

characterised by OCT: a new mechanismfor acute stent thrombosisI.J. Amat-Santos

18:15 Discussion and audience interaction18:20 Safety and efficacy of delayed stenting in

STEMI after successful balloon angioplastyand establishing TIMI 3 flow when there isheavy thrombus burdenS. Sangaraju

18:28 Discussion and audience interaction18:33 Long-term consequence of

underexpanded stentW. Trenkner





17:15 - 18:45ROOM 352A

Cases

Coronary perforations: bailoutstrategies - part 1Session comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: M. NocPanellists: H. Gamra, B.C. Kalmath(awaiting confirmation), J. Legutko

17:15 A very delicate left anterior descendingcoronary arteryM. Nobre Menezes

17:23 Discussion and audience interaction17:28 A sipper-like covered stent

M. Verdoia17:36 Discussion and audience interaction17:41 Covered stent delivery through a five-in-six

mother and child catheter to treat Ellisgrade 3 coronary perforationN. Kumar (awaiting confirmation)

17:49 Discussion and audience interaction17:54 Bailout covered-stent implantation for left

main bifurcation perforationN. Moriyama

18:02 Discussion and audience interaction18:07 The perils of a calcified left anterior

descending arteryH. Khan

18:15 Discussion and audience interaction18:20 Coronary perforation, BRS and graft stent:

what can we see?S.J. Camacho Freire

18:28 Discussion and audience interaction18:33 Complication during treatment of a

bifurcation lesion in an elderly patientH. Rahbi (awaiting confirmation)


17:15 - 18:45ROOM 352B

Cases

Perforations / rupture duringCTO PCISession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: M. OstojicPanellists: S. El Tobgi, H. Ouda (awaitingconfirmation), G. Sianos

17:15 A great number of complications in thetolerant patientR. Khameneh Bagheri

17:23 Discussion and audience interaction17:28 How I managed a case of left anterior

descending perforation with minimalcomplicationA. Mohammadi (awaiting confirmation)

17:36 Discussion and audience interaction17:41 Complications in CTO: a succesful case of

treatment of vessel perforationA. La Manna

17:49 Discussion and audience interaction17:54 Septal collateral perforation during

retrograde CTO PCIA. Kalnins (awaiting confirmation)

18:02 Discussion and audience interaction18:07 Double coronary perforation during

percutaneous CTO recanalisationF. Colombo (awaiting confirmation)

18:15 Discussion and audience interaction18:20 Successful retrograde ipsilateral CTO

recanalisation complicated by coronaryperforationF. Colombo (awaiting confirmation)

18:28 Discussion and audience interaction18:33 Management of massive coronary

perforation after BRS: consecutiveping-pong and child-in-mother techniquesI.J. Amat-Santos





17:15 - 18:45ROOM 353

Abstracts

Primary PCI for STEMI: focus onthe myocardiumSession comprising selected EuroPCR 2016abstract submissionsChairperson: B. AlekyanPanellists: P. Motreff (awaitingconfirmation), D. Pahlajani

17:15 Euro16A-OP0945 - Coronary venous returnas perfusion myocardial indicator afterangioplasty primaryL.E. Berumen Dominguez

17:23 Discussion and audience interaction17:30 Euro16A-OP0913 - Intramyocardial

haemorrhage is highly frequent in theearly phase after succesfully reperfusedacute myocardial infarctionR. Tijssen (awaiting confirmation)

17:38 Discussion and audience interaction17:45 Euro16A-OP0823 - The impact of acute

alterations in glucose homeostasis onmyocardial microvascular function in thesetting of STEMIM.A. Van Lavieren

17:53 Discussion and audience interaction18:00 Euro16A-OP0852 - Impact of direct

stenting on in-hospital outcomes indiabetic patients with STEMII. Bessonov

18:08 Discussion and audience interaction18:15 Euro16A-OP1007 - Simple vs. complex

stenting strategy for the treatment ofcoronary true bifurcation lesions withmajor side-branch involvement in patientswith acute myocardial infarctionT. Seker

18:23 Discussion and audience interaction18:30 Euro16A-OP0243 - The simultaneous

application of bone marrow cell therapyand PCI in patients with STEMI and lateadmission may be a new useful strategy toprevent severe heart failureA. Nemkov


17:15 - 18:45ROOM

ARLEQUIN

Images

An image is worth 1,000 wordsSession comprising selected EuroPCR 2016 imagesubmissionsFacilitators: L. Räber, D. Walters, T. Zeus


interpretation D. Walters

17:20 Image 8: unveiled and key findingsD.A. Zabalawi

17:25 Image 8: discussion and audienceinteraction D. Walters


interpretation L. Räber

17:35 Image 9: unveiled and key findings D. Dvir

17:40 Image 9: discussion and audienceinteractionL. Räber


interpretation T. Zeus

17:50 Image 10: unveiled and key findingsP. Degrell

17:55 Image 10: discussion and audienceinterpretationT. Zeus


interpretationD. Walters

18:05 Image 11: unveiled and key findings I. Hendrickx

18:10 Image 11: discussion and audienceinterpretationD. Walters


interpretationL. Räber

18:20 Image 12: unveiled and key findingsJ. Adjedj

18:25 Image 12: discussion and audienceinterpretationL. Räber


interpretationT. Zeus

18:35 Image 13: unveiled and key findingsO. Hashimoto

18:40 Image 13: discussion and audienceinteractionT. Zeus



Wednesday 18 May 2016 - Morning - Programme valid as of 12-04-2016

- 08:00 -08:30 - 10:00

THEATRE BLEUIndiaLive@EuroPCR - BRS in theemerging worldWith the collaboration of IndiaLive

Attend this session if you want:To understand the optimal role of BRSin real life PCI patientsTo learn how to safely and efficientlyuse BRS in complex lesion subsetsTo give insights into the nextgeneration BRS

08:30 - 10:00THEATRE

BORDEAUX

FocusInnovation

Hot Line

Advances in PCI proceduraltechniqueChairpersons: I. Al Rashdan, W. Wijns(awaiting confirmation)Panellists: D. Kettles, R. Mohd Ali(awaiting confirmation), S. Nakamura, S.Pala (awaiting confirmation), A. Pichard,M. Singh Sandhu

08:30 Impact of radial vs. femoral access on acutekidney injury in patients with ACSinvasively managed: the AKI-MATRIX(Acute Kidney Injury-Minimizing adversehemorrhagic events by TRansradial accesssite and systemic Implementation ofangioX) substudyB. Cortese

08:37 Discussion and audience interaction08:42 The first report of a prospective, controlled,

randomised, open-labeled, multicentre,clinical study ";rap and beat trial"; toevaluate safety and efficacy of novel 6Frsmall outer diameter sheath for transradialcoronary angiography and intervention.S. Saito

08:49 Discussion and audience interaction08:54 What is the better stent and the better

access for the treatment of the left main inthe era of second-generation DES? Insightsfrom the FAILS-2, a multicentre registryincluding 1,270 patientsC. Moretti (awaiting confirmation)

09:01 Discussion and audience interaction09:05 Upper extremity function post-transradial

(TR)-PCI: interim resultsE. Zwaan (awaiting confirmation)

09:12 Discussion and audience interaction09:16 Sealing intermediate non-obstructive

coronary SVG lesions with DES as a newapproach to maintaining vein graftpatency and reducing cardiac events TheVELETI II randomised clinical trialJ. Rodes Cabau

09:23 Discussion and audience interaction09:27 Prospective randomised comparison of

clinical and angiographic outcomesbetween everolimus-eluting vs.zotarolimus-eluting stents for treatment ofcoronary restenosis in DES: IVUSvolumetric analysisS.J. Hong

09:34 Discussion and audience interaction09:38 Impact of coronary CT angiography on

planning of bifurcation PCIR. Wolny

09:45 Discussion and audience interaction09:49 Structural damage of jailed guidewire

during the treatment of coronarybifurcations: a microscopic randomisedtrialM. Pan






Montreal Live@EuroPCR -Integrated approach to thepatient requiring oralanti-coagulation andpercutaneous interventionsWith the collaboration of Montreal Live

Attend this session if you want:To understand how to plan andperform LAA closuresTo discuss available interventionaloptions to treat patient at high risk ofbleedingTo learn about best pharmacologicpractices to reduce bleedingcomplications


FocusInnovation

Plenary

What to expect fromsecond-generation BRS?Chairpersons: J. Ormiston, R. VirmaniPanellists: H. Call, C. Di Mario, H. Mudra,E. Tenekecioglu

Attend this session if you want:To acquire basic knowledge onmechanical properties of bioresorbablematerialsTo understand the keyphysico-chemical factors ofbioresorbable materials and theirimplications on scaffolding propertiesand microenvironmentTo provide an overview of thesecond-generation BRS, theirmechanical properties and theexpected clinical benefit

08:30 Session objectivesR. Virmani

08:35 Synopsis of unresolved issues withfirst-generation BRSL. Räber

08:43 Discussion and audience interaction08:55 How to manufacture a thinner and

stronger scaffold with faster resorption?A. Lafont (awaiting confirmation)

09:03 Discussion and audience interaction09:15 How to improve blood rheology around

struts?C. Bourantas

09:23 Discussion and audience interaction09:35 Insights from preclinical studies and

translation into clinical practiceM. Joner


J. Ormiston

08:30 - 10:00ROOM

LEARNING

Learning antegrade CTOFacilitators: H.J. Büttner, E. Barbato

Attend this session if you want:To review the techniques needed forantegrade approachTo better understand the mostappropriate equipment selectionTo find out how to overcome ormanage the most frequent issues

08:30 - 10:00ROOM TERNES 1

Cases

BRS in daily practiceSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: A. Al NooryaniPanellists: M. Al Ghamdi (awaitingconfirmation), P. Capranzano, H. Khamis

08:30 Outstanding conformability of BRSF. De Vroey

08:38 Discussion and audience interaction08:43 Complex hybrid BRS / DES

revascularisationM. Leoncini

08:51 Discussion and audience interaction08:56 What is the best approach to treat

restenosis in drug-eluting coronary BRS?D. Deleanu

09:04 Discussion and audience interaction09:09 How to deliver bioresorbable vascular

stents in a balloon-uncrossed CTO calcifiedlesion?W.C. Huang

09:17 Discussion and audience interaction09:22 Usefulness of second-generation BRS in

complex casesG. Vizzari

09:30 Discussion and audience interaction09:35 BRS implantation in a 61-year old female

patient allergic to chromium and cobaltwith malignant recurrent in-stentrestenosis and neoatherosclerosisP. Kubler

09:43 Discussion and audience interaction09:48 IVUS and OCT-guided BRS implantation for

spontaneous coronary dissectionM.M. Mahmood





08:30 - 09:30ROOM TERNES 2

Cases

Aortic endovascular strategiesfor challenging clinical settings -part 1Session comprising selected EuroPCR 2016 clinicalcase submissionsChairpersons: Y. Goueffic (awaitingconfirmation), C. Setacci

08:30 Endovascular repair of ascending aortapseudoaneurysm in a patient withprevious aortic valve replacement: lookingfor a tailored approach...R. Nerla

08:38 Discussion and audience interaction08:43 Key learnings

E. Blessing08:45 Endovascular treatment of post-CABG

aortic pseudoaneurysm by patent ductusarteriosus pfm medical coilM. Ostovan


A. Micari09:00 Covered cheatham-platinum stenting of

coarctation of aorta with thoracic aorticaneurysmS. Kasturi


A.K. Bozkurt (awaiting confirmation)09:15 Suprarenal aortic aneurysm with contained

rupture, complex anatomy, managed withthoracic endovascular aortic repair (TEVAR)R. Kapoor


J.C. Van Den Berg

08:30 - 10:00ROOM 241

Cases

Challenging indications forrotablator - part 1Session comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: A. OngPanellists: D.S. Gambhir, J.H. Heo, F.Mauri

08:30 Is it possible to leave nothing behind in aheavily calcified coronary artery?A. Allali

08:38 Discussion and audience interaction08:43 Plaque modification with bioreabsorbable

technology and drug-coated balloon fordiffuse and severe calcified bifurcatedlesionM. Fuertes (awaiting confirmation)

08:51 Discussion and audience interaction08:56 Rotational atherectomy in CTO over

retrograd externalised rotawireA. Katona (awaiting confirmation)

09:04 Discussion and audience interaction09:09 PCI of heavily calcified very old CTO in

post-CABG patient using out of the boxtechniqueL. Sayami (awaiting confirmation)

09:17 Discussion and audience interaction09:22 PCI for unexpanded stent, rotablator or

excimer laserS. Hosogi

09:30 Discussion and audience interaction09:35 Stentablation: a challenging option in

underespanded stent? A technicalexampleS. Benincasa (awaiting confirmation)

09:43 Discussion and audience interaction09:48 Rotational atherectomy of the left anterior

descending through a stented left mainN. Gonzalo


08:30 - 10:00ROOM 242AB


YoungPractitioners


Practitioners

A primer on transfemoral TAVI,from vascular access to vascularclosureSenior Advisor: A. VahanianFacilitators: D. Mylotte, A. Wolf

Attend this session if you want:To discuss the preliminary workup forpatients selection and proceduralplanningTo review the essential steps to asuccessful TAVI procedureTo understand what are the currentrates of complications and how toprevent them

08:30 - 10:00ROOM 243

PCR SharingCentre

What are the rewards and risksof social media in my dailypractice?Facilitators: S. Brugaletta, M. Gilard(awaiting confirmation), R. Lassiaille(awaiting confirmation)




08:30 - 10:00ROOM 251

Abstracts

Reperfusion treatment forSTEMI: the network matters!Session comprising selected EuroPCR 2016abstract submissionsChairperson: Z. KaifoszovaPanellists: M. Al Mutairi, G. Olivecrona, V.Schächinger

08:30 Euro16A-OP0834 - Time of arrival athospital impacts time to treatment of thepatients with STEMIY. Mizuguchi

08:38 Discussion and audience interaction08:43 Euro16A-OP0306 - Single-centre

experience of different primaryangioplasty activation service modelsS. Kalra

08:51 Discussion and audience interaction08:56 Euro16A-OP0322 - Primary PCI:

single-centre registryF. Malik

09:04 Discussion and audience interaction09:09 Euro16A-OP0737 - No difference in

mortality between weekday vs. weekendadmissions in patients undergoing primaryPCI for STEMIJ. Farley

09:17 Discussion and audience interaction09:22 Euro16A-OP0340 - Pharmaco-invasive

therapy: hybrid approach as a feasiblealternative for STEMI in developingcountriesT.S. Huq

09:30 Discussion and audience interaction09:35 Euro16A-OP0961 - Evolution of the

interventional reperfusion strategy andreperfusion times in acute STEMIS. Azzaz (awaiting confirmation)

09:43 Discussion and audience interaction09:48 Euro16A-OP0815 - Cost-effectiveness of

reperfusion strategies for STEMI: real-worlddata from the Stent For Life initiative inItalyG. Callea (awaiting confirmation)


08:30 - 10:00ROOM 252AB

Percutaneous treatment ofabdominal aortic aneurysmWith the collaboration of the ESC Working Groupon Aortic and Peripheral circulationChairpersons: M. Brodmann, G. Torsello(awaiting confirmation)Panellists: F. Fanelli, Z. Krajcer, E. Stabile

Attend this session if you want:To discuss what is the standardpercutaneous treatment of abdominalaortic aneurysm

08:30 Session objectivesG. Torsello (awaiting confirmation)

08:33 Review of the tools to be used during theLIVE demonstrationF. Fanelli

08:39 LIVE demonstration from CliniquePasteur - Toulouse, France


M. Brodmann

08:30 - 10:00ROOM 253

All you need to know about LAAclosureChairpersons: R. Birkemeyer, E. EeckhoutPanellists: F. Hellig, A. Tzikas


08:30 Session objectivesE. Eeckhout

08:35 Background and clinical dataR. Birkemeyer

08:48 Discussion and audience interaction08:55 Technical aspects - LAA closure with

imaging guidanceS. Berti

09:08 Discussion and audience interaction09:15 Recommendations: established indications

and resultsH. Sievert

09:28 Discussion and audience interaction09:35 Unresolved issues and outlook

O. Muller09:48 Discussion and audience interaction09:55 Session evaluation and key learnings

R. Birkemeyer




08:30 - 10:00ROOM 341

Abstracts

PCR's Got Talent - round1: TAVI -part 2Session comprising selected EuroPCR 2016abstract submissionsChairpersons: P. MacCarthy, C. Ruiz(awaiting confirmation)Jury Members: A.M. Al Abdullah, F.Castriota, M.K.Y. Lee, R. Makkar, F.Ribichini, T. Walther (awaitingconfirmation)

08:30 Introduction08:32 Euro16A-OP0194 - Post-procedural

troponin elevation and clinical outcomesfollowing TAVIK. Koskinas

08:36 Euro16A-OP0206 - Spinal analgesiaimproves outcomes of transapical aorticvalve implantation - a single-centreexperienceM. Silaschi

08:40 Euro16A-OP0365 - Establishing a TAVIprogramme at a hospital without cardiacsurgery department: successfulcooperation in the Heart Team withexternal cardiosurgical supportH. Eggebrecht

08:44 Euro16A-OP0372 - Real-life TAVI andisolated surgical aortic valve replacementFrench hospital data: trends, outcomesand improvementsG. De Pouvourville (awaiting confirmation)

08:48 Euro16A-OP0382 - New nitinol thin-filmheart valves: analysis of the nickelimmersionS. Pokorny

08:52 Euro16A-OP0877 - The failing right heart:implication and evolution in high-riskpatients undergoing transcatheter aorticvalve replacementL. Testa

08:56 Euro16A-OP0451 - Prognostic value ofrenal function in patients with aorticstenosis treated with TAVIR.A. Meneguz-Moreno

09:00 Euro16A-OP0512 - Post-implant geometryof self-expandable transcatheter heartvalve in patients with bicuspid aortic valvestenosisZ. Zhao

09:04 Euro16A-OP0557 - Significant aorticregurgitation as a result of the interactionof self-, balloon- andmechanically-expanded transcatheterheart valves with aortic rootR. Rodriguez Olivares

09:08 Euro16A-OP0560 - Patients' experiences ofrecovery after TAVI: a qualitative studyB.H. Kirk

09:12 Euro16A-OP0643 - Prognostic impact,imaging predictors of improvement, andpotential percutaneous management ofmitral regurgitation after transcatheteraortic valve replacement: a multicentrestudyI.J. Amat-Santos

09:16 Euro16A-OP0674 - Patient selection forTAVI: the Heart Team approachH. Makki

09:20 Euro16A-OP0741 - Prognostic impact ofearly recovery in ejection fraction afterTAVI in patients with baseline leftventricular dysfunctionM. Angelillis

09:24 Euro16A-OP0747 - Mild residual aorticregurgitation after TAVI: follow-upevolution, impact and predictors of pooroutcomes after five yearsN. Buzzatti

09:28 Euro16A-OP0876 - Persistence of severepulmonary hypertension aftertranscatheter aortic valve replacement:incidence and prognostic impactL. Testa

09:32 Euro16A-OP0383 - Off-pump aortic valveresectionS. Pokorny

09:36 Euro16A-OP0925 - Cost-effectiveness ofTAVI vs. surgical aortic valve replacement:the CoreValve High Risk trial from aEuropean perspectiveR.L.J. Osnabrugge

09:40 Euro16A-OP988 - Impact of antithrombotictherapy in TAVI outcomesD. Matos

09:44 Euro16A-OP0500 - Physical activity duringhospitalisation post TAVI - an importantpart of patient rehabilitationT.W. Andersen


for round 2




08:30 - 10:00ROOM 342A

Plenary

Critical appraisal of devices forthe management ofhypertensionWith the collaboration of the Practical Course onHypertension (PCH)Chairpersons: T.F. Lüscher, F. MahfoudPanellists: E. Edelman, K. Tsioufis

Attend this session if you want:To appreciate the design of currentlyavailable devices and how thesedevices are validated in clinical trialsTo discuss most recent data fromongoing clinical trials in interventionalhypertension treatmentTo get a glimpse on current and futuredevelopment in the field of device forthe management of hypertension

08:30 Session objectivesF. Mahfoud

08:31 MEDTRONIC's trial programme: GLOBALSYMPLICITY SPYRAL D. Kandzari

08:38 Strengths and limitations of the studyM. Burnier (awaiting confirmation)

08:43 Discussion and audience interaction08:46 ST JUDE's trial programme: ENLIGHTN

F. Mahfoud (awaiting confirmation)08:53 Strengths and limitations of the study

T. Zeller08:58 Discussion and audience interaction09:01 BOSTON SCIENTIFIC's trial programme:

REINFORCEM.B. Leon (awaiting confirmation)

09:08 Strengths and limitations of the studyM. Burnier (awaiting confirmation)

09:13 Discussion and audience interaction09:16 RECOR's trial programme: RADIANCE HTN

J. Daemen (awaiting confirmation)09:23 Strengths and limitations of the study

T. Zeller09:28 Discussion and audience interaction 09:31 KONA's trial programme: WAVE IV

R. Schmieder09:38 Strengths and limitations of the study

M. Burnier (awaiting confirmation)09:43 Discussion and audience interaction09:46 ABLATIVE SOLUTIONS' trial programme

S. Bertog09:53 Strengths and limitations of the study

T. Zeller09:57 Discussion and audience interaction09:59 Session evaluation and key learnings

T.F. Lüscher

08:30 - 10:00ROOM 342B

Cases

Acute and early stentthrombosisSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: M. SabatéPanellists: A. El Etriby, J.B. Lee, O.Varenne (awaiting confirmation)

08:30 Acute stent thrombosis: technicalcomplication or predisposition?I. Stanca

08:38 Discussion and audience interaction08:43 Subacute simultaneous stents thrombosis

in two different coronary arteriesI. Rafie (awaiting confirmation)

08:51 Discussion and audience interaction08:56 Unsolvable stent thrombosis during

complex bifurcation PCI in STEMI withcardiogenic shockR. Costa (awaiting confirmation)

09:04 Discussion and audience interaction09:09 Acute STEMI: a challenging thrombotic

complicationP. Deharo

09:17 Discussion and audience interaction09:22 Stent or drug failure? Managing heat when

it gets too hotM. Wolfrum

09:30 Discussion and audience interaction09:38 OCT-guided intervention in STEMI patient

due to acute stent thrombosisS. Furkalo

09:43 Discussion and audience interaction09:48 The great detour of the wire

A.M. Muthuppalaniappan09:56 Discussion and audience interaction




08:30 - 10:00ROOM 343

Abstracts

LAA closure: what's new?Session comprising selected EuroPCR 2016abstract submissionsChairperson: P. KolhPanellists: J.K. Min, N. Qamar (awaitingconfirmation), L. Varghese

08:30 Euro16A-OP0066 - LAA occlusion for strokeprevention in atrial fibrillation: the BelgianregistryJ. Kefer

08:38 Discussion and audience interaction08:43 Euro16A-OP0144 - Safety and efficacy of

intracardiac vs. transesophagealechocardiography for LAA occlusion withwatchman: a comparative single-centreconsecutive cohort studyR. Binder

08:51 Discussion and audience interaction08:56 Euro16A-OP0255 - Thrombus formation

after LAA occlusion with the AmplatzerAmulet DeviceA. Sedaghat

09:04 Discussion and audience interaction09:09 Euro16A-OP0200 - Device-associated

thrombus formation after LAA occlusion: asystematic review of events reported withthe Watchman, Amplatzer cardiac plugand Amulet devicesM. Lempereur

09:17 Discussion and audience interaction09:22 Euro16A-OP0476 - Short-term (45 days)

therapeutic anticoagulation following LAAclosure has no effect on clinical outcomesM. Buchbinder

09:30 Discussion and audience interaction09:35 Euro16A-OP0742 - Anticoagulation versus

antiplatelet therapy during the first 45days after LAA closure: efficacy and safetyresults of a registryA.R.G. Francisco

09:43 Discussion and audience interaction09:48 Euro16A-OP0264 - Single-centre

experience of LAA occlusion with theAmplatzer Cardiac Plug device in elderlypatientsS. Fateh-Moghadam


08:30 - 10:00ROOM 351

Abstracts

Intravenous adjunctiveantithrombotic therapies for PCISession comprising selected EuroPCR 2016abstract submissionsChairperson: A. Bellemain-Appaix(awaiting confirmation)Panellists: A. Bartorelli, W. Desmet, J.Ezhilan

08:30 Euro16A-OP0118 - Local intracoronarybolus administration of combinationEptifibatide and Streptokinase in primaryangioplastyZ. Mukhtar (awaiting confirmation)

08:38 Discussion and audience interaction08:43 Euro16A-OP1023 - Use of intracoronary

rt-PA on top of tirofiban administration inpatients with high residual thrombusburden after failed manual thrombectomyA. Nicolino

08:51 Discussion and audience interaction08:56 Euro16A-OP0525 - Phosphate- or

citrate-buffered tirofiban vs.unfractionated heparin on the rates ofthrombocytopenia and outcomes inpatients with NSTE-ACS: a post-hocanalysis from the platelet receptorinhibitor in ischaemic syndromemanagement trialS. Ariotti

09:04 Discussion and audience interaction09:09 Euro16A-OP0664 - Incidence, predictors,

and outcomes of thrombocytopenia afterPCI: a pooled, patient-level analysis of theCHAMPION trialsM. Price

09:17 Discussion and audience interaction09:22 Euro16A-OP0584 - Impact of

anticoagulation strategy with bivalirudinor heparin for PCI on non-access sitebleedings: a meta-analysis of randomisedtrialsM. Verdoia

09:30 Discussion and audience interaction09:35 Euro16A-OP0393 - Post-procedural

bivalirudin infusion combined with potentP2Y12 inhibition following primary PCI toreduce stent thrombosisT. Kinnaird

09:43 Discussion and audience interaction09:48 Euro16A-OP0671 - Clinical outcomes

associated with bailout glycoproteinIIb/IIIa inhibitor use during PCI in theCHAMPION PHOENIX trialJ. Abtan





08:30 - 10:00ROOM 352A

How Should ITreat?

Croatia and Poland share theirmost educational cases:high-risk left main PCI in acutemyocardial infarction andcardiogenic shockWith the collaboration of the Working Group onInterventional Cardiology of the Croatian CardiacSociety and the Association of CardiovascularInterventions of the Polish Cardiac SocietyChairpersons: D. Dudek, E. Margetic

Attend this session if you want:To understand differences in left mainPCI technique used for high-riskpatients with STEMI and shock incomparison to elective stable patientsTo learn about advantages andlimitations of advanced mechanicalsupport (left ventricular assist device,extracorporeal membraneoxygenation) for high-risk left main PCITo reflect on optimal concomitantpharmacotherapy for high-risk leftmain PCI

08:30 Session objectivesE. Margetic

08:35 Case 1: high-risk left main PCI for acutemyocardial infarction with cardiogenicshock facilitated by venoarterialextracorporeal membrane oxygenationZ. Baricevic

08:40 How would I treat the case?W. Wojakowski

08:45 How would I treat the case?V. Tomulic

08:50 How did I treat the case?Z. Baricevic


D. Dudek09:15 Case 2: high-risk left main PCI with left

ventricular assist device support early afterinferior myocardial infarction complicatedby cardiogenic shockJ. Legutko

09:20 How would I treat the case?V. Tomulic

09:25 How would I treat the case?W. Wojakowski

09:30 How did I treat the case?J. Legutko


E. Margetic09:55 Session evaluation and key learnings

D. Dudek

08:30 - 10:00ROOM 352B

How Should ITreat?

Latvia and Russia share theirmost educational cases: firsthours of STEMI - modern trendsin the treatmentWith the collaboration of the Working Group onInterventional Cardiology of the Latvian Society ofCardiology and the Russian Society ofInterventional CardioangiologyChairpersons: A. Erglis, D.G. Iosseliani

Attend this session if you want:To understand the effectiveness ofearly myocardial reperfusion usingcombined pharmacological andendovascular techniquesTo learn modern trends in thetreatment of STEMITo reflect on the maximally earlyrestoration of antegrade blood flow inthe infarct-related artery

08:30 Session objectivesA. Erglis

08:35 Case 1: delayed intervention in a patientwith ACS and reinfarctionD. Sondore

08:40 How would I treat the case?S.P. Semitko

08:45 How would I treat the case?I. Kumsars

08:50 How did I treat the case?D. Sondore


D.G. Iosseliani09:15 Case 2: early myocardial reperfusion in

STEMI using combined thrombolytic andendovascular therapyD. Asadov

09:20 How would I treat the case?I. Kumsars

09:25 How would I treat the case?S.P. Semitko

09:30 How did I treat the case?D. Asadov


A. Erglis09:55 Session evaluation and key learnings

D.G. Iosseliani




08:30 - 10:00ROOM 353

Abstracts

Stent thrombosis: predictors andpreventivesSession comprising selected EuroPCR 2016abstract submissionsChairperson: A. GershlickPanellists: T. Adriaenssens, N. Amabile,C.H. Lee (awaiting confirmation)

08:30 Euro16A-OP0132 - BRS and thrombosis:insights from the GHOST-EU registryH. Kawamoto

08:38 Discussion and audience interaction08:43 Euro16A-OP1041 - Long-term risk of stent

thrombosis and restenosis after treatmentwith DES: a report from SCAARE. Omerovic

08:51 Discussion and audience interaction08:56 Euro16A-OP0847 - Quantitative coronary

angiography parameters do not predictthe one-year incidence of scaffoldthrombosis or device-oriented eventsfollowing implantation of BRS: quantitativecoronary angiography data from theBVS-EXAMINATION studyT. Gori

09:04 Discussion and audience interaction09:09 Euro16A-OP1097 - Three-year clinical

results of patients randomised to three- or12-month DAPT after zotarolimus-elutingstent implantationR. Costa (awaiting confirmation)

09:17 Discussion and audience interaction09:22 Euro16A-OP0524 - Gender-related impact

on two-year clinical outcomes in patientstreated with a six-month or 24-monthDAPT duration: insights from the PRODIGYtrialG. Gargiulo

09:30 Discussion and audience interaction09:35 Euro16A-OP0391 - One-year outcome after

PCI with polymer-free amphilimus-elutingstents in patients needing very short DAPT:the Italian Cre8 stent registryC. Godino

09:43 Discussion and audience interaction09:48 Euro16A-OP1093 - Long-term follow-up of

patients presenting with definite orprobable stent thrombosis after DESimplantationR. Costa (awaiting confirmation)


08:30 - 09:30ROOM

ARLEQUIN

FocusInnovation

Plenary

Will ABSORB III change mypractice? Chairpersons: A. Baumbach, C.Tamburino

Attend this session if you want:To achieve a detailed understanding ofthe results of a particular publishedtrial that may impact your clinicalpractice To evaluate the relevance of newresults for the treatment of yourpatients To share the current and futurepractice with colleagues from aroundthe world

08:30 Introduction - the trial headlinesA. Baumbach

08:35 A representative case from the study: howshould I treat?H. Nef

08:40 Discussion: what is common practicewhere you work?

08:45 What was known before ABSORB III?S. Cook

08:55 Trial(ist) review: methods, results,conclusionsD. Capodanno

09:10 Discussion and audience interaction: dowe need to change practice?

09:15 Case conclusion: how does this apply tomy practice?H. Nef





- 10:00 -10:30 - 12:00

THEATRE BLEUBRS in long lesions: optimisingimplantation resultsChairpersons: C. Cook, M. HaudePanellists: E. Edelman, T. Gori, D. Holmes,U. Kaul, T. Majwal, J. Ormiston

Attend this session if you want:To review available evidence of BRSTo learn practical application andlimitationsTo discuss the potential benefits ofnew technology

10:30 Session objectivesC. Cook

10:33 BRS for long lesions: what is known fromclinical studies?J. Hill (awaiting confirmation)

10:40 Time to React@PCR10:47 OCT and other techniques for procedural

guidanceT. Adriaenssens


LIVE demonstrationU. Kaul

11:07 LIVE demonstration from the NationalHeart Centre Singapore - Singapore


M. Haude

10:30 - 12:00THEATRE

BORDEAUX

FocusInnovation

Imaging and functionalassessmentChairpersons: B. De Bruyne (awaitingconfirmation), J. EscanedPanellists: J.J. Bax, C. Kyriakakis, M.Monaghan, L. Räber, H. Samady, R.Waksman

10:30 First-in-man evaluation of a compact,cardiac-oriented, dual tube CT scannerR. Rubinshtein

10:37 Discussion and audience interaction10:42 Non-invasive identification of high-risk

vulnerable coronary atherosclerotic plaqueusing 18f-sodium fluoride positronemission tomography in patients withstable coronary artery diseaseJ.M. Lee

10:49 Discussion and audience interaction10:54 Haemodynamic force analysis improves

non-invasive prediction of risk of ACS: theresults of first-in-man EMERALD (Exploringthe MEchanism of the plaque Rupture inAcute coronary syndrome using coronaryCT angiography and computationaL fluidDynamics) studyJ.M. Lee

11:01 Discussion and audience interaction11:05 PlaqueTec liquid biopsy system

N.E.J. West11:12 Discussion and audience interaction11:16 Intravascular assessment of arterial

diseases using compensated OCT:comparison and validation with histologyN. Foin

11:23 Discussion and audience interaction11:27 Quantitative assessment of

microcirculatory blood flow and resistance:a new window on the coronarymicrocirculationN.H. Pijls

11:34 Discussion and audience interaction11:38 A novel way of performing FFR: the first

dedicated infusion and pressure wiredelivery micro-catheterA. Elghamaz

11:45 Discussion and audience interaction11:49 100% non-contrast pre-treatment CT and

percutaneous endovascular abdominalaortic aneurysm repair using image fusionL.R. Virgen-Carrillo (awaiting confirmation)






Streamlining TAVI: how tobalance simplication, safety andefficacyChairpersons: M. Gilard, C. TamburinoPanellists: R. Gao (awaitingconfirmation), R. Makkar, H. Moellmann,R. Mohd Ali (awaiting confirmation)

Attend this session if you want:To learn how to select patients for astreamlined approach to TAVITo learn more about simplifyingin-hospital management of TAVIpatients

10:30 Session objectivesC. Tamburino

10:33 How to streamline TAVI procedures A. Linke (awaiting confirmation)


LIVE demonstrationM. Gilard

10:52 LIVE demonstration from SwissCardiovascular Centre, Bern UniversityHospital - Bern, Switzerland

11:32 Time to React@PCR11:42 Achieving the balance between

simplification and safetyP. MacCarthy


M. Gilard


FocusInnovation

Plenary

Innovative devices for tailoredmanagement of patients withdecompensated heart failureChairpersons: J. Bartunek, S. VerheyePanellists: J. Goicolea (awaitingconfirmation), G. Tarantini, J. Van DerHeyden, D. Weiss

Attend this session if you want:To become familiar with the role ofnew device-based interventions for themanagement of heart failure To understand how clinical andpathological factors govern deviceselectionTo understand the clinical outcomesassociated with devices for theinterventional treatment of advancedheart failure

10:30 Session objectivesJ. Bartunek

10:35 Direct invasive monitoring of congestiveheart failure

10:43 Discussion and audience interaction10:55 Left ventricular offloading in chronic heart

failure D. Burkhoff

11:03 Discussion and audience interaction11:15 New pacing targets for neuromodulation

in heart failureA. Erglis

11:23 Discussion and audience interaction11:35 When every therapy fails - catheter-based

approach for pump failureJ. Bartunek


S. Verheye

10:30 - 12:00ROOM

LEARNING

Learning retrograde CTOFacilitators: O. Gaemperli, O. GoktekinMedia Driver: A. Bacaksiz (awaitingconfirmation)Expert panellists: H.J. Büttner, R. Garbo

Attend this session if you want:To review the techniques needed forretrograde approachTo learn how to perform the techniquestep by step:

- Planning: pre-procedural aspects - Treating: procedural tools andtechniques - Preventing and managing: potentialprocedure-related complications




10:30 - 12:00ROOM TERNES 1

Cases

BRS, from single to very complexlesionsSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: I. Al RashdanPanellists: N. Melikian, S. Nakamura, A.Serra

10:30 Scaffold edge dissection in a primary PCI: isBRS post-dilation safe in STEMI culpritlesions?A. Sanchez-Espino

10:38 Discussion and audience interaction10:43 Excimer laser facilitated coronary

angioplasty of a heavily calcified lesiontreated with BRSR. Jabbour

10:51 Discussion and audience interaction10:56 True ostial left anterior descending lesion

treated with BRSA. Menozzi

11:04 Discussion and audience interaction11:09 Bioabsorbable vascular scaffold therapy in

a patient with sclerotic left anteriordescending disease and myocardialbridgingG. Friedrich

11:17 Discussion and audience interaction11:22 Treating BRS restenosis with another

newer novel BRSA. Bhatia (awaiting confirmation)

11:30 Discussion and audience interaction11:35 Pushing BRS to their limits: coronary

perforation and left main stem culotteM. Jackson

11:43 Discussion and audience interaction11:48 Disruption of BRS struts due to loss of

radial integrityA.R. Ramalho


10:30 - 12:00ROOM TERNES 2

Abstracts

Vascular supra aortic disease: anexpanding area for endovascularinterventionsSession comprising selected EuroPCR 2016abstract submissionsChairperson: Y. Goueffic (awaitingconfirmation)Panellists: I.C. Hsieh, H. Khamis, B.Reimers

10:30 Euro16A-OP0171 - Long-term outcome ofpatients undergoing carotid arterystenting in high-volume centresJ. Schofer

10:38 Discussion and audience interaction10:45 Euro16A-OP0636 - Outcomes of carotid

artery stenting with different types ofembolic protectionM. Malevannyi

10:53 Discussion and audience interaction11:00 Euro16A-OP0647 - Intermediate clinical

outcomes after endovascular stenting ofsymptomatic carotid artery disease withnear occlusion: a single-centre experiencein TaiwanC.H. Lee (awaiting confirmation)

11:08 Discussion and audience interaction11:15 Euro16A-OP0675 - Carotid artery stenting

with double cerebral embolic protectiontechnique in asymptomatic patients:diffusion-weighted MRI studyE. Vuruskan

11:23 Discussion and audience interaction11:30 Euro16A-OP0371 - Outcomes of stent

retriever thrombectomy for acuteischaemic stroke treatmentY. Kulikovskikh

11:38 Discussion and audience interaction11:45 Euro16A-OP0914 - Retrieval of larger

thrombi during thrombectomy isassociated with improved neurologicalrecoveryA.S. Autar





10:30 - 12:00ROOM 241

Plenary

The year in intervention:essential publications from theEuroIntervention Journal andthe European Heart JournalWith the collaboration of the EuroInterventionJournal and the European Heart Journal (EIJ-EHJ)Chairpersons: P.W. Serruys, W. Wijns(awaiting confirmation)Panellists: P. Cummins, S.B. King III

Attend this session if you want:To appraise these essential papers inthe form of robust, solid summariesTo reflect on the impact of thesepublications in your daily practice

10:30 Session objectivesP.W. Serruys

10:35 Percutaneous valvular intervention andTAVIN. Van Mieghem

10:50 Discussion and audience interaction11:15 Discussion and audience interaction11:20 Hypertension

J. Daemen11:25 Discussion and audience interaction11:30 Coronary intervention in stable coronary

artery diseaseP.G. Steg


W. Wijns (awaiting confirmation)

10:30 - 12:00ROOM 242AB


YoungPractitioners


Practitioners

This coronary is puzzling, turnthe light on (or rather theultrasound?): intravascularimaging before and after stentimplantationSenior Advisor: G. GuagliumiFacilitators: T. Johnson (awaitingconfirmation), M. Radu

Attend this session if you want:To understand when IVUS should bepreferred to OCT, and vice versaTo appreciate the advantages ofintracoronary diagnostics forprocedural planning and optimisationTo get insights into the properexecution of intravascular imaging

10:30 - 12:00ROOM 243

Focus ClinicalResearch

PCR SharingCentre

How to critically analyse apublished trial to improve mydaily practice: randomisedclinical trialFacilitators: R. Byrne, D. Capodanno

10:30 - 12:00ROOM 251


Professionals

Plenary

Ventricular assist devices incritical ill patients - the role ofnurses and allied professionals Facilitators: S. Carson, H. Faltot

Attend this session if you want:To understand what ventricular assistdevices are and how they workTo gain knowledge in the risk andbenefits of ventricular assist devicesTo recognise the principal ethicalissues with patients in critical condition

10:30 Session objectivesH. Faltot

10:35 Ventricular assist devices - rationale andmanagement in the coronary cathlabF. Pereira (awaiting confirmation)

10:50 Discussion and audience interaction11:02 Ventricular assist devices - problems and

issuesJ. Andersson

11:17 Discussion and audience interaction11:29 Ventricular assist devices - bridge to

survivalM. Sailer


H. Faltot

10:30 - 12:00ROOM 252AB

Treatment options for aortoiliacbifurcation and CTOChairpersons: A. Cremonesi, H. ReineckePanellists: O. Al Shammeri, M. Bosiers, R.Lorenzoni, E. Stabile

Attend this session if you want:To discuss what is the standardapproach for a safe aortoiliacprocedure today in: bifurcation lesion -CTO lesion

10:30 Session objectivesH. Reinecke

10:33 Review of the tools to be used during theLIVE demonstrationH. Reinecke



A. Cremonesi




10:30 - 12:00ROOM 253

All you need to know aboutpercutaneous mitral valve repairChairpersons: N. Moat, A. Vahanian


10:30 Session objectivesN. Moat

10:35 Background: mitral valve anatomy andpathophysiologyA. Vahanian

10:48 Discussion and audience interaction10:55 Technical aspects - Mitraclip procedure

with imaging guidanceS. Von Bardeleben

11:08 Discussion and audience interaction11:15 Recommendations - established

indications and results11:28 Discussion and audience interaction11:35 New systems and procedures in the

pipelineC. Grasso


A. Vahanian

10:30 - 12:00ROOM 341

Abstracts

PCR's Got Talent - round 1:Stents and scaffoldsSession comprising selected EuroPCR 2016abstract submissionsChairpersons: C. Di Mario, R. KoningJury Members: A. Bartorelli, G. Cayla, N.Curzen, A. De Belder, P. Ludman

10:30 Introduction10:32 Euro16A-OP0086 - Clinical outcomes after

implantation of bioresorbable stents in areal-world setting with predilatation,guided by IVUS and OCTS. Tarbine (awaiting confirmation)

10:36 Euro16A-OP0146 - Everolimus-eluting BRSthrombosis: is it myth or reality? - A trialsequential meta-analysis, clinical andstatistical significance analysisI. Tanboga

10:40 Euro16A-OP0222 - Stent thrombosis of DESand BRS: evidence from a networkmeta-analysis of 147 trialsS.H. Kang

10:44 Euro16A-OP0276 - Procedural safety andintermediate term efficacy ofZotarolimus-eluting Resolute Integritystent in the management of native verylong segment coronary artery lesion: aprospective observational real world studywith 12-month follow-upS. Patra

10:48 Euro16A-OP0373 - Clinical outcomes ofdiabetic patients treated with anamphilimus-eluting stent and a shortduration of DAPT in routine clinicalpractice: first results of the Utrecht Cre8(U-Cre8) registryR. Rozemeijer

10:52 Euro16A-OP0427 - Impact of gender onone-year outcomes after implantation ofdrug-eluting BRSM. Baquet

10:56 Euro16A-OP0483 - Comparison ofintracoronary brachytherapy outcomesamong patients with in-stent restenosispost single and multiple DES implantationJ. Singh

11:00 Euro16A-OP0572 - Impact of the vessel sizeon the angiographic and clinical outcomeafter implantation of everolimus-elutingBRS during daily practice: insights from theISAR ABSORB registryJ. Wiebe

11:04 Euro16A-OP0624 - Can BRS be adequatelyimplanted without intracoronary imaging?V. Flore

11:08 Euro16A-OP0692 - A meta-analysis of thesafety and efficacy of bioresorbable stentsvs. DES in ischaemic heart diseaseJ. Yap

11:12 Euro16A-OP0743 - Plastic healing ofspontaneous coronary artery dissectionusing BRS: a multicentre registryF. Zilio

11:16 Euro16A-OP0745 - PROcedure relatedmicrovascular ACTIVation in long lEsionstreated with BRS vs. everolimus-elutingstent implantation (PROACTIVE trial)M. Pellicano

11:20 Euro16A-OP0752 - Outcomes ofbioresorbable-polymer versusdurable-polymer everolimus-eluting stentsin patients with "complex" clinical andanatomical characteristicsM. Mennuni (awaiting confirmation)

11:24 Euro16A-OP0766 - An everolimus-elutingplatinum-chromium stent with durablepolymer evaluated in a real-worldall-comer population in RotterdamCardiology Hospital (the P-SEARCHregistry) Lemmert

11:28 Euro16A-OP0865 - Difference inhaemodynamic micro environment invessels scaffolded with BRS: a preclinicalstudy of endothelial shear stressE. Tenekecioglu

11:32 Euro16A-OP0907 - Clinical outcomes afterimmediate vs. delayed invasiveintervention in patients with NSTEMI:long-term follow-up of the randomisedRIDDLE-NSTEMI studyD. Milasinovic

11:36 Euro16A-OP0964 - Register of comparativeclinical use of the first Russian coronarystent with bioabsorbable polymer andzotarolimus DESA. Sozykin

11:40 Euro16A-OP1053 - Bioresorbable coronarydevices in diabetic patients: immediateand 30-day results of the REPARA registryF. Hernandez

11:44 Euro16A-OP1064 - Clinical outcomes ofmultiple, overlapping everolimus-elutingBRS: a subanalysis of the prospectivemulticentre Italian RAI registryM. Mojoli


for round 2




10:30 - 12:00ROOM 342A

Plenary

Catheter-based renaldenervation exchange forumaround the globe: building thefuture By and For yourexperienceWith the collaboration of the Practical Course onHypertension (PCH)Chairpersons: C. Lotan, K. TsioufisPanellists: M. Ntsekhe, A. Witkowski

Attend this session if you want:To learn and share your experience inthe field of catheter-based renaldenervationTo actively review and discuss currentevidenceTo express your opinion on how toreconcile the future of device-basedtherapies

10:30 Session objectivesK. Tsioufis

10:38 Hypertension around the globe - differentphenotypes, similar challenges!S. Laurent (awaiting confirmation)

10:45 Discussion and audience interaction10:53 The GLOBAL SYMPLICITY registry - what to

learn from 3000 patients treated aroundthe globeR. Schmieder

11:00 Discussion and audience interaction11:08 The nationwide UK registry on renal

denervationM.D. Lobo (awaiting confirmation)

11:15 Discussion and audience interaction11:23 The French DENER-HTN study - extended

follow-upA. Pathak

11:30 Discussion and audience interaction11:38 How to reconcile the evidence

F. Mahfoud11:45 Discussion and audience interaction11:53 Session evaluation and key learnings

C. Lotan

10:30 - 12:00ROOM 342B

Plenary

Challenging decisions in NSTEMIpatients Chairpersons: S. James, M. RoffiPanellists: L. Bolognese, M. Degertekin

Attend this session if you want:To discuss optimal interventionaltreatment strategies in NSTEMIpatientsTo assess options for periproceduralpharmaco-therapy To review the relevantrecommendations from the 2015 ESCpractice Guidelines

10:30 Session objectivesS. James

10:35 Case 1 - NSTEMI in a patient onhaemodialysis C. Hamm

10:43 Discussion and audience interaction10:55 Case 2 - NSTEMI and multivessel coronary

diseaseJ. Mehilli

11:03 Discussion and audience interaction11:15 Case 3 - NSTEMI in the elderly

S. Savonitto11:23 Discussion and audience interaction11:35 Case 4 - NSTEMI patient anticoagulated for

atrial fibrillation undergoing PCIJ.P. Collet


M. Roffi




10:30 - 12:00ROOM 343

Abstracts

TAVI in complex situationsSession comprising selected EuroPCR 2016abstract submissionsChairperson: G. ManoharanPanellists: A.M. Al Abdullah, K.Hayashida, M.S. Lin

10:30 Euro16A-OP0457 - Adverse effects of lowbody weight on outcomes in patientsundergoing TAVI or surgical aortic valvereplacementM. Spaziano

10:38 Discussion and audience interaction10:43 Euro16A-OP0275 - Impact of coronary

artery disease on clinical outcomes amongpatients undergoing TAVI: an age- andsex-matched cohort studyA. Franzone

10:51 Discussion and audience interaction10:56 Euro16A-OP0738 - Acute and

medium-term outcomes of TAVI inpatients with cirrhosisD. Regazzoli (awaiting confirmation)

11:04 Discussion and audience interaction11:09 Euro16A-OP0548 - Combined

percutaneous treatment of aortic stenosisand mitral regurgitationM. Patanè

11:17 Discussion and audience interaction11:22 Euro16A-OP0471 - Severe predicted

patient-prosthesis mismatch as a predictorof long-term mortality after aorticvalve-in-valve: insights from theValve-in-Valve International Data registry(VIVID)M. Simonato

11:30 Discussion and audience interaction11:35 Euro16A-OP0217 - Safety and efficacy of a

fully repositionable and retrievabletranscatheter heart valve in patients withbicuspid aortic valve stenosis: an analysisfrom the RESPOND studyD. Blackman

11:43 Discussion and audience interaction11:48 Euro16A-OP0205 - Is bivalirudin the

anticoagulant of choice for diabeticpatients with aortic stenosis undergoingTAVI? Insights from the BRAVO-3 study


10:30 - 12:00ROOM 351

Abstracts

Newer oral and intraveneousP2Y12 inhibitors for PCISession comprising selected EuroPCR 2016abstract submissionsChairperson: A. GershlickPanellists: S. Alam, A. Chopra (awaitingconfirmation), S. Jolly (awaitingconfirmation)

10:30 Euro16A-OP0986 - Premature disruptionand discontinuation of prasugrel andischaemic outcomes among patients withSTEMIL. Räber

10:38 Discussion and audience interaction10:43 Euro16A-OP0756 - Duration of PCI

procedure and risk of thrombotic andbleeding complications: insights from theCHAMPION PHOENIX trialP. Genereux

10:51 Discussion and audience interaction10:56 Euro16A-OP0085 - Safety and effectiveness

of the new P2Y12r inhibitors agents vs.clopidogrel in ACS patients according tothe geographic area: East Asia vs. EuropeF. Giordana (awaiting confirmation)

11:04 Discussion and audience interaction11:09 Euro16A-OP0344 - Effect of pretreatment

with P2Y12 receptor antagonists onmortality in patients undergoing PCI - areport from SCAARE. Omerovic

11:17 Discussion and audience interaction11:22 Euro16A-OP0904 - Impact of prasugrel vs.

clopidogrel therapy in complex PCI forACS: results from the PROMETHEUS studyJ. Chandrasekhar

11:30 Discussion and audience interaction11:35 Euro16A-OP0310 - Cangrelor is associated

with similar ischaemic risk but lower severebleeding risk compared with clopidogreland routine glycoprotein IIb / IIIainhibitors: a propensity-score matchedanalysis from the CHAMPION trialsM. Vaduganathan (awaiting confirmation)

11:43 Discussion and audience interaction11:48 Euro16A-OP0600 - Cangrelor

P2Y12-inhibition in real-life patients withSTEMID. Erlinge





10:30 - 12:00ROOM 352A

How Should ITreat?

Czech Republic and Slovakiashare their most educationalcases: how to handle thepotential complication duringtransfemoral TAVIWith the collaboration of the Czech InterventionalCardiology Association (CICA) and the SlovakWorking Group of Interventional CardiologyChairpersons: V. Fridrich, J. Stasek

Attend this session if you want:To understand potential complicationof the transfemoral TAVITo learn how to handle potentialcomplications during the procedureTo share the experience on how toresolve indication in complicatedpatients

10:30 Session objectivesV. Fridrich

10:35 Case 1: TAVI complicated by closure of leftmain during the procedureJ. Petrus

10:40 How would I treat the case?M. Mates

10:45 How would I treat the case?S. Juhas

10:50 How did I treat the case?J. Petrus


J. Stasek11:15 Case 2: TAVI valve-in-valve implantation in

a patient with very small anatomyM. Branny

11:20 How would I treat the case?S. Juhas

11:25 How would I treat the case?M. Mates

11:30 How did I treat the case?M. Branny


V. Fridrich11:55 Session evaluation and key learnings

J. Stasek

10:30 - 12:00ROOM 352B

How Should ITreat?

Germany and South Africa sharetheir most educational cases:how should I treat early and lateBRS failure?With the collaboration of the German NationalWorking Group of Interventional Cardiology (AGIK)and the South African Society of CardiovascularIntervention (SASCI)Chairpersons: A. Elsaesser (awaitingconfirmation), D. Kettles

Attend this session if you want:To understand the differentmechanisms and causes underlyingBRS failureTo reflect on the role of intravascularimaging in assessing BRS failureTo learn possible treatment strategiesfor acute and late BRS relatedcomplications

10:30 Session objectivesA. Elsaesser (awaiting confirmation)

10:35 Case 1: early and late BRS failure: expectthe unexpected!T. Schmitz

10:40 How would I treat the case?J.P. Theron

10:45 How would I treat the case?M. Abdel-Wahab

10:50 How did I treat the case?T. Schmitz


D. Kettles11:15 Case 2: good technique, bad result

D. Jankelow11:20 How would I treat the case?

M. Abdel-Wahab11:25 How would I treat the case?

J.P. Theron11:30 How did I treat the case?

D. Jankelow11:40 Discussion and audience interaction11:50 Consensus

A. Elsaesser (awaiting confirmation)11:55 Session evaluation and key learnings

D. Kettles




10:30 - 12:00ROOM 353

Abstracts

Functional assessment ofcoronary stenosis: from invasiveto non-invasiveSession comprising selected EuroPCR 2016abstract submissionsChairperson: G. DucrocqPanellists: S. Doucet (awaitingconfirmation), J. Dugal (awaitingconfirmation), S. Sen

10:30 Euro16A-OP1009 - Increased dose ofadenosine do not improve accuracy in FFRD. Zughaft

10:38 Discussion and audience interaction10:45 Euro16A-OP0770 - Clinical implications of

guiding extubation during FFRmeasurementsC. Pouillot

10:53 Discussion and audience interaction11:00 Euro16A-OP0948 - Impact of diabetes on

contrast-based FFR performanceG. Esposito (awaiting confirmation)

11:08 Discussion and audience interaction11:15 Euro16A-OP1030 - Feasibility and

diagnostic precision of in-procedurecomputed FFR: the Wire-free InvasiveFunctional Imaging (WIFI) study Krogsgaard Andersen

11:23 Discussion and audience interaction11:30 Euro16A-OP0827 - FFR prediction model

based on conventional quantitativecoronary angiography and the amount ofmyocardium subtended by anintermediate coronary artery stenosisL. Di Serafino

11:38 Discussion and audience interaction11:45 Euro16A-OP1027 - An FFR CT diagnostic

strategy vs. usual care in patients withsuspected coronary artery disease plannedfor coronary angiography at German sites:results of a subgroup analysis of thePLATFORM studyR. Colleran


10:30 - 11:30ROOM

ARLEQUIN

FocusInnovation

Plenary

Will LEADERS FREE change mypractice?Chairpersons: M. Behan, M.B. Leon


10:30 Introduction - the trial headlinesM. Behan

10:35 A representative case from the study: howshould I treat?K.G. Oldroyd


10:45 What was known before Leaders Free?G.G. Stefanini

10:55 Trial(ist) review: methods, results,conclusionsM. Valgimigli


11:15 Case conclusion: how does this apply tomy practice?K.G. Oldroyd

11:20 Discussion and audience interaction11:25 Concluding remarks

M.B. Leon




- 12:00 -12:30 - 14:30

THEATRE BLEU

Tools andTechniques

(TNT)

Left main and complexbifurcation stentingSponsored by TERUMOChairperson: M.C. Morice (awaitingconfirmation)Co-Chairperson: M. Al MutairiPanellists: R. Das, F. Fabbiocchi, R. Garbo,N.R. Holm, R. Kornowski, J. Stewart

Attend this session if you want:To understand how to propose thebest treatment option for the patientspresenting with left main and complexbifurcation lesionsTo learn how to optimise both strategyand technique using novel imagingtechnologies and PCI devicesTo share the latest Ultimaster DESresults in left main and bifurcations

12:30 Session objectivesM.C. Morice (awaiting confirmation)

12:33 Review of the tools to be used during theLIVE demonstrationM.C. Morice (awaiting confirmation)


13:18 Time to React@PCR13:25 Long term clinical outcome of bifurcation

lesions treated with UltimasterF. Fabbiocchi

13:30 A new device for complex PCI - FineDuoMicrocatheter R. Das

13:35 Review of the tools to be used during theLIVE demonstrationM.C. Morice (awaiting confirmation)



M. Al Mutairi

12:30 - 14:30THEATRE

BORDEAUX

Tools andTechniques

(TNT)

What is required for TAVI tobecome the standard of care inaortic stenosis patients?Sponsored by EDWARDS LIFESCIENCESChairperson: J. Rodes CabauCo-Chairperson: A. OwensPanellists: J.J. Bax, M. Guenoun, F.Leclercq, J. Webb

Attend this session if you want:To understand whether TAVI can beconsidered standard of care for aorticstenosis patientsTo understand the TAVI perspective ofa general cardiologistTo learn whether guideline changesare required to allow TAVI to be anoption for more patientsTo learn how innovation of the newSAPIEN 3 system further streamlinesthe procedure and advances patientcare

12:30 Session objectives: "What are the maindrivers for treatment choice in aorticstenosis today"J. Rodes Cabau

12:33 "Why would I like to see more patientstreated with TAVI ?" - Perspective of aGeneral CardiologistM. Guenoun

12:38 Review of the tools to be used during theLIVE demonstrationA. Owens


13:23 Time to React@PCR13:30 How to implement clinical practice in the

absence of new guidelines?J.J. Bax

13:35 Review of the tools to be used during theLIVE demonstrationJ. Rodes Cabau

13:40 Recorded case from St. Paul Hospital -Vancouver, Canada

J. Webb14:15 Time to React@PCR14:22 TAVI: from an option for few patients to an

option for many patients - What isrequired?F. Leclercq

14:27 Session evaluation and key learningsA. Owens





Tools andTechniques

(TNT)

PCI in diabetic patients: turningchallenges into today's solutionSponsored by ALVIMEDICA MEDICALTECHNOLOGIESChairperson: S. VerheyeCo-Chairperson: E. Eeckhout

Attend this session if you want:To understand how, and in which way,to improve PCI clinical outcome indiabetic patientsTo share how to manage complex PCIsin diabetic patients throughtransmitted LIVE caseTo learn the added efficacy and safetyvalue provided by theamphilimus-eluting polymer-free DES -Cre8

12:30 Session objectivesS. Verheye

12:32 Review of the tools to be used during theLIVE demonstrationS. Verheye


13:22 Time to React@PCR13:34 How the controlled formulation elution of

the polymer-free Cre8 DES impacts efficacyin diabetics R. Byrne

13:41 The latest Cre8 clinical evidence indiabetics empowers unique Amphilimusformulation efficacy G. Sardella

13:51 The polymer-free Cre8 DES in my everydayclinical practiceP. Stella

13:58 Session evaluation and key learningsE. Eeckhout


EBACaccreditation


programme

Managing the patient with anacute coronary syndrome /coronary artery disease:optimising antiplatelettreatment and reducing futureriskEBAC Accreditation has been applied for -Programme supported by an unrestrictededucational grant from ASTRAZENECAChairperson: P.G. StegCo-Chairperson: S. James

Attend this session if you want:To appreciate the clinical pathway forpatients with an acute coronarysyndrome / coronary artery diseaseand the critical decision points withregard to treatment and surgicalinterventionTo understand the current treatmentoptions for patients with an acutecoronary syndrome / coronary arterydisease and the roles of DAPT inreducing ongoing cardiovasculardisease To recognise the factors guidinglong-term clinical care plans forpatients with an acute coronarysyndrome / coronary artery diseaseand explore the optimal time ofinitiation and duration of DAPT

12:30 Session objectivesP.G. Steg

12:35 The patient with an acute coronarysyndrome: a clinical case study to optimiseDAPT - key decision pointsM. Valgimigli

12:55 Discussion and audience interaction13:05 Current control: treatment options for the

patient with an acute coronary syndrome /coronary artery diseaseR. Mehran

13:20 Discussion and audience interaction13:30 Future risk: risk assessment and long-term

treatment of the patient with an acutecoronary syndrome / coronary arterydiseaseU. Zeymer


S. James

12:30 - 14:00ROOM

LEARNING

Learning imaging for TAVIFacilitators: D. Mylotte, N. PiazzaExpert panellist: M. Chen

Attend this session if you want:To better understand the differentimaging modalities before, during andafter TAVI in 2016, including:

- Sizing - Access - Device choice

To find out how to overcome ormanage the potential complications




12:30 - 13:30ROOM TERNES 1

Cases

PCI for thrombotic left mainlesionSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: J. Tan (awaitingconfirmation)

12:30 Left anterior descending primary PCIresulting in unexpected left main stentingI. Ntarladimas


S.L. Chen (awaiting confirmation)12:45 Thrombotic lesion of a large left main: long

and dubious road to successI. Hadzibegovic


P. Karjalainen (awaiting confirmation)13:00 Thrombus at left main coronary artery:

destiny or coincidence?E. Karacop


I. Sheiban13:15 A simple solution to a complex primary PCI

P. Manoria13:23 Discussion and audience interaction13:28 Key learnings

S.M. Hiremath

12:30 - 13:30ROOM TERNES 2

Cases

Resistant hypertensionmanagementSession comprising selected EuroPCR 2016 clinicalcase submissionsChairpersons: F. Mahfoud, F. Ribichini

12:30 Repeated sympathetic renal denervationwith a tetra-polar radiofrequency catheterthree years after ablation with unipolarcatheterF. Ribichini


A. Pathak12:45 Simultaneous renal denervation and

coronary stenting in ACST. Szük


F. Sharif13:00 Resistant hypertension secondary to aortic

isthmus atresia treated withradiofrequency perforation and coveredstentF. Scalise


K. Tsioufis13:15 Critical stenosis of the renal artery in

patient with hypertension refractory tomedical therapy treated withself-expandable DESC. Moncalvo


E. Stabile

12:30 - 13:30ROOM 241

Symposium

Portico transcatheter aorticvalve: when novel technologydrives optimal clinical outcomesSponsored by ST. JUDE MEDICALChairperson: S. WorthleyCo-Chairperson: F. Maisano

Attend this session if you want:To learn about the latest worldwidedevelopments with the St. JudeMedical Portico aortic valveTo review and discuss a selection ofcomplex TAVI cases and how the totalresheathing technology helps solvingthemTo review the use of Portico andSolopath re-collapsible sheath for thechallenging femoral access

12:30 Session objectivesS. Worthley

12:35 St. Jude Medical overview programmemilestones - Transfemoral Europeanclinical results updateH. Moellmann

12:47 Discussion and audience interaction12:52 How Portico helps solve challenging cases:

horizontal aorta and calcified annulusL. Sondergaard

13:04 Discussion and audience interaction13:09 The use of the Solopath re-collapsible

sheath for troublesome femoral accesswith the Portico transcatheter valveA. Linke


F. Maisano

12:30 - 14:00ROOM 242AB


YoungPractitioners


Practitioners

I'm not treating a stenosis, I'mtreating a patient withischaemia! FFR made easySenior Advisor: B. De BruyneFacilitators: P. Deharo, G. Toth

Attend this session if you want:To learn a practical protocol for FFR usein your cathlabTo get insights into the properexecution of FFRTo appreciate strengths andopportunities of FFR, iFR and hybridstrategies in the diagnostics ofcoronary atherosclerosis




12:30 - 13:30ROOM 251

Case in Point

Left main disease: solving theprocedural challenges with aballoon-delivered self-apposingsirolimus-eluting stentSponsored by STENTYSChairperson: C. TamburinoCo-Chairperson: A. Baumbach

Attend this session if you want:To understand how self-apposingstents can overcome the challenges ofsizing and apposition in left mainstentingTo understand how balloon delivery ofself-apposing stents allows accuratepositioning and simplifies thetreatment of left main diseaseTo learn about the data and ongoingtrials supporting the use ofself-apposing stents in left main


12:36 Optimising management of a largediameter mismatch between left main andleft anterior descendingC. Briguori

12:43 Discussion and audience interaction12:53 Optimising management of ostial disease

with a single stent strategyM. Meyer-Gessner

13:00 Discussion and audience interaction13:10 Optimising management of left main

stenting as a bifurcationC. Kaiser


A. Baumbach

12:30 - 13:30ROOM 252AB

Symposium

Orsiro - Strengths and evidencefor an ultrathin strutbioabsorbable polymer DES incomplex lesionsSponsored by BIOTRONIKChairperson: J.F. Lassen

Attend this session if you want:To explore mechanical properties ofmodern, ultrathin strut, stent designTo experience the acute performanceof Orsiro in complex coronary lesionsTo understand the long-term clinicalevidence supporting Orsiro also in highrisk subgroups

12:30 Session objectivesJ.F. Lassen

12:33 Review of design attributes andmechanical properties of a modernultrathin DESN. Foin

12:43 Discussion and audience interaction12:47 Complex lesions - Case and follow-up: e.g.

calcified and tortuous lesionsJ. Van Der Heyden

12:57 Discussion and audience interaction13:00 Complex lesions - Case and follow-up: e.g.

bifurcationsH.C. Gwon

13:10 Discussion and audience interaction13:13 3-year outcomes for Orsiro in high-risk

subgroupsJ.F. Iglesias


J.F. Lassen




12:30 - 13:30ROOM 253

Cases

Percutaneous interventions inthe tricuspid valve and thepulmonary veinsSession comprising selected EuroPCR 2016 clinicalcase submissionsChairpersons: G. Manoharan, G. Nickenig

12:30 Percutaneous balloon valvotomy inpericardial bioprosthetic tricuspid valvestenosisC. Kanaderm (awaiting confirmation)


J. Goicolea (awaiting confirmation)12:45 First report of successful tricuspid

valvuloplasty using the MitraClip systemA. Mangieri (awaiting confirmation)


P. Musialek (awaiting confirmation)13:00 The first reported percutaneous

angioplasty with self-apposing DESimplantation for pulmonary vein stenosis:a one year follow-upM. Mielczarek


G. Manoharan13:15 Pulmonary vein in-stent restenosis: a snake

biting its tailA. Azzano


I. Reda

12:30 - 13:30NURSES AND

ALLIEDPROFESSIONALS

CORNER


Professionals

Abstracts

Nurses and Allied Professionalsmoderated postersChairpersons: M. De Ronde, R. Esteves

13:30 Euro16A-POS1037 - Teaching ofradiographic staff in the cardiac catheterlaboratory

13:30 Euro16A-POS0560 - Patients' experiencesof recovery after TAVI: a qualitative study

13:30 Euro16A-POS0543 - Study and imagingpre-TAVI

13:30 Euro16A-POS0920 - Occupationalexposures to ionising radiation frominterventional cardiology: literature andpractice review

13:30 Euro16A-POS0581 - Wearable cardioverterdefibrillator, a bridge-to-decisionprotection for patients with ischaemicheart failure

12:30 Euro16A-POS0009 - The prevention andmanagement of complications duringpercutaneous interventions

13:30 Euro16A-POS0885 - Interim results of anew paclitaxel-coated DEB in real-worldPCI indications

12:30 - 13:30ROOM 341

Cases

How to deal with coronaryperforation in ACS setting?Session comprising selected EuroPCR 2016 clinicalcase submissionsChairpersons: T. Mabin, J. Spratt(awaiting confirmation)

12:30 Coronary perforation after post-dilationA.A. Farsavian


A.G. Osiev12:45 Coronary artery perforation during primary

angioplastyR. Bhardwaj


F. Saia13:00 Coronary perforation in a patient

presenting with STEMIF.C. Fernandez


V. Schächinger13:15 Coronary perforation managed with

covered stent and pericardiocentesisT.R. Iragavarapu


G. Ghanem

12:30 - 13:30ROOM 342A

Case in Point

Your complex PCI: how can newtechnologies enhanceprocedural success? Sponsored by ORBUSNEICHChairperson: M. HaudeCo-Chairperson: M. Joner

Attend this session if you want:To review CTO techniques with a newgeneration balloon (Sapphire II Pro) toincrease your success rates in the mostdifficult casesTo review solutions for highly calcifiedlesions with complex anatomy wherescoring balloons can be an alternativeto rotablationTo share your own clinical experiencein similar scenarios and learn fromeach other

12:30 Session objectivesM. Haude

12:35 Simplifying CTO: the right device selectionis critical for success R. Van Der Schaaf

12:45 Discussion and audience interaction13:00 The challenge in tackling calcified lesions

with complex anatomyT. Kinnaird


M. Joner




12:30 - 13:30ROOM 342B

FocusInnovation

CRO / ARO

Planned and ongoing clinicaltrials: a status update fromCardiovascular Imaging CoreLaboratories (CICL)With the collaboration of Cardiovascular ImagingCore Laboratories (CICL)Chairpersons: H.G. Bezerra, H. Samady

Attend this session if you want:To be updated on planned or ongoingclinical trials that may change ourfuture practiceTo gain in-depth understanding of trialdesign and executionTo learn about upcoming milestonesfor trial recruitment, analysis andpresentation plan

12:30 Session objectivesH.G. Bezerra

12:35 OCT assessment of acute and nine-monthfollow-up results of bioresorbable vascularscaffolds implantation in CTOA. La Manna

12:42 Discussion and audience interaction12:45 A comparison of FFR CT, invasive FFR and

OCT for the assessment of coronary arterydisease severityH.G. Bezerra

12:52 Discussion and audience interaction12:55 Evaluation of wall-shear stress and

neointimal healing following PCI ofangulated vessels with resolute integrityzotarolimus-eluting coronary stentcompared to XIENCE XPEDITIONeverolimus-eluting coronary stent - theSHEAR-STENT studyH. Samady

13:02 Discussion and audience interaction13:05 Volumetric assessment by OCT of vascular

resistance ratio in comparison withinvasive FFRH.G. Bezerra

13:12 Discussion and audience interaction13:15 The REALITY study - prospective,

multicentre, IVUS / angiographic core labadjudicated observational study to assessatherectomy device effectiveness todebulk moderate and severely calcifiedfemoropopliteal artery atheroscleroticlesions in patients with symptomaticperipheral arterial diseaseK. Rocha-Singh


H. Samady

12:30 - 13:30ROOM 343

FocusInnovation

CRO / ARO

Update on new clinical trials atthe Cardiovascular ResearchFoundation (CRF)With the collaboration of Cardiovascular ResearchFoundation (CRF)Chairpersons: O. Ben-Yehuda (awaitingconfirmation), G.W. Stone


12:30 Session objectivesO. Ben-Yehuda (awaiting confirmation)

12:35 Horizons-Absorb: harmonising outcomeswith revascularisation, stents and Absorbin acute myocardial infarctionG.W. Stone

12:42 Discussion and audience interaction12:45 TAVR UNLOAD: transcatheter aortic valve

replacement to unload the left ventricle inpatients with advanced heart failure - arandomised trialM.B. Leon

12:52 Discussion and audience interaction12:55 Early TAVR: evaluation of a strategy of

transcatheter aortic valve replacementcompared to a strategy of medicalobservation in the treatment ofasymptomatic severe aortic stenosis P. Genereux

13:02 Discussion and audience interaction13:05 Biorest liposomal alendronate

administration for diabetic patientsundergoing drug-eluting stentpercutaneous coronary interventionO. Ben-Yehuda (awaiting confirmation)

13:12 Discussion and audience interaction13:15 Reducer: coronary sinus reducer for

refractory anginaG.W. Stone


G.W. Stone




12:30 - 13:30ROOM 351

Symposium

Bioresorbable vascular scaffoldsin your daily practice: why andhow to start?Sponsored by ABBOTT VASCULARChairperson: C.K. NaberCo-Chairperson: A. Colombo

Attend this session if you want:To understand how bioresorbablevascular scaffolds can progress PCIbeyond the acute treatmentTo learn more about which patientsbenefit most from longer term benefitsof bioresorbable vascular scaffoldsTo learn from beginning to advancedusage - how to handle the learningcurve


12:35 Exploring the potential benefits ofbioresorbable vascular scaffolds for yourpatientsN.E.J. West

12:45 Discussion and audience interaction12:52 How did I overcome my learning curve

with bioresorbable vascular scaffolds?T. Gori

13:02 Discussion and audience interaction13:09 From beginning to advanced experience

with bioresorbable vascular scaffolds -which patients to select best?C.K. Naber


A. Colombo

12:30 - 13:30ROOM 352A

Cases

Left main disease andcardiogenic shockSession comprising selected EuroPCR 2016 clinicalcase submissionsChairpersons: D. Dudek, A. Ghanem

12:30 Critical left main coronary artery stenosisbifurcation stenosis in ACS withcardiogenic shock tackled successfullyA. Kandoria


S. Alkandari12:45 "Ménage à trois" for left main trifurcation

disease for cardiogenic shockN. Kumar (awaiting confirmation)


M. De Belder (awaiting confirmation)13:00 STEMI with cardiogenic shock: what is the

best way to salvage myocardium and thepatient?A. Khurana


C. Spaulding13:15 Left main STEMI in polycythemia vera with

cardiogenic shockD. Kaewkes





12:30 - 14:30ROOM 352B

How Should ITreat?

Cyprus, Greece and the UnitedKingdom share their mosteducational cases: complicationsduring coronary intervention: ifthey cannot be avoided, howshould they be treated?With the collaboration of the Cyprus InterventionalCardiology Working Group, the Greek WorkingGroup of Interventional Cardiology and the BritishCardiovascular Intervention Society (BCIS)Chairpersons: S. Constantinides, A. DeBelder, G. Sianos

Attend this session if you want:To understand the risks ofcomplications during coronaryintervention and their mechanismsTo appreciate the importance ofpromptly recognising thesecomplicationsTo learn ways of dealing with variouscomplications safely and successfully

12:30 Session presentationS. Constantinides

12:32 Session objectivesG. Sianos

12:34 Case 1: catheter-induced left maindissection during PCI: recognition andmanagementN. Eteokleous

12:39 How would I treat the case?A. Banning

12:44 How would I treat the case?S. Theodorou

12:49 How did I treat the case?N. Eteokleous


S. Constantinides13:10 Case 2: epicardial channel perduring the

retrograde approachN. Konstantinidis

13:15 How would I treat the case?S. Theodorou

13:20 How would I treat the case?K. Raisakis

13:25 How did I treat the case?N. Konstantinidis


G. Sianos13:46 Case 3: management of wire detachment

in a coronary arteryN. Curzen

13:51 How would I treat the case?K. Raisakis

13:56 How would I treat the case?A. Banning

14:01 How did I treat the case?N. Curzen


A. De Belder14:22 Session evaluation and key learnings

A. De Belder

12:30 - 13:30ROOM 353

Cases

Acute dissection during PCISession comprising selected EuroPCR 2016 clinicalcase submissionsChairpersons: K. Al-Shaibi, F. Eberli

12:30 When the nightmare keeps coming backJ. Leon Jimenez


J.F. Tanguay12:45 Spontaneous coronary dissection: out of a

frying pan into the fireA. Paggi


M. Al Zaibag13:00 An unreported complication of PCI

G. Manik (awaiting confirmation)13:08 Discussion and audience interaction13:13 Key learnings

P. Karjalainen (awaiting confirmation)13:15 Coronary dissection during PCI: past,

present and future D. Foley (awaiting confirmation)

12:30 - 13:30ROOM

ARLEQUIN

Cases

Management of large coronaryaneurysmSession comprising selected EuroPCR 2016 clinicalcase submissionsChairpersons: H. Amin, M. Noc

12:30 IVUS-guided treatment of large coronaryaneurysmA. Khashaba


K. Niemela12:45 Management of coronary aneurysms: the

bigger, the better?A. Schaffer


M. Lesiak13:00 Percutaneous coiling of circumflex

aneurysmK. Longman


F. Mauri13:15 Giant coronary aneurysm in a patient with

non-ST myocardial infarctionA.R.G. Francisco (awaiting confirmation)


H. Gamra




- 13:00 -13:35 - 14:35

ROOM TERNES 1

Cases

PCI in multivessel disease: fromevidence-basedrecommendations to dailypracticeSession comprising selected EuroPCR 2016 clinicalcase submissionsChairpersons: H. Amin, A. Marchese

13:35 Complex coronary angioplasty: whichwould be your coronary stenting strategy?L. Paiva


H. Danenberg13:50 Complex angioplasty in multivessel

disease and severe ventricular dysfunction- haemodynamic support with ImpellaJ.M. Benitez Peyrat (awaiting confirmation)


P. Calvert14:05 What... and when are we going to do? (A

complex case of STEMI with multipledecisions to make)I. Calin


G. Cassel14:20 Less is more but sometimes more is better:

a complex case of three vessel diseaseL. Barbieri


O. Varenne (awaiting confirmation)

13:35 - 14:35ROOM TERNES 2

Cases

When IVUS is mandatorySession comprising selected EuroPCR 2016 clinicalcase submissionsChairpersons: J.M. De La TorreHernandez, A. Pichard

13:35 IVUS-guided management of spontaneouscoronary dissection presenting withlocalised coronary thrombusS. Sangaraju


J. Legutko13:50 To aspirate or not

Sim-Apura13:58 Discussion and audience interaction14:03 Key learnings

J. Goicolea (awaiting confirmation)14:05 A rare cause of ACS - the usage of

intravascular imagingL.C. Sung


H.M. Garcia-Garcia14:20 Unexpected refractory coronary spasm

after stenting caused by not onlyoverstretching, but also...S. Cho


G. Ghanem




13:35 - 14:35ROOM 241

Symposium

The Lotus Valve: simplifyingtreatment strategies andoptimising outcomes in the realworldSponsored by BOSTON SCIENTIFICChairperson: I. MeredithCo-Chairperson: T. FeldmanDiscussant: K. Dawkins

Attend this session if you want:To recognise key features andprocedural aspects of the Lotus valveTo learn how paravalvular leak can beminimised despite anatomicalcomplexitiesTo understand the current clinicalevidence, latest clinical data andpipeline

13:35 Session objectivesI. Meredith

13:40 My real-world experience with the LotusvalveM. Götberg

13:50 Discussion and audience interaction13:55 The Lotus valve: the benefit of total control

to simplify clinical practiceF. Castriota

14:05 Discussion and audience interaction14:10 TAVI in intermediate risk patients

L. Sondergaard14:20 Discussion and audience interaction14:25 Building the next chapter in transcatheter

valves - Lotus Edge and beyondK. Dawkins

14:31 Session evaluation and key learningsT. Feldman

13:35 - 14:35ROOM 251

Case in Point

Individualised treatmentdecision and novel technologyto improve patient outcome incomplex PCISponsored by MEDTRONICChairperson: T. CuissetCo-Chairperson: D. Kandzari

Attend this session if you want:To discuss individualised treatmentdecision to improve patient outcomein complex PCITo reflect on current technique tosolving complex PCI challenges: CTO,complex left main and long diffusediseaseTo learn about usefulness of noveltechnology in the treatment ofcomplex PCI

13:35 Session objectivesT. Cuisset

13:40 A patient with long diffuse lesionsP. De Araujo Goncalves

13:47 Discussion and audience interaction13:57 A patient with coronary CTO

O. Mendiz14:04 Discussion and audience interaction14:14 A patient with complex left main

R. Mohd Ali (awaiting confirmation)14:21 Discussion and audience interaction14:31 Session evaluation and key learnings

D. Kandzari




13:35 - 14:35ROOM 252AB

Symposium

Restoring the balance in atrialfibrillation stroke prophylaxiswith LAA occlusion: how toprevent strokes while avoidingbleedsSponsored by ST. JUDE MEDICALChairperson: H. SievertCo-Chairperson: D. Hildick-Smith

Attend this session if you want:To understand which patients maybenefit from LAA occlusion based onrecent developments, guidelines andconsensus statementsTo learn about implanting LAAocclusion devicesTo know how to start a LAA occlusionprogramme and how to get patientsreferred

13:35 Session objectivesH. Sievert

13:39 Patient selection: should we change ourpractice based on new data?L. Sondergaard

13:48 Discussion and audience interaction13:52 LAA anatomy; the LAA is unique as a

fingerprint, how to close thosesuccessfully?H. Omran

14:01 Discussion and audience interaction14:05 How to treat the untreatable; what are the

options?D. Arzamendi

14:14 Discussion and audience interaction14:18 How to successfully build a referral LAA

practice? Involving referrals is key, but howto do that?W. Budts


D. Hildick-Smith

13:35 - 14:35ROOM 253

Cases

ACS with unexpected scenarioSession comprising selected EuroPCR 2016 clinicalcase submissionsChairpersons: P. Ludman (awaitingconfirmation), A. Ochala

13:35 Spontaneous coronary artery dissection: ifstable, wait and seeK. Bejar


M. Bunc13:50 High-risk ACS with "vanishing" three-vessel

diseaseS. Schnupp (awaiting confirmation)


A. El Etriby14:05 Successfull treatment in a patient of

cardio-pulmonary arrest with ACS andabdominal aortic aneurysm ruptureK. Dan


M.J. Bosiers14:20 Course of early ischaemic mitral

regurgitation during NSTEMI in the era ofPCIF. Boukerche


A. Low

13:35 - 14:35ROOM 341

Cases

Sealing strategies for coronaryperforations clinical case submissionsChairpersons: J. Belardi, H. Eteiba(awaiting confirmation)

13:35 Cardiogenic shock caused by pericardialand intraventricular haematoma with rightventricle obstruction caused by coronaryinterventionO. Hashimoto


A. Erglis13:50 Plugging the leak

J. Kolanthaivelu13:58 Discussion and audience interaction14:03 Key learnings

M. Lesiak14:05 The successful haemostasis with gelatine

sponge for the coronary perforationT. Iwaki

14:13 Discussion and audience interaction14:18 Key learnings14:20 It is never too late for a complication

K. Hassan14:28 Discussion and audience interaction14:33 Key learnings

H.C. Tan




13:35 - 14:35ROOM 342A

Symposium

Advancing BRS throughinnovative biomaterialsSponsored by REVA MEDICALChairperson: A. AbizaidCo-Chairperson: N. Frey

Attend this session if you want:To gain insight into REVA's novelbiomaterialsTo get a better understanding of theimplant and imaging advantages ofthe Fantom scaffoldTo see current clinical data from theFantom BRS clinical trial series

13:35 Session objectivesA. Abizaid

13:40 Advantages of desaminotyrosinepolycarbonate polymersG.W. Stone

13:52 Discussion and audience interaction13:57 Case reviews: results from selected Fantom

clinical casesL. Koltowski

14:09 Discussion and audience interaction14:14 FANTOM II trial: clinical results from the

Fantom sirolimus-eluting BRSN. Frey


A. Abizaid

13:35 - 14:35ROOM 342B

FocusInnovation

CRO / ARO

Planned and ongoing clinicaltrials: a status update fromMediolanum CardiovascularResearch (MCR)With the collaboration of MediolanumCardiovascular Research (MCR)Chairpersons: A. Colombo, M.C.J. Jori

Attend this session if you want:To be updated on planned or ongoingclinical trials that may change ourfuture practiceTo gain in depth understanding of trialdesign and executionTo learn about upcoming milestonesfor trial recruitment, analysis andpresentation plan

13:35 Session objectivesM.C.J. Jori

13:40 The ELDERLY ACS 2 study: a comparison ofreduced-dose prasugrel and clopidogrel inelderly patients with ACS undergoing earlyPCI - an updateS. Savonitto

13:47 Discussion and audience interaction13:50 BIO.DETECT HF IV - SELENE HF: selection of

potential predictors of worsening heartfailure - a prospective, multicentre,exploratory studyA. Gargaro (awaiting confirmation)

13:57 Discussion and audience interaction14:00 The DEB SFA-LONG study: safety and

efficacy of the drug-eluting balloon for thetreatment of the superficial femoral arteryischaemic vascular disease in symptomaticpatients presenting with long lesions:lesson learned and perspectives - anupdate A. Micari

14:07 Discussion and audience interaction14:10 The WOLARE trial: women LAA

morphology difference trial - a multicentreprospective observational trialM. Mennuni

14:17 Discussion and audience interaction14:20 The AURORE SD registry: a long term

observational study of LAA closure - whyanother registryG. Vicedomini


A. Colombo




13:35 - 14:35ROOM 343

FocusInnovation

CRO / ARO

Planned and ongoing clinicaltrials: a status update fromgenaeWith the collaboration of genaeChairpersons: M. Brodmann, A. Talen(awaiting confirmation)


13:35 Session objectivesA. Talen (awaiting confirmation)

13:40 An update on the DESolve programmeM. Vrolix

13:47 Discussion and audience interaction13:50 ILLUMINATE: an update on the Stellarex

drug-coated balloon clinical programmeM. Brodmann

13:57 Discussion and audience interaction14:00 Providing technology from emerging

markets and collecting robust datathrough collaborationD. Scheinert (awaiting confirmation)

14:07 Discussion and audience interaction14:10 Study objectives, design and status of the

MValve mitral valve replacement systemJ. Bartunek

14:17 Discussion and audience interaction14:20 The SAPIEN 3 global clinical experience

M. Urena14:27 Discussion and audience interaction14:30 Session evaluation and key learnings

M. Brodmann

13:35 - 14:35ROOM 351

Symposium

Sudden cardiac death riskmanagement: are you screeningand protecting your post acutemyocardial infarction patients?Sponsored by ZOLLChairperson: M. HaudeCo-Chairperson: H. Nef

Attend this session if you want:To understand the risk of suddencardiac death after AMITo discuss how to protect the post-MIpatient from sudden cardiac deathwith the Wearable CardioverterDefibrillatorTo learn more about the actualWearable Cardioverter Defibrillatordata and screening tools

13:35 Session objectivesH. Nef

13:38 Clinical case scenario Part I: evaluation andtreatment of the myocardial infarctionpatient G. Nickenig

13:48 Clinical updates - sudden cardiac deathrisk assessment and the guidelinesJ. Monsegu

14:03 Screening protocols and the WearableCardioverter Defibrillator: a systematic wayto protect myocardial infarction patientsfrom sudden cardiac deathP.A.M. Sinha

14:18 Clinical case scenario Part II: using theWearable Cardioverter Defibrillator toprotect the post-myocardial infarctionpatientG. Nickenig


M. Haude




13:35 - 14:35ROOM 352A

Cases

PCI and cardiac support: fromintra-aortic balloon pump toextracorporeal membraneoxygenationSession comprising selected EuroPCR 2016 clinicalcase submissionsChairpersons: T.H. Koh, M. Noc

13:35 Impellent impellerF. Costa


G. Olivecrona13:55 PCI in cardiogenic shock under

veno-arterial extracorporeal membraneoxygenation (VA-ECMO) supportJ.S. Park


M. De Belder (awaiting confirmation)14:15 Extracorporeal membrane oxygenation

supported double vessel STEMI PCIfollowed by severe platelet reductionN. Kuroiwa


D. Dudek

13:35 - 14:35ROOM 353

Cases

Diagnostic insights from OCT clinical case submissionsChairpersons: T. Adriaenssens, F. Prati

13:35 STEMI in a teenager with acne: aetiologicalinsights from imagingH.D. Mejia-Renteria


T. Akasaka13:55 Misfortune never goes singly!

C.F. Lin (awaiting confirmation)14:05 Discussion and audience interaction14:12 Key learnings

J. Tan (awaiting confirmation)14:15 OCT-guided primary PCI: an ignored culprit

lesion discovered by OCT!C.F. Lin (awaiting confirmation)


A. Al Nooryani

13:35 - 14:35ROOM

ARLEQUIN

Cases

Management of aneurysm inacute myocardial infarctionSession comprising selected EuroPCR 2016 clinicalcase submissionsChairpersons: F. Hellig, U. Kaul

13:35 Treatment of an ectatic right coronaryartery in a STEMI caseG. Amoroso


R. Parma13:50 STEMI in an aneurysmatic right coronary

artery: a challenging caseM. Siry


A.G. Osiev14:05 Recurrent thrombotic occlusion of

aneurysmal right coronary arteryP. Pati


I. Alhaddad14:20 Coronary aneurysm: just an innocent

bystander?M. Pellicano


M. Balghith

- 14:00 -14:45 - 16:15

ROOM 243


PCR SharingCentre

How to critically analyse apublished meta analysis toimprove my daily practiceFacilitators: D. Capodanno, M. Ntsekhe,R.L.J. Osnabrugge

- 16:00 -16:30 - 18:00

ROOM 243

PCR SharingCentre

Practical use of CT scan for TAVIand structural interventionalprocedures: Fluoro-CT appFacilitators: M. Chen, N. Piazza



Wednesday 18 May 2016 - Afternoon - Programme valid as of 12-04-2016

- 12:00 -12:30 - 14:00

ROOM 243

PCR SharingCentre

Non left main bifurcationtechniques: step-by-stepprocedural strategyFacilitators: N. Amabile, G. Stankovic

- 14:00 -14:45 - 16:15

THEATRE BLEUPrimary PCI and multivesseldisease: strategies for optimalcomplete revascularisationChairpersons: E. Eeckhout, F. MalikPanellists: M. Balghith, C. Cook, C.Dubois, A. Gershlick, J. Koolen, M. Strozzi

Attend this session if you want:To learn about the differentrevascularisation strategies duringprimary PCI for multivessel diseaseTo learn how to assess residualischaemia in patients with multivesseldisease who have undergone primaryPCITo learn about the evidence forcomplete revascularisation in thissetting

14:45 Session objectivesF. Malik

14:48 Complete revascularisation for multivesseldisease after primary PCI: what is theevidence?S. James

14:55 Time to React@PCR15:02 Review of the tools and technique to be

used during the LIVE demonstrationC. Cook


15:48 Time to React@PCR15:58 Staging of procedures: when and how?

G.G. Stefanini16:05 Time to React@PCR16:12 Session evaluation and key learnings

E. Eeckhout

14:45 - 16:15THEATRE

BORDEAUX

FocusInnovation

New DEB. Novel device-basedtherapies for heart failureChairpersons: E. Edelman, M. JonerPanellists: F. Alfonso Manterola, H.Baumgartner (awaiting confirmation), D.Burkhoff, M. Cayli, T. Gori, P. Stella

14:45 Paclitaxel coated balloon catheters with aneptfe surface: first evaluation in theporcine coronary modelB. Scheller

14:52 Discussion and audience interaction14:57 Next generation DEB catheter: adjustable,

no shear, evaginating DEB designR.J. Solar (awaiting confirmation)

15:04 Discussion and audience interaction15:09 A novel Sirolimus coated balloon catheter -

in-vivo evaluation in a porcine coronarymodelB. Scheller

15:16 Discussion and audience interaction15:20 Six-month angiographic and IVUS results

of the first-in-human study of a new DEBcatheter for de novo coronary lesionsA. Abizaid

15:27 Discussion and audience interaction15:31 Novel nanocarrier Sirolimus-coated

balloon for coronary applicationS. Dani (awaiting confirmation)

15:38 Discussion and audience interaction15:42 ePTFE balloon with a paclitaxel coating

engineered for enhanced arterial retentionA. Tzafriri

15:49 Discussion and audience interaction15:53 Aortic autonomic neuromodulation for

heart failureD. Weiss

16:00 Discussion and audience interaction16:04 Endovascular post-myocardial infarction

scar exclusion in ischemic heart failureC. Schmitz (awaiting confirmation)






Plenary

Challenges in TAVI in AsiaWith the collaboration of AsiaPCR, PCR-CIT ChinaChengdu Valves and PCR Tokyo ValvesFacilitators: C.K. Naber, N. PiazzaPanellists: M. Chen, K. Hayashida, P.H.L.Kao, R. Mohd Ali (awaiting confirmation),S. Saito, Y. Wu (awaiting confirmation)

Attend this session if you want:To appreciate particular challenges forpercutaneous treatment of aortic valvestenosis in AsiaTo discuss with experts aboutchallenging transfemoral TAVI casesand potential solutionsTo exchange with colleagues on dailypractice of TAVI in Asia

14:45 EuroPCR welcomes AsiaPCR, PCR-CIT ChinaChengdu Valves and PCR Tokyo ValvesC.K. Naber

14:48 Case 1 - TAVI in a patient with small sinusof valsalvaR. Mohd Ali (awaiting confirmation)

14:56 How would I treat?Y. Wu (awaiting confirmation)

15:02 Discussion and audience interaction15:08 How did I treat?

R. Mohd Ali (awaiting confirmation)15:16 Case 2 - TAVI in a patient with bicuspid

valveM. Chen

15:24 How would I treat?S. Saito


M. Chen15:44 Case 3 - TAVI in a patient with severely

calcified aortic valveK. Hayashida

15:52 How would I treat?P.H.L. Kao


K. Hayashida16:12 Session evaluation and key learnings

N. Piazza


FocusInnovation

Hot Line

New valvular interventions andenabling technologiesChairpersons: M. Buchbinder, T. FeldmanPanellists: T. Johnson (awaitingconfirmation), R. Makkar, G. Manoharan,I. Reda

14:45 Does use of a direct thrombin inhibitorprevent the occurrence of cerebral emboliduring TAVI? Insights from the BRAVO-3studyE. Van Belle

14:53 Discussion and audience interaction14:58 A pooled analysis of triguard cerebral

protection compared to unprotectedtranscatheter aortic valve replacement.Results of a pooled patient level analysisA. Lansky

15:06 Discussion and audience interaction15:11 12-month results of a novel large access

closure device: insights from the FRONTIERII trialA. Schwindt

15:19 Discussion and audience interaction15:24 LAA occlusion is associated with a superior

clinical outcome compared with standardcare in patients with atrial fibrillation and aprior intracerebral haemorrhage: apropensity matched score follow-up studyJ.E. Nielsen-Kudsk

15:32 Discussion and audience interaction15:37 One-year follow-up date of a novel

self-expanding TAVI system in aprospective, bi-centric, single arm pilottrialT. Schuetz

15:45 Discussion and audience interaction15:50 Mitral valve repair using a novel

percutaneous septal sinus shorteningdeviceJ. Joseph (awaiting confirmation)

15:58 Discussion and audience interaction16:03 Millipede percutaneous mitral

annuloplasty ringR. Lashinski (awaiting confirmation)


14:45 - 16:15ROOM

LEARNING

Learning LAA closureFacilitators: M. Behan, M.W. BergmannExpert panellist: S. Berti

Attend this session if you want:To understand how to define the scopeof the problem of atrial fibrillationTo learn how to select patients for leftatrial appendage occlusionTo learn the key steps whenperforming left atrial appendageocclusion using Amplatzer andWatchman




14:45 - 16:15ROOM TERNES 1

Cases

BRS in bifurcation lesionsSession comprising selected EuroPCR 2016 clinicalcase submissionsPanellists: J.H. Heo, H. Nef, A. Serra

14:45 Utility of OCT while stenting using BRSduring a primary PCI in a doublebifurcationW. Elabbassi

14:53 Discussion and audience interaction14:58 Double bifurcation (left main bifurcation

and left anterior descending-D1) treatedwith single BRSR. Bhagwat

15:06 Discussion and audience interaction15:11 BRS adjustment in ostial lesion with Szabo

techniqueC. Galvão Braga

15:19 Discussion and audience interaction15:24 Spontaneous left anterior descending

artery missed dissection presented withACS treated first with DEB and with full leftanterior descending BRS jacket andT-scaffolding of left anterior descending /first diagonal bifurcation: FFR andIVUS-guided procedureF. Fouladvand

15:32 Discussion and audience interaction15:37 BRS in bifurcation lesions

W.C. Huang15:45 Discussion and audience interaction15:50 T-stenting and small protusion (TAP)

technique with BRSK. Longman

15:58 Discussion and audience interaction16:03 Treatment of a coronary bifurcation lesion

using one dedicated sirolimus-elutingbifurcation stent in combination with aBRS: a novel option for coronarybifurcation approachJ. Benezet


14:45 - 16:15ROOM TERNES 2

Cases

Aortic endovascular strategiesfor challenging clinical settings -part 2Session comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: B. ReimersPanellists: F.Y. Kuo, G. Torsello (awaitingconfirmation), T.D. Wang

14:45 Endovascular treatment of juxtarenalaneurysm with low profile stent-graft andchimney techniqueM.P. Borrelli (awaiting confirmation)

14:53 Discussion and audience interaction14:58 Hybrid solution for a complicated acute B

type aortic dissection puzzleM. Stolcova

15:06 Discussion and audience interaction15:11 A rare case of thoraco-abdominal aortic

aneurysm with asymptomatic mesentericischaemia: how did I treat?A. Mohanty (awaiting confirmation)

15:19 Discussion and audience interaction15:24 Aortic aneurysm with mesenteryc artery

diseaseR. Llano

15:32 Discussion and audience interaction15:37 Pararenal aneursym after aortic sugery:

endovascular aneurysm sealing anddouble chimneysM.P. Borrelli (awaiting confirmation)

15:45 Discussion and audience interaction15:50 Pull-down technique of stent graft for

abdominal aortic aneurysm with doublerenal arteriesK. Kawaguchi

15:58 Discussion and audience interaction16:03 Post-thoracic endovascular aortic repair,

delivery system entrapmentR. Vijayvergiya





14:45 - 16:15ROOM 241

Cases

Challenging indications forrotablator - part 2Session comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: F. MauriPanellists: A.B. Catakoglu, S.Gunasekaran, A. Ong

15:30 Calcium can challenge but diamonds canbring sparkle in lifeA.K. Chaurasia

15:38 Discussion and audience interaction15:43 Rotational atherectomy in a patient with

ACS and complex multivessel diseaseJ. Jose Erungaren (awaiting confirmation)

15:51 Discussion and audience interaction15:56 Transradial rotational atherectomy and,

T-stenting and small protusion (TAP) of aseverely calcified and occluded rightcoronary arteryZ. Ruzsa

16:04 Discussion and audience interaction16:09 How to tackle a calcified vessel during

primary PCI?H. Khan

16:17 Discussion and audience interaction16:22 Elective use of Impella 2.5L to support

percutaneous treatment of an inoperablepatient with complex coronary arterydisease and severe aortic stenosisG. Visconti

16:30 Discussion and audience interaction16:35 High-risk rotational atherecomy with

percutaneous mechanical circulatorysupportL. Pyka (awaiting confirmation)

16:43 Discussion and audience interaction16:48 OCT-supported PCI of calcified left anterior

descending lesionR. Vijayvergiya


14:45 - 16:15ROOM 242AB


YoungPractitioners


Practitioners

Atherectomy for calcifiedcoronary plaques: diamonds arean interventionalist's best friendSenior Advisor: E. GrubeFacilitators: P. Calvert, J. Daemen

Attend this session if you want:To understand which calcified plaquesneed rotational atherectomyTo learn (or revise) the moderntechnique of rotational atherectomyLearning how to avoid and deal withcomplications

14:45 - 16:15ROOM 251


Professionals

Plenary

The new Core Curriculum forcathlab nurses and alliedprofessionals in Europe An initiative from the EAPCI Nurses and AlliedProfessionals groupChairpersons: L. Kloevgaard, T. VanHeckePanellists: S. Carson, R. Esteves

Attend this session if you want:To become familiar with the new CoreCurriculumTo get inspired on how to implement itTo become integrated in the Europeannurses and allied professionalsnetwork

14:45 Session objectivesL. Kloevgaard

14:48 Presentation of the Core CurriculumL. Hinterbuchner

Implementation - how is practice todayand is it possible to translate andimplement the education programmeinto daily practice?

15:03 From a German point of viewM. Jacobs

15:10 From a Danish point of viewM. Norgaard Wetendorff

15:17 Discussion and audience interactionFuture - is there a need for certification?

15:35 Introduction to the ESCeL learningplatformS. Coelho

15:42 Discussion and audience interaction15:52 Exchanging knowledge: networking in our

communityV. Rodriguez Garcia-Abad


T. Van Hecke




14:45 - 16:15ROOM 252AB

Femoropopliteal diseaseWith the collaboration of the ESC Working Groupon Aortic and Peripheral circulationChairpersons: F. Castriota, D. Scheinert(awaiting confirmation)Panellists: M. Brodmann, M. De Carlo, R.Ferraresi, Z. Krajcer

Attend this session if you want:To discuss what is the standardapproach for a safe femoropoplitealprocedure today in: stenosis ofpopliteal segment - occlusion ofsuperficial femoral artery

14:45 Session objectivesD. Scheinert (awaiting confirmation)

14:48 How to manage calcified lesion andin-stent restenosisM. Brodmann

14:58 Review of the tools to be used during theLIVE demonstrationJ.C. Van Den Berg



F. Castriota

14:45 - 16:15ROOM 253

Abstracts

OCT to assess the acute andlong-term PCI resultsSession comprising selected EuroPCR 2016abstract submissionsChairperson: F. PratiPanellists: T. Akasaka, A. Omeish(awaiting confirmation), M. Radu

14:45 Euro16A-OP1078 - Novel method for directstent strut length assessment using 3DOCTI.R. Balleby

14:53 Discussion and audience interaction15:00 Euro16A-OP0996 - Clinical impact of

suboptimal stenting and residualintrastent plaque / thrombus protrusion inpatients with ACS: the Centro per la Lottacontro l’Infarto-Optimisation of PCI(CLI-OPCI) ACS studyL. Gatto

15:08 Discussion and audience interaction15:15 Euro16A-OP0531 - OCT-guided excimer

laser coronary angioplasty for in-stentrestenosis after DES implantationS. Hashimoto

15:23 Discussion and audience interaction15:30 Euro16A-OP0696 - De novo lesions and

in-stent restenosis in coronary SVG: datafrom OCTOPUS studyT. Roleder

15:38 Discussion and audience interaction15:45 Euro16A-OP0916 - Multi-analysis with OCT

and vasomotion in everolimus-elutingcoronary stents and scaffolds: the movestrialS. Puricel

15:53 DSI198 - Discussion and audienceinteraction

16:00 Euro16A-OP0517 - Five-year serial OCT forassessment of lumen morphology(eccentricity and asymmetry) changes aftercomplete resorption of BRS in ABSORBCohort B trialP. Suwannasom





14:45 - 16:15ROOM 341

Abstracts

PCR's Got Talent - round 1:Structural and peripheralinterventionsSession comprising selected EuroPCR 2016abstract submissionsChairpersons: P. Boekstegers (awaitingconfirmation), S. VerheyeJury Members: F. Bedogni, O. Goktekin, A.Micari, E. Stabile, E. Vuruskan, O. Wendler

14:45 Introduction14:47 Euro16A-OP0018 - Intracardiac ultrasound

guided endovascular ASD closureI. Buzaev (awaiting confirmation)

14:51 Euro16A-OP0134 - Discoloration ofischaemic foot by indigo carmine injectionafter successful angioplasty in patientswith critical limb ischaemia

14:55 Euro16A-OP0192 - Predictors of proceduraloutcomes of LAA closure in patients withatrial fibrillationK. Koskinas

14:59 Euro16A-OP0207 - Transcutaneoustranscatheter technique in treatment ofischaemic strokeI. Maksimovich

15:03 Euro16A-OP0250 - LAA occlusion with useof minimal contrast dyeA. Sedaghat

15:07 Euro16A-OP0378 - Incidence and clinicalimpact of device-associated thrombus andperi-device leak following LAA closure withthe Amplatzer Cardiac PlugJ. Saw

15:11 Euro16A-OP0526 - OCT after carotidsteting with new generationmesh-covered stents: rate of stentmalapposition, plaque prolapse andfibrous cap rupture compared withconventional designed carotid stentsT. Umemoto

15:15 Euro16A-OP0598 - Stent-based isolation ofpulmonary veinsG. Van Langenhove

15:19 Euro16A-OP0665 - Five-year outcomes oftranscatheter mitral repair in the real-worldN. Buzzatti

15:23 Euro16A-OP1062 - Septal occluder devicefor percutaneous closure of patentforamen ovale associated with atrial septalaneurysm: short and mid-term clinical andechocardiographic outcomesD. Chin

15:27 Euro16A-OP0795 - Drug-eluting versusplain balloon angioplasty forfemoropopliteal artery disease: an updatedmeta-analysis supplemented by sensitivityanalyses and Bayesian estimationD. Giacoppo

15:31 Euro16A-OP0902 - Study to evaluate safetyand efficacy of stem cell therapy usingbone marrow mononuclear cells inpatients with severe left ventricular systolicdysfunctionR. Anantharaman

15:35 Euro16A-OP0955 - Clinical characterisationof cerebrovascular events after LAAocclusionX. Freixa

15:39 Euro16A-OP0998 - 3D heart models andsimulators for planning of percutaneoustricuspid interventionsM. Taramasso (awaiting confirmation)

15:43 Euro16A-OP1031 - Five-year experiencewith multilayer flow modulator stent inaortic dissections and aneurysmsI. Petrov

15:47 Euro16A-OP1022 - Outcomes andpredictors of success for paravalvular leakclosure: an analysis of the SpanisHreal-wOrld paravalvular LEaks closureregistry (HOLE registry)I. Cruz-Gonzalez (awaiting confirmation)

15:51 Euro16A-OP1090 - Endovascular therapy ofsubtotal carotid stenosis - combinedcarotid and coronary atherosclerosis Tsonev

15:55 Euro16A-OP0683 - Stenting of totalocclusions of the renal arteries in patientswith resistant hypertensionI. Petrov

15:59 Euro16A-OP0763 - Efficay and safety ofpercutaneous LAA closure in patients withatrial fibrillation: results of a six-yearregistryM. Nobre Menezes


for round 2

14:45 - 16:15ROOM 342B

Cases

There is thrombus in the lesionSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: F. WeidingerPanellists: A. Ochala, D. Pahlajani, K.Punamiya

14:45 Acute myocardial infarction in a 28year-old maleM. Nobre Menezes

14:53 Discussion and audience interaction14:58 A very large thrombus containing right

coronary artery in a patient presentingwith STEMIH. Lu

15:06 Discussion and audience interaction15:11 "Guideliner" catheter used as a

thrombectomy device in vein graft primaryPCIK. Sandhu

15:19 Discussion and audience interaction15:24 An unusual rescue PCI

S. Kubba15:32 Discussion and audience interaction15:37 The challenging triad: STEMI and a huge

thrombotic aneurysmA. Cohen

15:45 Discussion and audience interaction15:50 Saddle thrombus in the left main

S. Rahman15:58 Discussion and audience interaction16:03 Primary PCI for left main occlusion

K. Altahmody16:11 Discussion and audience interaction




14:45 - 16:15ROOM 343

Abstracts

New approaches to CTOSession comprising selected EuroPCR 2016abstract submissionsChairperson: O. GaemperliPanellists: M. Al-Kuraishi, T.H. Koh, G.Werner

14:45 Euro16A-OP0748 - Can the J-CTO score beimproved?A.R.G. Francisco

14:53 Discussion and audience interaction14:58 Euro16A-OP0646 - Contemporary use of

BRS vs. metallic DES in the treatment ofcoronary CTOS. Ojeda

15:06 Discussion and audience interaction15:11 Euro16A-OP0311 - Time to resorb:

mid-term clinical outcomes foreverolimus-eluting bioresorbable scaffoldsin CTOA. May

15:19 Discussion and audience interaction15:24 Euro16A-OP0776 - Everolimus-eluting BRS

for treatment of complex CTOR. Diletti

15:32 Discussion and audience interaction15:37 Euro16A-OP0946 - Results of X-ray

equipment modification on radiationexposure in CTO-PCIJ. Reifart

15:45 Discussion and audience interaction15:50 Euro16A-OP0090 - Implications of

intraprocedural coronary CT angiographyduring coronary CTO interventionB.K. Kim

15:58 Discussion and audience interaction16:03 Euro16A-OP0660 - Safety and feasibility of

the transradial approach in the treatmentof chronic CTO, tailored by alow-intermediate grade J-CTO score: asingle-centre experienceF. Del Furia


14:45 - 16:15ROOM 351

Abstracts

Resting versus hyperaemicfunctional indices of coronarystenosis severitySession comprising selected EuroPCR 2016abstract submissionsChairperson: C. Di MarioPanellists: H. Abu-Hantash, D. Al Khdair,S.A. Pyxaras

14:45 Euro16A-OP0152 - One year clinicalfollow-up outcome of onsite iFR-FFRhybrid approach: j-DEFINE registryM. Nakamura

14:53 Discussion and audience interaction14:58 Euro16A-OP0385 - Discordances of

tandem lesion treatment based on iFRpullback curve vs. hyperaemic iFR pullbackcurve: is it always the same?J. Kikuchi

15:06 Discussion and audience interaction15:11 Euro16A-OP0356 - Different performance

of iFR in the right and left coronary arteryL.X. Van Nunen

15:19 Discussion and audience interaction15:24 Euro16A-OP0434 - Predictive value of

resting Pd / Pa on hyperaemia FFR inintermediate coronary artery stenosisC. Bietau (awaiting confirmation)

15:32 Discussion and audience interaction15:37 Euro16A-OP0258 - Diagnostic

performances of resting and hyperaemicinvasive physiologic indices to definemyocardial ischaemia: validation with13N-ammonia positron emissiontomographyD. Hwang

15:45 Discussion and audience interaction15:50 Euro16A-OP0575 - Relationship between

non-invasive coronary flow reserve and theFFR for guiding PCI for significant leftanterior descending coronary lesionT. Moustafa (awaiting confirmation)

15:58 Discussion and audience interaction16:03 Euro16A-OP0534 - FFR result post PCI is

suboptimal in long diffuse coronary arterydisease treated with newer generation DESA. Baranauskas





14:45 - 16:15ROOM 352A

How Should ITreat?

Algeria and Lebanon share theirmost educational cases: complexprimary PCI in high-risk STEMIpatientsWith the collaboration of the Algerian Group ofInterventional Cardiology (AGIC) and the LebaneseSociety of Cardiology Interventional WorkingGroupChairpersons: M. Chettibi, Z. Ghazzal

Attend this session if you want:To understand how to identify thedegree of difficulties to treat complexlesions in acute situationsTo learn tips and tricksTo be aware of potential errors injudgment and how to avoid them

14:45 Session objectivesM. Chettibi

14:50 Case 1: STEMI with left main lesionW. Takdemt

14:55 How would I treat the case?J. Elias

15:00 How would I treat the case?R. Senoussaoui

15:05 How did I treat the case?W. Takdemt


Z. Ghazzal15:30 Case 2: STEMI with multivessel disease

F.A. Jaoude15:35 How would I treat the case?

R. Senoussaoui15:40 How would I treat the case?

J. Elias15:45 How did I treat the case?

F.A. Jaoude15:55 Discussion and audience interaction16:05 Consensus

M. Chettibi16:10 Session evaluation and key learnings

Z. Ghazzal

14:45 - 16:15ROOM 352B

Complications

Ireland and Switzerland sharetheir most educational cases:you thought that coronaryinterventions were low riskWith the collaboration of the Irish Cardiac Society,Intervention section and the Swiss Working Groupfor Interventional Cardiology and Acute CoronarySyndromeChairpersons: D. Foley, M. Roffi

Attend this session if you want:To know how to immediatelyrecongnise major coronarycomplicationsTo know how to treat major coronarycomplicationsTo know the equipment needed tohandle major coronary complications

14:45 Session objectivesD. Foley

14:48 Case 1: an unusual complication followinga usual oneI. Moarof (awaiting confirmation)

14:54 Discussion with the audience15:02 Case 2: five stents to plug the hole

A.J. Peace15:08 Discussion with the audience15:16 Case 3: nightmare in the cathlab

A. Zuffi15:22 Discussion with the audience15:30 Case 4: just finishing up, we'll be done in

two minutesT. Kiernan (awaiting confirmation)

15:36 Discussion with the audience15:44 Case 5: stuck in the middle of you

C. O'Sullivan15:50 Discussion with the audience15:58 Case 6: when the coronary hardware just

lets you downS. O'Connor (awaiting confirmation)


M. Roffi




14:45 - 16:15ROOM 353

Abstracts

Mid- and long-term follow-upafter bifurcation PCISession comprising selected EuroPCR 2016abstract submissionsChairperson: D. WagnerPanellists: S. Brugaletta, I.H. Chae(awaiting confirmation), D. Kettles

14:45 Euro16A-OP0157 - Long-term clinicaloutcomes of T-stenting with smallprotrusion for coronary bifurcation lesionstreated with second generation DESR. Jabbour

14:53 Discussion and audience interaction14:58 Euro16A-OP0184 - Three-year clinical

follow-up of the COBRA (complex coronarybifurcation lesions: randomisedcomparison of a strategy using a dedicatedself-expanding biolimus A9-eluting stentvs. a culotte strategy usingeverolimus-eluting stents) studyJ. Bennett

15:06 Discussion and audience interaction15:11 Euro16A-OP1052 - Favorable clinical

long-term follow-up of mini-crushingtechnique for treatment of truebifurcations in all-comers populationA. Nicolino

15:19 Discussion and audience interaction15:24 Euro16A-OP0542 - Treatment of

bifurcation lesions with a thin-strut drugeluting stent with bioresorbable polymer:three-year clinical outcomes of theCENTURY II trialR. Kornowski (awaiting confirmation)

15:32 Discussion and audience interaction15:37 Euro16A-OP0594 - Intracoronary

electrocardiography changes predictmortality at mid-term follow-up (up to 60months) after stenting coronarybifurcation lesions from intracoronaryelectrocardiogram (ECG) and myonecrosisafter bifurcation stenting (COSIBRIA&CO)(ClinicalTrials.gov Identifier:NCT01268228)K. Karamfiloff

15:45 Discussion and audience interaction15:50 Euro16A-OP0186 - Five-year clinical

follow-up of the PYTON (prospectiveevaluation of the TRYTON side-branchstent with an additional XIENCE-Veverolimus-eluting stent in coronarybifurcation lesions) studyJ. Bennett

15:58 Discussion and audience interaction16:03 Euro16A-OP0599 - Bifurcation culprit

lesion in STEMI: interventional strategies,procedural success and clinical outcomesat five years of follow-upH.D. Mejia-Renteria


14:45 - 16:15ROOM

ARLEQUIN

Images

An image is worth 1,000 wordsSession comprising selected EuroPCR 2016 imagesubmissionsFacilitators: T. Hovasse (awaitingconfirmation), A. Pichard, N. VanMieghem


interpretation 14:50 Image 14: unveiled and key findings

A. Bucsa14:55 Image 14: discussion and audience

interaction Image 15

15:00 Image 15: facilitated audience imageinterpretation A. Pichard

15:05 Image 15: unveiled and key findings M.T. Lopez Lluva

15:10 Image 15: discussion and audienceinteractionA. Pichard


interpretation N. Van Mieghem

15:20 Image 16: unveiled and key findingsS. Cannata (awaiting confirmation)

15:25 Image 16: discussion and audienceinterpretationN. Van Mieghem


interpretation15:35 Image 17: unveiled and key findings

K. Koegler15:40 Image 17: discussion and audience

interpretationImage 18

15:45 Image 18: facilitated audience imageinterpretationA. Pichard

15:50 Image 18: unveiled and key findingsG. Bruschi

15:55 Image 18: discussion and audienceinterpretationA. Pichard


interpretationN. Van Mieghem

16:05 Image 19: unveiled and key findingsY. Abdelmonem

16:10 Image 19: discussion and audienceinteractionN. Van Mieghem




- 15:00 -15:00 - 16:00

ROOM 342A

FocusInnovation

Plenary

Will SPRINT change my practice?Chairpersons: R. Schmieder, W. Wijns

Attend this session if you want:To achieve a detailed understanding ofthe results of a particular publishedtrial that may impact your clinicalpractice To evaluate the relevance of newresults for the treatment of yourpatientsTo share the current and futurepractice with colleagues from aroundthe world

15:00 Introduction - the trial headlinesW. Wijns

15:05 A representative case from the study: howshould I treat?K. Tsioufis


15:15 What was known before SPRINT?M.D. Lobo

15:25 Trial(ist) review: methods, results,conclusionsF. Mahfoud


15:45 Case conclusion: how does this apply tomy practice?A. Pathak


R. Schmieder

- 16:00 -16:30 - 18:30

THEATRE BLEU

EBACaccreditation


programme

Innovation and new evidence inOCT and vessel preparation toachieve better patient outcomesEBAC Accreditation has been applied for -Programme supported by an unrestrictededucational grant from ST. JUDE MEDICAL ANDORBUSNEICHChairperson: C. TamburinoCo-Chairperson: T. AdriaenssensPanellists: T. Kinnaird, J.F. Lassen, H. Nef,L. Räber

Attend this session if you want:To see the benefits of the latest OCTtechnology and learn about the clinicalevidence supporting the use of OCT incomplex lesionsTo understand where lesionpreparation with a scoring balloon canimprove outcomes in complexsituationsTo discover the value of OCT in scaffoldimplantation


16:32 Why OCT is a valuable tool for decisionmaking before DES and BRS implantation? L. Räber

16:39 Why vessel preparation with a scoringballoon is key before DES or BRSimplantationT. Kinnaird

16:49 Time to React@PCR16:53 LIVE demonstration from Clinique

Pasteur - Toulouse, France17:33 Time to React@PCR17:44 Why OCT is a valuable tool to reduce late

failure in DES and BRS?H. Nef

17:51 Time to React@PCR17:55 Recorded case from Righspitalet -

Copenhagen, Denmark J.F. Lassen


T. Adriaenssens




16:30 - 18:00THEATRE

BORDEAUX

Symposium

Bioresorbable vascular scaffoldsin the real world - consideringthe ongoing evidence for safetyand efficacySponsored by ABBOTT VASCULARChairperson: P.W. SerruysCo-Chairperson: P. SmitsPanellist: H.C. Gwon

Attend this session if you want:To learn about the early and mid-termsafety and efficacy of bioresorbablevascular scaffolds in all-comer patientsTo learn more about all-comerregistries on lesion indications basedon available evidenceTo discuss the incremental value ofreal-world registries

16:30 Session objectivesP. Smits

16:35 Review of the available meta-analysisP.W. Serruys

16:45 Time to React@PCR16:50 Acute results from the FRANCE ABSORB

registryR. Koning

16:58 Acute results from the all-comer UKregistryJ. Hill

17:06 Acute results from the RAI registry B. Cortese

17:14 Time to React@PCR17:24 Mid-term results from the GABI-R registry

C. Hamm17:32 Mid-term results from real-world REPARA

registryF. Hernandez


P.W. Serruys


Symposium

MitraClip: controversies inintervention and imagingSponsored by ABBOTT VASCULAR - PHILIPSChairperson: A. VahanianCo-Chairperson: F. Maisano

Attend this session if you want:To learn about new developments anddata in mitral intervention and imagingTo learn new approaches to MitraClipimaging and anaesthesiaTo participate in challengingdiscussion on mitral intervention andimaging

16:30 Session objectivesA. Vahanian

Controversy 1: does the latest survivaldata already predict COAPT outcomes?

16:35 YesM. Swaans

16:42 NoA. Vahanian

16:49 Discussion and audience interactionControversy 2: optimal proceduralguidance: fusion imaging or only Echo

16:55 Fusion imaging is neededM. Swaans

17:02 Echo is enoughH. Sievert

17:09 Discussion and audience interactionControversy 3: In light of more than30000 patients treated with MitraClipwhat will be the respective role of repairversus replacement?

17:15 Transcatheter valve repair will remain themost popularF. Maisano

17:22 Transcatheter mitral valve replacement willbe the winnerV. Bapat

17:29 Discussion and audience interactionControversy 4: deep sedation or localanaesthesia: what's better for thepatient?

17:35 Deep sedationS. Von Bardeleben

17:42 Local anaesthesiaH. Sievert


F. Maisano





Symposium

Sharing solutions to frequentchallenges in PCI strategies withcomplex anatomies and patientsSponsored by TERUMOChairperson: P. UrbanCo-Chairperson: C. Spaulding

Attend this session if you want:To learn about strategies to addresschallenges in complex patients andinterventionsTo explore technical choices incomplex PCIsTo discuss DAPT in high bleeding riskpatients

16:30 Session objectivesP. Urban

16:33 A challenging bifurcation caseA. Colombo

16:41 Is there an alternative strategy?J. Mehilli


P. Urban17:01 A challenging STEMI patient

G. Sardella17:09 Is there an alternative strategy?

C. Moris17:17 Discussion and audience interaction17:27 Key learnings

C. Spaulding17:29 A challenging high bleeding risk patient

M. Valgimigli17:37 Is there an alternative strategy?

B. Chevalier17:45 Discussion and audience interaction17:55 Key learnings

P. Urban17:57 Session evaluation and key learnings

C. Spaulding

16:30 - 18:00ROOM

LEARNING

Learning acute strokeinterventionsFacilitators: A. Cremonesi, O. Goktekin,O. OzdemirMedia Driver: E. Karacop (awaitingconfirmation)Expert panellist: M. Meuwissen

Attend this session if you want:To assess optimal patient indicationsfor endovascular acute stroketreatment, using a stent or a balloonTo learn how to perform the procedurestep by step:


16:30 - 18:00ROOM TERNES 1

Cases

Mid- and long-term follow-upafter BRSSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: N.E.J. WestPanellists: H. Al Guindy, P. Kala, T. Majwal

16:30 BRS in a case of severe in-stent restenosisT. Choudhury

16:38 Discussion and audience interaction16:43 Aneurysmatic remodelling after CTO PCI

with a BRSM. Vlachojannis (awaiting confirmation)

16:51 Discussion and audience interaction16:56 Application of bioresorbable vascular stent

in a right coronary artery CTO case withone year follow-upW.C. Huang

17:04 Discussion and audience interaction17:09 Risk stratification of earlier antiplatelet

discontinuation after bioresorbablescaffold for STEMI: neointimal coverageassessment by OCTL. Leite

17:17 Discussion and audience interaction17:22 Restored physiological vasomotion

imitating intra-scaffold restenosis threeyears after BRS implantationM.B. Ancona (awaiting confirmation)

17:30 Discussion and audience interaction17:35 13-month OCT follow-up of full-plastic

jacket BRS implantationR. Jabbour

17:43 Discussion and audience interaction17:48 Progression of calcification after

implantation of a fully BRS: a serial andcombined IVUS-OCT follow-up of five yearsY. Zeng





16:30 - 17:30ROOM TERNES 2

Cases

Unusual peripheral complicationSession comprising selected EuroPCR 2016 clinicalcase submissionsChairpersons: B. Reimers, D. Scheinert(awaiting confirmation)

16:30 Successful retrieval of trapped inferiorvena cava filter during May-thurnersyndrome intervention


I. Alhaddad16:45 Embolic complication post TAVI

Q. Labarre16:53 Discussion and audience interaction16:58 Key learnings

E. Vuruskan17:00 Successful retrieval for fractured tip of

high-frequency-vibration CTOrecanalisation catheter using doublelumen microcatheterM. Kimura


H. Reinecke17:15 Unusual percutaneous extraction

A.R.G. Francisco17:23 Discussion and audience interaction17:28 Key learnings

A.K. Bozkurt (awaiting confirmation)

16:30 - 18:00ROOM 241

Case in Point

Strategies for complex PCItreatment: optimising yourprocedural outcomes whilemanaging costs through noveland innovative technologiesSponsored by PHILIPS VOLCANOChairperson: A. BanningCo-Chairperson: F. Pinto

Attend this session if you want:To understand how physiology canhelp you guide, decide and confirmyour treatment strategies in complexanatomyTo appraise how novel image guidancetechnologies can improve complex PCIproceduresTo specifically discuss the healtheconomics considerations of novelimaging and physiology driventreatment strategies

16:30 Session objectivesA. Banning

16:35 Resolving serial and diffuse lesions with iFRScoutF. Hellig

16:43 Discussion and audience interaction16:51 Using IVUS co-registration imaging

technologies to improve left main lesionguidance and associated outcomesD. Dudek

16:59 Discussion and audience interaction17:07 Identifying the revascularisation targets in

a multivessel disease with physiology andIVUS guidanceJ. Escaned

17:15 Discussion and audience interaction17:23 Complex bifurcation lesion treatment can

be made easier with the novel cardiacRoadMap image guidance technologyT. Zeus

17:31 Discussion and audience interaction17:39 Reflections on the impact of imaging and

physiolgy related innovative technologies:what is in it for you?L. Annemans

17:54 Session evaluation and key learningsF. Pinto

16:30 - 18:00ROOM 242AB

Learning alcohol septal ablationFacilitators: I. Al Rashdan, T. Cuisset, G.Toth

Attend this session if you want:To share tips and tricks to make septalablation easy and successfulTo discuss how to prevent and managepotential complicationsTo discuss how to integrate availableevidence into daily practice




16:30 - 18:00ROOM 251

Symposium

Direct Flow Medical: from a TAVIsolution to a universal structuralheart platformSponsored by DIRECT FLOW MEDICALChairperson: J.J. PopmaCo-Chairperson: N. Moat

Attend this session if you want:To learn how to avoid aorticregurgitation in simple steps using theDirect Flow Medical valveTo understand the key implantlearnings to optimise resultsTo review the newest clinical andtechnological developments

16:30 Session objectivesN. Moat

16:35 What does the data tell us?C.K. Naber

16:50 Discussion and audience interaction16:55 Avoiding aortic regurgitation in simple

stepsA. Linke (awaiting confirmation)

17:10 Discussion and audience interaction17:15 Advanced techniques to optimise results

F. De Marco17:30 Discussion and audience interaction17:35 Pushing the limits and future perspectives

A. Latib17:50 Discussion and audience interaction17:55 Session evaluation and key learnings

J.J. Popma

16:30 - 18:00ROOM 252AB

Tools andTechniques

(TNT)

Resorbable magnesium scaffoldMagmaris: opening a new eraSponsored by BIOTRONIKChairperson: R. WaksmanCo-Chairperson: J. KoolenPanellist: R. Mohd Ali (awaitingconfirmation)

Attend this session if you want:To understand the fundamentalmechanics of magnesium as naturalelement and scaffold materialTo learn from users how to optimisethe scaffold implantationTo review the clinical outcomes ofBiotronik magnesium scaffold

16:30 Session objectivesJ. Koolen

16:33 The ABCs of MagnesiumJ. Maier

16:40 Bioresorption of magnesiumM. Joner

16:47 BIOSOLVE-II dataC. Von Birgelen

16:54 Time to React@PCR16:59 Recorded case from Städtische Kliniken

Neuss, Lukaskrankenhaus GmbH -Neuss, Germany

M. Haude17:29 Time to React@PCR17:34 Technical and procedural aspects

R. Tölg17:44 Current potential indications for scaffolds

versus modern DESW. Wijns

17:51 Session evaluation and key learningsR. Waksman




16:30 - 18:00ROOM 253

Cases

MitraClip unusual cases and tipsand tricksSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: H. IncePanellists: E. Brochet, D. Kahali (awaitingconfirmation), W.H. Yin

16:30 Fortuitous catheter entrapment during leftanterior mitral leaflet pushing manoeuverfor MitraClip implantation: a word ofcautionI.J. Amat-Santos

16:38 Discussion and audience interaction16:43 Percutaneous mitral valve repair after

annuloplasty ring dehiscence: clip the gap!E.W. Holy

16:51 Discussion and audience interaction16:56 "Uncle SAM" MitraClip treatment for severe

mitral regurgitation due to stress-inducedsystolic anterior motionP. Denti

17:04 Discussion and audience interaction17:09 Percutaneous transcatheter mitral valve

repair: two weeks after implantationJ.F. Velu

17:17 Discussion and audience interaction17:22 MitraClip-induced systolic anterior motion

complicated by pericardial effusionA. Levi (awaiting confirmation)

17:30 Discussion and audience interaction17:35 MitraClip repair with concomitant left

ventricle thrombus: can we (safely) do it?N. Buzzatti

17:43 Discussion and audience interaction17:48 Looking for solutions... Left Amplatz

catheter to place MitraClip in a patientwith asymmetrical tetheringR. Nerla


16:30 - 18:00ROOM 341

Abstracts

PCR's Got Talent - round 1: Acutecoronary syndromesSession comprising selected EuroPCR 2016abstract submissionsChairpersons: R. Kornowski, P. L'AllierJury Members: R. Byrne, D. Capodanno, C.Di Mario, J.F. Tanguay, F. Weidinger

16:30 Introduction16:32 Euro16A-OP0037 - Angiographic findings

and revascularisation success in patientswith acute myocardial infarction andprevious coronary bypass surgeryF. Blachutzik

16:36 Euro16A-OP0043 - Mechanical aspirationin a 27 year-old patient and subacuteSTEMIJ. Hakim

16:40 Euro16A-OP0073 - Slow-speed rotationalatherectomy in ACS: a single-centreexperience in 78 high-risk patientsJ. Palazuelos

16:44 Euro16A-OP0411 - Temporal trends inincidence, management andneurologically intact survival followingout-of-hospital cardiac arrest in the UKT. Patterson

16:48 Euro16A-OP0416 - Indications and findingsof emergency coronary angiogram inpatients with sudden cardiac arrestM. Cardenas Manilla

16:52 Euro16A-OP0519 - Five-year follow-up ofpolymer-free sirolimus- andprobucol-eluting stents vs. new generationzotarolimus-eluting stents in patientspresenting with STEMIR. Colleran

16:56 Euro16A-OP1091 - Correlates of early, lateand very late stent thrombosis followingimplantation of first and secondgeneration DES in daily clinical practiceR. Costa (awaiting confirmation)

17:00 Euro16A-OP0761 - Prognostic impact ofthrombus aspiration in patients withSTEMI: a report from the Swedish coronaryangiography and angioplasty registryO. Angeras

17:04 Euro16A-OP0773 - Everolimus-eluting BRSversus metallic DES for treatment ofpatients presenting with acute myocardialinfarction insights from the maximalfootprint analysisR. Diletti

17:08 Euro16A-OP0911 - Newer antiplatelet andanticoagulant strategies following PCI andsubsequent bleeding: a real-worldcomparison of multiple combinationsR. Amin

17:12 Euro16A-OP0931 - Invasive coronarytreatment strategies for out-of-hospitalcardiac arrest: in-hospital mortality andoutcomes at six months from asingle-centre registryS. Muraglia

17:16 Euro16A-OP0934 - Systematic OCT-guidedimplantation of BRS in STEMI patientsA. Al Nooryani

17:20 Euro16A-OP1075 - Monocytesubpopulation 1 and 2 and theirphagocytic activity predict major adversecardiac events (MACE) post-STEMIA. Ghattas




17:24 Euro16A-OP0982 - Circadian pattern ofsymptoms onset and major cardiacadverse event in acute myocardialinfarction patientsN.Q. Nguyen

17:28 Euro16A-OP1002 - Changes in coronaryblood flow responses after myocardialinfarction: combined results from a patientstudy and an experimental porcine modelG. De Waard

17:32 Euro16A-OP1039 - Impact of baselineSYNTAX score on the effects of immediateversus delayed invasive intervention inNSTEMI patients: a subanalysis of therandomised RIDDLE-NSTEMI studyD. Milasinovic

17:36 Euro16A-OP1044 - Influence of gender ondelays and early mortality in STEMI: insightfrom the first French meta-registry,2005-2012 patient-level pooled analysisS. Manzo-Silberman

17:40 Euro16A-OP0967 - Prognostic value ofarterial lactate level on admission inpatients with acute myocardial infarctionN.Q. Nguyen

17:44 Euro16A-OP0644 - Coronary arteryperforation in patients suffering from ACS:the worst complication in the worst clinicalscenarioI.J. Amat-Santos


for round 2

16:30 - 18:00ROOM 342A

Case in Point

Experience Evolut R in complexcasesSponsored by MEDTRONICChairperson: U. GerckensCo-Chairperson: G. ManoharanPanellists: H. Danenberg, I. Meredith, T.Modine, F. Ribichini

Attend this session if you want:To discuss complex situations intranscatheter aortic valve interventionwith experts commenting casesTo discuss technical points in leveragespecific features of the CoreValveEvolut R system to achieve superioroutcomes

16:30 Session objectivesU. Gerckens

16:35 Evolut R recapture: when and how?I. Meredith

16:43 Discussion and audience interaction16:55 TAVI / PCI concomitant procedure

F. Ribichini17:03 Discussion and audience interaction17:15 Evolut R in failed surgical valves

H. Danenberg17:23 Discussion and audience interaction17:35 Evolut R through alternative access

T. Modine17:43 Discussion and audience interaction17:55 Session evaluation and key learnings

G. Manoharan

16:30 - 18:00ROOM 342B

Cases

Visceral and unexpectedperipheral interventionsSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: T. ZellerPanellists: R. Akdemir, E. Blessing, F.Fanelli

16:30 Endovascular management of chronicmesenteric ischaemiaR. Vijayvergiya

16:38 Discussion and audience interaction16:43 Superior mesentric artery stenting in

mesentric ischaemiaA. Patil

16:51 Discussion and audience interaction16:56 Endovascular treatment of an aberrant

splenic artery aneurysmM.P. Borrelli (awaiting confirmation)

17:04 Discussion and audience interaction17:09 An unusual cause of recurrent hemoptysis

and its successful interventionS. Chidambaram

17:17 Discussion and audience interaction17:22 Chest pain caused by fractured inferior

vena cava filter stuck within heart andsuccessful removal by catheterinterventionO. Hashimoto

17:30 Discussion and audience interaction17:35 Acute upper extremity ischaemia

successfully treated by catheter-basedintra-arterial thrombolysisS.H. Jo (awaiting confirmation)

17:43 Discussion and audience interaction17:48 Early SVG axillary to brachial artery disease

treated with BRSH. Abu-Hantash





16:30 - 18:00ROOM 343

Abstracts

Mid- and long-term outcome ofCTOSession comprising selected EuroPCR 2016abstract submissionsPanellists: A. Al Ghamdi (awaitingconfirmation), R. Lorenzoni, W.Udayachalerm

16:30 Euro16A-OP0514 - Survival after failedcomplete revascularisation in patients withcoronary CTOA. Toma

16:38 Discussion and audience interaction16:43 Euro16A-OP0445 - Long-term follow-up in

patients with ventricular arrhythmias afterrevascularisation of total occludedcoronary arteryC. Bietau (awaiting confirmation)

16:51 Discussion and audience interaction16:56 Euro16A-OP0028 - Percutaneous

revascularisation of the collateral supplyvessel for patients with multivessel diseaseand a chronically occluded vesselW. Sumaya

17:04 Discussion and audience interaction17:09 Euro16A-OP0578 - Long-term follow-up of

patients with previous coronary arterybypass grafting undergoing PCI for CTOA. Toma

17:17 Discussion and audience interaction17:22 Euro16A-OP0051 - Long-term clinical

results of PCI for CTO: latest report fromRetrograde Summit RegistryH. Park (awaiting confirmation)

17:30 Discussion and audience interaction17:35 Euro16A-OP0515 - Survival after PCI for

coronary CTO in elderly patientsA. Toma

17:43 Discussion and audience interaction17:48 Euro16A-OP0154 - Evaluation of antegrade

approach for coronary CTO: sub-analysis ofJapanese multicentre registryW. Nagamatsu


16:30 - 17:30ROOM 351

Case in Point

Expanding treatment options inleft atrial appendage closurepatients - WatchmanSponsored by BOSTON SCIENTIFICChairperson: T. FeldmanCo-Chairperson: D. Hildick-Smith

Attend this session if you want:To learn which patients benefit fromleft atrial appendage closure and howto balance best the risk of stroke andbleedingTo know the latest clinical data andguidelines for left atrial appendageclosureTo understand the expected benefitsof Watchman in complex anatomies

16:30 Session objectivesT. Feldman

16:35 Case 1 - My 66 year-old patient hasuncontrolled hypertension and alreadysuffered a strokeD. Foley

16:42 Discussion and audience interaction16:52 Case 2 - My patient has a challenging

anatomy of the left atrial appendage and ahigh bleeding riskM. Sandri

16:59 Discussion and audience interaction17:09 Case 3 - My patient cannot take Warfarin -

not even for 6 weeksM.W. Bergmann


D. Hildick-Smith




16:30 - 18:00ROOM 352A

How Should ITreat?

Iran and Kazakhstan share theirmost educational cases:complexity of coronary PCI inacute settingWith the collaboration of the Iranian Society ofInterventional Cardiology (ISOIC) and the Societyof interventional cardiologists of Kazakhstan Chairpersons: M. Hashemian, O. Sakhov

Attend this session if you want:To discuss the differentrevascularisation strategies in NSTEMIpatients and multivessel coronaryartery diseaseTo discuss the importance of IVUSstudy in left main stenting, andcomplete coverage of coronarydissectionTo share effective techniques that canbe useful for difficult PCI cases

16:30 Session objectivesO. Sakhov

16:35 Case 1: NSTEMI and multivessel disease ina patient with obesityM. Kudratullayev

16:40 How would I treat the case?B. Geraiely

16:45 How would I treat the case?M. Aripov (awaiting confirmation)

16:50 How did I treat the case?M. Kudratullayev


M. Hashemian17:15 Case 2: iatrogenic left main dissection

during PCI of an ACSA. Firouzi

17:20 How would I treat the case?M. Aripov (awaiting confirmation)

17:25 How would I treat the case?B. Geraiely

17:30 How did I treat the case?A. Firouzi


O. Sakhov17:55 Session evaluation and key learnings

M. Hashemian

16:30 - 18:00ROOM 352B

How Should ITreat?

Israel and Slovenia share theirmost educational cases: patientswith severe coronary arterydisease and severe symptomaticaortic stenosis: what should beperformed first, PCI or TAVI? With the collaboration of the Israel Working Groupfor Interventional Cardiology and the SlovenianWorking Group for Interventional CardiologyChairpersons: M. Bunc, A. Finkelstein

Attend this session if you want:To understand the complexity ofpatients with a combination of severecoronary artery disease and severeaortic stenosisTo discuss the main considerations inchoosing the therapeutic strategyincluding what should be performedfirst: PCI or TAVITo share and learn tips and tricks inperforming PCI in patients with severeaortic stenosis or patients who haveundergone TAVI

16:30 Session objectivesA. Finkelstein

16:35 Case 1: urgent TAVI for deterioratingcritical aortic stenosis with extensiveanterior wall myocardial infarctionK. Orvin

16:40 How would I treat the case?M. Noc

16:45 How would I treat the case?A. Segev

16:50 How did I treat the case?K. Orvin


M. Bunc17:15 Case 2: TAVI in a patient with a significant

left anterior descending lesionM. Cercek

17:20 How would I treat the case?A. Segev

17:25 How would I treat the case?M. Noc

17:30 How did I treat the case?M. Cercek


A. Finkelstein17:55 Session evaluation and key learnings

M. Bunc




16:30 - 18:00ROOM 353

Abstracts

The radial approach revisitedSession comprising selected EuroPCR 2016abstract submissionsChairperson: S. SaitoPanellists: H.H. Ho , P. Jagtap, S.A.Pyxaras

16:30 Euro16A-OP0845 - Transradial approachfor coronary intervention: data from theCENTURY II studyD. Carrié

16:38 Discussion and audience interaction16:43 Euro16A-OP0297 - Safety and feasibility of

same-day discharge after transradial PCI: amulticentre prospective registryJ.G. Córdoba Soriano

16:51 Discussion and audience interaction16:56 Euro16A-OP0932 - Radial artery spasm:

prevalence, prevention and safetyvasodilators agents in a prospectiverandomised meta-analysisJ. Adjedj

17:04 Discussion and audience interaction17:09 Euro16A-OP0778 - Assessment of acute

and chronic effects on the radial arteryafter a trasradial coronary intervention byOCTR. Rihani

17:17 Discussion and audience interaction17:22 Euro16A-OP0952 - Femoral vs. radial

access for coronary intervention (PCI):results from a large monitor-controlledGerman registry (QuIK)J. Reifart

17:30 Discussion and audience interaction17:35 Euro16A-OP0556 - Transradial vs. the

transfemoral approach in alcohol septalablationF. Sawaya

17:43 Discussion and audience interaction17:48 Euro16A-OP0039 - Relationship between

femoral vascular closure devices andshort-term mortality from 271 845 PCIprocedures performed in the UnitedKingdom between 2006-2011: apropensity score corrected analysis fromthe British Cardiovascular InterventionSociety (BCIS)V. Farooq


16:30 - 18:00ROOM

ARLEQUIN

Images

An image is worth 1,000 wordsSession comprising selected EuroPCR 2016 imagesubmissionsFacilitators: O. Muller, B. Scheller, O.Wendler


interpretation B. Scheller

16:35 Image 20: unveiled and key findingsI. Petrov

16:40 Image 20: discussion and audienceinteraction B. Scheller


interpretation O. Muller

16:50 Image 21: unveiled and key findings G. Katsimagklis

16:55 Image 21: discussion and audienceinteractionO. Muller


interpretation O. Wendler

17:05 Image 22: unveiled and key findingsR. Bogle

17:10 Image 22: discussion and audienceinterpretationO. Wendler


interpretationB. Scheller

17:20 Image 23: unveiled and key findings L. Paiva

17:25 Image 23: discussion and audienceinterpretationB. Scheller


interpretationO. Muller

17:35 Image 24: unveiled and key findingsG. Gelpi (awaiting confirmation)

17:40 Image 24: discussion and audienceinterpretationO. Muller


interpretationO. Wendler

17:50 Image 25: unveiled and key findingsT. Roleder

17:55 Image 25: discussion and audienceinteractionO. Wendler



Thursday 19 May 2016 - Morning - Programme valid as of 12-04-2016

- 08:00 -08:30 - 10:00

THEATRE BLEUPhysiological and imagingguidance in non culprit lesionsafter primary PCI for STEMIChairpersons: H. Samady, N. Van RoyenPanellists: G. Amoroso, F. De Vroey, K. ElMerri, D. Holmes, J. Koolen, S.J. Park

Attend this session if you want:To discuss the limitations ofangiography as a method to guidecomplete revascularisation in patientswith STEMI and multivessel diseaseTo review current evidence on the useof intracoronary functional testing toselect proper treatment in patientswith STEMITo consider the value of intracoronaryimaging to take decisions relevant torevascularisation of the culprit andnon-culprit lesions in STEMI patients

08:30 Session objectivesN. Van Royen

08:33 How could intracoronary physiologycontribute to improve outcomes inpatients with STEMI? J. Escaned


LIVE demonstrationK. El Merri

08:53 LIVE demonstration from RashidHospital, Dubai Health Authority -Dubai, United Arab Emirates

09:33 Time to React@PCR09:43 How could imaging modify the strategy of

primary PCI? G. Guagliumi


H. Samady

08:30 - 10:00THEATRE

BORDEAUX

FocusInnovation

TAVI and structuralChairpersons: T. Modine, C. Ruiz(awaiting confirmation)Panellists: F. Bedogni, H. Eltchaninoff, T.Keles, M.K.Y. Lee, B. Prendergast, G.Tarantini

08:30 Foldavalve: a novel 14-Frenchrepositionable and retrievable TAVIA. Kheradvar

08:37 Discussion and audience interaction08:42 New transcatheter prosthesis aiming zero

paravalvular leakD. Gaia

08:49 Discussion and audience interaction08:54 New modular aortic valve prosthesis09:01 Discussion and audience interaction09:05 A novel bioprosthesis designed for

optimisation of valve-in-valve procedures:bench-testing, chronic animal and humancadaveric implantsD. Dvir

09:12 Discussion and audience interaction09:16 Nitinol thin-film heart valve leaflets

K. Loger (awaiting confirmation)09:23 Discussion and audience interaction09:27 A novel non-implant based approch for

treating calcified aortic valvesG. Manoharan

09:34 Discussion and audience interaction09:38 Heart access technology: paradigm change

in structural disease treatmentW. Sherman

09:45 Discussion and audience interaction09:49 Unidirectional left-to-right interatrial shunt

for the treatment of heart failure: results ofthe first-in-human multicenter experienceJ. Rodes Cabau






Acute and long-term strokeprevention in TAVI patientsChairpersons: A. Lansky, C.K. NaberPanellists: M. Balghith, A. Linke, F.J.Neumann, L. Sondergaard

Attend this session if you want:To learn how to select the best TAVIstrategy for patients at high risk ofperi-procedural strokeTo learn how to minimise stroke riskusing medical therapyTo observe a LIVE case involving use ofa distal protection device


08:33 Cerebral embolic protection devices forprevention of peri-procedural strokeC. Tamburino


LIVE demonstrationC.K. Naber


09:33 Time to React@PCR09:43 Anti-thrombotic treatment for prevention

of post-procedural strokeM. Valgimigli


A. Lansky


FocusInnovation

Plenary

Novel stents and scaffolds fromAsiaChairpersons: R. Gao, P.W. SerruysPanellists: N. Foin, A. Lafont (awaitingconfirmation), E. Lehto, P. Wong(awaiting confirmation)

Attend this session if you want:To become familiar with stent, scaffoldthat have been developed in AsiaTo learn about potential indicationsand specific techniques fordeployment of novel stents andscaffoldsTo appreciate the potential ofnanotechnologies for novel drugdelivery systems in development

08:30 Session objectivesR. Gao

08:35 Sirolimus-eluting stent with abluminalgroove filled by biodegradable polymerQ. Luo

08:42 Discussion and audience interaction08:45 Polymer-free nanoporous sirolimus-eluting

stent and NeoVas fully biodegradablesirolimus-eluting stentP. Suwannasom

08:52 Discussion and audience interaction08:55 Cobalt chromium-based biodegradable

polymer sirolimus-eluting stentY.L. Han (awaiting confirmation)

09:02 Discussion and audience interaction09:05 Fully bioresorbable PLLA-based

sirolimus-eluting scaffold J.B. Ge (awaiting confirmation)

09:12 Discussion and audience interaction09:15 Sirolimus-eluting fully bioresorbable

scaffold with mixed PLLA / PDLA A. Lafont (awaiting confirmation)

09:32 Discussion and audience interaction09:35 MeRes 100: fully bioresorbable PLLA

scaffold eluting-sirolimusU. Kaul

09:42 Discussion and audience interaction09:45 Nano-microsphere for drug-elution

M. Doshi09:52 Discussion and audience interaction09:55 Key learnings

P.W. Serruys




08:30 - 10:00ROOM

LEARNING

Learning bifurcation:double-kissing crush techniqueFacilitators: S.L. Chen (awaitingconfirmation), J.F. Lassen, H. Routledge

Attend this session if you want:To understand what is the rightstrategy for each individual patient,taking into consideration specificanatomiesTo learn how to perform thedouble-kissing crush technique step bystep:


08:30 - 10:00ROOM TERNES 1

Cases

Left main PCI in challengingclinical situationsSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: T. LefevrePanellists: Z. Ghazzal, M. Loutfi, M. Ridha(awaiting confirmation)

08:30 Ostial circumflex stenosis with recurrentpulmonary oedemaM. Sreedharan

08:38 Discussion and audience interaction08:43 Unprotected left main and complex

circumflex PCI in an unstable patientK. Sandhu

08:51 Discussion and audience interaction08:56 Hybrid polymer-free Biolimus-coated stent

and drug-coated balloon angioplasty inanterior STEMI involving ostial left maindisease in high bleeding risk patientD.A. Sinaga

09:04 Discussion and audience interaction09:09 Two lives at stake

A.F. Omar09:17 Discussion and audience interaction09:22 But the patient can't lie flat... Long-term

success of complex cathlab procedures insemi-upright positionE. Roberts

09:30 Discussion and audience interaction09:35 Caugh responsible for myocardial

infarctionN. Zaoui

09:43 Discussion and audience interaction09:48 PCI with stenting of left main coronary

artery and stenting of left subclavian arteryin a young girl with Takayasu arteritisS. Kasturi


08:30 - 10:00ROOM TERNES 2

Cases

Multiple cases of DES in-stentrestenosisSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: A. Mehta (awaitingconfirmation)Panellists: E. Lev, R. Natarajan, O.Varenne (awaiting confirmation)

08:30 "There are no two without three"A. Jurado-Roman

08:38 Discussion and audience interaction08:43 Re-restenosis after DES in bare-metal stent

S. Gupta08:51 Discussion and audience interaction08:56 Between the stents...

P.H. Chan09:04 Discussion and audience interaction09:09 A case of recurrent in-stent restenosis

caused by calcified nodule: serialobservation by OCTN. Makiguchi

09:17 Discussion and audience interaction09:22 A case of PCI for in-stent restenosis which

had been deployed in the subintimallumenT. Asada (awaiting confirmation)

09:30 Discussion and audience interaction09:38 The time course of restenosis with "black

holes" after implantation ofplatinum-chromium everolimus-elutingstent (PtCr-EES): observation using optimalfrequency domain imaging (OFDI)S. Kikuchi

09:43 Discussion and audience interaction09:48 In scaffold restenosis, a new kid in the

block!H. Abu-Hantash





08:30 - 10:00ROOM 241

Abstracts

DES for selected angiographicsubsetsSession comprising selected EuroPCR 2016abstract submissionsChairperson: R.J. Van GeunsPanellists: J. Byrne, A. Chieffo, S.Y. Choi

08:30 Euro16A-OP0360 - Treatment of severelycalcified coronary lesions in patients withACS using newer-generation DES: two-yearclinical outcomeJ. Huisman


following implantation of 44mm / 48mmbiodegradable polymer coatedsirolimus-eluting stents in long coronarylesions: results from the real-worldFLEX-LONG studyR.S. Polavarapu (awaiting confirmation)

08:51 Discussion and audience interaction08:56 Euro16A-OP0496 - Two-year clinical

outcome in 1,811 all-comers treated withnovel coronary DES in at least one smallvessel versus larger sized vessels onlyL.C. Van Der Heijden


outcomes in a real-world population ofpatients with long coronary lesions treatedwith the 38mm cobalt-chromiumeverolimus-eluting stentJ. Benezet

09:17 Discussion and audience interaction09:22 Euro16A-OP0503 - Impact of severe target

lesion calcification on the outcome ofpatients with stable angina pectoristreated with newer-generation permanentpolymer-coated DESJ. Huisman

09:30 Discussion and audience interaction09:35 Euro16A-OP0838 - Clinical impact of

various types of stents on late-termprognosis of patients with vasospasticanginaR. Hata

09:43 Discussion and audience interaction09:48 Euro16A-OP0358 - Small vessel treatment

with novel newer-generation DES inall-comers: which threshold is mostappropriate for defining "small coronaryvessels"?L.C. Van Der Heijden


08:30 - 10:00ROOM 242AB


I have a great idea. How totransform it into a study design?Facilitators: D. Capodanno, C. Cook, R.L.J.Osnabrugge

Attend this session if you want:To understand the pros and cons ofdifferent study designs To be able to select the right trialdesign to prove your hypothesisTo calculate the sample size of yourtrial

08:30 - 10:00ROOM 251


Professionals

Abstracts

Abstract session for nurses andallied professionalsSession comprising selected EuroPCR 2016abstract submissionsChairpersons: J. Laub, D. Zughaft

08:30 Euro16A-OP0370 - 3D OCT: fromeducational tool to clinical use. Asingle-centre overviewK. Witberg

08:38 Discussion and audience interaction08:43 Euro16A-OP0384 - Are non-contrast

flushing agents in coronary OCT feasiblealternatives to contrast flushing?C.H. Egeland

08:51 Discussion and audience interaction08:56 Euro16A-OP0214 - Barriers against

improving flow and capacity in cardiaccatheterisation laboratory: a challenge fornurse managersM. Ghorbati

09:04 Discussion and audience interaction09:09 Euro16A-OP0908 - Risk of contrast induced

nephropathy in patients with impairedkidney function undergoing ambulatorycoronary angiographyE. Girukwishaka

09:17 Discussion and audience interaction09:22 Euro16A-OP0867 - Reduction of radiation

exposure in the cathlab after addition ofnew radiation protocols and sensitisationof cathlab personnelL. De Block

09:30 Discussion and audience interaction09:35 Euro16A-OP0140 - High procedural

radiation eye dose found for scrub nurse(second operator) compared to physician(primary operator): discovered deficienciesin current, above table shieldingG. Ison

09:43 Discussion and audience interaction09:48 Euro16A-OP0187 - Prospective study of

peripheral vascular events and one monthfollow-up in patients undergonetransfemoral aortic valve replacementV. Rodriguez Garcia-Abad


08:30 - 10:00ROOM 252AB

Learning below-the-kneeangioplastyFacilitators: E. Blessing, T. ZellerMedia Driver: A. Bacaksiz (awaitingconfirmation)Expert panellists: H. Reinecke, E.Vuruskan






08:30 - 10:00ROOM 253

All you need to know about TAVIChairpersons: R. Kornowski, N. Piazza


08:30 Session objectivesR. Kornowski

08:35 Clinical results with established TAVIdevicesN. Piazza

08:48 Discussion and audience interaction08:55 Technical issues: adjunctive technology to

facilitate and improve outcomesS. Redwood

09:08 Discussion and audience interaction09:15 Guidelines and recommendations 2016

A.S. Petronio09:28 Discussion and audience interaction09:35 Unresolved issues and outlook - new

indications, new valve systemsD. Mylotte


N. Piazza

08:30 - 10:00ROOM 341

Abstracts

PCR's Got Talent - round 2:Session 1Session comprising selected EuroPCR 2016abstract submissionsChairpersons: O. Bertrand (awaitingconfirmation), A. SauguetJury Members: N. Curzen, B. Honton, G.Nickenig, I. Petrov, D. Wagner

08:30 - 10:00ROOM 342A

Plenary

Acute ischemic strokeinterventionChairpersons: O. Goktekin, N. HopkinsPanellists: A. Cremonesi, B. Reimers

Attend this session if you want:To discuss proper patient selection inview of existing evidenceTo appreciate why it is critical to createor integrate an acute stroke networkfor optimal endovascular treatmentTo discuss how endovasculartreatment can be safely performed

08:30 Session objectivesO. Goktekin

08:33 Patient selectionO. Ozdemir

08:43 Discussion and audience interaction08:51 New evidence in recent stroke trials

B. Reimers09:01 Discussion and audience interaction09:09 Practical clinical case

N. Hopkins09:19 Discussion and audience interaction09:27 Round-table and discussion and audience

interaction - why it is critical to create orintegrate an acute stroke network foroptimal endovascular treatment O. Goktekin

09:57 Key learnings and session evaluationN. Hopkins

08:30 - 10:00ROOM 342B

Cases

OCT in ACSSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: F. PratiPanellists: M. Ashraf Al Anie (awaitingconfirmation), A.B. Catakoglu, N. Uren

08:30 Unraveling the pathophysiology ofnon-culprit disease in ACS: insights fromOCT imagingK. De Silva

08:39 Discussion and audience interaction08:45 Usefulness of OCT in STEMI without culprit

lesionG. Mouillet (awaiting confirmation)

08:54 Discussion and audience interaction09:00 Migrating outflow "disease": the value of

intracoronary imagingH. Khan

09:09 Discussion and audience interaction09:15 Ventricular tachycardia in thrombus

recanalisationA. Pavei

09:24 Discussion and audience interaction09:30 Severe coronary vasospasm presenting

with STEMIV. Ploscaru

09:39 Discussion and audience interaction09:45 PCI of a tapered circumflex in a STEMI case

G. Amoroso09:54 Discussion and audience interaction




08:30 - 10:00ROOM 343

Abstracts

CTO interventions: it's all abouttechniques!Session comprising selected EuroPCR 2016abstract submissionsChairperson: D. DudekPanellists: M. Ochiai, W. Udayachalerm

08:30 Euro16A-OP0380 - Predictors forprocedure failure of PCI for CTO with priorCABG surgery: two-year data fromJapanese retrograde SUMMIT registryM. Tanabe

08:38 Discussion and audience interaction08:43 Euro16A-OP0963 - Primary use of channel

dilator for antegrade recanalisation ofcoronary CTOJ. Reifart

08:51 Discussion and audience interaction08:56 Euro16A-OP0105 - Percutaneous

intervention in coronary CTO due toin-stent restenosis: a multicentre registryJ.M. De La Torre Hernandez

09:04 Discussion and audience interaction09:09 Euro16A-OP0443 - Treatment of

bifurcation lesions involved in therecanalisation process of coronary CTOS. Ojeda

09:17 Discussion and audience interaction09:22 Euro16A-OP0150 - A novel manoeuvre to

facilitate retrograde wire externalisationduring retrograde CTO PCIR. Jabbour

09:30 Discussion and audience interaction09:35 Euro16A-OP0529 - Outcomes of the

antegrade dissection and re-entrytechnique as part of the contemporary,hybrid CTO-PCI practice: the RECHARGEregistryJ. Maeremans (awaiting confirmation)

09:43 Discussion and audience interaction09:48 Euro16A-OP0029 - Retrograde approach in

CTO: 10-year experienceM. Boukhris


08:30 - 10:00ROOM 351

Abstracts

Optimising the outcome of leftmain PCISession comprising selected EuroPCR 2016abstract submissionsChairperson: V. SchächingerPanellists: W.H. Ahmed, R. Parma, B.Singh

08:30 Euro16A-OP0604 - Should we abandonpercent diameter stenosis as an index ofleft main stenosis severity?H.D. Mejia-Renteria

08:38 Discussion and audience interaction08:43 Euro16A-OP0124 - Euroscore II strongly

predicts all-cause mortality duringfollow-up in patients with significant leftmain coronary artery disease undergoingPCI or CABG surgeryS. Moura-Ferreira

08:51 Discussion and audience interaction08:56 Euro16A-OP1073 - Use of customised

measurement planes in imaging of the leftmain coronary artery bifurcation: feasibilityand first comparison to standard imagingT.M. Nielsen

09:04 Discussion and audience interaction09:09 Euro16A-OP0121 - Procedures for left main

coronary artery disease in the real-worldclinical practice - stents, CABG, or hybridprocedures: a single-centre experienceS. Moura-Ferreira

09:17 Discussion and audience interaction09:22 Euro16A-OP0117 - Choice of

revascularisation mode in relation tocoronary artery anatomy, comorbiditiesand outcome in patients with unprotectedleft main coronary artery stenosisJ.L. Persson (awaiting confirmation)

09:30 Discussion and audience interaction09:35 Euro16A-OP0125 - Predictors of all-cause

mortality during follow-up afternon-emergent CABG surgery or PCI due toleft main coronary artery diseaseS. Moura-Ferreira

09:43 Discussion and audience interaction09:48 Euro16A-OP0609 - Comparative evaluation

of the left main coronary bifurcationstenting using different generations of DESD. Maximkin





08:30 - 10:00ROOM 352A

How Should ITreat?

Denmark and Sweden sharetheir most educational cases:complete revascularisation inSTEMIWith the collaboration of the Danish WorkingGroup on Interventional Cardiology and theWorking Group on Interventional Cardiology ofthe Swedish Society of Cardiology Chairpersons: T. Engstroem, N. Witt

Attend this session if you want:To understand the complexity and thediversity of the clinical scenariosamong patients presenting with STEMIand multivessel coronary artery diseaseTo learn about the current evidencebase for different treament options inthis setting (timing of remote vesselPCI, lesion selection by physiologicassessment and imaging)To reflect on the prognosticimplications of completerevascularisation in STEMI patients

08:30 Session objectivesN. Witt

08:35 Case 1: a STEMI patient with multivesseldisease including a coronary CTOJ. Odenstedt

08:40 How would I treat the case?E. Christiansen

08:45 How would I treat the case?E. Omerovic

08:50 How did I treat the case?J. Odenstedt


T. Engstroem09:15 Case 2: right coronary artery STEMI with a

subtotal occlusion of the left anteriordescending arteryK. Tange Veien

09:20 How would I treat the case?E. Omerovic

09:25 How would I treat the case?E. Christiansen

09:30 How did I treat the case?K. Tange Veien


N. Witt09:55 Session evaluation and key learnings

T. Engstroem

08:30 - 10:00ROOM 352B

How Should ITreat?

Macedonia and the Netherlandsshare their most educationalcases: managing TAVIcomplicationsWith the collaboration of the Macedonian Societyof Cardiology and the Dutch Working Group ofInterventional Cardiology (WIC)Chairpersons: S. Kedev, J. Vos (awaitingconfirmation)

Attend this session if you want:To understand the limitations andpotential complications associatedwith currently available TAVI devicesTo learn the potential mechanisms ofdifferent TAVI complicationsTo share various techniques formanaging TAVI complications fromreal-life practice

08:30 Session objectivesS. Kedev

08:35 Case 1: primary PCI for anterior STEMI in apatient after CoreValve implantationI. Vasilev

08:40 How would I treat the case?J. Baan

08:45 How would I treat the case?S. Antov

08:50 How did I treat the case?I. Vasilev


J. Vos (awaiting confirmation)09:15 Case 2: transfemoral TAVI in tortuous aorta

P. Den Heijer09:20 How would I treat the case?

S. Antov09:25 How would I treat the case?

J. Baan09:30 How did I treat the case?

P. Den Heijer09:40 Discussion and audience interaction09:50 Consensus

S. Kedev09:55 Session evaluation and key learnings

J. Vos (awaiting confirmation)




08:30 - 10:00ROOM 353

Abstracts

BRS for bifurcation PCISession comprising selected EuroPCR 2016abstract submissionsChairperson: A. Serra (awaitingconfirmation)Panellists: P. Agarwal, P. Ludman, J.Wykrzykowska

08:30 Euro16A-OP0678 - Sequential proximaloptimising technique (rePOT) inprovisional bifurcation stenting witheverolimus-eluting BRSF. Derimay (awaiting confirmation)

08:38 Discussion and audience interaction08:43 Euro16A-OP0765 - Everolimus-eluting BRS

implanted in coronary bifurcation lesionsimpact of polymeric wide struts onside-branch impairmentR. Diletti

08:51 Discussion and audience interaction08:56 Euro16A-OP0731 - Impact of side branch

post-dilation with single balloon onscaffold geometry during the treatment ofbifurcation coronary lesions with simplestrategy: an OCT analysisJ. Suarez de Lezo

09:04 Discussion and audience interaction09:09 Euro16A-OP0061 - In-vivo evaluation of

the provisional strategy for aneverolimus-eluting BRS for coronarybifurcation lesions: interim OCT resultsN. Jepson


following bifurcation double stenting withBRSA. Tanaka

09:30 Discussion and audience interaction09:35 Euro16A-OP0059 - Bifurcational coronary

lesions treated with everolimus-elutingBRS: procedural strategies and clinicaloutcomesD. Robaei

09:43 Discussion and audience interaction09:48 Euro16A-OP1020 - One-year outcomes of

the use of BRS to treat bifurcationsJ. Molina-Martin de Nicolas


08:30 - 10:00ROOM

ARLEQUIN

Images

An image is worth 1,000 wordsSession comprising selected EuroPCR 2016 imagesubmissionsFacilitators: J.J. Bax, D. Kettles, F.Ribichini


interpretation J.J. Bax

08:35 Image 26: unveiled and key findingsK. Koegler

08:40 Image 26: discussion and audienceinteraction J.J. Bax


interpretation D. Kettles

08:50 Image 27: unveiled and key findings V. Ng

08:55 Image 27: discussion and audienceinteractionD. Kettles


interpretation F. Ribichini

09:05 Image 28: unveiled and key findingsR. Hammami

09:10 Image 28: discussion and audienceinterpretation


interpretationJ.J. Bax

09:20 Image 29: unveiled and key findings S. Ishihara

09:25 Image 29: discussion and audienceinterpretationJ.J. Bax


interpretationD. Kettles

09:35 Image 30: unveiled and key findingsG. Bruschi

09:40 Image 30: discussion and audienceinterpretationD. Kettles


interpretationF. Ribichini

09:50 Image 31: unveiled and key findingsW. Wojakowski

09:55 Image 31: discussion and audienceinteractionF. Ribichini




- 10:00 -10:30 - 12:00

THEATRE BLEUPCI in a patient with diseasedvein graftChairpersons: H. Eteiba, M. GilardPanellists: S. Alam, F. Della Rosa, F. Eberli,U. Kaul, F. Malik, S. Mathew

Attend this session if you want:To learn the critical issues in patientswith previous CABG To better understand the choice ofdrugs, stents and technique forsaphenous vein graft PCI To learn the tips and tricks for thetransradial PCI of the graft

10:30 Session objectivesH. Eteiba

10:33 When and in whom to treat the diseasedvein graft?P. Kala


LIVE demonstrationF. Della Rosa


11:33 Time to React@PCR11:43 What technique, which stent, what

approach?J. Mehilli


M. Gilard

10:30 - 12:00THEATRE

BORDEAUX

FocusInnovation

Mitral and tricuspidChairpersons: N. Piazza, A. VahanianPanellists: H. Ince, M.B. Leon, H.Moellmann, G. Nickenig

10:30 Medtronic Intrepid transcatheter mitralvalve replacementR. Taneja

10:37 Discussion and audience interaction10:42 M-Valve: a novel approach for treatment of

mitral regurgitation - latest updateM. Buchbinder

10:49 Discussion and audience interaction10:54 MIA and Permavalve: transcatheter valve

repair and replacementW. Hennemann (awaiting confirmation)

11:01 Discussion and audience interaction11:05 AccuFit transapical mitral valve

replacement system: technical updateC. Zheng (awaiting confirmation)

11:12 Discussion and audience interaction11:16 Four-leaflet elliptical transcatheter mitral

valveG. Agreli (awaiting confirmation)

11:23 Discussion and audience interaction11:28 Novel catheter guided tricuspid valved

stent for secondary tricuspid regurgitation:verification in chronic animal studiesJ.L. Navia (awaiting confirmation)

11:35 Discussion and audience interaction11:39 Functional tricuspid regurgitation: an

innovative transcatheter valve repairsolutionF. Maisano

11:46 Discussion and audience interaction11:50 Percutaneous tricuspid valve repair:

imaging techniques and early clinicalresultsF. Praz






LAA closure for strokepreventionChairpersons: M.W. Bergmann, E.EeckhoutPanellists: S. Gafoor, F. Hellig, D. Holmes,T. Schmitz

Attend this session if you want:To gain insights into the LAA occlusionprocedureTo understand the strategic work-up,different devices and implantationtechniquesTo learn about latest data and futuredevelopments

10:30 Session objectivesM.W. Bergmann

10:33 Patient selection focused on imaging10:40 Time to React@PCR10:47 Review of the tools to be used during the

LIVE demonstrationM.W. Bergmann


11:33 Time to React@PCR11:43 From recent data to patient follow-up

S. Gafoor11:50 Time to React@PCR11:57 Session evaluation and key learnings

E. Eeckhout


FocusInnovation

Hot Line

FFR / iFRChairpersons: C. Di Mario, S.J. Park(awaiting confirmation)Panellists: C. Berry, N. Curzen, J. Davies,N.R. Holm

10:30 Impact of routine FFR on managementdecision and one-year clinical outcome ofACS patients insights from the POST-IT andR3F integrated multicentre registries -implementation of FFR in routine practice(PRIME-FFR)L. Raposo

10:39 Discussion and audience interaction10:45 iFR / FFR and IVUS-guided percutaneous

coronary revascularisation withnew-generation DES in patients with DeNovo three vessel disease: 30-dayoutcomes of the SYNTAX II trialP.W. Serruys

10:54 Discussion and audience interaction11:00 DEFINE REAL: a prospective, observational,

non-randomised, European, multicentreregistry, collecting real-life information forthe utilisation of iFR in assessing coronarystenosis relevance in the multivesseldisease patients populationE. Van Belle

11:09 Discussion and audience interaction11:15 Image-based FFR during coronary

catheterisationM. Pellicano

11:24 Discussion and audience interaction11:30 Diagnostic accuracy of a fast

computational approach to derive FFRfrom coronary X-ray angiography: resultsfrom the international multicentre FAVOR(Functional Assessment by Various flOwReconstructions) pilot studyS. Tu

11:39 Discussion and audience interaction11:45 Graft patency after FFR-guide vs.

angio-guided CABG: a randomised clinicaltrial (GRAFFITI trial)E. Barbato (awaiting confirmation)


10:30 - 12:00ROOM

LEARNING

Learning how to simplify TAVIFacilitators: S. Redwood, C. Tamburino,N. Van MieghemExpert panellists: K. Hayashida, N.Jaussaud (awaiting confirmation)

Attend this session if you want:To understand who is a suitablepatient for TAVI without generalanaesthesiaTo understand how to safely plan andperform a simplified transfemoral TAVITo identify the potential benefits of asimplified procedure




10:30 - 12:00ROOM TERNES 1

Cases

Challenging anatomy for leftmain PCISession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: A. BartorelliPanellists: S. Salama, E. Torresani

10:30 Anomalous left main stem from rightcoronary cusp and segmental origin of leftanterior descending and left circumflexH. Shaalan

10:38 Discussion and audience interaction10:43 Primary percutaneous reconstructed left

main stenting in very young patient afterrepaired anomalous left coronary arteryfrom the pulmonary artery (ALCAPA)M. Crisci

10:51 Discussion and audience interaction10:56 When the culprit is left main ostium

S. Narayanan11:04 Discussion and audience interaction11:09 A challenging case of a large tapered left

main PCIH. Lu

11:17 Discussion and audience interaction11:22 Sequence and approach of acute total

occlusion of left main stem duringdiagnostic angiography in two challengingcasesK. Amber

11:30 Discussion and audience interaction11:38 Complex stenting of ectatic left main

stenosesP. Kubler

11:43 Discussion and audience interaction11:48 Complex left main bifurcation and left

anterior descending: how do I treat?M.G. Pillai


10:30 - 12:00ROOM TERNES 2

Cases

How to deal with in-stentrestenosis bifurcation?Session comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: A.G. OsievPanellists: M.A.K. Akanda, R. Kumar(awaiting confirmation), M. Pan

10:30 Treatment dilemma in an aggressive earlyin-stent restenosis post bifurcationcoronary angioplastyP. Raju

10:38 Discussion and audience interaction10:43 Fixing a broken shotgun

S.R. Kandan10:51 Discussion and audience interaction10:56 How to treat an in-stent restenosis in a

bifurcation previously treated with thetechnique of "mini-crushing" in which wasnot finished with the kissing balloon?L. Dallan

11:04 Discussion and audience interaction11:09 A novel child catheter helps you overcome

difficult coronary stent delivery: dramaticimprovement of backup supportT. Isawa

11:17 Discussion and audience interaction11:22 Management of complex DES in-stent

restenosis - the value of OCT imaging indecision makingS. Balakrishnan Nair (awaiting confirmation)

11:30 Discussion and audience interaction11:38 Ostial circumflex in-stent restenosis

treated with BRSN. Salvatella

11:43 Discussion and audience interaction11:48 A stent re-restenosis case after DEB

treatmentS. Mogi


10:30 - 12:00ROOM 242AB


I am participating in a clinicalstudy. How can I improve myrecruitment rate?Facilitators: S. Kedev, M.C. Morice(awaiting confirmation), D. MylotteExpert advisor: F. Mahfoud

Attend this session if you want:To learn how to build an efficient teamTo understand how to set up thelogistics for your recruitment activityTo learn tips & tricks on how toimprove your recruitment rate

10:30 - 12:00ROOM 243

PCR SharingCentre

X-ray exposure: how to stayhealthy and continue practiceinterventional cardiologyFacilitators: P. Capranzano, A. Roguin




10:30 - 12:00ROOM 251


Professionals

Abstracts

Abstract session for nurses andallied professionalsSession comprising selected EuroPCR 2016abstract submissionsChairpersons: L. Kloevgaard, T. VanHecke

10:30 Euro16A-OP0072 - Early discharge inpatients undergoing TAVIC. Florio (awaiting confirmation)

10:38 Discussion and audience interaction10:43 Euro16A-OP0500 - Physical activity during

hospitalisation post TAVI - an importantpart of patient rehabilitationT.W. Andersen

10:51 Discussion and audience interaction10:56 Euro16A-OP0170 - New training for cathlab

/ cardiac care unit nursesD. Mulder

11:04 Discussion and audience interaction11:09 Euro16A-OP0444 - Radial artery

compression after transradial coronaryangiography: does compression devicematter?N. Due-Tønnessen

11:17 Discussion and audience interaction11:22 Euro16A-OP0309 - The effect of

vasodilatory medications on radial arteryspasm in patients undergoing transradialcoronary artery procedures: a systematicreviewE. Curtis

11:30 Discussion and audience interaction11:35 Euro16A-OP0241 - Pre-hospital cardiac

patients are triaged by nurse specialistsL. Haaber Cohen

11:43 Discussion and audience interaction11:48 Euro16A-OP0726 - Mind the gap: gender

inequities in cardiovascular careR. Deible


10:30 - 12:00ROOM 252AB

Revascularisation techniques incritical limb ischaemiaChairpersons: R. Ferraresi, A. Sauguet(awaiting confirmation)Panellists: I. Alhaddad, M. Bosiers, M.Manzi (awaiting confirmation), J.C. VanDen Berg

Attend this session if you want:To discuss what is the standardrevascularisation approach in criticallimb ischaemia, specifically in: longtibial CTO - focal tibial stenosis

10:30 Session objectivesR. Ferraresi

10:33 Review of the tools to be used during theLIVE demonstrationM. Manzi (awaiting confirmation)

10:39 LIVE demonstration from Maria CeciliaHospital, GVM Care & Research -Cotignola, Italy

11:39 Time to React@PCR11:53 Review of the DEB and DES trials

T. Zeller11:57 Session evaluation and key learnings

A. Sauguet (awaiting confirmation)

10:30 - 12:00ROOM 253

Cases

Rotablator for the treatment ofcalcified left main lesionsSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: F. MauriPanellists: T. Lall, A. Marchese, S. Padhi

10:30 Complex distal left main stem PCIU.E. Sheikh

10:38 Discussion and audience interaction10:43 Left main bifurcation - rotablation and V

stentingS.M. Sista

10:51 Discussion and audience interaction10:56 Calcified left main coronary artery stenosis

bifurcation: how do we do?M.G. Pillai

11:04 Discussion and audience interaction11:09 Left main rotational atherectomy

S.T. Rab11:17 Discussion and audience interaction11:22 Reverse wire technique followed by

rotablation for calcified distal left mainbifurcation lesionH.R. Li

11:30 Discussion and audience interaction11:35 Rotablation of left main coronary artery

stenosis in NSTE-ACSM. Sreedharan

11:43 Discussion and audience interaction11:48 Urgent left main rotational atherectomy

supported by extracorporeal membraneoxygenation in cardiogenic shock patientK. Wilczek (awaiting confirmation)





10:30 - 12:00ROOM 341

Abstracts

PCR's Got Talent - round 2:Session 2Session comprising selected EuroPCR 2016abstract submissionsChairpersons: M. Brodmann, I. Meredith(awaiting confirmation)Jury Members: H. Faltot, J. Laub, H.Reinecke, M. Valgimigli, S. VonBardeleben, E. Vuruskan

10:30 - 12:00ROOM 342A

Plenary

Pharmaco-invasive strategy forSTEMI: worldwide perspectiveChairpersons: K. Al-Shaibi, T. CuissetPanellists: E. Merkulov, A. Protopopov

Attend this session if you want:To understand the current role ofthrombolytic therapy in the treatmentof STEMITo discuss how to optimise the use ofpharmaco-invasive in a non-PCIcapable hospitalTo appraise when and how to applyPCI post-lysis

10:30 Session objectivesT. Cuisset

10:35 Case 1: how should I treat? Clinicalscenario: high-risk early anteriormyocardial infarction with an anticipatedsignificant transfer delay to PCI centre innon-PCI centreK. Al Faraidy

10:40 How would I treat this patient in India?R. Chakraborty

10:47 How would I treat this patient in Africa?S. Khan

10:54 How would I treat this patient in SouthEast Asia?N.Q. Nguyen

11:01 How did I treat?K. Al Faraidy

11:31 Pharmaco-invasive treatment of STEMI: theevidence "STREAM and beyond"T. Cuisset

11:51 Discussion and audience interaction:burning questions

11:56 Session evaluation and key learningsK. Al-Shaibi

10:30 - 12:00ROOM 342B

Cases

STEMI in the young: place of OCTSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: H.M. Garcia-GarciaPanellists: D.A. Sinaga, K. Toutouzas

10:30 Acute myocardial infarction followingdiagnostic catheterisation in a youngwomanA. Bairam

10:38 Discussion and audience interaction10:43 It is not easy with the young

M.A. Ahmed10:51 Discussion and audience interaction10:56 Usefulness of OCT for the diagnosis and

management of an ACS in a very youngpatientC. Biagioni (awaiting confirmation)

11:04 Discussion and audience interaction11:09 Myocardial infarction in a very young

patientV. Rubimbura

11:17 Discussion and audience interaction11:22 STEMI caused by a spontaneous coronary

artery dissection in two vessels: how tomanage?O. Toleva

11:30 Discussion and audience interaction11:35 OCT-supported PCI of spontaneous

coronary artery dissectionR. Vijayvergiya

11:43 Discussion and audience interaction11:48 OCT-guided approach to postpartum

coronary artery dissection: a case report11:56 Discussion and audience interaction




10:30 - 12:00ROOM 343

Abstracts

Critical limb ischaemia andbelow-the-knee interventionsSession comprising selected EuroPCR 2016abstract submissionsChairperson: F. RibichiniPanellists: B. Honton, M.S. Mourali, J. Tan(awaiting confirmation)

10:30 Euro16A-OP0622 - Below knee angioplastyas limb salvage in critical ischaemiaA.P. Mollon

10:38 Discussion and audience interaction10:43 Euro16A-OP0651 - 24-month results of

hybrid interventions in patients withcritical lower limb ischaemiaD. Maximkin

10:51 Discussion and audience interaction10:56 Euro16A-OP0906 - Our outcomes with

percutaneous below-the-knee balloonangioplasty interventions in patients withcritical leg ischaemiaO. Ozcan Celebi

11:04 Discussion and audience interaction11:09 Euro16A-OP0909 - Minimal footprint

implant for dissection repair afterbelow-the-knee balloon angioplasty

11:17 Discussion and audience interaction11:22 Euro16A-OP1056 - Invasive treatment of

critical hand ischaemiaZ. Ruzsa

11:30 Discussion and audience interaction11:35 Euro16A-OP0691 - Bioabsorbable scaffold

stents for the endovascular treatment ofinfrapopliteal lesions in critical limbischaemiaD. Garcia

11:43 Discussion and audience interaction11:48 Euro16A-OP0473 - Endovascular

arteriovenous fistula for haemodialysis:initial outcomes from the NovelEndovascular Access Trial (NEAT)K. Thomson


10:30 - 12:00ROOM 351

Abstracts

TAVI in contemporary practice -part 2Session comprising selected EuroPCR 2016abstract submissionsChairperson: L. SondergaardPanellists: J. Abdullakutty, M. Ashmawy(awaiting confirmation), U. Gerckens

10:30 Euro16A-OP0672 - Comparison ofballoon-expandable and mechanicallyexpanded transcatheter aortic valves:matched comparison from a single-centreexperienceM. Abdel-Wahab

10:38 Discussion and audience interaction10:43 Euro16A-OP0257 - Clinical and

echocardiographic outcome 30-days andone-year after second generation balloonexpandable transcatheter heart valveimplantation (Edwards sapien 3)S. Fateh-Moghadam

10:51 Discussion and audience interaction10:56 Euro16A-OP0151 - Short- and mid-term

clinical outcomes with the repositionableLotus TAVI system: a single-centreexperience of 100 casesL. McCormick

11:04 Discussion and audience interaction11:09 Euro16A-OP0435 - Multicentre clinical

study evaluating a novel self-expandingand resheathable transcatheter aorticvalve system six-month resultsJ. Johnson

11:17 Discussion and audience interaction11:22 Euro16A-OP0350 - Early outcomes of TAVI

using the new generation CoreValveEvolut R: results from a single-centreexperienceM. Barbanti

11:30 Discussion and audience interaction11:35 Euro16A-OP0826 - Correlation of

CoreValve Implantation "true cover index"with paravalvular regurgitation:implantation depth really mattersK. Kalogeras

11:43 Discussion and audience interaction11:48 Euro16A-OP0266 - Impact of implantation

depth on pacemaker rate and paravalvularleakage after balloon-expandable TAVI(Edwards Sapien 3)S. Fateh-Moghadam





10:30 - 12:00ROOM 352A

How Should ITreat?

Bulgaria and Romania sharetheir most educational cases:challenging situations in thetreatment of patients with ACSWith the collaboration of the Bulgarian Society ofInterventional Cardiology and the InterventionalCardiology Working Group of the RomanianSociety of CardiologyChairpersons: S.D. Mot, D. Trendafilova

Attend this session if you want:To understand the possible complexityof so called "simple primary PCIprocedures"To learn the techniques that can solvedifficult situationsTo share the expertise after a largeexperience in treating STEMI withprimary PCI

10:30 Session objectivesD. Trendafilova

10:35 Case 1: left main treatment in a patientwith ACSI. Jeleva

10:40 How would I treat the case?D. Deleanu

10:45 How would I treat the case?D. Vassilev

10:50 How did I treat the case?I. Jeleva


S.D. Mot11:15 Case 2: multiple complications of a STEMI

case with a very large thrombus burdenM. Postu

11:20 How would I treat the case?D. Vassilev

11:25 How would I treat the case?D. Deleanu

11:30 How did I treat the case?M. Postu


D. Trendafilova11:55 Session evaluation and key learnings

S.D. Mot

10:30 - 12:00ROOM 352B

How Should ITreat?

Austria and Italy share theirmost educational cases:challenging TAVI, more than onesolution?With the collaboration of the Working Group onInterventional Cardiology of the Austrian Societyof Cardiology and the Italian Society ofInterventional Cardiology (SICI-GISE) Chairpersons: G. Musumeci, T. Neunteufl

Attend this session if you want:To critically assess the chances for asuccessfull TAVI implantation inpatients with atherosclerotic aorticdiseaseTo learn how to manage complexanatomical situations and proceduralcomplications

10:30 Session objectivesT. Neunteufl

10:35 Case 1: transfemoral aortic valveimplantation in a patient with severelycalcified low flow, low gradient aorticstenosis and severely calcifyingatherosclerosis (aorta, aortic arch, femoralvessels...)A. Geppert

10:40 How would I treat the case?C. Gandolfo

10:45 How would I treat the case?G. Delle-Karth

10:50 How did I treat the case?A. Geppert


G. Musumeci11:15 Case 2: double trouble during transfemoral

aortic valve implantationS. Berti

11:20 How would I treat the case?G. Delle-Karth

11:25 How would I treat the case?C. Gandolfo

11:30 How did I treat the case?S. Berti


T. Neunteufl11:55 Session evaluation and key learnings

G. Musumeci




10:30 - 12:00ROOM 353

Abstracts

Stroke post-TAVI: predictors andpreventivesSession comprising selected EuroPCR 2016abstract submissionsChairperson: R. MakkarPanellists: R. Bhindi, D. Davidson(awaiting confirmation), J.T. Liou(awaiting confirmation)

10:30 Euro16A-OP0439 - Prevalance andetiopathology of thrombembolic debrisduring transcather interventional aorticvalve replacement: preliminary results ofthe SENTINEL H-studyC. Jensen

10:38 Discussion and audience interaction10:43 Euro16A-OP0198 - Silent cerebral injury

after TAVI and the preventive role ofembolic protection devices: a systematicreview and meta-analysisM. Pagnesi

10:51 Discussion and audience interaction10:56 Euro16A-OP0099 - A

diffused-weighted-MRI andmulti-slice-CT-Study to assess predictors ofcerebral embolism during TAVIJ. Schofer

11:04 Discussion and audience interaction11:09 Euro16A-OP0937 - Subclinical brain

infarctions but not cerebrovascularmicroembolic events after TAVI negativelyimpact cognitive function and cerebralmorphology in long-term follow-upA. Ghanem

11:17 Discussion and audience interaction11:22 Euro16A-OP0254 - Procedural and clinical

predictors for 30-day stroke aftertransfemoral TAVIS. Fateh-Moghadam

11:30 Discussion and audience interaction11:35 Euro16A-OP0098 - First clinical experience

with the third generation TriGuard devicefor cerebral embolic protection duringTAVIJ. Schofer

11:43 Discussion and audience interaction11:48 Euro16A-OP0856 - LAA thrombus in TAVI:

prevalence, clinical impact and the role ofcardiac CTP.D. Williams


10:30 - 12:00ROOM

ARLEQUIN

Images

An image is worth 1,000 wordsSession comprising selected EuroPCR 2016 imagesubmissionsFacilitators: J. Bartunek, E. Brochet, T.Modine


interpretationJ. Bartunek

10:35 Image 32: unveiled and key findingsL.L. Gheorghe

10:40 Image 32: discussion and audienceinteractionJ. Bartunek


interpretationE. Brochet

10:50 Image 33: unveiled and key findingsA. Lopez Suarez (awaiting confirmation)

10:55 Image 33: discussion and audienceinteractionE. Brochet


interpretationT. Modine

11:05 Image 34: unveiled and key findingsN. Zaoui

11:10 Image 34: discussion and audienceinteractionT. Modine


interpretationJ. Bartunek

11:20 Image 35: unveiled and key findingsA.R.G. Francisco

11:25 Image 35: discussion and audienceinteractionJ. Bartunek


interpretationE. Brochet

11:35 Image 36: unveiled and key findingsT. Adrega

11:40 Image 36: discussion and audienceinteractionE. Brochet


interpretationT. Modine

11:50 Image 37: unveiled and key findingsD. D'Amario

11:55 Image 37: discussion and audienceinteractionT. Modine




- 12:00 -12:30 - 14:30

THEATRE BLEU

Tools andTechniques

(TNT)

Complex PCI and trans-radialapproachSponsored by TERUMOChairperson: J. FajadetCo-Chairperson: C.K. NaberPanellists: A. Al Nooryani, A. Aminian, R.Calvino, M. Gilard, H. Khamis, E.E.Ribeiro, O. Sakhov

Attend this session if you want:To appreciate the value of transradialapproach for complex PCITo demonstrate how to optimisechallenging PCI using new dedicateddevices in trans-radial approachTo acknowledge Ultimaster DES resultsin complex patients population

12:30 Session objectivesJ. Fajadet

12:33 Review of the tools to be used during theLIVE demonstrationJ. Fajadet


13:18 Time to React@PCR13:25 Long term clinical outcomes of patients

with multivessel disease treated withUltimaster DESR. Calvino

13:30 Innovation in transradial accessA. Aminian

13:35 Review of the tools to be used during theLIVE demonstrationJ. Fajadet



C.K. Naber

12:30 - 14:30THEATRE

BORDEAUX

Tools andTechniques

(TNT)

Achieving procedural excellenceand efficiency with theCoreValve Evolut R systemSponsored by MEDTRONICChairperson: L. SondergaardCo-Chairperson: N. PiazzaPanellists: R. Bekeredjian, A. Latib, D.Mylotte, G. Nickenig

Attend this session if you want:To learn more on how the evolution inpatient characteristics will impact theTAVI procedureTo learn more about the importance ofpatient selection, sizing and proceduralplanning when attempting to simplifyyour TAVI procedure safelyTo learn how to optimise TAVIimplantation with Evolut R withoutcompromise on clinical outcomes andpatient safety

12:30 Session objectivesL. Sondergaard

12:35 Treating tomorrow's patients: are all TAVItechnologies created equal?G. Nickenig


13:25 Time to React@PCR13:30 Pre-procedural planning: the key for TAVI

simplificationD. Mylotte

13:40 Time to React@PCR13:45 Optimising the TAVI procedure: leveraging

the unique features of the Evolut R systemR. Bekeredjian

13:55 Time to React@PCR14:00 Recorded case from San Raffaele

Hospital - Milan, Italy: simplified EvolutR Procedure

A. Latib14:20 Time to React@PCR14:25 Session evaluation and key learnings

N. Piazza





Tools andTechniques

(TNT)

Innovative solutions for complexPCI and coronary CTO treatmentSponsored by ASAHI INTECCChairperson: M. OchiaiCo-Chairperson: G. WernerPanellists: E. Christiansen, R. Garbo, G.Sianos, J. Spratt

Attend this session if you want:To improve your skills as a CTOoperatorTo learn about the latest innovations indevices

12:30 With continuous time to React@PCR12:30 Session objectives

M. Ochiai12:35 Why should we focus on guiding

catheters?M. Ochiai

12:45 Is there place for another microcatheter?G. Sianos

12:50 Guide-wire algorithm for complex PCI andCTO treatment J. Spratt

12:55 Review of the tools to be used during theLIVE demonstrationG. Werner

13:00 LIVE demonstration from Bristol HeartInstitue - Bristol, United Kingdom

13:40 Review of the tools to be used during theLIVE demonstrationM. Ochiai

13:45 LIVE demonstration from Bristol HeartInstitue - Bristol, United Kingdom

14:25 Session evaluation and key learningsG. Werner


Case in Point

Building the next chapter instructural heart - Imaging andInterventionSponsored by BOSTON SCIENTIFIC AND SIEMENSHEALTHCAREChairperson: B. PrendergastCo-Chairperson: A. Vahanian

Attend this session if you want:To understand the benefits ofadvanced imaging techniques incomplex structural heart interventionsTo learn how paravalvular leak can beminimised despite anatomicalcomplexitiesTo expand the usage of left atrialappendage closure

12:30 Session objectivesB. Prendergast

12:35 Case 1 - Bicuspid aortic valve: how imagingimproves accuracy of sizingN. Van Mieghem

12:43 Discussion and audience interaction12:52 Case 2 - Imaging of Complex LAA anatomy

and choice of the right deviceT. Schmitz

13:00 Discussion and audience interaction13:09 Case 3 - Hybrid TAVI and LAAC: does

imaging optimise outcomes?H. Ince


A. Vahanian

12:30 - 14:00ROOM

LEARNING

Learning PCI in calcified lesionsFacilitators: F. Hellig, E. Merkulov, A. Ong

Attend this session if you want:To review the basic principles, patientand lesion selectionTo understand how to safely andsuccessfully use rotationalatherectomyTo find out how to overcome ormanage the most frequent issues




12:30 - 13:30ROOM TERNES 1

Cases

Unusual causes of ACS - part 1Session comprising selected EuroPCR 2016 clinicalcase submissionsChairpersons: J. Byrne, F. Weidinger

12:30 A case of coronary stent abscessA. Vupputuri


A. Mehta (awaiting confirmation)12:45 Non-compaction cardiomyopathy

presenting as acute myocardial infarctionwith multivessel thrombi - a case seriesS. Sangaraju


R. Parma13:00 Two cases of Kounis syndrome

D.F. Filip13:08 Discussion and audience interaction13:13 Key learnings

N. Uren13:15 Late coronary embolisation from a

transcatheter aortic valveM. Neuss (awaiting confirmation)


M. Sobhy

12:30 - 13:30ROOM TERNES 2

Cases

How to avoid and solve technicaldifficulties?Session comprising selected EuroPCR 2016 clinicalcase submissionsChairpersons: A. Cribier, H. Eltchaninoff

12:30 Positioning of next-generationballoon-expandable devices during aorticvalve-in-valve: what all should knowD. Dvir


J. Mehilli12:45 TAVI in degenerative sutureless

bioprosthesisU. Landes


P.H.L. Kao13:00 Late coronary artery occlusion after

transcatheter valve-in-valve: a case reportC. Fiorina (awaiting confirmation)


A. Linke (awaiting confirmation)13:15 Antegrade transseptal approach for

crossing the valve during a valve-in-valveTAVI procedureJ.G. Córdoba Soriano


L. Nombela-Franco

12:30 - 13:30ROOM 241

Case in Point

A user's guide to drug coatedballoons: enhancing yourtoolbox for daily practiceSponsored by BIOTRONIKChairperson: R. ByrneCo-Chairperson: M.V. WainsteinPanellist: P.J.L. Ong

Attend this session if you want:To share practical step by stepteaching how to use drug-coatedballoons in your daily practiceTo appraise the available evidence fordrug-coated balloons in both in-stentrestenosis and de-novo disease

12:30 Session objectivesR. Byrne

12:35 Drug-coated balloons in in-stentrestenosis: case presentationM.V. Wainstein

12:45 Drug-coated balloons in in-stentrestenosis: concept and evidenceR. Byrne

12:53 Discussion and audience interaction13:00 Drug-coated balloons in de novo-disease:

case presentationM. Vink

13:10 Drug-coated balloons in de novo-disease:concept and evidenceJ. Wöhrle


M.V. Wainstein

12:30 - 14:00ROOM 242AB

Learning left main stentingFacilitators: D. Kettles, E. KretovExpert panellists: K. Al-Shaibi, R. Mohd Ali(awaiting confirmation)

Attend this session if you want:To discuss possible strategies foroptimal left main stentingTo understand what is the beststrategy for each individual patient,taking anatomy into considerationTo better assess the role of imaging




12:30 - 14:00ROOM 251

Case in Point

From LEADERS FREE to clinicalpractice: a case-based approachin tailoring stent treatment topatients and their bleeding riskSponsored by BIOSENSORS INTERNATIONALChairperson: P. UrbanCo-Chairperson: C. Tamburino

Attend this session if you want:To understand the criteria for highbleeding risk patients and to identifythese patients in clinical practiceTo understand how a drug-coatedstent allows DAPT to be shortened andtailored to the individual patientTo explore howbiodegradable-polymer andpolymer-free drug-coated stentsprovide solutions to patients with orwithout a high bleeding risk


12:35 Case 1 - From DAPT to triple therapy,increasing the risk of bleedingG. Richardt

12:43 Discussion and audience interaction13:03 Discussion and audience interaction13:15 Case 3 - Uncertain bleeding risk in the case

of STEMID. Carrié

13:23 Discussion and audience interaction13:35 Case 4 - Coronary stenting in patients

scheduled for TAVIR. Moreno


P. Urban

12:30 - 13:30ROOM 252AB

Symposium

DES, BRS and DAPT duration - dowe now know what's best for ourpatients?Sponsored by ABBOTT VASCULARChairperson: M. ValgimigliCo-Chairperson: R. MehranPanellists: T. Kimura, T. Palmerini, R.Virmani

Attend this session if you want:To review and discuss the availableevidence on DAPT duration after DESor BRS implantationTo understand the characteristics ofpolymers and the impact on patientoutcomeTo learn more about the first evidenceon DAPT duration after BRSimplantation

12:30 Session objectivesR. Mehran

Debate on weighing the evidence onDAPT duration post DES implantation

12:32 Pro shorter-term DAPTM. Valgimigli

12:39 Pro longer-term DAPTR. Mehran

12:46 Discussion and audience interaction12:53 Role of polymer thromboresistance in

DAPTR. Virmani

13:03 Optimal management of my high-bleedingrisk patientT. Palmerini

13:10 Discussion and audience interaction13:14 DAPT discontinuation one year after BRS

implantationR.J. Van Geuns


M. Valgimigli




12:30 - 13:30ROOM 253

Cases

Mitral valvuloplasty, unusualcasesSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: E. Brochet

12:30 The sole witnessed catecholamine inducediatrogenic Takotsubo cardiomyopathyduring percutaneous balloon mitralvalvuloplasty (PBMV)M. Toluey


J. Goicolea (awaiting confirmation)12:45 Subacute transient atrioventricular block

after percutaneous mitral valvuloplastyS. Mayordomo Gómez (awaitingconfirmation)


O. Franzen (awaiting confirmation)13:00 Percutaneous balloon mitral valvotomy

and PCI in a patient with kyphoscoliosis inthe same sittingJ.P. Gnanaraj


S. Von Bardeleben13:15 A non-thrombotic cerebral accident during

percutaneous transvenous mitralcommissurotomyA. Firouzi


E. Eeckhout

12:30 - 13:30ROOM 341

Cases

How to improve the guidingsupport?Session comprising selected EuroPCR 2016 clinicalcase submissionsChairpersons: S. Khan, P. L'Allier

12:30 Novel use of guiding extension catheter inthe complex bifurcation lesionT. Warisawa


I. Petrov12:45 Novel use of a guide catheter extension

and the "telescope" technique to facilitateprimary PCI in a patient with anteriorSTEMI and a severely dilated aortic rootL. Tapp (awaiting confirmation)


E. Stabile13:00 The use of a novel guide catheter

extension system during PCI of ananomalous right coronary artery arisingfrom the left sinus of ValsalvaT. Isawa


H. Gamra13:15 Szabo technique to stabilise a dancing

stentA. Bairam


K. Niemela




12:30 - 14:00ROOM 342A

Case in Point

The Portico valve: whereexpertise meets simplicity.Please join us for case studies tolearn more about the true easeof use advantages in prep,placement and control of thissystemSponsored by ST. JUDE MEDICALChairperson: R. MakkarCo-Chairperson: G. Manoharan

Attend this session if you want:To understand how a novel technology- Portico - is addressing current therapypitfallsTo learn about use of Portico valve forchallenging femoral access and how itoptimises treatment of complexclinical scenariosTo learn more about the aorticreplacement and master tips and tricksin a real case simulation

12:30 Session objectivesR. Makkar

12:35 Case 1 - Unique case without arterialintroducer sheaths in patients withreduced-caliber, tortuous and calcifiedvessels by using the new generation aorticprosthesis Portico valveG. Sorropago (awaiting confirmation)

12:43 Discussion and audience interaction12:55 Case 2 - The use of Portico valve in

challenging femoral accessesM. Van Wely

13:03 Discussion and audience interaction13:15 Case 3 - Portico valve: how a recapturable

system designed for positioning accuracyis changing the game in highly challengingcasesJ. Kefer

13:23 Discussion and audience interaction13:35 Case 4 - Why is Portico valve the choice in

patient with severe coronary artery diseaseF. Nietlispach


G. Manoharan

12:30 - 13:30ROOM 342B

FocusInnovation

CRO / ARO

Planned and ongoing clinicaltrials: a status update fromCardialysis and the EuropeanCardiovascular ResearchInstitute (ECRI)With the collaboration of Cardialysis and theEuropean Cardiovascular Research Institute (ECRI)Chairpersons: P.W. Serruys, G.A. Van Es(awaiting confirmation)


12:30 Session objectivesG.A. Van Es (awaiting confirmation)

12:35 SYNTAX III Revolution P.W. Serruys

12:42 Discussion and audience interaction12:45 AF-PCI: edoxabaN in PCI patients with

atrial fibrillation P. Vranckx

12:52 Discussion and audience interaction12:55 Target AC all-comer trial

W. Wijns13:02 Discussion and audience interaction13:05 ACCUFIT first-in-man study

F. Maisano13:12 Discussion and audience interaction13:15 High Bleeding Risk under DAPT

P. Smits13:22 Discussion and audience interaction13:25 Session evaluation and key learnings

P.W. Serruys




12:30 - 13:30ROOM 343

FocusInnovation

CRO / ARO

Planned and ongoing clinicaltrials: a status update fromCardiovascular EuropeanResearch Center (CERC)With the collaboration of CardiovascularEuropean Research Center (CERC)Chairpersons: B. Chevalier, M.C. Morice(awaiting confirmation)


12:30 Session objectivesM.C. Morice (awaiting confirmation)

12:35 LEADERS FREE: how will further plannedanalyses modulate the conclusions?M.C. Morice (awaiting confirmation)

12:42 Discussion and audience interaction12:45 STRENGTH trial: RenalGuard to prevent

contrast-induced nephropathy in complexPCI and TAVI procedures for patients withrenal failure - recruitment ongoingH. Sievert

12:52 Discussion and audience interaction12:55 EBC MAIN one- or two-stents for treating

complex distal left main lesions?Recruitment ongoingD. Hildick-Smith

13:02 Discussion and audience interaction13:05 VIVA trial: CoreValve in degenerated

prostetic valve recruitment ongoingB. Chevalier

13:12 Discussion and audience interaction13:15 SENIOR trial is SYNERGY stent superior to

bare-metal stent in patients older than75-years-old with similar short term DAPT -recruitment finished, population andprocedural resultsO. Varenne (awaiting confirmation)


B. Chevalier

12:30 - 14:00ROOM 351

Case in Point

My patient is presenting with anacute coronary syndrome (ACS)requiring PCI: TiNOX coatedbioactive stent is non-inferior toXience V (everolimus-eluting)stent!Sponsored by HEXACATHChairpersons: B. De Bruyne (awaitingconfirmation), P. KarjalainenFacilitators: T. Cuisset, J. Marco

By attending this session, together wewill critically reflect on the use of DES inpatients presenting with ACS in order to :

Collaboratively consider for whichpatients it is better to avoid DES andwhyPropose an evidence-based alternativeto everolimus eluting stent (Xience V)for ACS patients

12:30 - 14:00ROOM 352A

Plenary

Overcoming radiation exposurerisk in interventional cardiologyWith the collaboration of the EAPCI WomenCommitteeChairpersons: P. Presbitero, A. RoguinPanellists: N. Karan, G. Mikhail

Attend this session if you want:To learn about radiation exposure andrisksTo learn about radiation exposure as afemale interventional cardiologistTo learn about radiation and technicalissues

12:30 Session objectivesP. Presbitero

12:35 Biological effect of chronic radiation -results of GISI surveyE. Piccaluga

12:43 Discussion and audience interaction12:55 How do I protect patient and myself in

complex proceduresA. Chieffo

13:03 Discussion and audience interaction13:15 Catheter intervention during pregnancy -

is it really a risk?G. Boccuzzi

13:23 Discussion and audience interaction13:35 How to work in interventional cardiology

during pregnancy - my personalexperienceM. Velázquez


A. Roguin




12:30 - 14:30ROOM 352B

Complications

Iraq, Jordan and Tunisia sharetheir most educational cases:selected serious complicationsof PCI - recognition andsolutionsWith the collaboration of the Iraqi Working Groupon Interventional Cardiology of the IraqiCardio-Thoracic Society, the Jordan WorkingGroup on Interventional Cardiology and theTunisian Working Group on InterventionalCardiology (GTCI)Chairpersons: I. Alhaddad, T. Alkinani, K.Ben HamdaPanellist: M. Al-Kuraishi

Attend this session if you want:To recognise and understand potentialserious complications of PCITo learn different strategies in solvingsuch complicationsTo share knowledge and experienceduring interactive and educationaldiscussion

12:30 Session presentationI. Alhaddad

12:33 Session objectivesT. Alkinani

12:36 Case 1: coronary perforation during PCI: asafe endingM. Albakri

12:44 Discussion and audience interaction12:54 Case 2: iatrogenic aortic dissection during

coronary CTO PCIZ. Belhadj

13:02 Discussion and audience interaction13:12 Case 3: stent detachment during left main

stem coronary angioplasyA. Merza (awaiting confirmation)

13:20 Discussion and audience interaction13:30 Case 4: dissection of aorta, left main, left

anterior descending and left circumflexartery during primary PCI for anteriorSTEMIZ. Alqaqa

13:38 Discussion and audience interaction13:48 Case 5: accidental retrieval of a DES after its

deploymentN. Hajlaoui

13:56 Discussion and audience interaction14:06 Case 6: fractured wire and damaged stent

caused by pulling back a folded-over wireH. Riyadh


K. Ben Hamda

12:30 - 13:30ROOM

ARLEQUIN

Images

An image is worth 1,000 wordsSession comprising selected EuroPCR 2016 imagesubmissionsFacilitators: V. Bapat, C. Grasso (awaitingconfirmation), M. Radu


interpretationV. Bapat

12:33 Image 38: unveiled and key findingsS.R. Kandan

12:37 Image 38: discussion and audienceinteractionV. Bapat



G. Capretti12:47 Image 39: discussion and audience

interactionImage 40

12:50 Image 40: facilitated audience imageinterpretationM. Radu

12:53 Image 40: unveiled and key findingsA. Nicolino

12:57 Image 40: discussion and audienceinteractionM. Radu


interpretationV. Bapat

13:03 Image 41: unveiled and key findingsS. Degrauwe

13:07 Image 41: discussion and audienceinteractionV. Bapat



M. Nobre Menezes13:17 Image 42: discussion and audience

interactionImage 43

13:20 Image 43: facilitated audience imageinterpretationM. Radu

13:23 Image 43: unveiled and key findingsT. Warisawa

13:27 Image 43: discussion and audienceinteractionM. Radu




- 13:00 -13:35 - 14:35

ROOM MAILLOT

Case in Point

Practical approaches and noveltechnology to optimise left mainprocedure outcomeSponsored by MEDTRONICChairperson: G. StankovicCo-Chairperson: H.S. Kim

Attend this session if you want:To reflect on practical cases of onestent and two stents techniquesTo benefit from examples ofcomplication prevention in complexleft main casesTo learn about usefulness of novelgeneration DES dedicated to largevessel treatment

13:35 Session objectivesG. Stankovic

13:40 Provisional approach for distal left mainstentingA. Banning

13:47 Discussion and audience interaction13:57 Technique for double stenting in

unprotected left mainM. Kurdi

14:04 Discussion and audience interaction14:14 Complication prevention in real word

complex left main casesJ. Escaned


H.S. Kim

13:35 - 14:35ROOM TERNES 1

Cases

Unusual causes of ACS - part 2Session comprising selected EuroPCR 2016 clinicalcase submissionsChairpersons: F. Eberli, F. Malik

13:35 Migration of thrombus from right coronaryartery to circumflex through intercoronarycommunicationG. Parale


A. Serra (awaiting confirmation)13:50 An unusual case of postoperative

ST-segment elevation following CABGsurgeryS. Ubaid


F. Burzotta14:05 Complete regression of severe left main

coronary artery stenosis after pulse steroidtherapy in a patient with takayasu arteritisB. Karadag (awaiting confirmation)


P. L'Allier14:20 A "paradoxal" ACS

A. Azzano14:28 Discussion and audience interaction14:33 Key learnings

O. Varenne (awaiting confirmation)

13:35 - 14:35ROOM TERNES 2

Cases

TAVI in pure aortic regurgitationSession comprising selected EuroPCR 2016 clinicalcase submissionsChairpersons: J. Goicolea (awaitingconfirmation), A. Linke (awaitingconfirmation)

13:35 Is "rescue" TAVI becoming a possibleemergent therapy?F. De Vroey


M. Chen13:50 First-in-man percutaneous implantation of

the Symetis neo transcatheter heart valvein pure aortic regurgitationA.G. Cerillo


K. Hayashida14:05 Second generation transcatheter valve for

the treatment of aortic regurgitationS. Koul (awaiting confirmation)


M. Balghith14:20 First-in-man transfemoral TAVI with a

self-expanding valve for the treatment ofuncalcified aortic regurgitationS. Toggweiler


A.S. Petronio




13:35 - 14:35ROOM 252AB

Symposium

TAVI: current and futureperspectives for adjunctiveantithrombotic therapySponsored by BAYER PHARMA AGChairperson: G. DangasCo-Chairperson: R. Welsh

Attend this session if you want:To understand TAVI: patientpopulation characteristics, approveddevices and expected clinicaloutcomesTo evaluate current and futureantithrombotic therapy optionsaround TAVITo learn about future perspectives andupcoming studies

13:35 Session objectivesG. Dangas

13:39 TAVI: a paradigm shift in the treatment ofaortic stenosis - past, present and futureM.B. Leon

13:47 Discussion and audience interaction13:52 Valve leaflet motion abnormality

R. Mehran14:00 Discussion and audience interaction14:05 Solved and unsolved issues of

antithrombotic therapy after TAVIU. Landmesser

14:13 Discussion and audience interaction14:18 Future perspective and upcoming studies

P. Vranckx14:26 Discussion and audience interaction14:31 Session evaluation and key learnings

R. Welsh

13:35 - 14:35ROOM 253

Cases

Percutaneous treatment of themitral valveSession comprising selected EuroPCR 2016 clinicalcase submissionsChairpersons: C. Ruiz (awaitingconfirmation), A. Vahanian

13:35 Successful treatment of severe mitralregurgitation with mitral valvecommissural prolapse utilising occluderdevice following transcatheteredge-to-edge mitral valve repairS. Kubo


H. Ince13:50 Inflatable TAVI in mitral ring to treat mitral

regurgitationG. Bruschi


R. Kornowski14:05 The avant-garde of structural intervention:

simultaneous percutaneous transseptalmitral valve-in-valve and leak closureJ. Ribeiro


C. Grasso (awaiting confirmation)14:20 Transseptal implantation of a

balloon-expandable transcatheter heartvalve in a minimally calcified mitralannulus for treatment of radiation-inducedvalvulopathyF. Praz


S. Von Bardeleben




13:35 - 14:35ROOM 341

Cases

When do we need FFR?Session comprising selected EuroPCR 2016 clinicalcase submissionsChairpersons: N.H. Pijls, E. Schampaert

13:35 FFR-guided revascularisation of the "singleright" coronary arteryZ. Koszegi


G. Toth13:50 IVUS vs. FFR in ostial left main stenosis: an

unusual caseM. Araya


E. Regar14:05 Myocardial bridge - ventricular tachycardia

and false positive pressure wire studyS. Sangaraju

14:13 Discussion and audience interaction14:18 Key learnings14:20 Myocardial bridging of left anterior

descending presented with ACS: coronaryCT angiography, FFR and IVUS-guidedtreatment with self-expandable balloonreleasable DESF. Fouladvand


M. Abdel-Wahab

13:35 - 14:35ROOM 342B

FocusInnovation

CRO / ARO

Planned and ongoing clinicaltrials: a status update fromUppsala Clinical Research Center(UCR)With the collaboration of Upssala ClinicalResearch Center (UCR)Chairpersons: S. James, C. Varenhorst

Attend this session if you want:To be updated on ongoing registrybased randomised clinical trials thatmay change our future practiceTo gain in-depth understanding ofregister randomized clinical trial designand execution

13:35 Session objectivesJ. Oldgren

13:40 Bivalirudin vs. heparin in NSTEMI andSTEMI in patients on modern antiplatelettherapy in SWEDEHEARTD. Erlinge

13:47 Discussion and audience interaction13:50 Detox-AMI: determination of the role of

oxygen in acute myocardial infarctionR. Hofmann

13:57 Discussion and audience interaction14:00 SWEDEPAD: swedish drug-elution trial in

peripheral artery disease - DES vs.bare-metal stent and DEB vs. plainold-balloon angioplastyM. Falkenberg

14:07 Discussion and audience interaction14:10 PROSPECT II: providing regional

observations to study predictors of eventsin the coronary tree-twoG.W. Stone

14:17 Discussion and audience interaction14:20 Spirit HFPEF: spironolactone initiation

registry randomised interventional trial inheart failure with preserved ejectionfractionL. Lund


C. Varenhorst




13:35 - 14:35ROOM 343

FocusInnovation

CRO / ARO

Planned and ongoing clinicaltrials: a status update from theCardiovascular Research Centre(CRC)With the collaboration of Cardiovascular ResearchCenter (CRC)Chairpersons: A.S. Abizaid, M.C. Morice(awaiting confirmation)


13:35 Session objectivesA. Abizaid

13:39 Innovative metallic DES clinicalprogrammes: discovery, meriT series -IBiOSS, BioFreedom FIM/EGO, RevElutionR. Costa (awaiting confirmation)

13:49 Discussion and audience interaction13:52 Next-generation BRS clinical trials:

DESolve, Mirage FIM, Phantom, MeResJ.D.R. Costa Jr

14:02 Discussion and audience interaction14:05 Applying customised OCT methodologies

to evaluate different BRSD. Chamié

14:15 Discussion and audience interaction14:18 First-in-man studies to evaluate new

transcatheter valve replacement systems:Symetis Accurate I / Nautilus / Millipede Iris/ M Valve Dock IA. Abizaid


A.S. Abizaid

13:35 - 14:35ROOM 353

Cases

Complications of LAA and ASDclosureSession comprising selected EuroPCR 2016 clinicalcase submissionsChairpersons: S. Berti, H. Sievert

13:35 An unusual complication of LAA closureM. Eskandari


E. Garcia13:50 Percutaneous retrieval of a dislodged LAA

occluderF. Colombo (awaiting confirmation)


M.W. Bergmann14:05 Successful retrieval of ASD closure device

with a challenging approachA. Khosravi (awaiting confirmation)


M. Behan14:20 Lost occluder - two different scenarios

K. Gorican14:28 Discussion and audience interaction14:33 Key learnings

A. Tzikas




13:35 - 14:35ROOM

ARLEQUIN

Images

An image is worth 1,000 wordsSession comprising selected EuroPCR 2016 imagesubmissionsFacilitators: G. Ducrocq, D. Foley, A. Wolf


interpretationG. Ducrocq

13:38 Image 44: unveiled and key findingsT. Bochenek

13:42 Image 44: discussion and audienceinteractionG. Ducrocq


interpretationD. Foley

13:48 Image 45: unveiled and key findingsN. Ryan

13:52 Image 45: discussion and audienceinteractionD. Foley


interpretationA. Wolf

13:58 Image 46: unveiled and key findingsS. Liu

14:02 Image 46: discussion and audienceinteractionA. Wolf


interpretationG. Ducrocq

14:08 Image 47: unveiled and key findingsW. Wojakowski

14:12 Image 47: discussion and audienceinteractionG. Ducrocq


interpretationD. Foley

14:18 Image 48: unveiled and key findingsS. Moura-Ferreira

14:22 Image 48: discussion and audienceinteractionD. Foley


interpretationA. Wolf

14:28 Image 49: unveiled and key findingsN. Zaoui

14:32 Image 49: discussion and audienceinteractionA. Wolf

- 16:00 -16:30 - 18:00

ROOM 243

PCR SharingCentre

How to recognise, anticipate andtreat most frequent coronarycomplicationsFacilitators: P. Calvert, M. Haude, O.Muller



Thursday 19 May 2016 - Afternoon - Programme valid as of 12-04-2016

- 08:00 -08:30 - 10:00

ROOM 243

PCR SharingCentre

Personalised medicine - treatinga patient with bifurcation lesion:why we do what we do!Facilitators: S. Gunasekaran, R. Mohd Ali(awaiting confirmation), T. Schmitz

- 12:00 -12:30 - 14:00

ROOM 243

PCR SharingCentre

Ambulatory diagnostic andinterventions: the loungeconceptFacilitators: H. Benamer, F. Kiemeneij, E.Van Laer

12:30 - 13:30ROOM 353

Cases

Acute coronary syndromes:unusual anatomies, unusualmechanismsSession comprising selected EuroPCR 2016 clinicalcase submissionsChairpersons: J. Koolen, F. Mauri

12:30 Vasopastic angina: a forgotten ACSF. Rey


F. Malik12:45 Spontaneous coronary dissection: one

problem, three steps solutionA. Cohen


E. Lev13:00 Intracoronary imagenology in primary PCI:

to understand mechanism and selecttreatment strategyM. Araya


G. Pedrazzini (awaiting confirmation)13:15 Care for ladies - spontaneous coronary

dissection in STEMIA. Pavei


G. Olivecrona

- 14:00 -14:45 - 16:15

THEATRE BLEUDeveloping basic skills inantegrade CTO interventionChairpersons: J. Escaned, M. YamanePanellists: H.J. Büttner, E. Barbato, K.T.Chan, M. Lesiak, M. Ochiai, T. SchmitzCommentator: J. Spratt

Attend this session if you want:To learn what anatomy is suitable forantegrade approach to CTO PCITo apply a stepwise approach toantegrade CTO PCITo understand the benefits ofappropriate tool selection in each step

14:45 Session objectivesJ. Escaned

14:47 Review of the tools and technique to beused during the LIVE demonstrationE. Barbato

14:53 Continuous LIVE demonstration fromBristol Heart Institute - Bristol, UnitedKingdom

14:53 Continuous Time to React@PCR15:57 Patient selection and procedure planning

for antegrade approach G. Werner

16:02 Wires and catheters for successfulantegrade CTO intervention: the toolboxO. Goktekin

16:07 Wire escalation and dissection re-entrytechniques in antegrade approachG. Sianos

16:12 Session evaluation and key learningsM. Yamane




14:45 - 16:15THEATRE

BORDEAUX

FocusInnovation

Plenary

Vulnerable plaque: futuredirectionsChairpersons: M. Joner, R. WaksmanPanellists: T. Akasaka, K. Al-Shaibi, V.Farooq, D. Holmes, S.J. Park, R. Virmani

Attend this session if you want:To get an update on novel invasive andnon-invasive imaging tools to detectvulnerable plaqueTo become familiar with the newdevelopments in hybrid intravascularimagingTo gain insights about innovativeendovascular approaches of plaquesealing

14:45 Session objectivesM. Joner

14:50 Non-invasive imaging: for screening andpreclinical diagnosisD. Newby

14:58 Discussion and audience interaction15:10 Lessons learnt from the first applications of

hybrid intravascular imaging modalitiesC. Bourantas

15:18 Discussion and audience interaction15:30 Attention to the non-culprit lesion: is it hot

or cold? To treat or not to treat?D. Erlinge

15:38 Discussion and audience interaction15:50 Trials supporting the invasive sealing of

high-risk lesions: status updateP.W. Serruys


R. Waksman


Plenary

Devices for the interventionalmanagement of heart failure Chairpersons: D. Burkhoff, S. RedwoodPanellists: J. Bartunek, A. Erglis, T.Santoso, J. Van Der Heyden

Attend this session if you want:To understand the role of device-basedinterventions within themultidisciplinary management of heartfailureTo become familiar with tools forappropriate patient and proceduralselectionTo learn about the available evidenceand clinical outcomes of device-basedinterventions in heart failure

14:45 Session objectivesS. Redwood

14:48 Physiological principals and evidence todateD. Burkhoff

14:58 Time to React@PCR15:05 Catheter-based interventions for tailored

management of heart failure: why, whenand what?A. Erglis

15:15 Time to React@PCR15:22 Recorded case

J. Bartunek16:02 Time to React@PCR16:12 Session evaluation and key learnings

D. Burkhoff





FocusInnovation

Plenary

Innovation in TAVI: new devicesand outlook for new applicationsChairpersons: F. Hellig, B. PrendergastPanellists: M. Abdelghani, M. Chen, P.H.L.Kao, G. Yucel

Attend this session if you want:To gain insight into novel technologyavailable for aortic valve implantationTo review early data for devices andaccessories which have just beenintroduced To discuss the future of TAVIprocedures in the light of noveldevelopments

14:45 Session objectivesF. Hellig

14:50 Novel devices: most recent first-in-humanand CE-marked TAVI devicesC. Tamburino

15:00 Discussion and audience interaction15:10 Novel device-based approaches for stroke

preventionE. Grube

15:20 Discussion and audience interaction15:30 New imaging strategies for procedural

planning and follow-upN. Piazza

15:40 Discussion and audience interaction15:50 Does technological progress allow

expansion of current indications?A. Vahanian


B. Prendergast

14:45 - 16:15ROOM

LEARNING

Learning mitral edge-to-edgerepair with MitraclipFacilitators: E. Brochet, S. Von BardelebenExpert panellists: A. Al Nooryani, J.F.Obadia

Attend this session if you want:To identify the key tips and tricks for asuccessful Mitraclip procedureTo understand how to avoid andmanage potential complications

14:45 - 16:15ROOM TERNES 1

Cases

Complications during left maininterventionSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: M. SobhyPanellists: H.M. Kwon, P.H. Lo, I. Ungi(awaiting confirmation)

14:45 An ordinary case of exceptional disaster: anightmare in left main stentingM. Bande

14:53 Discussion and audience interaction14:58 Ruptured wire in a heavy calcified left main

Q. Labarre15:06 Discussion and audience interaction15:11 I wish I had not done that

U. Rao15:19 Discussion and audience interaction15:24 Left main stem stent DES fracture

M. Dooley15:32 Discussion and audience interaction15:37 Left main complication

A. Deshpande15:45 Discussion and audience interaction15:50 Shooting in the dark - nightmare in

cathblabN.B. Senguttuvan

15:58 Discussion and audience interaction16:03 Always be ready to treat left main

bifurcation during primary PCIC.F. Lin (awaiting confirmation)





14:45 - 16:15ROOM TERNES 2

Cases

PCI of diseased SVGSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: S. BertiPanellists: A. Bartorelli, J. Ezhilan, M.H.Pham

14:45 Old SVG with important degenerationtreated with self-expandable DES: ourexperienceC. Moncalvo

14:53 Discussion and audience interaction14:58 Stenting of a SVG through double layer of

self-expandable transcatheter aortic valvestrutsD. D'Amario

15:06 Discussion and audience interaction15:11 "Local stent delivery"; technique for

challenging SVG intervention: the treasurekeyM. Pellicano

15:19 Discussion and audience interaction15:24 A tough graft

S.T. Rab15:32 Discussion and audience interaction15:37 Unusual indication of rotational

atherectomy: SVG resistant lesionB. Zoghlami

15:45 Discussion and audience interaction15:50 Beyond the coronaries: primary PCI of a

vein graftG. Latsios

15:58 Discussion and audience interaction16:03 IVUS-guided antegrade CTO recanalisation

with contralateral contrast injectionthrough occluded bypassS.A. Pyxaras


14:45 - 16:15ROOM 241

Abstracts

New insights in renaldenervationSession comprising selected EuroPCR 2016abstract submissionsChairperson: R. SchmiederPanellists: K. Chawla, Y.G. Yap

14:45 Euro16A-OP0733 - Renal denervation withtwo radiofrequency catheters: impact ofbranch vs. distally focused main renalartery denervation in a porcine modelF. Mahfoud

14:53 Discussion and audience interaction14:58 Euro16A-OP1074 - New generation renal

artery denervation systems: assessinglesion size and thermodynamics using athermochromic liquid crystal phantomS. Al Raisi

15:06 Discussion and audience interaction15:11 Euro16A-OP1079 - Transcatheter

perivascular alcohol denervation addressestechnical challenges of energy-based renaldenervationS. Bertog

15:19 Discussion and audience interaction15:24 Euro16A-OP0228 - Systematic evaluation

of haemodynamic parameters to predicthaemodynamic responders to renal arterydenervationJ. Davies

15:32 Discussion and audience interaction15:37 Euro16A-OP0097 - Renal haemodynamic

changes after renal denervationR. Schmieder

15:45 Discussion and audience interaction15:50 Euro16A-OP0091 - Efficacy of

percutaneous renal denervation in a swinemodel of mineralocorticoid-inducedarterial hypertensionA. Perez de Prado

15:58 Discussion and audience interaction16:03 Euro16A-OP1105 - Cost-effectiveness

threshold analysis of various age andsystolic blood pressure reduction scenariosfor renal denervation therapyR. Schmieder (awaiting confirmation)


14:45 - 16:15ROOM 242AB


I have my clinical data. How can Ianalyse it by myself?Facilitators: D. Capodanno, S. Kedev,R.L.J. OsnabruggeExpert advisor: I. Durand Zaleski

Attend this session if you want:To select the right stastistical tests foryour study To be able to run simple statisticsTo balance clinical relevance withstatistical significance




14:45 - 16:15ROOM 251


Professionals

Plenary

The role of nurses and alliedprofessionals in managingprocedure-related complications

Chairpersons: S. Griggio, V. RodriguezGarcia-AbadFacilitators: L. Hinterbuchner, K. Wilson

Attend this session if you want:To understand that prevention isbetter than cureTo know what is the best tool box fornurses and allied professsionalsTo improve team and patientcommunication before, during andafter a procedure-related complication

14:45 Session objectivesS. Griggio

14:50 The human factor: the importance ofcommunication G. Rocchi

Four clinical cases15:00 Iatrogenic in structural heart disease

R. Fernandes15:10 Discussion and audience interaction15:14 Plaque displacement

M. Longoni15:24 Discussion and audience interaction15:28 Femoral complication

H. Santiago15:38 Discussion and audience interaction15:42 Air embolisation

V. Rodriguez Garcia-Abad15:52 Discussion and audience interaction15:56 The nurse and allied professional's role in

complication reductionM. Bowers


V. Rodriguez Garcia-Abad

14:45 - 16:15ROOM 252AB

Learning carotid artery stentingstep by stepFacilitators: O. Al Shammeri, A.Cremonesi, E. VuruskanExpert panellist: W. Gray (awaitingconfirmation)



14:45 - 16:15ROOM 253

Abstracts

PCI in elderly patients: can't wedo better?Session comprising selected EuroPCR 2016abstract submissionsChairperson: C. KaiserPanellists: D. Echeverri (awaitingconfirmation), K. Kadota, C. Spaulding

14:45 Euro16A-OP0357 - Clinical outcome of PCIin elderly and very elderly patients:one-year results from a tertiary-centreexperience Monello

14:53 Discussion and audience interaction14:58 Euro16A-OP0654 - A retrospective study of

nonagarerian PCI in the setting of anon-surgical centre in the United KingdomP.P. Sadarmin

15:06 Discussion and audience interaction15:11 Euro16A-OP0213 - Long-term outcomes of

first and second-generation DES in elderlypatients (Katowice-Zabrze registry)W. Wanha (awaiting confirmation)

15:19 Discussion and audience interaction15:24 Euro16A-OP0328 - Effects of age and sex

on clinical outcomes after PCI relative toCABG in patients with triple vesselcoronary artery diseaseK. Yamaji

15:32 Discussion and audience interaction15:37 Euro16A-OP0807 - PCI in octogenarians: a

risk scoring system to predict outcomesJ. Cockburn

15:45 Discussion and audience interaction15:50 Euro16A-OP0710 - Underuse of coronary

intervention in elderly with myocardialinfarction and its effect on mortality: apropensity matched analysis of theHungarian Myocardial Infarction registryA. Komócsi

15:58 Discussion and audience interaction16:03 Euro16A-OP0452 - Effect of aging on

ischaemic and bleeding outcomes inpatients undergoing a prolonged vs.shortened duration of DAPT: insights fromthe PRODIGY trialR. Piccolo


14:45 - 16:15ROOM 341

Abstracts

PCR's Got Talent - round 2:Session 3Session comprising selected EuroPCR 2016abstract submissionsChairpersons: G. Manoharan, M.ValgimigliJury Members: T. Adriaenssens, P.Boekstegers (awaiting confirmation), Y.Goueffic (awaiting confirmation), M.D.Lobo, T. Van Hecke




14:45 - 16:15ROOM 342A

Plenary

ANZET@EuroPCR - coronaryintervention downunderWith the collaboration of the Australia and NewZeland Endovascular Therapies Meeting (ANZET)Chairpersons: J. Stewart, W. WijnsPanellist: D. Walters

Attend this session if you want:To get insights into the mechanisms oflate stent failureTo understand the place of CTOangioplasty in coronaryrevascularisationTo be updated on PCI in STEMI and leftmain stem disease

14:45 EuroPCR welcomes ANZETW. Wijns

14:47 Session objectivesJ. Stewart

14:50 Mechanisms of late stent failure - insightsfrom OCTP. Barlis

14:58 Discussion and audience interaction15:10 How to simplify CTO angioplasty?

S. Harding15:18 Discussion and audience interaction15:30 STEMI intervention: dilemmas on the front

lineR. Bhindi

15:38 Discussion and audience interaction15:50 Case-based insights into left main stem

angioplastyS. Shetty


14:45 - 16:15ROOM 342B

Cases

When OCT gives the diagnosticSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: F. PratiPanellists: G. Cassel, V. Sirbu (awaitingconfirmation)

14:45 Beware the non-diagnostic angiogramC.Y. Chin

14:53 Discussion and audience interaction14:58 Hidden tears

B. Vandeloo15:06 Discussion and audience interaction15:11 Discovering the "pearl" found in coronary

arteryH.F.D. Chow

15:19 Discussion and audience interaction15:24 Embolic coronary occlusion demonstrated

with OCTN. Gonzalo

15:32 Discussion and audience interaction15:37 STEMI with normal coronary angiogram:

an unexpected intravascular imagingfinding that led to plaque sealingM. Oliveira-Santos (awaiting confirmation)

15:45 Discussion and audience interaction15:50 Loss of flow in right coronary artery

post-PCI: optical frequency domainimaging saves the day!A. Khurana

15:58 Discussion and audience interaction16:03 Intraluminal narrowing in ACS-value of

intracoronary imagingS. Khan





14:45 - 16:15ROOM 343

Abstracts

Contemporary DES: focus onbioresorbable polymers - part 1Session comprising selected EuroPCR 2016abstract submissionsChairperson: L. Nombela-FrancoPanellists: M. Mani, E. Regar, S. Verheye

14:45 Euro16A-OP0833 - Contemporary real-lifePCI practices: three-month clinicaloutcomes in patients treated with thin vs.thick strut DES - data from two large,international registriesJ. Polad

14:53 Discussion and audience interaction14:58 Euro16A-OP0324 - Clinical outcomes in

995 unselected real-world patients treatedwith an ultra-thin biodegradablepolymer-coated sirolimus-eluting stent:12-month results from the FLEX-registryA. Abhyankar


outcomes of coronary DES withbioresorbable coating: results of theCENTURY studyB. Beleslin (awaiting confirmation)

15:19 Discussion and audience interaction15:24 Euro16A-OP0169 - Final five-year clinical

outcomes in the EVOLVE trial: arandomised evaluation of a novelbioabsorbable polymer-coated,everolimus-eluting stentI. Meredith

15:32 Discussion and audience interaction15:37 Euro16A-OP0708 - Assessment of strut

coverage of biodegradable polymer DES atone, two and three months after stentimplantation by optical frequency domainimaging: final results of DISCOVERY 1TO3studyB. Chevalier


outcomes of patients with multivesselcoronary artery disease after treatmentwith thin strut DES with bioresorbablepolymer: results from CENTURY II trialB. Chevalier

15:58 Discussion and audience interaction16:03 Euro16A-OP1048 - Randomised

comparison of sirolimus-eluting andbiolimus-eluting bioresorbable polymerstents. The SORT-OUT VII OCT studyL.N. Andreasen


14:45 - 16:15ROOM 351

Abstracts

TAVI in contemporary practice -part 1Session comprising selected EuroPCR 2016abstract submissionsChairperson: N. Van MieghemPanellists: H. Eltchaninoff, C.P. Lin, N.Trehan (awaiting confirmation)

14:45 Euro16A-OP0386 - Clinical impact of aorticvalve pre-dilatation during TAVI with thethird-generation balloon-expandable valveM. Spaziano

14:53 Discussion and audience interaction14:58 Euro16A-OP0175 - Next generation

transcatheter heart valves improve clinicaloutcomes in patients undergoing TAVIJ.M. Sinning

15:06 Discussion and audience interaction15:11 Euro16A-OP0719 - TAVI with second

generation Medtronic Evolut R,comparison with first generationMedtronic CoreValve: a single-centreexperienceC. Fiorina (awaiting confirmation)

15:19 Discussion and audience interaction15:24 Euro16A-OP0069 - A comparison between

first-generation and second-generationTAVI devices: a propensity-matchedsingle-centre experienceM.B. Ancona (awaiting confirmation)

15:32 Discussion and audience interaction15:37 Euro16A-OP0282 - Improving on current

outcomes: matched comparison of novelversus first generation self-expandabletranscatheter heart valvesL. Conradi (awaiting confirmation)

15:45 Discussion and audience interaction15:50 Euro16A-OP0699 - Comparison of

balloon-expandable versusself-expandable transcatheter prostheseswith regard to the degree of calcificationof the aortic valve and aortic root: do weneed more than one TAVI device?J. Blumenstein

15:58 Discussion and audience interaction16:03 Euro16A-OP0466 - The repositionable

Lotus valve for transfemoral aortic valveimplantation in patients with symptomaticsevere aortic stenosis: impact of valve sizeB. Gonska





14:45 - 16:15ROOM 352A

How Should ITreat?

Hungary and Serbia share theirmost educational cases: complexcoronary interventions in ACSpatientsWith the collaboration of the HungarianAssociation of Cardiovascular Intervention and theWorking Group on Catheterisation andPercutaneous Coronary Interventions of theCardiology Society of SerbiaChairpersons: B. Merkely, S. Stojkovic

Attend this session if you want:To emphasise the role of IVUS incomplex left main coronary arteryinterventionTo understand how to approach a verylarge left main coronary artery withnew designed self-expandable DESTo highlight feasibility and safety andto disclose the tips of IVUS guidedtwo-stent technique in a bifurcationlesion with heavily calcified sidebranch stenosis in a NSTEMI patient

14:45 Session objectivesB. Merkely

14:50 Case 1: IVUS-guided bifurcational left maincoronary artery intervention withself-expandable DES in ACSZ. Ruzsa

14:55 How would I treat the case?M.A. Nedeljkovic

15:00 How would I treat the case?Z. Piroth

15:05 How did I treat the case?Z. Ruzsa


S. Stojkovic15:30 Case 2: IVUS-guided balloon crush

technique in a true bifurcation with heavilycalcified side branch stenosis in a NSTEMIpatientD. Orlic

15:35 How would I treat the case?Z. Piroth

15:40 How would I treat the case?M.A. Nedeljkovic

15:45 How did I treat the case?D. Orlic


B. Merkely16:10 Session evaluation and key learnings

S. Stojkovic

14:45 - 16:15ROOM 352B

How Should ITreat?

Morocco and Saudi Arabia sharetheir most educational cases:how to manage a dissection or athrombus during bifurcation PCIWith the collaboration of the Working Group onInterventional Cardiology of the Moroccan Societyof Cardiology (SMC) and the Saudi ArabianCardiac Interventional Society (SACIS)Chairpersons: K. Al Faraidy, A. Chaara

Attend this session if you want:To discuss bifurcation strategiesTo discuss complications of PCIspecifically acute stent thrombosis andthe use of a circulatory supportTo discuss further long-term dualantiplatelet therapy

14:45 Session objectivesK. Al Faraidy

14:50 Case 1: culotte: when the trousers are tooriskyM. Alasnag

14:55 How would I treat the case?M. Sabry

15:00 How would I treat the case?A. Waqar

15:05 How did I treat the case?M. Alasnag


A. Chaara15:30 Case 2: double dissection complicating a

bifurcation stenosisD. Benzarouel

15:35 How would I treat the case?A. Waqar

15:40 How would I treat the case?M. Sabry

15:45 How did I treat the case?D. Benzarouel


K. Al Faraidy16:10 Session evaluation and key learnings

A. Chaara




14:45 - 16:15ROOM 353

Abstracts

Rotarectomy for heavily calcifiedstenosisSession comprising selected EuroPCR 2016abstract submissionsChairperson: C. Di MarioPanellists: J. Elias, G. Toth

14:45 Euro16A-OP0866 - Rotational atherectomyin DES era: a single-centre experienceD.K. Baruah

14:53 Discussion and audience interaction14:58 Euro16A-OP0071 - The comparison of

strategies to prepare severely calcifiedcoronary lesions: rotational atherectomyversus cutting balloonK. Amemiya

15:06 Discussion and audience interaction15:11 Euro16A-OP0976 - Long term outcomes of

patients undergoing rotationalatherectomy due to failed PCI depend onthe reason of primary intervention failureW. Zimoch

15:19 Discussion and audience interaction15:24 Euro16A-OP0606 - Establishing

interventional technologies to treatnon-dilatable stents: an expanding role forexcimer coronary laser?V. Kodoth

15:32 Discussion and audience interaction15:37 Euro16A-OP0107 - Coronary rotational

atherectomy during TAVI: immediate andlong-term results of a consecutive seriesF. Ribichini


outcome of early-generation vs.new-generation DES in patientsundergoing rotational atherectomyA. Allali

15:58 Discussion and audience interaction16:03 Euro16A-OP0410 - Direct stenting after

orbital atherectomyE. Shlofmitz


14:45 - 16:15ROOM

ARLEQUIN

Abstracts

Renal failure: patterns,therapeutic strategies andoutcomesSession comprising selected EuroPCR 2016abstract submissionsChairperson: R. MehranPanellists: M. De Belder (awaitingconfirmation), F. Sharif, G.G. Stefanini

14:45 Euro16A-OP0919 - Impact of Prasugrelversus Clopidogrel by presence of chronickidney disease in ACS PCI: results from thePROMETHEUS studyJ. Chandrasekhar

14:53 Discussion and audience interaction14:58 Euro16A-OP0425 - Renal artery resistance

index and flow mediated dilation afterdiagnostic coronary angiography, apossible correlation: our experienceA. Dachille

15:06 Discussion and audience interaction15:11 Euro16A-OP0308 - A first-in-man

evaluation of a novel contrast mediasaving device, the DyeVert systemJ. Sapontis

15:19 Discussion and audience interaction15:24 Euro16A-OP0421 - Outcomes of orbital

atherectomy in patients with end stagerenal disease on dialysisE. Shlofmitz

15:32 Discussion and audience interaction15:37 Euro16A-OP0375 - Renal function post

TAVI, a significant predictor of mortality:introducing the ACEF-7 scoreS. Obeid

15:45 Discussion and audience interaction15:50 Euro16A-OP0447 - Chronic kidney disease

and acute kidney injury stages after TAVIR.A. Meneguz-Moreno

15:58 Discussion and audience interaction16:03 Euro16A-OP0687 - Unique coronary lesion

characteristics in haemodialysis patients asassessed by OCTC.Y. Chin





- 16:00 -16:30 - 18:45

THEATRE BLEUDeveloping basic skills inretrograde CTO interventionOpen end session: it ends when it is open!Chairpersons: J. Escaned, M. YamanePanellists: O. Goktekin, P. Ludman, S.Rinfret, T. Santoso, A. Serra (awaitingconfirmation)Commentator: J. Spratt

Attend this session if you want:To learn what anatomy is suitable forretrograde approach to CTOTo apply a stepwise approach toretrograde PCITo understand the benefits ofappropriate tool selection in each step

16:30 Session objectivesJ. Escaned

16:32 Review of the tools and technique to beused during the LIVE demonstrationO. Goktekin

16:38 Continuous LIVE demonstration fromBristol Heart Institute - Bristol, UnitedKingdom

16:38 Continuous Time to React@PCR17:42 When should retrograde approach be

considered as a primary PCI strategy?S. Sumitsuji

17:47 Selecting collaterals for safe and successfulwire crossingS. Rinfret

17:52 My wire has reached the target vessel -what now?H.A. Noor

17:57 Session evaluation and key learningsM. Yamane

16:30 - 18:00THEATRE

BORDEAUX

FocusInnovation

DES and scaffoldsChairpersons: R. Byrne, H. CallPanellists: C. Bourantas, J.J. Cheng, R.Dawood (awaiting confirmation), B.Eryonucu, G.G. Stefanini, K.K. Yeo

16:30 Slender sirolimus-eluting coronarystent-on-a-wire integrated delivery systemG. Amoroso

16:37 Discussion and audience interaction16:42 Mechanical properties of a novel

drug-filled coronary stent: comparisonwith standard DESN. Foin

16:49 Discussion and audience interaction16:54 PCI with the Angiolite DES: an OCT study.

The "ANCHOR" studyJ. Rodes Cabau

17:01 Discussion and audience interaction17:05 Innovative balloon technology designed to

minimize vessel traumaJ. Mustapha (awaiting confirmation)

17:12 Discussion and audience interaction17:16 Smart scaffolds

A. Mathur17:23 Discussion and audience interaction17:27 Combining magnesium and polylactide to

create a novel BRS: UNITY hybrid scaffoldY. Onuma (awaiting confirmation)

17:34 Discussion and audience interaction17:38 Fully resorbable stent: programme and

updateS. Dinesh (awaiting confirmation)

17:45 Discussion and audience interaction17:49 Multicentric retrospective registry of

polymer-free DES: all comers and diabeticsanalysis (INVESTIG8)G. Sardella






Cases

TAVI complications - part 1Session comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: S. RedwoodPanellists: K. El Merri, U. Gerckens, M.Gilard

16:30 Challenging the limit of TAVIC.K.K. Kwok

16:38 Discussion and audience interaction16:43 A trans-aortic approach complication case

during TAVI: its management anddifferences with other routesS. Fournier

16:51 Discussion and audience interaction16:56 Unexpected complications in a seemingly

" straightforward " TAVI caseA.G. Cerillo

17:04 Discussion and audience interaction17:09 Balloon post-dilation after TAVI

implantation with a balloon-expandablevalve: the devil is in the detailD. Chin

17:17 Discussion and audience interaction17:22 TAVI: what can go wrong?

W. Mattar17:30 Discussion and audience interaction17:35 Acute post-procedural left ventricular

deterioration following TAVIK. Tigen

17:43 Discussion and audience interaction17:48 Unexpected valve-in-valve complication:

what we should have excluded beforeinterventionD. Dvir



FocusInnovation

Plenary

CT innovation for TAVIoptimisationChairpersons: K. Hayashida, B.PrendergastPanellists: M. Buchbinder, M. Chen, A.Ghanem

Attend this session if you want:To learn about recent CT innovationsfor the diagnosis of aortic stenosis andplanning of TAVI proceduresTo become familiar with the use ofcomprehensive CT analysis to optimiseTAVI outcomesTo discuss emerging CT technologiesgeared towards online TAVI deviceselection

16:30 Session objectivesK. Hayashida

16:35 Reclassification of aortic stenosis severityusing 3D CT analysisJ.J. Bax

16:43 Discussion and audience interaction16:55 Detection of valve leaflet functionality and

thrombosis using 4D dynamic CTL. Sondergaard

17:03 Discussion and audience interaction17:15 New tools to predict and avoid TAVI

complications using comprehensive CTexaminationJ. Leipsic

17:23 Discussion and audience interaction17:35 Emerging CT-based technologies to

optimize TAVI device selectionN. Piazza


B. Prendergast

16:30 - 18:00ROOM

LEARNING

Learning pericardiocentesisFacilitators: C. Kyriakakis, M. NtsekheExpert panellist: F. Bourlon

Attend this session if you want:To explore the different types ofpericardial effusionTo learn how to choose the mostappropriate approach for pericardialdrainageTo master the steps for safepericardiocentesis




16:30 - 18:00ROOM TERNES 1

Cases

Atherectomy for the treatmentof calcified lesionsSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: F. RibichiniPanellists: H. Al Guindy, M. Loutfi

16:30 Debulking strategyS. Gupta

16:38 Discussion and audience interaction16:43 Subintimal tracking and re-entry (STAR)

after failed rotablation as a bailoutalternativeV. Sasi

16:51 Discussion and audience interaction16:56 Acutely recoiling stent after rotablation in

proximal left anterior descending artery:how to salvage the situation!A. Khurana

17:04 Discussion and audience interaction17:09 OCT-guided treatment of severely calcified

in-stent restenosis with orbitalatherectomyE. Shlofmitz

17:17 Discussion and audience interaction17:22 The light at the end of the tunnel: the use

of laser atherectomy in complex high-riskPCIS. Arri

17:30 Discussion and audience interaction17:38 Complex revascularisation in NSTEMI

elderly patient with comorbiditiesL. Calmac

17:43 Discussion and audience interaction17:48 When is a buddy not your friend?

G. Fahrni17:56 Discussion and audience interaction

16:30 - 18:00ROOM TERNES 2

Cases

Challenging PCI in patients withprior CABGSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: A. Mehta (awaitingconfirmation)Panellists: A. Iyisoy (awaitingconfirmation), G. Musumeci, R. Singh

16:30 PCI of RIMA - the real challenge!J. Marques

16:38 Discussion and audience interaction16:43 Usefulness of triple-step support system

for severe stenosis in the anastomosis siteN. Kokubu

16:51 Discussion and audience interaction16:56 V stenting in a LIMA to left anterior

descending artery bypass graftL.M. Predescu

17:04 Discussion and audience interaction17:09 A recurrent case of unstable angina at site

of the synthetic graft after BentalloperationT. Shibasaki

17:17 Discussion and audience interaction17:22 Successful revascularisation after open

repair for big pseudo aneurysm of veingraft for distal right coronary arteryE. Ko

17:30 Discussion and audience interaction17:35 An interesting case of post-CABG

intervention using minicrush techniqueV. Janakaloti Ramachandrareddy (awaitingconfirmation)

17:43 Discussion and audience interaction17:48 CTO and left main coronary artery stenosis

T-stenting and small protrusionD. Kumar





16:30 - 18:00ROOM 241

Abstracts

Long-term clinical outcomesafter DES implantationSession comprising selected EuroPCR 2016abstract submissionsChairperson: S. JamesPanellists: P.H.L. Kao, Q.T. Nguyen, A.Roguin

16:30 Euro16A-OP0045 - Independent predictorsof Major Adverse Cardiac Events (MACE) atdifferent time points after the treatment ofnon-selected patients with DES: an analysisof the DESIRE registryJ.D.R. Costa Jr

16:38 Discussion and audience interaction16:43 Euro16A-OP0989 - Long-term outcomes of

Balloon AngioPlasty Only (POBA)compared to DES performed as landmarkanalysis >1 year after procedure in theSCAAR registryS. Koul (awaiting confirmation)

16:51 Discussion and audience interaction16:56 Euro16A-OP0941 - Long-term follow-up at

cohort of DES in acute STEMI (second andthird generation)G. Pimentel Morales

17:04 Discussion and audience interaction17:09 Euro16A-OP0709 - Direct implantation of

rapamycin-eluting stents withbioresorbable drug carrier technologyutilising the svelte coronarystent-on-a-wire: the DIRECT II Study 2-yearfollow-upA. Khattab

17:17 Discussion and audience interaction17:22 Euro16A-OP0502 - Clinical event rates and

chest pain five years after treatment withdurable polymer zotarolimus-eluting andeverolimus-eluting coronary stents inparticipants of the randomised TWENTEtrialC. Von Birgelen


treating all-comers with novel zotarolimusand everolimus-eluting coronary stents:three-year outcome of the randomisedDUTCH PEERS trialL.C. Van Der Heijden

17:43 Discussion and audience interaction17:48 Euro16A-OP0404 - Four-year results from

the multicentre PROMUS ElementEuropean Post-Approval (PE-Prove)Registry: outcomes in 1010 unselectedpatients treated with aplatinum-chromium, everolimus-elutingstentR. Moreno


16:30 - 18:00ROOM 242AB


I have completed my study. Howto write an abstract and get itaccepted? Facilitators: C. Cook, M.C. Morice(awaiting confirmation), D. MylotteExpert advisors: P. Cummins, P.W. Serruys

Attend this session if you want:To improve your abstract writingTo hear from peers, abstract gradersand programme committee To maximize your chance of beeingaccepted

16:30 - 18:00ROOM 251


Professionals

Cases

Clinical case session for nursesand allied professionalsSession comprising selected EuroPCR 2016abstract submissionsChairpersons: J. Laub, T. Van Hecke

16:30 A novel double guide and triple kissingtechnique of complex distal left mainprimary PCIA novel double guide andtriple kissing technique of complex distalleft main primary PCIB. Nallaperumal

16:38 Discussion and audience interaction16:43 Combined catheter ablation and LAA

closure as a hybrid procedure for thetreatment of persistent atrial fibrillationM. Van Der Heijden

16:51 Discussion and audience interaction16:56 Use of an automated chest compression

device during cardiopulmonaryresuscitation in our cathlabN. Koufakis

17:04 Discussion and audience interaction17:09 A challenging percutaneous transluminal

angioplasty of left subclavian arteryB. Nallaperumal

17:17 Discussion and audience interaction17:22 Usefulness of intra cardiac echo catheter in

percutaneous transluminal septalmyocardial ablation (PTSMA) forhypertrophic obstructive cardiomyopathy(HOCM)A. Yamauchi

17:30 Discussion and audience interaction17:35 Use of real time patient skin dose imaging

system to prevent significant skin damageduring complex PCIG. Ison

17:43 Discussion and audience interaction17:48 Right coronary artery dissection

M. Van Der Heijden17:56 Discussion and audience interaction




16:30 - 18:00ROOM 252AB

Carotid angioplasty anno 2016Chairpersons: M. Roffi, A. SauguetPanellists: W. Gray (awaitingconfirmation), B. Honton, S. Kedev, P.Montorsi

Attend this session if you want:To discuss what is the standardapproach for a safe carotid angioplastyand stenting procedure todayTo evaluate new access options anddevices

16:30 Session objectivesA. Sauguet

16:33 Review of the tools to be used during theLIVE demonstrationM. Roffi

16:39 LIVE demonstration from Maria CeciliaHospital, GVM Care & Research -Cotignola, Italy


M. Roffi

16:30 - 18:00ROOM 253

Abstracts

Drug-eluting balloons forin-stent restenosis and de novolesionsSession comprising selected EuroPCR 2016abstract submissionsChairperson: L. GonçalvesPanellists: D. Foley, C. Kaiser, R. Sethi(awaiting confirmation)

16:30 Euro16A-OP0504 - Clinical performance ofthe Pantera LUX paclitaxel releasingballoon vs. the drug-eluting Orsiro hybridstent system in patients with in-stentrestenosis: a randomised controlled trial(BIOLUX RCT)

16:38 Discussion and audience interaction16:43 Euro16A-OP0510 - Sirolimus-coated

balloon for in- stent restenosis and denovo coronary artery disease: results froma multicentre NANOLUTE registryP.K. Natarajapillai

16:51 Discussion and audience interaction16:56 Euro16A-OP0562 - Impact of the number

of pre-implanted stent for clinical outcomeof DEB treatment for in-stent restenosislesion: the New-Tokyo registryH. Yabushita

17:04 Discussion and audience interaction17:09 Euro16A-OP1057 - Prospective, large-scale

multicentre trial for the use ofpaclitaxel-coated balloons (PCB) in denovo coronary lesions: the PCB-only allcomer registryM. Rosenberg

17:17 Discussion and audience interaction17:22 Euro16A-OP0818 - Sirolimus-coated

balloon in the treatment of small vesseldiseaseB. Cortese

17:30 Discussion and audience interaction17:35 Euro16A-OP0172 - Treatment of de novo

coronary lesions with a novel secondgeneration paclitaxel-coated ballooncatheter: 5-month clinical resultsJ. Benezet

17:43 Discussion and audience interaction17:48 Euro16A-OP0486 - Single centre all comers

registry for DEB angioplasty in de novolesionsA.A. Nuruddin





16:30 - 18:00ROOM 341

Cases

Difficult and alternative accessSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: A. CribierPanellists: J. Mehilli, G. Nickenig, C. Ruiz(awaiting confirmation)

16:30 A case of TAVI in a tortuous s-shaped aortaS. Liu

16:38 Discussion and audience interaction16:43 Challenges in TAVI: extreme obesity

K.N. Asrress (awaiting confirmation)16:51 Discussion and audience interaction16:56 Implantation of fully retrievable second

generation TAVI valve via subclavianaccessS. Khogali (awaiting confirmation)

17:04 Discussion and audience interaction17:09 Valve-in-valve implantation through

Brachiocephalic trunk for severe aorticparavalvular regurgitationP. Sbarzaglia (awaiting confirmation)

17:17 Discussion and audience interaction17:22 Direct aortic access and sheathless delivery

of fully retrievable second-generation TAVIdeviceS. Khogali (awaiting confirmation)

17:30 Discussion and audience interaction17:35 Transapical valve-in-valve TAVI in a patient

with two failing surgical bioprothesis withEdwards Sapien 3 valves using cerebralprotection systemA. Wolf

17:43 Discussion and audience interaction17:48 First transcarotid CoreValve Evolut R

implantationP. Sbarzaglia (awaiting confirmation)


16:30 - 18:00ROOM 342A

Plenary

STEMI and acute stroke:commonalities and dividesWith the collaboration of Stent for Life Initiative(SFL)Chairpersons: N. Hopkins, P. KalaPanellists: A. Bonafé, G. Olivecrona

Attend this session if you want:To discuss the best approach to STEMItreatment and organisation of careTo improve the quality of care ofpatients surviving the acute heartattackTo learn how acute ischaemic strokepatients can access to endovasculartreatment

16:30 Session objectivesP. Kala

16:35 Hot lines in STEMI treatmentF. Weidinger

16:43 Discussion and audience interaction16:55 Endovascular treatment for acute

ischaemic stroke: access to treatment inStent for Life Initiative countriesZ. Kaifoszova

17:03 Discussion and audience interaction17:15 Early secondary prevention after

myocardial infarction: Contract4LifeA. Abreu

17:23 Discussion and audience interaction17:35 Stent for Life Initiative achievements in

Europe and beyondZ. Kaifoszova


N. Hopkins




16:30 - 18:00ROOM 342B

Cases

Outcome after stenting: place ofOCTSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: G. GuagliumiPanellists: A. Al Shamsi, L. Kjoller-Hansen,A. Pichard

16:30 OCT-guided PCI with stenting of BRSin-stent restenosisS. Kasturi

16:38 Discussion and audience interaction16:43 Neoatherosclerotic plaque rupture

mimicking peri-stent aneurysm treated byself-expandable DESL. Paraggio

16:51 Discussion and audience interaction16:56 A case of acute stent recoil

V. Vizzi17:04 Discussion and audience interaction17:09 Differential healing with everolimus

W. Kristanto17:17 Discussion and audience interaction17:22 Early left main in-stent restenosis:

OCT-guided treatmentA. Di Giorgio

17:30 Discussion and audience interaction17:35 Optical frequency domain imaging

showed multiple inter-strut hollow ninemonths after very late stent thrombosis ineverolimus-eluting stent in bare-metalstent site treated with drug-coated balloonY. Kaetsu

17:43 Discussion and audience interaction17:48 OCT analysis of a restenotic

polytetrafluoroethylene-covered stentimplanted to treat a iatrogenic coronaryfistulaS. Nava


16:30 - 18:00ROOM 343

Abstracts

Novelties in interventional heartfailure managementSession comprising selected EuroPCR 2016abstract submissionsChairperson: J. BartunekPanellists: D. Burkhoff, N. Van Royen, W.Wojakowski

16:30 Euro16A-OP0048 - New transcathetertreatment of the dilated ischaemiccardiomyopathy with ReviventTM systemM. Hernández-Enríquez

16:38 Discussion and audience interaction16:43 Euro16A-OP0928 - Randomised,

double-blinded, placebo-controlled trial toassess the effects of intramyocardial bonemarrow (BM)-derived immunoselectedCD133+ cells on left ventricle perfusionand function assessed by single-photonemission CT (SPECT) and MRI in patientswith inducible ischaemia and refractoryangina (REGENT-VSEL)W. Wojakowski

16:51 Discussion and audience interaction16:56 Euro16A-OP1018 - Baseline

heamodynamic characteristics of patientsin the REDUCE elevated Left Atrial Pressurein patients with Heart Failure (REDUCELAP-HF) trialD. Burkhoff

17:04 Discussion and audience interaction17:09 Euro16A-OP0853 - Outcome after

implantation of a microaxial-flow pump inpatients with cardiogenic shockA. Schäfer

17:17 Discussion and audience interaction17:22 Euro16A-OP0565 - The perkat system: a

novel right heart assist device-first in vivodataD. Kretzschmar

17:30 Discussion and audience interaction17:35 Euro16A-OP0759 - First-in-man prolonged

pressure-controlled intermittent coronarysinus occlusion to treat refractory leftventricular dysfunction and ischaemiaM.B. Ancona (awaiting confirmation)

17:43 Discussion and audience interaction17:48 Euro16A-OP0923 - Effects on

haemodynamics and renal function of apercutaneous ventricular assist deviceF. Schersten





16:30 - 18:00ROOM 351

Abstracts

BRS, evolving technologies andapplicationsSession comprising selected EuroPCR 2016abstract submissionsChairperson: M. Abdel-WahabPanellists: V. Farooq, P. Kumar Sahoo(awaiting confirmation), E. Regar

16:30 Euro16A-OP0199 - Bench testingevaluation of a novel fully drug-elutingBRSN. Bullett

16:38 Discussion and audience interaction16:43 Euro16A-OP1014 - Early healing after

novolimus-eluting bioresorbable stentimplantation in treatment of coronarybifurcation lesions: the BIFSORB pilot studyE.N. Holck

16:51 Discussion and audience interaction16:56 Euro16A-OP0930 - Intra-individual

angiographic comparison ofeverolimus-eluting BRS and drug-elutingmetallic stentsD. Giacoppo

17:04 Discussion and audience interaction17:09 Euro16A-OP0402 - DESolve 150 vs.

DESolve 100: a comparison study usingOCTN. Boeder (awaiting confirmation)

17:17 Discussion and audience interaction17:22 Euro16A-OP0942 - Multicentre evaluation

of the novolimus-eluting, fully BRS:three-year clinical and imaging endpointsL. Morrison (awaiting confirmation)

17:30 Discussion and audience interaction17:35 Euro16A-OP0232 - Safety and clinical

performance of the drug-elutingabsorbable metal scaffold in the treatmentof subjects with de novo lesions in nativecoronary arteries at 12-month follow-upBIOSOLVE-IIM. Stieler (awaiting confirmation)

17:43 Discussion and audience interaction17:48 Euro16A-OP0044 - Initial results of the

FANTOM 1 trial: a first-in-man evaluation ofa novel, radiopaque sirolimus-eluting BRSJ.D.R. Costa Jr


16:30 - 18:00ROOM 352A

Complications

Moldova and Ukraine share theirmost educational cases:periprocedural complicationsduring PCIWith the collaboration of the Moldavian WorkingGroup of Interventional Cardiology and theUkrainian Association of Interventional Cardiology(UAIC)Chairpersons: M. Postu, M. Sokolov

Attend this session if you want:To identify lesion subsets that couldlead to possible complications and totry to prevent themTo be able to use the right tools andtechniques in complicated proceduresand discuss various managementstrategiesTo understand that good team work iscrucial in these particular situations

16:30 Session objectivesM. Postu

16:33 Case 1: emergency stent implantation assurvival strategy into heavy calcificationleft main lesion in patient with NSTEMI andcardiogenic shockI. Danylchuk

16:39 Discussion and audience interaction16:47 Case 2: rupture of the left circumflex artery

A. Surev16:53 Discussion and audience interaction17:01 Case 3: no-reflow syndrome, calcified

coronary artery and hemopericardium, leftventricular septum rupture - threeproblems, three lessons for the futureA. Krivchun

17:07 Discussion and audience interaction17:15 Case 4: distal left anterior descending

coronary artery rupture during PCI in apatient with STEMI presented at 12 hoursafter symptom onsetA. Grib

17:21 Discussion and audience interaction17:29 Case 5: unexpected left main artery

complication after coronary angiographyprocedureD. Sebov

17:35 Discussion and audience interaction17:43 Case 6: coronary dissection during primary

PCIE. Calenici


M. Sokolov




16:30 - 18:00ROOM 352B

How Should ITreat?

Portugal and Spain share theirmost educational cases:challenging vascular disease -degenerated mitro-aorticsurgical bio-prothesis and verysevere calcified aortic stenosisWith the collaboration of the PortugeseAssociation of Interventional Cardiology (APIC) and the Spanish Working Group on InterventionalCardiologyChairpersons: V. Gama Ribeiro (awaitingconfirmation), R. Hernandez Antolin

Attend this session if you want:To understand how to evaluate andapproach concomitant aortic andmitral diseaseTo learn how to treat very smalldegenerated bioprosthetic valvesTo share how to prevent and managerelatively frequent and seriouscomplications after TAVI

16:30 Session objectivesV. Gama Ribeiro (awaiting confirmation)

16:35 Case 1: degenerated aortic Mitroflow 19and mitral Carpentier-Edwards 31R. Teles

16:40 How would I treat the case?J.M. Hernandez

16:45 How would I treat the case?P. Canas Da Silva

16:50 How did I treat the case?R. Teles


R. Hernandez Antolin17:15 Case 2: unexpansion of a Portico

percutaneous valve inducing a lowimplantation in a patient with severenative valve calcificationM. Pan

17:20 How would I treat the case?P. Canas Da Silva

17:25 How would I treat the case?J.M. Hernandez

17:30 How did I treat the case?M. Pan


V. Gama Ribeiro (awaiting confirmation)17:55 Session evaluation and key learnings

R. Hernandez Antolin

16:30 - 18:00ROOM 353

Abstracts

Pulmonary embolismmanagement and aorticendovascular repairSession comprising selected EuroPCR 2016abstract submissionsChairperson: M.J. BosiersPanellists: P. Musialek (awaitingconfirmation), C. Nienaber (awaitingconfirmation), T. Zeller

16:30 Euro16A-OP0905 - High-risk pulmonaryembolism thrombectomy using 8Fr rightguiding coronary Judkins catheter (urgent,cheaper and feasible)L.E. Berumen Dominguez

16:38 Discussion and audience interaction16:43 Euro16A-OP0438 - Ultrasound-assisted

catheter-directed thrombolysis in high-riskand intermediate-high-risk pulmonaryembolism: a meta-analysisC. Kaymaz (awaiting confirmation)

16:51 Discussion and audience interaction16:56 Euro16A-OP0813 - Refined balloon

pulmonary angioplasty driven bycombined assessment of intra-arterialanatomy with IVUS / OCT and physiologywith pressure wire in patients withnon-operable distal chronicthromboembolic pulmonary hypertensionM. Roik

17:04 Discussion and audience interaction17:09 Euro16A-OP0538 - Stent repair for

interruption of the aortic arch in childrenand adults: immediate and follow-upfindingsJ. Suarez de Lezo

17:17 Discussion and audience interaction17:22 Euro16A-OP1045 - Endovascular treatment

for coarctation of the aorta, a four-yearexperience in one centreO. Millan Iturbe

17:30 Discussion and audience interaction17:35 Euro16A-OP0428 - New stent grafts for the

thoracic and thoracoabdominal segment:the valiant thoracoabdominal designP. Kelly

17:43 Discussion and audience interaction17:48 Euro16A-OP1087 - Complicated Type B

aortic dissection: case reportO. Gomez-Monterrosas





16:30 - 18:00ROOM

ARLEQUIN

Cases

Mitral paravalvular leak closureSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: E. GarciaPanellists: P. Chandra, H. Sievert, W.H.Yin

16:30 Percutaneous transcatheter closure ofprosthetic mitral paravalvular leakO. Millan Iturbe

16:39 Discussion and audience interaction16:45 Paravalvular leakage after mitral

valve-in-valve: what you need to expectD. Dvir

16:54 Discussion and audience interaction17:00 Concomitant percutaneous mitral

paravalvular leak closure and mitralvalve-in-valveD. Regazzoli (awaiting confirmation)

17:09 Discussion and audience interaction17:15 Large mitral valve leak initially treated

percutaneously to stabilise the patient thatgot fixed surgically in a second procedureL.L. Gheorghe

17:24 Discussion and audience interaction17:30 Failed attempt to occlude a large mitral

paravalvular leakageM. Neuss (awaiting confirmation)

17:39 Discussion and audience interaction17:45 An usual complication after percutaneous

closure of a mitral para-annular / valvularleakS. Fournier




Friday 20 May 2016 - Morning - Programme valid as of 12-04-2016

- 09:00 -09:00 - 10:30

THEATRE BLEUCBS@EuroPCR - Strategies forleft main coronary artery diseaseand complex bifurcation lesionsWith the collaboration of the Left Main andCoronary Bifurcation Summit (CBS) and the AsianBifurcation Club

Attend this session if you want:To understand stenting strategies forleft main coronary artery diseaseTo discuss the importance ofintravascular imaging modalites inguiding complex bifurcation stentingTo evaluate theadvantages/disadvantages of BRS forcomplex bifurcation lesions

09:00 - 10:30THEATRE

BORDEAUX

Cases

Complication ForumSession comprising selected EuroPCR 2016 clinicalcase submissionsChairpersons: E. Eeckhout, M. HaudePanellists: J. Belardi, S. Doucet (awaitingconfirmation), S. El Tobgi, A. Mehta(awaiting confirmation), G. Yucel

09:00 "All just a little bit of history repeating": acase of recurrent very late stentthrombosisD. Collison

09:08 Discussion and audience interaction09:13 Dual complications: coronary intramural

haematoma and stent migration09:21 Discussion and audience interaction09:26 Very late aneurysm formation after DES

implantationT. Ozawa

09:34 Discussion and audience interaction09:39 A giant haematoma in the left atrial wall: a

rare complication of PCIM.E. Ozpelit (awaiting confirmation)

09:47 Discussion and audience interaction09:52 Stent failure presenting as left main

occlusion and cardiogenic shockH.D. Mejia-Renteria

10:00 Discussion and audience interaction10:05 Percutaneous closure of iatrogenic VSD

after TAVIA.C. Garcia

10:13 Discussion and audience interaction10:18 Percutaneous retrieval of a dislodged LAA

occluderF. Colombo (awaiting confirmation)



Cases

Balloons and wires relatedcomplications during PCISession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: F. EberliPanellists: B.K. Koo, T. Mabin, A.J. Peace

09:00 Nightmare during balloon predilationB. Majumder

09:08 Discussion and audience interaction09:13 Unusual left main culotte

M.B. Ancona (awaiting confirmation)09:21 Discussion and audience interaction09:26 Unusual guide wire entrapment

W. Kehasukcharoen09:34 Discussion and audience interaction09:39 Jailed wire trapped: how can we manage?

B. Enany09:47 Discussion and audience interaction09:52 A case of an unravelling wire

I.J. Gudmundsdottir10:00 Discussion and audience interaction10:05 When wires don't behave!

W. Tassanawiwat10:13 Discussion and audience interaction10:18 Rotablation and broken wire with coronary

dissectionY.L. Cheng






FocusInnovation

Plenary

Transcatheter mitral valveimplantation: proof of conceptin human subjectsChairpersons: R. Kornowski, H.MoellmannPanellists: J. Hancock, T. Modine, B.Prendergast, D. Tchétché

Attend this session if you want:To become familiar with the newcatheter-based mitral valves that haveobtained proof of concept in human To understand the emergingindications, patients candidates andthe preparations needed fortranscatheter mitral valve implantationTo acknowlege initial clinical outcomesof transcatheter mitral valvereplacement

09:00 Session objectivesR. Kornowski

09:05 Clinical indications for transcatheter mitralvalve implantationA. Vahanian

09:17 Discussion and audience interaction09:25 Imaging assessment prior to transcatheter

mitral valve implantationR. Rajani

09:37 Discussion and audience interaction09:45 Transcatheter mitral valve implantation:

device and procedural overviewV. Bapat

09:57 Discussion and audience interaction10:05 Transcatheter mitral valve implantation:

early clinical outcomesI. Meredith


H. Moellmann

09:00 - 10:30ROOM

LEARNING

Learning STEMI: how to treat theculprit and non-culprit lesionsFacilitators: A. Banning, T. Cuisset, M. Noc

Attend this session if you want:To learn how to identify the culpritlesion in cases with multivesselpresentationTo understand how to investigateischaemia in non-culprit vesselsTo discuss the best managementstrategy for non-infarct related arteriesin STEMI

09:00 - 10:30ROOM TERNES 1

Cases

Endovascular options for renalinterventionsSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: F. RibichiniPanellists: B. Honton, M. Roffi, C.S. Su(awaiting confirmation)

09:00 Renal artery CTO recanalisation via radialartery accessZ. Ruzsa

09:08 Discussion and audience interaction09:13 No reflow during renal artery angioplasty

H. Abu-Hantash09:21 Discussion and audience interaction09:26 Bilateral renal artery occlusion: response to

percutaneous interventionR. Vijayvergiya

09:34 Discussion and audience interaction09:39 Percutaneous exclusion of giant renal

artery aneurysm with endoprosthesisC. Moncalvo

09:47 Discussion and audience interaction09:52 Percutaneus treatment of iatrogenic

postoperative arterio-venous (AV) fistulaZ. Stankov

10:00 Discussion and audience interaction10:05 Flash pulmonary oedema associated with

severe renal artery stenosis and solitaryfunctional kidney: impact of renal arteryangioplastyS. Moura-Ferreira

10:13 Discussion and audience interaction10:18 Improvement of resistant hypertension

following renal artery total occlusionrevascularisation





09:00 - 10:30ROOM TERNES 2

Cases

When perform a VSD closureSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: E. GarciaPanellists: M. Chopda (awaitingconfirmation), B.R. Kannan, H. Thiele

09:00 Percutaneous transcatheter closure ofsubaortic VSD

09:09 Discussion and audience interaction09:15 Percutaneous closure of VSD from a

gunshot woundM. Coello (awaiting confirmation)

09:24 Discussion and audience interaction09:30 Percutaneous closure of a iatrogenic VSD,

a rare complication after TAVIF. Del Furia

09:39 Discussion and audience interaction09:45 Simultaneous ventricular septal rupture

and cardiac free wall rupture followingacute myocardial infarction treated withrescue balloon closureJ. Zalewski

09:54 Discussion and audience interaction10:00 Percutaneous post-infarction VSD closure

S. Tarbine (awaiting confirmation)10:09 Discussion and audience interaction10:15 Focal right coronary sinus rupture with

fistula in right ventricular outflow tractafter TAVIM.B. Ancona (awaiting confirmation)


09:00 - 10:30ROOM 241

Abstracts

PCR's Got Talent - round 3Session comprising selected EuroPCR 2016abstract submissionsChairpersons: C. Di Mario, R. VirmaniJury Members: R. De Palma (awaitingconfirmation), S. Ewen, F. Fanelli(awaiting confirmation), M. Joner, G.Lutter, C. Setacci

09:00 - 10:30ROOM 242A

Abstracts

Percutaneous mitraledge-to-edge repair: outcome inselected subsets of patientsSession comprising selected EuroPCR 2016abstract submissionsChairperson: G. NickenigPanellists: D. Davidson (awaitingconfirmation), M.H. Pham, F. Praz(awaiting confirmation)

09:00 Euro16A-OP0495 - Interventionaltransvascular repair of the mitral valve isless successful in patients withregurgitation due to chordal ruptureM. Neuss (awaiting confirmation)

09:08 Discussion and audience interaction09:13 Euro16A-OP0100 - Tricuspid regurgitation

is a predictors of mortality after successfulMitraClipJ. Schofer

09:21 Discussion and audience interaction09:26 Euro16A-OP0406 - Comparison of

percutaneous mitral valve repair infunctional and degenerative mitral valveregurgitation using the Mitral ValveAcademic Research Consortium criteriaJ. Seeger

09:34 Discussion and audience interaction09:39 Euro16A-OP0746 - Acute ischaemic mitral

regurgitation: safety and efficacy ofMitraClip implantationM. Adamo

09:47 Discussion and audience interaction09:52 Euro16A-OP0036 - Novel procedure for

residual mitral regurgitation aftertranscatheter edge-to-edge mitral valverepair using occluder deviceS. Kubo

10:00 Discussion and audience interaction10:05 Euro16A-OP0774 - Effectiveness of

MitraClip therapy in patients withrefractory heart failureG. Bruschi

10:13 Discussion and audience interaction10:18 Euro16A-OP0951 - Transcatheter mitral

repair for radiation-induced mitralregurgitation: a case seriesN. Buzzatti





09:00 - 10:00ROOM 242B

Cases

BRS thrombosisSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: R. Waksman

09:00 BRS subacute thrombosis managed withthrombus aspiration and IIbIIIa inhibitorsN. Salvatella


H. Nef09:15 Neointimal coverage of BRS via coronary

angioscopy with late scaffolds thrombosisT. Nakayoshi (awaiting confirmation)


N.E.J. West09:30 Very late BRS thrombosis: an interplay of

factorsC. Jorge


D. Capodanno09:45 Not everything is what it seems...

M. Nobre Menezes09:53 Discussion and audience interaction09:58 Key learnings

H. Khamis

09:00 - 10:30ROOM 251


Professionals

Plenary

TAVI: what's new! Chairpersons: S. Griggio, P. LüttgeThomassenPanellists: M. De Ronde, M. Oberhoff

Attend this session if you want:To be updated on the newestgeneration of transcatheter aorticvalve typesTo learn about the nursing care duringinterventions under local / generalanaesthesiaTo assist in the prevention of TAVIprocedure-related complications

09:00 Session objectivesP. Lüttge Thomassen

09:05 Update on the new generation of aorticvalvesP. Jimenez-Quevedo

09:15 Discussion and audience interaction09:18 Key steps of the nursing care during a TAVI

procedure B. Wulff

Three clinical case complications:09:43 Vascular complications

J. Buhl Stentoft09:50 Discussion and audience interaction09:57 Heart perforation: pericardial

effusion/pericardial tamponadeF. Germinal

10:04 Discussion and audience interaction10:11 Valve embolisation

M. Lacueva10:18 Discussion and audience interaction10:25 Session evaluation and key learnings

S. Griggio

09:00 - 10:30ROOM 252A

Cases

Complex techniques, complexdecisionsSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: M. LesiakPanellists: M. Degertekin, L. Kalidoss(awaiting confirmation), O. Sakhov

08:30 Unusual presentation of an unusualcomplication after rescue angioplasty foracute myocardial infarctionS. Kubba

08:38 Discussion and audience interaction08:43 Direct scaffolding the culprit lesion

without predilatation during transradialprimary angioplastyT. Ghose

08:51 Discussion and audience interaction08:56 The use of DEB in STEMI patient with

unrecognised hypertrophiccardiomyopathyD. Nikolic

09:04 Discussion and audience interaction09:09 Complex bifurcation lesion in

antero-lateral STEMI after unsuccessfulthrombolysisG. Sitafidis

09:17 Discussion and audience interaction09:22 ACS with diffuse three-vessel disease

A.R.G. Francisco09:30 Discussion and audience interaction09:35 Rescue PCI of 100% left main on STEMI by

bilateral radial approachM. Vanegas

09:43 Discussion and audience interaction09:48 Primary PCI for inferior STEMI, triple vessel

disease, multiple CTO... what to do andwhat to leave?W. Elabbassi





09:00 - 10:30ROOM 252B

Abstracts

Contemporary DES: focus onbioresorbable polymers - part 2Session comprising selected EuroPCR 2016abstract submissionsChairperson: A. Lafont (awaitingconfirmation)Panellists: R. Byrne (awaitingconfirmation), S. Sathe (awaitingconfirmation), M. Vrolix

09:00 Euro16A-OP0540 - Safety and efficacy ofbiodegradable polymer DES inmanagement of patients with acute STEMI:MASTER study - one-year clinical outcomesS. Kedev


outcomes of thin struts biodegradablecoated sirolimus-eluting stents implantedin all-comers patient populationM. Jelonek (awaiting confirmation)

09:23 Discussion and audience interaction09:30 Euro16A-OP0279 - External validity of the

"all-comers" design: insights from theBIOSCIENCE trialA. Franzone

09:38 Discussion and audience interaction09:45 Euro16A-OP0278 - Angiographic

complexity of coronary artery diseaseaccording to SYNTAX score and clinicaloutcomes after revascularisation withnewer generation DES: a sub-study of theBIOSCIENCE trialA. Franzone

09:53 Discussion and audience interaction10:00 Euro16A-OP0448 - Biodegradable polymer

sirolimus-eluting stents vs. durablepolymer everolimus-eluting stents inpatients with STEMI: two-year follow-up ofthe BIOSCIENCE trialR. Piccolo

10:08 Discussion and audience interaction10:15 Euro16A-OP0926 - Multicentre,

prospective, randomised, single blind,consecutive enrollment evaluation anovolimus-eluting coronary stent systemwith bioabsorbable polymer compared toa zotarolimus-eluting coronary stentsystem: final long term (60-month) clinicalfollow-up from the EXCELLA BD studyL. Morrison (awaiting confirmation)


09:00 - 10:30ROOM 253

Abstracts

Application of BRS inchallenging anatomical subsetsSession comprising selected EuroPCR 2016abstract submissionsChairperson: A. BartorelliPanellists: S.R. Khan, H. Mehta

09:00 Euro16A-OP1024 - One-year outcomes ofthe use of BRS to treat long lesionsJ. Molina-Martin de Nicolas


following BRS implantation in small vesselsvs. large vesselsA. Tanaka

09:21 Discussion and audience interaction09:26 Euro16A-OP1036 - Full plastic jacket PCI

with everolimus-eluting BRS: results fromthe Italian multicentre RAI registryG. Masiero

09:34 Discussion and audience interaction09:39 Euro16A-OP0189 - One-year clinical

outcomes following BRS implantation fordiffuse coronary lesions: a sub-study fromthe GHOST-EU registryH. Kawamoto

09:47 Discussion and audience interaction09:52 Euro16A-OP1015 - Clinical outcomes of

BRS use in patients with small vs. largevessels coronary artery disease: resultsfrom the Italian multicentre RAI registryB. Cortese

10:00 Discussion and audience interaction10:05 Euro16A-OP0891 - Sealing spontaneous

coronary artery dissection with BRSimplantation: results on a cohort of 18patients from the RAI registryA. Ielasi


outcomes following BRS implantation forthe treatment of coronary in-stentrestenosis: an Italianmulticentre-experienceE. Moscarella





09:00 - 10:30ROOM 341

Abstracts

Conduction disturbances afterTAVI: predictiors and outcomeSession comprising selected EuroPCR 2016abstract submissionsChairperson: M. AbdelghaniPanellists: S. Chaudhury (awaitingconfirmation), A.S. Petronio, N. Trehan(awaiting confirmation)

09:00 Euro16A-OP0454 - Predictors ofpacemaker implantation with aself-expanding repositionabletranscatheter aortic valveI. Meredith

09:08 Discussion and audience interaction09:13 Euro16A-OP0536 - The fate of right bundle

branch block in TAVI: a multicentrecollaborationL. van Gils

09:21 Discussion and audience interaction09:26 Euro16A-OP0460 - Influence of calcium,

implantation depth and oversizing on theoccurrence of conduction disturbancesand need for pacemaker implantation afterimplantation of the balloon-expandableEdwards Sapien 3 valveB. Gonska

09:34 Discussion and audience interaction09:39 Euro16A-OP0537 - Aorto-mitral continuity

calcification predicts new pacemakerinsertion and new atrial fibrillation inpatients undergoing TAVIM. Spaziano

09:47 Discussion and audience interaction09:52 Euro16A-OP0695 - Comparison of new

pacemaker insertion rates between twogenerations of the balloon-expandabletranscatheter heart valveF. Sawaya

10:00 Discussion and audience interaction10:05 Euro16A-OP0441 - New permanent

pacemaker request with retrievable vs.non-retrievable self-expanding prosthesisin the TAVIJ. Roa-Garrido

10:13 Discussion and audience interaction10:18 Euro16A-OP0288 - Does the timing of

pacemaker implantation after TAVI affectcosts?S. Clancy


09:00 - 10:30ROOM 342A

Plenary

GRCI@EuroPCR - rotationalatherectomy: an old friendalways within your reachWith the collaboration of the Groupe de Réflexionsur la Cardiologie Interventionnelle (GRCI)Chairpersons: P. Aubry, J. MonseguPanellists: K. Boughalem, B. Livarek(awaiting confirmation)

Attend this session if you want:To understand the role of plaquedebulkingTo share experience on rotationalatherectomyTo learn how to prevent complications

09:00 EuroPCR welcomes GRCI M. Buchbinder

09:02 Session objectivesP. Aubry

09:05 Rational for primary and bailout rotationalatherectomyH. Benamer

09:13 Discussion and audience interaction09:25 Tips and tricks for a safe rotablation

C. Brasselet09:33 Discussion and audience interaction09:45 How to avoid and how to manage

complications with rotablation?G. Rangé

09:53 Discussion and audience interaction10:05 Present and future of the rotational

atherectomyB. Faurie


J. Monsegu




09:00 - 10:30ROOM 342B

Cases

How to manage an iatrogenicaortic dissection?Session comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: M. NtsekhePanellists: B. Goyal, A. Low

09:00 Aorto-ostial dissection of left maincoronary artery during primary PCIM. Hassan

09:08 Discussion and audience interaction09:13 A disastrous approach for the treatment of

simple right coronary artery stenosesC. Brenner

09:21 Discussion and audience interaction09:26 Retrograde aortic dissection after

rotational atherectomyD. Kaewkes

09:34 Discussion and audience interaction09:39 The spiral of evil

P. Canova (awaiting confirmation)09:47 Discussion and audience interaction09:52 Guide to disaster

K. Hassan10:00 Discussion and audience interaction10:05 Iatrogenic aortic dissection caused by

extracorporeal membrane oxygenatorarterial cannula and overcomed by a novelmethodJ. Lee

10:13 Discussion and audience interaction10:18 Nothing is simple at 33! Successfully

managing a series of complications /dissections in a single PCI procedureG. Katsimagklis


09:00 - 10:30ROOM 343

Cases

Stent deformation anddislodgementSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: P. L'AllierPanellists: K. Kadota, B.K. Kim, A. Yearoo

09:00 Vanished proximal left anterior descendingstentA. Mechery

09:09 Discussion and audience interaction09:15 An unusual complication of bifurcation PCI

H. Ben Ahmed09:24 Discussion and audience interaction09:30 Rescue retrieval of dislodged stent and

expanded stent in NSTEMIY.C. Huang (awaiting confirmation)

09:39 Discussion and audience interaction09:45 IVUS detection of a rare coronary stent

complicationC. Cigalini (awaiting confirmation)

09:54 Discussion and audience interaction10:00 The twisted metal demolition derby

R. Good10:09 Discussion and audience interaction10:15 Beware of the calcium in coronaries:

dehiscence of the stent shaft withsuccessful retrievalS. Sangaraju





09:00 - 10:30ROOM 351

Cases

Special tips and tricksSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: O. GoktekinPanellists: H.J. Büttner, D. Desai, M.Ochiai (awaiting confirmation)

09:00 CTO of an invisible left anterior descendingA. La Manna

09:08 Discussion and audience interaction09:13 Combined excimer laser and rotational

atherectomy - a "Raser" CTO caseM. Orzalkiewicz

09:21 Discussion and audience interaction09:26 Successful PCI for CTO lesion with

contralateral angiography using a single5Fr sheathless guiding catheterF. Yoshimachi

09:34 Discussion and audience interaction09:39 Jailed side branch under the dissection

after retrograde CTO revascularisationZ. Valuckiene

09:47 Discussion and audience interaction09:52 CT-guided PCI at stumpless left anterior

descending CTO, obscured by cross-overstent with very hard neointima of diagonalarteryS.M. Park (awaiting confirmation)

10:00 Discussion and audience interaction10:05 Retrograde left anterior

descending-CTO-recanalisation through aseptal side-branch and ping-pong cathetertechniqueS.A. Pyxaras

10:13 Discussion and audience interaction10:18 A step backward to move forward

S. Padhi10:26 Discussion and audience interaction

09:00 - 10:30ROOM 352A

Plenary

Gender bias in infarction: is it theend of the myth or not yet?With the collaboration of the EAPCI WomenCommitteeChairpersons: Y. Appelman, M.C. Morice(awaiting confirmation)Panellists: Z. Kaifoszova, F. Mauri, J.Mehilli

Attend this session if you want:To appreciate gender differences inoutcome after ACS and STEMITo learn about gender differences fordiagnosis and treatment of ACS inEuropeTo discuss how gender differences canbe overcome

09:00 Session objectivesY. Appelman

09:05 Higher mortality among young womenwith ACS - still true in France?S. Manzo-Silberman

09:13 Discussion and audience interaction09:25 Impact of gender gap in time-to-treatment

on mortality - lessons from UK and SwedenregistriesV. Kunadian

09:33 Discussion and audience interaction09:45 Impact of treatment strategy on gender

differences in STEMI outcomes - lessonsfrom Catalonia registryN. Salvatella

09:53 Discussion and audience interaction10:05 Gender differences in secondary

prevention among STEMI patients in theNetherlandsM. ten Haaf


M.C. Morice (awaiting confirmation)




09:00 - 10:30ROOM 352B

Cases

IVUS in the management of PCISession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: F. Alfonso ManterolaPanellists: H. Al Lawati, B.C. Kalmath(awaiting confirmation), D. Walters

09:00 Retrograde percutaneous recanalisation ofCTO of left anterior descending artery. Oneyear follow-up after sirolimus stents withIVUSS. Tarbine (awaiting confirmation)

09:08 Discussion and audience interaction09:13 Intramural haematoma caused by balloon

rupture in CTO coronary vesselsY.L. Cheng

09:21 Discussion and audience interaction09:26 Flush occlusion of the left anterior

descendingP. Tajti

09:34 Discussion and audience interaction09:39 IVUS / Crusade microcatheter-assisted

parallel wiring technique for a case withleft circumflex CTO

09:47 Discussion and audience interaction09:52 Stent deformation by intramural

haematoma in a patient with thecatheter-induced right coronary arterydissectionY. Antoku

10:00 Discussion and audience interaction10:05 From caesarean section to coronary

dissection: the use of multi-modalityimaging in the management ofpost-partum spontaneous coronary arterydissectionL. McClenaghan

10:13 Discussion and audience interaction10:18 Successful PCI in haemophilia patient with

acute myocardial infarctionS.M. Park (awaiting confirmation)


09:00 - 10:30ROOM 353

Abstracts

IVUS-guided therapies ofcoronary artery diseaseSession comprising selected EuroPCR 2016abstract submissionsChairperson: H. MudraPanellists: K. Al Faraidy (awaitingconfirmation), D. Dudek, H.M.Garcia-Garcia

09:00 Euro16A-OP0727 - The impact of coronaryplaque composition assessed byintegrated-backscatter IVUS on coronarycirculation improvement after PCIH. Ota

09:08 Discussion and audience interaction09:13 Euro16A-OP0625 - Do we need to image

more than the proximal left anteriordescending artery to detect early cardiacallograft vasculopathy with IVUS?V. Flore

09:21 Discussion and audience interaction09:26 Euro16A-OP0734 - Limitations of OCT in

identifying and quantifying lipidcomponents: an in vivo comparison studywith IVUS-near infrared spectroscopyL. Di Vito

09:34 Discussion and audience interaction09:39 Euro16A-OP0070 - IVUS predictors of

major adverse cardiovascular events afterimplantation of everolimus-eluting stentsfor long coronary lesionsS.Y. Lee

09:47 Discussion and audience interaction09:52 Euro16A-OP0947 - IVUS-guided DES

implantation: an updated meta-analysis ofrandomised control trialsA. Steinvil

10:00 Discussion and audience interaction10:05 Euro16A-OP0050 - Effect of ezetimibe in

combination with statins on coronaryplaque regression in patients aftercoronary stentingK. Sadamatsu

10:13 Discussion and audience interaction10:18 Euro16A-OP1001 - Changes of coronary

artery plaques phenotypes during lipidlowering therapy in diabetic vs.non-diabetic patients: study with 3D IVUSand virtual histologyT. Kovarnik





09:00 - 10:30ROOM

ARLEQUIN

Abstracts

New evidences forfemoropopliteal angioplastySession comprising selected EuroPCR 2016abstract submissionsChairperson: M.J. BosiersPanellists: Y. Goueffic (awaitingconfirmation), M.S. Mourali

09:00 Euro16A-OP0720 - Plaque modificationwith an orbital atherectomy systemenhances drug distribution in calcifiedperipheral arteriesA. Tzafriri

09:08 Discussion and audience interaction09:13 Euro16A-OP0234 - First clinical experience

with the Multi-LOC multiple stent deliverysystem for focal stenting infemoropopliteal lesionsK. Amendt (awaiting confirmation)


radial artery access for aortoiliac andfemoropopliteal lesion interventionsA. Roy

16:51 Discussion and audience interaction09:39 Euro16A-OP0796 - Long-term

anti-restenotic efficacy of drug-eluting vs.plain balloon angioplasty in patients withfemoropopliteal artery disease: an updatedfrequentist and Bayesian meta-analysisD. Giacoppo

09:47 Discussion and audience interaction09:52 Euro16A-OP0265 - Six-month results of a

global all-comers registry usingdrug-coated balloon in infra-inguinalartery disease

10:00 Discussion and audience interaction10:18 Euro16A-OP0848 - Paclitaxel

self-expanding stents demonstratefavorable one-year outcomes in simpleand complex superficial femoral arterylesionsA. Roy

10:13 Discussion and audience interaction10:05 Euro16A-OP0587 - Efficacy of a novel

fluoropolymer-coated paclitaxel-elutingperipheral stent in a familialhypercholesterolemic swine model ofballoon-injured femoral arteriesT. Zeller


- 10:00 -10:45 - 12:15

THEATRE BLEURotational atherectomy forchallenging casesChairpersons: E. Barbato, A. SerraPanellists: T. Mabin, A. Ong, F. Ribichini,G. Szabo (awaiting confirmation), H.C.Tan

Attend this session if you want:To learn how to perform rotationalatherectomy in challenging indicationscoronary lesionsTo prevent and/or managecomplications related to rotablationTo understand when to stop rotationalatherectomy

10:45 Session objectivesE. Barbato

10:50 How to prevent and deal withcomplications: burr lodging, wire and burrfracture, perforationA. De Belder


LIVE demonstrationJ. Wykrzykowska

11:10 LIVE demonstration from Contilia Heartand Vascular Cenre, Elisabeth Hospital -Essen, Germany


A. Serra




10:45 - 12:15THEATRE

BORDEAUX

Cases

Acute complications during PCISession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: F. WeidingerPanellists: J. Ezhilan, D. Pahlajani, L.Pathak

10:45 Complications - have we seen everythingyet?S. Surowiec

10:52 Discussion and audience interaction10:57 Osteal LAD PCI: precise stent position

matters!H. Gilhotra

11:04 Discussion and audience interaction11:09 Entrapment and fracture of a side branch

guidewire during PCI and DESimplantation of a bifurcation stenosisT. Butz

11:16 Discussion and audience interaction11:20 Iatrogenic guidewire-induced coronary

arteriovenous fistulaB. Lambert

11:27 Discussion and audience interaction11:31 Renal artery perforation, a rare

complication of primary PCI, successfullytreated by vascular plugN.Q. Nguyen

11:38 Discussion and audience interaction11:42 How to successfully treat iatrogenic left

main dissectionT. Satoh

11:49 Discussion and audience interaction11:53 A giant haematoma in the left atrial wall: a

rare complication of PCIM.E. Ozpelit (awaiting confirmation)

12:00 Discussion and audience interaction12:04 What are the true predictors and outcomes

of coronary perforation - an insight from acontemporary national registry?T. Kinnaird



Cases

TAVI complications - part 2Session comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: A. CribierPanellists: A. Linke (awaitingconfirmation), S. Roy (awaitingconfirmation), W.H. Yin

10:45 Disconnected nose-cone during TAVIW. Mattar

10:54 Discussion and audience interaction11:03 Dislocation of a fully recapturable

self-expandable TAVI complicated byprolonged sudden cardiac arrestL. Paraggio

11:12 Discussion and audience interaction11:21 Valve implantation in the false lumen after

iatrogenic aortic dissectionM. Taramasso

11:30 Discussion and audience interaction11:39 Ascending aorta dissection after right

coronary artery PCI and unsuccessful TAVI11:48 Discussion and audience interaction11:57 Bicuspid aortic valve stenosis: are we ready

to treat with TAVI?V. Voudris (awaiting confirmation)






FocusInnovation

Plenary

Innovations in CardiovascularInterventionsChairpersons: R. Beyar, C. LotanPanellists: A. Abizaid, O. Bertrand(awaiting confirmation), T. Brinton, J.Ormiston

Attend this session if you want:To understand the importance ofbiotechnical innovationsTo evaluate outstanding examples ofmedical innovations presented at ICI2015To discuss and understand unmetfuture needs in the cardiovasculararena

10:45 Introduction and objectivesR. Beyar

10:48 The ICI technology parade andpresentation of the ICI Innovation of theYear Award winner in 2015C. Lotan

10:58 DiACardio - winner of the 2015 ICIInnovation of the Year AwardH. Goldman-Aslan

11:06 Discussion and audience interaction11:09 The changing world of biomedical

innovation: the Digital RevolutionA. Segev

11:17 Discussion and audience interaction11:20 Implant-based non-invasive isolation of

the pulmonary veins: Fulgur Medical LtdG. Van Langenhove

11:28 Discussion and audience interaction11:31 Aortic arch endograft: the Endospan FIM

experienceD. Planer

11:39 Discussion and audience interaction11:42 Realview holographic display and interface

for medical imaging applicationsA. Kaufman (awaiting confirmation)

11:50 Discussion and audience interaction11:53 The interface between physician,

entrepreneur and bioengineer - What isneeded for innovation?R. Beyar

12:01 Discussion and audience interaction12:04 Future clinical needs in the cardiovascular

arena12:09 Discussion and audience interaction12:12 Session evaluation and key learnings

C. Lotan

10:45 - 12:15ROOM

LEARNING

Learning bioresorbable scaffoldsFacilitators: I. Al Rashdan, H. Nef, N.E.J.WestExpert panellist: A. Colombo

Attend this session if you want:To learn how to select the appropriatepatientTo understand the importance oflesion preparation, optimal techniquefor BRS implantation and to betterassess the role of imaging

10:45 - 12:15ROOM TERNES 1

Cases

Aortic coarctation managementSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: G. Torsello (awaitingconfirmation)Panellists: O. Al Shammeri, F.Y. Kuo

10:45 Challenging endovascular reconstructionof type A and B interrupted aortic archeswith one year follow-upK. Amber

10:53 Discussion and audience interaction10:58 Recanalisation of interrupted aortic

coarctation by below-the-knee CTOtechniqueM. Ostovan

11:06 Discussion and audience interaction11:11 Coarctation of aorta: self-expanding

stenting of aortic archS. Kasturi

11:19 Discussion and audience interaction11:24 A successful endovascular treatment of

isthmic total aortic coarctation in adultwoman?T. Umemoto

11:32 Discussion and audience interaction11:37 Thoracic endovascular aortic repair for

aortic transection in a twelve-year-oldmaleJ. Brooks (awaiting confirmation)

11:45 Discussion and audience interaction11:50 One year follow-up of the first ever

successful endovascular treatment of typeB aortic dissection in a childI. Petrov

11:58 Discussion and audience interaction11:03 Endovascular treatment of acute aortic

syndrome associated with spontaneousrenal artery dissectionO. Millan Iturbe





10:45 - 12:15ROOM TERNES 2

Cases

Transcatheter closure: a solutionfor some situationsSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: E. GarciaPanellists: H. Khamis, H. Thiele, R. TrilloNouche

10:45 3D-printed heart model to guide asuccessful left ventricular post-surgicalpseudoaneurysm percutaneous closureM. Stolcova

10:53 Discussion and audience interaction10:58 Alternative percutaneous technique for

closure of severely tortuous arteriovenouscollaterals using coronary stents and avascular plug - Successful treatment ofhaemoptysis in a complex congenital heartdisease patientM. Nassif

11:06 Discussion and audience interaction11:11 Percutaneous closure of ascending aorta

pseudoaneurysmK. Kalogeras

11:19 Discussion and audience interaction11:24 Transcatheter closure of patent ductus

arteriosus in interrupted left sided inferiorvena cava with hemiazygos continuation:subclavian venous approachS. Patra

11:32 Discussion and audience interaction11:37 Successful percutaneous closure of three

ASD with interlocking devices in an adultpatientO. Narayan

11:45 Discussion and audience interaction11:50 Percutaneous closure of iatrogenic VSD

after TAVIA.C. Garcia

11:58 Discussion and audience interaction12:03 A sword in the heart

D. Chin12:11 Discussion and audience interaction

10:45 - 12:15ROOM 241

Abstracts

Remainig issues in daily TAVIpracticeSession comprising selected EuroPCR 2016abstract submissionsChairperson: H. Baumgartner (awaitingconfirmation)Panellists: B. Hanif, T. Modine, S.Stortecky (awaiting confirmation)

10:45 Euro16A-OP0939 - IVUS vs. multidetectorCT for annular sizing during TAVID. Hakim

10:53 Discussion and audience interaction10:58 Euro16A-OP0409 - Impact of suture

mediated femoral access site closure withthe Prostar XL compared to the PercloseProGlide system on outcome in TAVIJ. Seeger

11:06 Discussion and audience interaction11:11 Euro16A-OP0033 - Predilatation prior to

TAVI: is it still a prerequisite?M. Pagnesi

11:19 Discussion and audience interaction11:24 Euro16A-OP0426 - Impact of renal

dysfunction on transcatheter aortic valvereplacement outcome in a largemulticentre cohortA. Levi (awaiting confirmation)

11:32 Discussion and audience interaction11:37 Euro16A-OP0509 - Long-term outcomes

following TAVI for severe aortic stenosis inelderly patients with a low left ventricularejection fraction: a single-centre registry of2.000 patients (TAVIK Register)P. Tzamalis

11:45 Discussion and audience interaction11:50 Euro16A-OP0307 - The impact of coronary

artery disease on survival after TAVIJ.M. Sinning

11:58 Discussion and audience interaction12:03 Euro16A-OP0997 - Percutaneous device

closure of paravalvular leak: combinedexperience from the United Kingdom andIrelandP. Calvert





10:45 - 12:15ROOM 242A

Cases

Complications during or afterPCISession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: J.F. TanguayPanellists: Z. Ghazzal, G. Musumeci, S.Rathnavel

10:45 STEMI responsible of stomach ulcer (to thecardiologist)N. Zaoui

10:53 Discussion and audience interaction11:00 Acute STEMI: when primary PCI is not

enough!T. Alkinani

11:08 Discussion and audience interaction11:15 Cardiac arrest following no-reflow during

primary PCI: a close saveD.K. Baruah

11:23 Discussion and audience interaction11:30 Sudden death within 20 minutes of a

successful multivessel angioplasty in anelderly male: what went wrong?S. Kubba

11:38 Discussion and audience interaction11:45 Friend or foe? In myocardial infarction

Y.C. Huang (awaiting confirmation)11:53 Discussion and audience interaction12:00 Coronary cameral fistula: a rare

complication post-myocardial infarctionD. Kodati (awaiting confirmation)


10:45 - 11:45ROOM 251

Focus ClinicalResearch andFocus Nurses

and AlliedProfessionals

I am a cathlab nurse / alliedprofessional. I would like to beinvolved in research and studies.What will be the challenges?

Attend this session if you want:To appreciate the opportunity andchallenges to be part of a researchteamTo learn from expert research nursesTo understand how to optimise yourworkflow as a research nurse / alliedprofessional

10:45 - 12:15ROOM 252A

Abstracts

Novel stents for diabeticcoronary diseaseSession comprising selected EuroPCR 2016abstract submissionsChairperson: C. SpauldingPanellists: M.A.K. Akanda, J. Mehilli, K.Punamiya

10:45 Euro16A-OP0729 - Impact of diabetesmellitus on the clinical outcomes afterdeployment of the abluminal sirolimuscoated bio-engineered stent in anall-comers registry at one year follow-upD. Kalkman

10:53 Discussion and audience interaction10:58 Euro16A-OP0204 - Impact of diabetic

status on outcomes followingrevascularisation with DES in relation tocoronary artery disease complexity: apatient-level pooled analysis of 6,081patientsK. Koskinas


outcomes in patients with diabetes treatedwith polymer-free sirolimus- andprobucol-eluting stents verses newgeneration zotarolimus-eluting stentsY. Harada

11:19 Discussion and audience interaction11:24 Euro16A-OP0401 - Two-year clinical

outcomes of a bioabsorbablepolymer-coated, everolimus-elutingcoronary stent in patients with diabetesI. Meredith (awaiting confirmation)

11:32 Discussion and audience interaction11:37 Euro16A-OP0160 - BIOFLOW-III satellite

Israeli diabetic prospective registry withthe ORSIRO sirolimus-eluting stent andcomprehensive diabetic care: one-yearclinical outcomesM. Stieler (awaiting confirmation)

11:45 Discussion and audience interaction11:50 Euro16A-OP0347 - One-year clinical

outcome of amphilimus polymer free DESin diabetes mellitus patients: insight fromthe ASTUTE registry (AmphilimuS iTalianmUlticenTer rEgistry)C. Godino

11:58 Discussion and audience interaction12:03 Euro16A-OP0518 - Clinical outcomes of

patients treated with a novel abluminalcoated sirolimus-eluting stent: an overallanalysis and a subgroup analysis from anall-comers en-ABL e-registryS. Dani





10:45 - 12:15ROOM 252B

Cases

TAVI in complex casesSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: D. TchétchéPanellists: P. Chandra, S.A. Pyxaras

10:45 Is it suitable for TAVI?J.L.K. Chan

10:53 Discussion and audience interaction10:58 Emergency TAVI in a dying heart

C.K.K. Kwok11:06 Discussion and audience interaction11:11 TAVI in depressed ventricular function with

low flow, low gradient aortic stenosisassisted with extracorporeal mebraneoxygenationJ. Quintanilla

11:19 Discussion and audience interaction11:24 Emergency TAVI for early and acute failure

of sutureless perceval aortic valveN. Bouhzam

11:32 Discussion and audience interaction11:37 Percutaneous implantation of

self-expandable aortic valve in a patientwith homozygous familialhypercholesterolemia, severe aorticstenosis and porcelain aortaS. Asil

11:45 Discussion and audience interaction11:50 Concomitant structural procedures: why

not?M. Taramasso

11:58 Discussion and audience interaction12:03 TAVI in a patient with severe aortic valve

stenosis, concomitant aortic rootaneurysm and aortic coarctationM. Mach


10:45 - 12:15ROOM 253

Cases

Intra-coronary thrombusmanagement during primary PCISession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: S. KhanPanellists: K. Al Faraidy (awaitingconfirmation), A. Yildirir (awaitingconfirmation)

10:45 Deferred stenting in NSTEMI with highthrombus burdenC. Camaro

10:53 Discussion and audience interaction11:00 Large refractory intracoronary thrombus

after systemic thrombolysis in a patientsuffering from STEMI: innovative solutionsfor an unresolved problemI.J. Amat-Santos

11:08 Discussion and audience interaction11:15 Treatment options for high thrombus

burden in a left anterior descendingA. Mechery

11:23 Discussion and audience interaction11:30 A young male with STEMI successfully

treated by lone manual thrombusaspirationM. Kodaira

11:38 Discussion and audience interaction11:45 Catch me if you can

N. Salvatella11:53 Discussion and audience interaction12:00 Your best friend can be your worst enemy

S.F. Chui12:08 Discussion and audience interaction




10:45 - 12:15ROOM 341

Cases

Complications that you mayavoidSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: O. GaemperliPanellists: I.H. Chae (awaitingconfirmation), G. Sianos, H. Warda

10:45 When dealing with CTO, be prepared thateverything can happenM. Terlecki (awaiting confirmation)

10:53 Discussion and audience interaction10:58 Nightmare of CTO treatment: importance

of confirmation of wire position by IVUSY. Kinoshita

11:06 Discussion and audience interaction11:11 Endless case: the best of the worst

W. Ammar (awaiting confirmation)11:19 Discussion and audience interaction11:24 PCI to CTO of left circumflex artery

complicated by coronary perforationS. Sangaraju

11:32 Discussion and audience interaction11:37 Contained coronary rupture post-BRS

implantationH. Kawamoto

11:45 Discussion and audience interaction11:50 Periprocedural complication during

retrograde CTO PCIP. Tajti

11:58 Discussion and audience interaction12:03 Septal perforation complicating retrograde

CTO revascularisation: have you ever seenworse?M. Boukhris


10:45 - 12:15ROOM 342A

Plenary

WCCI@EuroPCR - BRS: a journeyfrom present to the futureWith the collaboration of the Warsaw Course onCardiovascular Interventions (WCCI)Chairpersons: H. Amin, R.J. GilPanellists: E. Khedi, A. Witkowski

Attend this session if you want:To learn about the use of BRS indifferent clinical scenariosTo understand the role of intravascularimaging in guidance of BRSimplantationTo share current experience with newmetallic BRS

10:45 EuroPCR welcomes WCCIH. Amin

10:47 Session objectivesR.J. Gil

10:50 BRS in acute coronary syndromeD. Dudek

10:58 Discussion and audience interaction11:10 How and when to use OCT to guide BRS

deploymentF. Prati

11:18 Discussion and audience interaction11:30 Complex coronary interventions with BRS -

are we ready today?M. Lesiak

11:38 Discussion and audience interaction11:50 Current status of metallic BRS

M. Haude11:58 Discussion and audience interaction12:10 Session evaluation and key learnings

A. Witkowski




10:45 - 12:15ROOM 342B

Cases

Dissections during PCISession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: J. WöhrlePanellists: B.C. Kalmath (awaitingconfirmation), H. Kelbaek (awaitingconfirmation), A.G. Osiev

10:45 Catheter-induced spiral disection of theleft system during diagnostic coronaryangiographyA. Mirza

10:53 Discussion and audience interaction10:58 Plugging the hole: an unconventional

approach to treating coronary arteryperforationC. McQuillan

11:06 Discussion and audience interaction11:11 Edge dissection presenting 2 hours

post-angioplastyK. Sandhu

11:19 Discussion and audience interaction11:24 The iatrogenic left main and left

descending artery during plannedcoronary angiography via the righttransradial approachM. Swierad (awaiting confirmation)

11:32 Discussion and audience interaction11:37 Unfrequent PCI complication in severily

tortuous vessels A. Furukawa

11:45 Discussion and audience interaction11:50 Unusual cause of left main dissection:

acute treatment strategy?S. Matiullah (awaiting confirmation)

11:58 Discussion and audience interaction12:03 A "spider" in the cathlab...

B. Brochado12:11 Discussion and audience interaction

10:45 - 12:15ROOM 343

Cases

When "lumen to lumen"approach is not possibleSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: H.J. BüttnerPanellists: S.R. Khan, G. Navasundi(awaiting confirmation), S. Rinfret

10:45 Plaque modification helps in CTOD. Kumar

10:54 Discussion and audience interaction11:00 Unconventional view help in wiring the

right lumen in difficult left anteriordescending CTOS. Banerjee

11:09 Discussion and audience interaction11:15 Antegrade dissection reentry for CTO right

coronary arteryH. Shaalan

11:24 Discussion and audience interaction11:30 What if you can't stick or move the

proximal cap of left anterior descendingCTO?S. Mansour

11:39 Discussion and audience interaction11:45 How to prepare to open the CTO in patient

with chronic kidney disease and previousfailure attemptM. Terlecki (awaiting confirmation)

11:54 Discussion and audience interaction12:00 PCI for CTO implanted BRS

S. Hosogi12:09 Discussion and audience interaction




10:45 - 12:15ROOM 351

Cases

Very complexSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: M. Ochiai (awaitingconfirmation)Panellists: V. Aytekin, B.K. Kim, J. Spratt(awaiting confirmation)

10:45 Successfully managing CTO... only todiscover a "hidden" bifurcation lesionA. Mastrokostopoulos

10:54 Discussion and audience interaction11:00 Solving problems with high-risk CTO

A. Kristensen11:09 Discussion and audience interaction11:15 The retrograde ultimatum. Angioplasty of

a ostial flush occlusion / CTO of a venousgraft via a heavily calcified and tortuousnative vesselH.K. Bali (awaiting confirmation)

11:24 Discussion and audience interaction11:30 Reverse controlled antegrade and

retrograde subintimal tracking (CART) forCTO - "Never say never again"T. Hussain (awaiting confirmation)

11:39 Discussion and audience interaction11:45 Retrograde left anterior descending ostial

CTO: when an already complex procedureturns out to be even more complex!T. Alkinani

11:54 Discussion and audience interaction12:00 Anatomical mimicking misleads diagonal

stenting as left anterior descending indistal left anterior descending CTOS. Banerjee


10:45 - 11:45ROOM 352A

FocusInnovation

Plenary

Will PARTNER II change mypractice?Chairpersons: H. Eltchaninoff, L.Sondergaard


10:45 Introduction - the trial headlinesH. Eltchaninoff

10:50 A representative case from the study: howshould I treat?R. Makkar


11:00 What was known before Partner II?P. MacCarthy

11:10 Trial(ist) review: methods, results,conclusionsB. Prendergast


11:30 Case conclusion: how does this apply tomy practice?R. Makkar


L. Sondergaard




10:45 - 12:15ROOM 352B

Cases

How to deal with aneurysmsafter stent implantation?Session comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: H. PereiraPanellists: O. Al Baghal (awaitingconfirmation), M. Loutfi, A. Ochala

10:45 Coronary artery aneurysm formationfollowing a stent post-dilatationA. Hailan

10:53 Discussion and audience interaction10:58 How to overcome the aneurysm, fracture

and in-stent restenosis with transradialapproach?J.H. Heo

11:06 Discussion and audience interaction11:11 Pseudoaneurysm after DES implantation

B.U.A. Gill11:19 Discussion and audience interaction11:24 Very late aneurysm formation after DES

implantationT. Ozawa

11:32 Discussion and audience interaction11:37 Coronary pseudoaneurysm after CTO

angioplasty: IVUS findings andmanagementN. Ben Mansour

11:45 Discussion and audience interaction11:50 A case of iatrogenically-induced coronary

artery aneurysm after DES insertionR.Y. Lim

11:58 Discussion and audience interaction12:03 Giant coronary artery aneurysm after

implantation of DES: clinical dilemma andmanagementD.K. Baruah


10:45 - 12:15ROOM 353

Cases

Mitral, aortic, tricuspidparavalvular leak closureSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: E. EeckhoutPanellists: J. Goicolea (awaitingconfirmation), S. Venkatesh (awaitingconfirmation)

10:45 Minimally invasive transradialpercutaneous closure of aorticparavalvular leaks: following the steps ofPCIG. Giacchi

10:53 Discussion and audience interaction10:58 Transradial paravalvular leak closure 3

years after successful transapical TAVIusing Amplatzer vascular plug IIIA. Assali (awaiting confirmation)

11:06 Discussion and audience interaction11:11 Self-expandable TAVI to treat paravalvular

regurgitation of a balloon-expandablevalveG. Bruschi

11:19 Discussion and audience interaction11:24 Large tricuspid paravalvular leak:

percutaneous closure using two muscularVSD occludersR. Anantharaman

11:32 Discussion and audience interaction11:37 Complete percutaneous valvular

reconstructionE. Karacop

11:45 Discussion and audience interaction11:50 Simultaneous closure of a perivalvular

bioprothesis mitral leak and ASDJ. Palazuelos

11:58 Discussion and audience interaction12:03 Angioplasty for paravalvular leak closure

C.K.K. Kwok12:11 Discussion and audience interaction




10:45 - 12:15ROOM

ARLEQUIN

Cases

FFR in complex situationSession comprising selected EuroPCR 2016 clinicalcase submissionsChairperson: M. BalghithPanellists: N. Amabile, B.K. Koo, A.Rajagopal (awaiting confirmation)

10:45 Out-of-hospital cardiac arrest in a patientwith a total occlusion of the left anteriordescending protected by large collateralformationG. Wijntjens

10:53 Discussion and audience interaction10:58 Dedicated self-expandable bifurcation DES

for the left main and retrograde rightcoronary artery CTO reopening throughright mammary artery: IVUS and FFR (withmicrocatheter) guided procedureF. Fouladvand

11:06 Discussion and audience interaction11:11 A complex left main and left anterior

descending / D1 bifurcation stenting casewith IVUS and FFR guidanceJ.J. Zhang

11:19 Discussion and audience interaction11:24 Treatment modification in complex left

main bifurcation stenosisP. Dingli

11:32 Discussion and audience interaction11:37 Acute myocardial infarction due to left

anterior descending occlusion in patientwith well collateralised CTO of leftcircumflex and right coronary artery: do weneed complete revascularisation?M. Araya

11:45 Discussion and audience interaction11:50 FFR-guided PCI in non-culprit vessels

post-STEMI: is the functional assessmentreliable?L. Leite

11:58 Discussion and audience interaction12:03 Does Tako-Tsubo cardiomyopathy affect

FFR?A. Ferrara


- 11:00 -11:45 - 12:15

ROOM 251


Professionals

Ceremony

Nurses and Allied ProfessionalsBest Abstract and Clinical Casepresentation Award - closingceremonyPanellists: M. Gilard, M. Oberhoff

11:45 Session objectivesS. Griggio

11:47 EuroPCR 2016 Nurses and AlliedProfessionals Best Abstract and CinicalCase announcementD. Zughaft

12:13 Closing the EuroPCR 2016 Nurses andAllied Professionals programmeL. Kloevgaard

valid as of 12 april 2016 - НП "Здоровое...

Documents